drug_name,condition,condition_id,label,smiles,lookup
GADOTERIDOL,cancer (localized),8,0,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,direct
Tegretol,increased intraocular pressure,927,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Loxapine,sepsis,17,0,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,direct
midazolam,hypersensitivity,313,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
penicillamine,chronic obstructive pulmonary disease (COPD),6,0,[H][C@](N)(C(O)=O)C(C)(C)S,direct
HYDROCODONE/APAP,chronic overdose,698,1,CC(=O)NC1=CC=C(O)C=C1,direct
vilazodone,sepsis,17,0,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,direct
Ketorocaine LM Kit,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Foscavir,liver cirrhosis,4,0,OC(=O)P(O)(O)=O,direct
Varenicline,liver disease (non-cirrhotic),20,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
PrednisoLONE,mental illness,14,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
LISINOPRIL AND HYDROCHLOROTHIAZIDE,renal artery stenosis,1209,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Galantamine Hydrobromide,sepsis,17,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
Rapivab,diabetes mellitus,5,0,[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O,direct
YONSA,metastatic crpc who,998,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Zafirlukast,renal failure,19,0,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,direct
Timoptic,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Corvert,sepsis,17,0,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Estradiol Vaginal Cream,autoimmune disease,15,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Foscavir,chronic obstructive pulmonary disease (COPD),6,0,OC(=O)P(O)(O)=O,direct
MEXILETINE HYDROCHLORIDE,sepsis,17,0,CC(N)COC1=C(C)C=CC=C1C,direct
Esterified Estrogens and Methyltestosterone,renal failure,19,0,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3,direct
XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE),autoimmune disease,15,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
SPORANOX,hypersensitivity,313,1,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Brimonidine tartrate and Timolol maleate,congestive heart failure,2,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
INVANZ,hypersensitivity,313,1,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Pitavastatin,cancer (localized),8,0,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
PANTOPRAZOLE SODIUM,myocardial infarction,1,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Chloroquine Phosphate,congestive heart failure,2,0,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,direct
PROMETHAZINE DM,depression,27,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
cephalexin,hypersensitivity,313,1,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
Pravastatin Sodium,stroke,51,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Esomeprazole Sodium,liver cirrhosis,4,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
BUPROPION HYDROCHLORIDE,severe hepatic cirrhosis,1243,1,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Dutasteride,prostate cancer,265,1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)NC1=CC(=CC=C1C(F)(F)F)C(F)(F)F,direct
LOTRONEX,asthma,12,0,CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2,direct
Toronova SUIK,hypersensitivity,313,1,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Clomiphene Citrate,liver cirrhosis,4,0,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
Nabumetone,impaired renal function,919,1,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
CARTIA XT,myocardial infarction,49,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
prochlorperazine maleate,previous brain damage,1166,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
BOSULIF,severe infection,18,0,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,direct
NITROGLYCERIN,these conditions,1310,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Betoptic S,shock,419,1,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
Rozlytrek,AIDS,10,0,CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1,direct
Haloperidol Lactate,dementia,7,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
ETHACRYNATE SODIUM,hypokalemia,133,1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
fluconazole,chronic kidney disease,3,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
PREDNISONE,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Demser,arrhythmia,43,1,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,direct
Metolazone,hypertension,11,0,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,direct
Paclitaxel protein-bound particles for injectable suspension (albumin-bound),neutropenia,85,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Stendra,cancer (localized),8,0,COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1,direct
RAPAFLO,cancer (localized),8,0,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,direct
ETHOSUXIMIDE,hypersensitivity,313,1,CCC1(C)CC(=O)NC1=O,direct
nystatin,liver disease (non-cirrhotic),20,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Tetracaine Hydrochloride,cancer (metastatic),9,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
propranolol hydrochloride,angina pectoris,596,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Tizanidine,myocardial infarction,1,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
TOLMETIN SODIUM,hypersensitivity,313,1,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,direct
Busulfan,stroke,7,0,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
DEFINITY RT,pediatric patients,13,1,FC(F)(F)C(F)(F)C(F)(F)F,direct
Topotecan hydrochloride,diabetes mellitus,5,0,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
Diflorasone Diacetate,severe infection,18,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Midazolam,sepsis,17,0,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
DEXAMETHASONE SODIUM PHOSPHATE,unexplained diarrhea,1341,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Acetaminophen And Codeine,cancer (localized),8,0,CC(=O)NC1=CC=C(O)C=C1,direct
Azasan,ra appears to,1196,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Indomethacin,congestive heart failure,2,0,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,direct
Doxycyclate Hyclate,liver disease (non-cirrhotic),20,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Ketorolac Tromethamine,the aspirin triad,1295,1,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Diclofenac Sodium Delayed Release Delayed Release,hypersensitivity,313,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution,chronic obstructive pulmonary disease (COPD),6,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Deferasirox,high-risk mds,865,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Atenolol,untreated pheochromocytoma,1345,1,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,direct
Lacosamide Oral Solution,partial-onset seizures who,1108,1,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
PARSABIV,anemia,13,0,C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O)C(=O)N[C@H](CCCNC(N)=N)C(N)=O,direct
Nortriptyline Hydrochloride,depressive symptoms,769,1,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
ACETYLCYSTEINE,hypersensitivity,313,1,CC(=O)N[C@@H](CS)C(O)=O,direct
Venlafaxine Hydrochloride,asthma,12,0,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
Isosorbide,myocardial infarction,49,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
Imatinib,chronic kidney disease,3,0,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Pitavastatin,chronic obstructive pulmonary disease (COPD),6,0,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
Epirubicin Hydrochloride,early breast cancer,785,1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
FUROSEMIDE,hypersensitivity,313,1,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O,direct
Fluvastatin Sodium,chd who,682,1,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,direct
Flecainide Acetate,arrhythmia,43,1,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1,direct
VARENICLINE,cancer (metastatic),9,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Dexamethasone sodium phosphate,cerebral malaria,674,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
INPEFA,anemia,13,0,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)C=C1,direct
EVOMELA,multiple myeloma,1024,1,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Pemetrexed,mpm who,1020,1,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
zoledronic acid,underlying risk factors,1340,1,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
Thermazene Silver Sulfadiazine,renal failure,19,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
Cefuroxime Axetil,liver cirrhosis,4,0,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,direct
sevelamer hydrochloride,bowel obstruction,641,1,NCC=C.ClCC1CO1,direct
Pantoprazole sodium delayed-release,hypersensitivity,313,1,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
BRINZOLAMIDE,glaucoma,481,1,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
XYOSTED,chronic kidney disease,3,0,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Rosuvastatin calcium,hypersensitivity,313,1,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Brimonidine tartrate,glaucoma,481,1,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
"Carbidopa Tablets, 25 mg",narrow-angle glaucoma,1030,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
LEVALBUTEROL,mental illness,14,0,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
Topotecan hydrochloride,cancer (metastatic),9,0,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
haloperidol,sepsis,17,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Cladribine,neutropenia,85,1,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
PEMAZYRE,advanced malignancies,563,1,CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F,direct
Hydroxychloroquine Sulfate,mental illness,14,0,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
Histamine Positive Skin Test Control,bronchial hyperactivity,651,1,NCCC1=CNC=N1,direct
Vancomycin Hydrochloride,mental illness,14,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
SUCCINYLCHOLINE CHLORIDE,hypersensitivity,313,1,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,direct
Melphalan,anemia,13,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
LISDEXAMFETAMINE DIMESYLATE,renal failure,19,0,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
E-Z-Paste,cancer (localized),8,0,[Ba++].[O-]S([O-])(=O)=O,direct
MEMANTINE HYDROCHLORIDE,hypertension,11,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Asclera,acute thromboembolic diseases,555,1,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,direct
MIDAZOLAM,liver cirrhosis,4,0,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
CHANTIX,hypersensitivity,313,1,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
PROPAFENONE HYDROCHLORIDE,anemia,13,0,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,direct
CELEBREX,liver disease (non-cirrhotic),20,0,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
Oxaliplatin,colon cancer,734,1,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,direct
Methyldopa,hypertension,11,0,C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O,direct
SOMATULINE DEPOT,hypersensitivity,313,1,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],direct
Zolpidem tartrate sublingual,hypersensitivity,313,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Methylene blue,AIDS,10,0,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,direct
Pemfexy,autoimmune disease,15,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
Potassium Chloride ER,hyperkalemia,131,1,[Cl-].[K+],direct
BIVALIRUDIN,chronic kidney disease,3,0,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,direct
NITRO-BID,congestive heart failure,41,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Methylprednisolone acetate,stroke,7,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Clomipramine Hydrochloride,severe infection,18,0,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
Doxorubicin Hydrochloride,cancer (localized),8,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
METHYLPREDNISOLONE,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
ASENAPINE,bipolar mania,634,1,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
PRENATE Enhance,chronic kidney disease,3,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Acetaminophen,hypersensitivity,313,1,CC(=O)NC1=CC=C(O)C=C1,direct
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE,hypersensitivity,313,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Neoral,hypersensitivity,313,1,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Sitagliptin and Metformin Hydrochloride,AIDS,10,0,CN(C)C(=N)NC(N)=N,fuzzy:saxagliptin and metformin hydrochloride
CYSTEINE HYDROCHLORIDE,cancer (metastatic),9,0,N[C@@H](CS)C(O)=O,direct
Folditam,sepsis,17,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Febuxostat,hyperuricemia and gout,900,1,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
KENALOG-40,diabetes mellitus,5,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Testosterone Cypionate,cancer (metastatic),9,0,[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Brimonidine tartrate and Timolol maleate,asthma,193,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
APREMILAST,plaque psoriasis who,1129,1,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,direct
Bisoprolol Fumarate and Hydrochlorothiazide,myocardial infarction,1,0,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,direct
Gloperba,liver cirrhosis,4,0,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Esomeprazole sodium,hypersensitivity,313,1,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Levobunolol Hydrochloride,glaucoma,481,1,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCCC2=O,direct
TERIFLUNOMIDE,renal failure,19,0,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
ALFA 0.9% SODIUM CHLORIDE,stroke,7,0,[Na+].[Cl-],fuzzy:0.9% sodium chloride
cinacalcet hydrochloride,ckd who,716,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Rifabutin,chronic kidney disease,3,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21,direct
Coreg CR,shock,419,1,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
OPFOLDA,myocardial infarction,1,0,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,direct
Hydroxyzine Hydrochloride,cancer (localized),8,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Davimet,chronic kidney disease,3,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
APREMILAST,hypertension,11,0,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,direct
Rezurock,severe infection,18,0,CC(C)NC(=O)COC1=CC=CC(=C1)C1=NC2=C(C=CC=C2)C(NC2=CC=C3NN=CC3=C2)=N1,direct
Oxcarbazepine,anxiety,19,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Gastrografin,renal failure,19,0,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Omlonti,hypertension,39,1,CC(C)OC(=O)CNC1=CC=CC(CN(CC2=CC=C(C=C2)N2C=CC=N2)S(=O)(=O)C2=CC=CN=C2)=N1,direct
Nystatin Topical Powder,renal failure,19,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Sulfamethoxazole and Trimethoprim DS,chronic kidney disease,3,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Prenate Elite,anemia,13,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Sulfamethoxazole and Trimethoprim DS,diabetes mellitus,5,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
spironolactone,the following conditions,1301,1,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
PROMETHAZINE DM,bone marrow depression,637,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Atomoxetine,diabetes mellitus,5,0,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
Monoferric,iron deficiency,405,1,[Fe+3].OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O,direct
SELEGILINE HYDROCHLORIDE,myocardial infarction,1,0,C[C@H](CC1=CC=CC=C1)N(C)CC#C,direct
FARXIGA,pregnancy,16,0,CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1,direct
Tizanidine HCL,multiple sclerosis,153,1,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Cleviprex,asthma,12,0,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,direct
Rivaroxaban,atrial fibrillation,65,1,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,direct
Synjardy,mental illness,14,0,CN(C)C(=N)NC(N)=N,direct
HydrOXYzine Hydrochloride,renal failure,19,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Voriconazole,pregnancy,16,0,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
cinacalcet hydrochloride,these symptoms,1314,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Aldactone,cancer (localized),8,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
LIDOCAINE HCl AND EPINEPHRINE,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
sorafenib,rcc or hcc,1198,1,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
Acular,hypersensitivity,313,1,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Pyridostigmine Bromide,autoimmune disease,15,0,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
SINEMET,hypertension,11,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
DermacinRx Purefoltin,autoimmune disease,15,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
PIOGLITAZONE HYDROCHLORIDE,chronic kidney disease,3,0,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
Nilutamide,severe infection,18,0,CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,direct
Albendazole 200 mg,hypersensitivity,313,1,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,direct
Brinzolamide,stroke,7,0,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Imipramine Pamoate,AIDS,10,0,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
CARBAMAZEPINE,depression,27,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Clomid,liver disease (non-cirrhotic),20,0,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
Alvesco,sepsis,17,0,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,direct
Esomeprazole Magnesium DR,congestive heart failure,2,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Deferoxamine mesylate,stroke,7,0,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
Trisenox,hypersensitivity to arsenic,883,1,O=[As]O[As]=O,direct
BRIMONIDINE TARTRATE,glaucoma,481,1,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Glycopyrrolate,ileostomyor colostomy,911,1,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
Dorzolamide HCl,glaucoma,481,1,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Positive Skin Test Control - Histamine,myocardial infarction,1,0,NCCC1=CNC=N1,direct
clofarabine,sepsis,17,0,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,direct
Tolectin,renal failure,19,0,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,fuzzy:tolmetin
TARCEVA,chronic obstructive pulmonary disease (COPD),6,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
Cevimeline,autoimmune disease,15,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
Lyrica CR,chronic kidney disease,3,0,CC(C)C[C@H](CN)CC(O)=O,direct
RELAFEN DS,severe infection,18,0,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
TRIESENCE,chronic kidney disease,3,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
CLONAZEPAM,renal failure,19,0,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,direct
ZEVTERA,hypokalemia,133,1,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCN(C1)C(=O)OCC1=C(C)OC(=O)O1,direct
Atovaquone and Proguanil Hydrochloride Pediatric,malaria,305,1,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,direct
Livalo,primary hyperlipidemia,1175,1,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
MultiHance,pregnancy,16,0,[Gd+3].OC(=O)CN(CCN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)C(COCC1=CC=CC=C1)C(O)=O,direct
FIRVANQ,hypersensitivity,313,1,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
"PredniSONE Tablets, USP, 20 mg",mental illness,14,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Sulfamethox-TMP DS,hypersensitivity,313,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Alclometasone dipropionate,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])[C@H](Cl)CC2=CC(=O)C=C[C@]12C,direct
DILTIAZEM HCI,congestive heart failure,2,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Fluocinonide Cream,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,direct
THEOPHYLLINE,cancer (metastatic),9,0,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
budesonide,anemia,13,0,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Plenvu,mild renal impairment,1010,1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Melphalan,renal damage,1210,1,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
CHLORTHALIDONE,chronic kidney disease,3,0,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
DOXERCALCIFEROL,chronic kidney disease,3,0,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
CIDOFOVIR DIHYDRATE,cmv retinitis,731,1,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,direct
Pregabalin Extended Release,autoimmune disease,15,0,CC(C)C[C@H](CN)CC(O)=O,direct
CLOBAZAM,sepsis,17,0,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,direct
bortezomib,anorexia,399,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
BOSULIF,AIDS,10,0,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,direct
CIPRODEX,congestive heart failure,2,0,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,direct
valsartan,liver disease (non-cirrhotic),20,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Galantamine hydrobromide,hypersensitivity,313,1,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
TOLCAPONE,dystonia,461,1,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,direct
ezetimibe,hypersensitivity,313,1,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
Nystatin Topical Powder,hypersensitivity,313,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Bexagliflozin,diabetes mellitus,111,1,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(OCCOC3CC3)C=C2)=C1,direct
Ativan,pregnancy,16,0,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,direct
Trijardy XR,stroke,7,0,CN(C)C(=N)NC(N)=N,direct
PNV-DHA,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Sotalol,hypertension,11,0,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Adenosine,sepsis,17,0,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
NIFEDIPINE,hypersensitivity,313,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Daunorubicin Hydrochloride,cancer (metastatic),9,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,direct
Heparin Sodium in Dextrose,chronic kidney disease,3,0,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C=O,direct
Amphetamine Sulfate,chronic kidney disease,3,0,CC(N)CC1=CC=CC=C1,direct
spironolactone,primary hyperaldosteronism,1174,1,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
Imipramine Hydrochloride,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
LANOXIN,pediatric patients,13,1,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,direct
Dabigatran etexilate,non-valvular atrial fibrillation,1053,1,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
ACETAZOLAMIDE,chronic kidney disease,3,0,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
0.5% LIDOCAINE HCl,cancer (localized),8,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Cetirizine hydrochloride,anemia,13,0,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Exelon,autoimmune disease,15,0,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,direct
Octreotide,hypothyroidism,115,1,C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=CC=CC=C23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,fuzzy:edotreotide
PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release,hypersensitivity,313,1,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,fuzzy:pantoprazole sodium delayed-release delayed-release
carmustine,sepsis,17,0,ClCCNC(=O)N(CCCl)N=O,direct
PREDNISONE,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Morphine Sulfate,ulcerative colitis,225,1,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,direct
Quinidine gluconate,heart disease,377,1,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
PROPRANOLOL HYDROCHLORIDE,hypertrophic subaortic stenosis,899,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Atomoxetine Hydrochloride,sepsis,17,0,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
aspirin-dipyridamole,renal failure,19,0,CC(=O)OC1=CC=CC=C1C(O)=O,direct
OZEMPIC,liver disease (non-cirrhotic),20,0,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CN=CN1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O,direct
chlorpromazine hydrochloride,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
SUBVENITE,pediatric patients,13,1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
Ammonia N 13,coronary artery disease,37,1,[13NH3],direct
Guanfacine,congestive heart failure,2,0,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,direct
Lanreotide Acetate,anemia,13,0,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],direct
HALOPERIDOL DECANOATE,sepsis,17,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Fenofibric Acid,cancer (localized),8,0,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
Envarsus XR,diabetes mellitus,5,0,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,direct
Nebivolol,anemia,13,0,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
FLUPHENAZINE DECANOATE,liver disease (non-cirrhotic),20,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
EMFLAZA,sepsis,17,0,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@]([H])(O)C[C@]3(C)[C@@]1(N=C(C)O2)C(=O)COC(C)=O,direct
POTASSIUM CITRATE EXTENDED RELEASE,liver disease (non-cirrhotic),20,0,[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,direct
Ipratropium Bromide,perennial rhinitis,1112,1,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,direct
IMURAN,rheumatoid arthritis who,1215,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Tazarotene,hypertension,11,0,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,direct
Imipramine Hydrochloride,liver disease (non-cirrhotic),20,0,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
CARTIA XT,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Nystatin Topical Powder,autoimmune disease,15,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Pyridostigmine Bromide,liver cirrhosis,4,0,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
ARIKAYCE,hypersensitivity,313,1,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,direct
Zolpidem,chronic insomnia who,690,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Memantine hydrochloride,hypersensitivity,313,1,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Angiomax,congestive heart failure,2,0,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,direct
Erlotinib,liver disease (non-cirrhotic),20,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
paroxetine hydrochloride,cancer (localized),8,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Omnitrope,closed epiphyses,724,1,O,direct
Abiraterone Acetate,cancer (metastatic),9,0,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
gemcitabine hydrochloride,hypersensitivity,313,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
Haloperidol decanoate,psychosis,31,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Everolimus,sega and tsc,1225,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,direct
MOVANTIK,non-cancer related pain,1041,1,COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC=C)[C@H]1O5,direct
PRUDOXIN,stroke,7,0,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
Rubraca,brca -mutated mcrpc,646,1,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,direct
Nateglinide,liver cirrhosis,4,0,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,direct
Dabigatran Etexilate,pregnancy,16,0,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
Rifampin,cancer (localized),8,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
hydrochlorothiazide,autoimmune disease,15,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
CITRANATAL B-CALM,AIDS,10,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Zetia,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
Bupivacaine hydrochloride,sepsis,17,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
"Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral",normal baseline who,1060,1,[Mg++].[O-]S([O-])(=O)=O,direct
Vitafol One,asthma,12,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
FARXIGA,hypertension,11,0,CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1,direct
Fomepizole,hypersensitivity,313,1,CC1=CNN=C1,direct
Levalbuterol Inhalation Solution,liver cirrhosis,4,0,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
Dopram,stroke,7,0,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,direct
DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Rectiv,increased intracranial pressure,926,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
GENTAMICIN SULFATE,mental illness,14,0,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,direct
Mefloquine Hydrochloride,depression,27,1,OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F,direct
Oxycodone and Acetaminophen,severe infection,18,0,CC(=O)NC1=CC=C(O)C=C1,direct
Mometasone Furoate,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Zanaflex,multiple sclerosis,153,1,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Cladribine,insomnia,441,1,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
Ventrixyl Fe,cancer (localized),8,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
CARBOplatin,depression,27,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Timolol maleate,anemia,13,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
ERTAPENEM,chronic kidney disease,3,0,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Clomipramine Hydrochloride,myocardial infarction,1,0,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
Davimet,chronic obstructive pulmonary disease (COPD),6,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
ASMANEX HFA,asthma,12,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Pramosone Cream,autoimmune disease,15,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Omeprazole,autoimmune disease,15,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
TESTOSTERONE ENANTHATE,chronic kidney disease,3,0,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
HALOPERIDOL DECANOATE,psychosis,31,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Amphetamine Sulfate,liver cirrhosis,4,0,CC(N)CC1=CC=CC=C1,direct
Zolpidem,insomnia,441,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
imatinib mesylate,cancer (localized),8,0,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Docetaxel,renal failure,19,0,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
Captopril,hypertension,39,1,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,direct
Brimonidine tartrate and Timolol maleate,sinus bradycardia,1261,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
"Fluocinolone Acetonide Topical Solution USP, 0.01%",cancer (localized),8,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
desoximetasone,mental illness,14,0,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE),pediatric patients,13,1,COC1=CC(=CC(OC)=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1,direct
Nascobal,anemia,81,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Ceftriaxone Sodium,liver disease (non-cirrhotic),20,0,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
Ethamolin,asthma,12,0,NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O,direct
pregabalin,congestive heart failure,2,0,CC(C)C[C@H](CN)CC(O)=O,direct
tizanidine hydrochloride,AIDS,10,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
IMURAN,leukemia,267,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Phenelzine Sulfate,endogenous features,793,1,NNCCC1=CC=CC=C1,direct
Fluvastatin,stroke,7,0,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,direct
PRAZIQUANTEL,severe infection,18,0,O=C(C1CCCCC1)N1CC2N(CCC3=CC=CC=C23)C(=O)C1,direct
varenicline,cancer (metastatic),9,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Imbruvica,stroke,7,0,NC1=NC=NC2=C1C(=NN2[C@@H]1CCCN(C1)C(=O)C=C)C1=CC=C(OC2=CC=CC=C2)C=C1,direct
LEVOPHED(R) NOREPINEPHRINE BITARTRATE,arrhythmia,43,1,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Tolsura,hypersensitivity,313,1,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Bystolic,severe infection,18,0,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
Norepinephrine bitartrate,liver cirrhosis,4,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Reglan,severe infection,18,0,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,direct
ACETYLCYSTEINE,anemia,13,0,CC(=O)N[C@@H](CS)C(O)=O,direct
Keppra XR,diabetes mellitus,5,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
FLUORESCITE,hypersensitivity,313,1,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
OXCARBAZEPINE,tremor,459,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
2% LIDOCAINE HCI,AIDS,10,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Ammonia N 13,pregnancy,16,0,[13NH3],direct
Isotretinoin,disorders of keratinization,779,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Halog,severe infection,18,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
desmopressin acetate,diabetes mellitus,5,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
TRAMADOL HYDROCHLORIDE,liver disease (non-cirrhotic),20,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Dextrose And Sodium Chloride,hypersensitivity,313,1,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C=O,direct
Focalin,myocardial infarction,1,0,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,direct
Rapivab,chronic kidney disease,3,0,[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O,direct
daptomycin,left-sided infective endocarditis,962,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
Estradiol Vaginal Cream,chronic kidney disease,3,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
LIDOCAINE HCl,sepsis,17,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Trelstar,prostate cancer,265,1,CC(C)C[C@H](NC(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,direct
Sorbitol,liver disease (non-cirrhotic),20,0,OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,direct
AirDuo RespiClick,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Midodrine hydrochloride,liver disease (non-cirrhotic),20,0,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,direct
Amantadine Hydrochloride,diabetes mellitus,5,0,NC12CC3CC(CC(C3)C1)C2,direct
Raloxifene Hydrochloride,myocardial infarction,1,0,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,direct
Bupivilog Kit,pregnancy,16,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
LIDOCAINE,diabetes mellitus,5,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
IC-Green,renal failure,19,0,CC1(C)C(=CC=CC=CC=CC2=[N+](CCCCS([O-])(=O)=O)C3=CC=C4C=CC=CC4=C3C2(C)C)N(CCCCS(O)(=O)=O)C2=CC=C3C=CC=CC3=C12,direct
nitrofurantoin (macrocrystals),hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Diazepam Intensol,renal failure,19,0,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,direct
2% LIDOCAINE HCI,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
"Butalbital, aspirin, and caffeine",severe infection,18,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
olopatadine hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2,direct
Jentadueto XR,pancreatitis,233,1,CN(C)C(=N)NC(N)=N,direct
SOLU-CORTEF,autoimmune disease,15,0,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
KLAYESTA,cancer (localized),8,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Methotrexate,non-metastatic osteosarcoma who,1049,1,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
Betamethasone dipropionate,hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Ammonia N 13,cancer (metastatic),9,0,[13NH3],direct
"PredniSONE Tablets, USP, 10 mg",unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Cefotaxime,diabetes mellitus,5,0,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
PANTOPRAZOLE SODIUM I.V.,congestive heart failure,2,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Mexiletine hydrochloride,cancer (metastatic),9,0,CC(N)COC1=C(C)C=CC=C1C,direct
Tasmar,elevated enzymes,788,1,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,direct
levetiracetam,partial seizures,1104,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
Arsenic Trioxide,liver disease (non-cirrhotic),20,0,O=[As]O[As]=O,direct
Hydroxychloroquine sulfate,chronic obstructive pulmonary disease (COPD),6,0,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
Desferal,cancer (metastatic),9,0,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
SAPHRIS,pediatric patients,13,1,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
ABILIFY,hypersensitivity,313,1,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
Meclizine Hydrochloride,diabetes mellitus,5,0,CC1=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=CC=C1,direct
ZOLADEX,bone metastases,638,1,CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,direct
Kyzatrex,AIDS,10,0,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,direct
CAPECITABINE,chronic kidney disease,3,0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
IMATINIB MESYLATE,thrombocytopenia,79,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
HALOPERIDOL,dementia,7,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Istalol,sinus bradycardia,1261,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
amantadine hydrochloride,mental illness,14,0,NC12CC3CC(CC(C3)C1)C2,direct
Nalbuphine hydrochloride,depression,27,1,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
ASMANEX HFA,diabetes mellitus,5,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
CYCLOSPORINE,chronic plaque psoriasis,702,1,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,cancer (metastatic),9,0,CC(=O)NC1=CC=C(O)C=C1,direct
Corlanor,cardiomyopathy,69,1,COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1,direct
Doxorubicin Hydrochloride,impaired cardiac function,913,1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
Calcipotriene,severe infection,18,0,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
psorcon,congestive heart failure,2,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Cimetidine,congestive heart failure,2,0,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N,direct
Chloroquine Phosphate,porphyria the condition,1141,1,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,direct
Hydrocortisone Acetate Pramoxine Hcl,myocardial infarction,1,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Humira,active as,521,1,CC(C)O,direct
fluphenazine hydrochloride,mental retardation,993,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Diclofenac sodium,asthma,12,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Sodium Chloride,brain edema,643,1,[Na+].[Cl-],direct
Effer-K Orange,liver disease (non-cirrhotic),20,0,[K+].OC([O-])=O,direct
Norco,chronic overdose,698,1,CC(=O)NC1=CC=C(O)C=C1,direct
VAFSEO,anemia,81,1,OC(=O)CNC(=O)C1=C(O)C=C(C=N1)C1=CC(Cl)=CC=C1,direct
Marcaine,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Methotrexate,immunodeficiency,315,1,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
labetalol hydrochloride,AIDS,10,0,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
LEUPROLIDE ACETATE,cancer (localized),8,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
sirolimus,lymphangioleiomyomatosis safety,974,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
nitrofurantoin (macrocrystals),myocardial infarction,1,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
ESTRADIOL,chronic kidney disease,3,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Pentam 300,asthma,12,0,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
zolmitriptan,hypersensitivity,313,1,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
Brinzolamide,glaucoma,481,1,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
CARVEDILOL,severe hepatic impairment,1245,1,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
CARNITOR,hypersensitivity,313,1,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
AIRSUPRA,stroke,7,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
PIOGLITAZONE,chronic obstructive pulmonary disease (COPD),6,0,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
Alosetron,myocardial infarction,1,0,CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2,direct
VELCADE,leukopenia,83,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
BELRAPZO,chronic kidney disease,3,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Pyridostigmine Bromide,sepsis,17,0,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Spritam,pregnancy,16,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
TAZICEF,cancer (localized),8,0,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
Zoledronic Acid,bone metastases,638,1,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
Capecitabine,metastatic colorectal cancer,996,1,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
Meropenem,sepsis,17,0,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
Dronabinol,pregnancy,16,0,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,direct
CORDRAN,hypersensitivity,313,1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,direct
diltiazem hydrochloride,myocardial infarction,49,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Neomycin and Polymyxin B Sulfates,chronic kidney disease,3,0,[H][C@]1(NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CCN)NC(=O)[C@H](CCNC1=O)NC(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)CCCCC(C)CC)[C@@H](C)O)[C@@H](C)O,direct
SELEGILINE HYDROCHLORIDE,hypersensitivity,313,1,C[C@H](CC1=CC=CC=C1)N(C)CC#C,direct
Glycopyrrolate,anemia,13,0,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
HYDROXYCHLOROQUINE SULFATE,chronic obstructive pulmonary disease (COPD),6,0,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
Cortisone Acetate,pancreatitis,233,1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Zolpidem Tartrate Extended-Release,primary insomnia who,1177,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
TIAZAC EXTENDED RELEASE,hypotension,75,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
E-Z-Paque,the following conditions,1301,1,[Ba++].[O-]S([O-])(=O)=O,direct
XELJANZ,liver cirrhosis,4,0,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,direct
Travoprost,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Triamcinolone Acetonide,active tuberculosis,535,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Alendronate Sodium,congestive heart failure,2,0,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
sevelamer carbonate,bowel obstruction,641,1,NCC=C.ClCC1CO1,direct
VIVJOA,diabetes mellitus,5,0,O[C@@](CN1C=NN=N1)(C1=CC=C(F)C=C1F)C(F)(F)C1=CC=C(C=N1)C1=CC=C(OCC(F)(F)F)C=C1,direct
PRAVASTATIN SODIUM,clinically evident chd,718,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
paroxetine hydrochloride,sepsis,17,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Arestin,renal failure,19,0,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,direct
Atracurium Besylate,hypersensitivity,313,1,[O-]S(=O)(=O)C1=CC=CC=C1.[O-]S(=O)(=O)C1=CC=CC=C1.COC1=CC2=C(C=C1OC)C(CC1=CC(OC)=C(OC)C=C1)[N+](C)(CCC(=O)OCCCCCOC(=O)CC[N+]1(C)CCC3=C(C=C(OC)C(OC)=C3)C1CC1=CC(OC)=C(OC)C=C1)CC2,direct
LIDOCAINE HCI,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
TEMOZOLOMIDE,hypersensitivity,313,1,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
prochlorperazine maleate,hypersensitivity,313,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
MEROPENEM,diabetes mellitus,5,0,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
FLUOCINOLONE ACETONIDE,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
PredniSONE,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ESTRADIOL,hypersensitivity,313,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
XYLOCAINE- MPF (LIDOCAINE HCl ),tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ATENOLOL,angina pectoris,596,1,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,direct
FASLODEX,chronic kidney disease,3,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],direct
Fulvestrant,stroke,7,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],direct
Lorazepam,sleep apnea,3,1,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,direct
Molindone Hydrochloride,pregnancy,16,0,CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2,direct
Flavoxate Hydrochloride,suspected glaucoma,1282,1,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,direct
prochlorperazine maleate,mental retardation,993,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
ANASPAZ,pregnancy,16,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Zolpidem Tartrate,diabetes mellitus,5,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
propranolol hydrochloride,AIDS,10,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Sumatriptan Succinate,severe hepatic impairment,1245,1,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,direct
Nifedipine,diabetes mellitus,5,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Lidocaine Hydrochloride,diabetes mellitus,5,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ALPHAGAN P,glaucoma,481,1,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Methotrexate,rheumatoid arthritis,159,1,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
KLOR-CON M,hyperkalemia,131,1,[Cl-].[K+],direct
Dopram,hypersensitivity,313,1,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Glycopyrrolate,liver disease (non-cirrhotic),20,0,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
Latuda,chronic kidney disease,3,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
PARAPLATIN,poor performance status,1139,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Docetaxel anhydrous,solid tumors,1264,1,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE",stroke,7,0,CC(N)CC1=CC=CC=C1,direct
EPINEPHRINE,hypotension,75,1,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
ARIKAYCE,renal failure,19,0,NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O,direct
ORSERDU,breast cancer,263,1,CCNCCC1=CC=C(CN(CC)C2=C(C=CC(OC)=C2)[C@@H]2CCC3=CC(O)=CC=C3C2)C=C1,direct
TOLMETIN SODIUM,congestive heart failure,2,0,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,direct
Adalimumab-aacf,active as,521,1,CC(C)O,direct
Enalaprilat,edema,417,1,[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@@]1([H])C(O)=O,direct
Midodrine hydrochloride,hypertension,39,1,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,direct
Irbesartan and Hydrochlorothiazide,renal failure,19,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
tafluprost,chronic obstructive pulmonary disease (COPD),6,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
ertapenem sodium,hypersensitivity,313,1,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Lidocaine and prilocaine,severe infection,18,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Propranolol,congestive heart failure,2,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
ESZOPICLONE,hypersensitivity,313,1,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,direct
FENTORA,asthma,12,0,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
Pramipexole Dihydrochloride,anemia,13,0,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
plerixafor,lymphoma,269,1,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
Tranexamic Acid in Sodium Chloride,myocardial infarction,1,0,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Paclitaxel protein-bound particles,neutropenia,85,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
BRENZAVVY,autoimmune disease,15,0,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(OCCOC3CC3)C=C2)=C1,direct
Amiloride Hydrochloride and Hydrochlorothiazide,sepsis,17,0,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
DOXERCALCIFEROL,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
Propranolol Hydrochloride ER,hypertrophic subaortic stenosis,899,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
pregabalin,cancer (localized),8,0,CC(C)C[C@H](CN)CC(O)=O,direct
Norco,anemia,13,0,CC(=O)NC1=CC=C(O)C=C1,direct
Ammonia N-13,pregnancy,16,0,[13NH3],direct
amantadine hydrochloride,renal failure,19,0,NC12CC3CC(CC(C3)C1)C2,direct
diflunisal,myocardial infarction,1,0,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,direct
LIPIODOL,pregnancy,321,1,COC1=CC=C(C=C1)C(=O)CC(=O)C1=CC=C(C=C1)C(C)(C)C,fuzzy:lipidol
zoledronic acid,liver disease (non-cirrhotic),20,0,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
Ethacrynate Sodium,diabetes mellitus,5,0,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Prochlorperazine,congestive heart failure,2,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
cyanocobalamin,anemia,81,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Alprazolam Extended Release,asthma,12,0,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE,mental illness,14,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Zintrexyl-C,autoimmune disease,15,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Brexpiprazole,mdd and schizophrenia,989,1,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,direct
CEFTRIAXONE AND DEXTROSE,autoimmune disease,15,0,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
LANOXIN,liver cirrhosis,4,0,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,direct
Fluticasone Propionate,cancer (metastatic),9,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Tiagabine Hydrochloride,epilepsy who,799,1,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1,direct
Diltiazem Hydrochloride Extended-Release,cancer (localized),8,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
SEREVENT DISKUS,asthma,12,0,OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1,direct
Lodosyn,cancer (localized),8,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
CORTEF,cancer (metastatic),9,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Adapalene and Benzoyl Peroxide,AIDS,10,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Pentobarbital Sodium,known barbiturate sensitivity,948,1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,direct
ACCURETIC,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Korlym,hypersensitivity,313,1,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],direct
Febuxostat,chronic obstructive pulmonary disease (COPD),6,0,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
Dichlorphenamide,cancer (localized),8,0,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O,direct
Conray,hypertension,11,0,CNC(=O)C1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Lurasidone Hydrochloride,bipolar depression,632,1,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Glimepiride,liver cirrhosis,4,0,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O,direct
celecoxib,renal failure,19,0,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
NITROGLYCERIN,severe anemia,1235,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Dobutamine Hydrochloride in Dextrose,hypersensitivity,313,1,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
CARBOPLATIN,depression,27,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
2% LIDOCAINE HCI,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Daptomycin,prosthetic valve endocarditis,1186,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
methylphenidate hydrochloride CD,severe infection,18,0,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
NATEGLINIDE,hypertension,11,0,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,direct
Voltaren,chronic obstructive pulmonary disease (COPD),6,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
AZACTAM,hypersensitivity,313,1,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(=O)O)\C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O,direct
Zolpidem,asthma,12,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Folixapure,severe infection,18,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Xarelto,nonvalvular atrial fibrillation,1056,1,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,direct
IMATINIB MESYLATE,hypertension,11,0,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
LEXISCAN(R) (REGADENOSON),congestive heart failure,2,0,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
tizanidine,chronic kidney disease,3,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
CETIRIZINE HYDROCHLORIDE,hypersensitivity,313,1,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Erlotinib,pancreatic cancer,1097,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
LEUCOVORIN CALCIUM,chronic kidney disease,3,0,[H]C(=O)N1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2,direct
nicardipine hydrochloride,pregnancy,16,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
"Betamethasone Dipropionate USP, 0.05%",hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
POTASSIUM CITRATE,cancer (metastatic),9,0,[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,direct
CombiPatch (estradiol/norethindrone acetate transdermal system),hypercalcemia,139,1,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],direct
BOSULIF,newly-diagnosed cp cml,1037,1,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,direct
Timoptic in Ocudose,pregnancy,16,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Venlafaxine Hydrochloride,concomitant illness,740,1,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
Meclizine Hydrochloride,hypersensitivity,313,1,CC1=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=CC=C1,direct
GENTAMICIN SULFATE,hypersensitivity,313,1,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,direct
FLUCYTOSINE,bone marrow depression,637,1,NC1=C(F)C=NC(=O)N1,direct
ALVAIZ,anemia,81,1,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,direct
DOXYCYCLINE HYCLATE,impaired renal function,919,1,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
NALFON,mental illness,14,0,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,direct
Icosapent Ethyl,chronic obstructive pulmonary disease (COPD),6,0,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
tramadol hydrochloride,anemia,13,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
UBRELVY,hypersensitivity,313,1,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=NC=CC=C42)C(=O)N1CC(F)(F)F)C1=CC=CC=C1,direct
Onivyde,metastatic pancreatic adenocarcinoma,1003,1,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
Evista,anemia,13,0,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,direct
Dextromethorphan Hydrobromide and Promethazine Hydrochloride,mental illness,14,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Eszopiclone,hypersensitivity,313,1,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,direct
Isotretinoin,tics,23,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Adenosine,chronic obstructive pulmonary disease (COPD),6,0,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
LAMIVUDINE AND ZIDOVUDINE,severe infection,18,0,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
TEMOZOLOMIDE,anaplastic astrocytoma are,593,1,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
FLUOROURACIL,congestive heart failure,2,0,FC1=CNC(=O)NC1=O,direct
ACETAMINOPHEN,AIDS,10,0,CC(=O)NC1=CC=C(O)C=C1,direct
carisoprodol,liver disease (non-cirrhotic),20,0,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
Vitrexyl plus Iron,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
AKEEGA,prostate cancer,265,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
"Timolol Maleate Ophthalmic Gel Forming Solution, 0.25%",severe infection,18,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Cayston,pseudomonas aeruginosa,1188,1,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(=O)O)\C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O,direct
ETOPOPHOS,pregnancy,16,0,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@@H]1O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O,direct
Plaquenil,severe infection,18,0,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
labetalol hydrochloride,this tumor,1318,1,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Xeloda,anemia,81,1,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
Dexamethasone sodium phosphate,tuberculosis,213,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Thermazene Silver Sulfadiazine,sepsis,291,1,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
promethazine hydrochloride,depression,27,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Cefprozil,mental illness,14,0,[H][C@]12SCC(C=CC)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
VANFLYTA,arrhythmia,43,1,CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1,direct
Sotalol Hydrochloride AF,ventricular arrhythmias,1354,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
FOSFOMYCIN TROMETHAMINE,congestive heart failure,2,0,C[C@@H]1O[C@@H]1P(O)(O)=O,direct
Rosuvastatin,stroke,7,0,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
PYLERA,myocardial infarction,1,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
Triamcinolone Acetonide,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Penicillin G Sodium,impaired renal function,919,1,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,direct
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution,AIDS,10,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Sofosbuvir and Velpatasvir,anemia,81,1,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
Nizatidine,chronic obstructive pulmonary disease (COPD),6,0,CNC(NCCSCC1=CSC(CN(C)C)=N1)=C[N+]([O-])=O,direct
COMBIGAN,sepsis,17,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Nulibry,pediatric patients,13,1,[H][C@@]12COP(O)(=O)O[C@]1([H])C(O)(O)[C@]1([H])NC3=C(NC(N)=NC3=O)N[C@]1([H])O2,direct
LORAZEPAM,asthma,12,0,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,direct
CLONAZEPAM,cancer (localized),8,0,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,direct
Prochlorperazine Maleate,previous brain damage,1166,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
1% LIDOCAINE HCI,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Bystolic,hypertension,39,1,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
Melphalan,chronic obstructive pulmonary disease (COPD),6,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
MLK Kit F2,liver cirrhosis,4,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Strong Iodine Solution,chronic obstructive pulmonary disease (COPD),6,0,II,direct
Prolia,hypertension,11,0,OC(=O)[C@@H]1CCCN1,fuzzy:prolina
methylprednisolone acetate,pregnancy,16,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
XELJANZ XR,diabetes at baseline,772,1,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,direct
Trileptal,edema,417,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Ropivacaine Hydrochloride,mental illness,14,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
ZALDYON,ulcerative colitis,225,1,NC1=CC(C(O)=O)=C(O)C=C1,direct
PROMACTA,thrombocytopenia,79,1,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,direct
Rezurock,congestive heart failure,2,0,CC(C)NC(=O)COC1=CC=CC(=C1)C1=NC2=C(C=CC=C2)C(NC2=CC=C3NN=CC3=C2)=N1,direct
Acetaminophen And Codeine,chronic obstructive pulmonary disease (COPD),6,0,CC(=O)NC1=CC=C(O)C=C1,direct
CLOMIPRAMINE HYDROCHLORIDE,depressive symptoms,769,1,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
PROCTOZONE-HC,stroke,7,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Azithromycin Dihydrate,anemia,13,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Nicardipine hydrochloride,diabetes mellitus,5,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
AMMONIA N-13,coronary artery disease,37,1,[13NH3],direct
Spironolactone,cancer (localized),8,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
Clonidine hydrochloride,renal failure,19,0,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
PREGABALIN,cancer (localized),8,0,CC(C)C[C@H](CN)CC(O)=O,direct
pyridostigmine bromide,bronchial asthma,650,1,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Brimonidine Tartrate/Timolol Maleate,sinus bradycardia,1261,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Disopyramide Phosphate,ventricular arrhythmias,1354,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
Keppra XR,hypersensitivity,313,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
prochlorperazine edisylate,mental retardation,993,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Oxcarbazepine,insomnia,441,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
acetazolamide,diabetes mellitus,5,0,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE),AIDS,10,0,COC1=CC(=CC(OC)=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1,direct
CHLORTHALIDONE CHLORTHALIDONE,asthma,12,0,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Dexamethasone sodium phosphate,unexplained diarrhea,1341,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Lidocaine Hydrochloride and Epinephrine,chronic kidney disease,3,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Aldactone,myocardial infarction,1,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
Valsartan and hydrochlorothiazide,hypersensitivity,313,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
azithromycin dihydrate,pneumonia who,1132,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Multiple Electrolytes pH 5.5,myocardial infarction,1,0,[Cl-].[K+],direct
Timolol Maleate,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
NORLIQVA,anemia,13,0,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,direct
Atovaquone and Proguanil Hydrochloride,liver disease (non-cirrhotic),20,0,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,direct
Ribavirin,AIDS,10,0,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
LAMPIT,pediatric patients,13,1,CC1CS(=O)(=O)CCN1\N=C\C1=CC=C(O1)[N+]([O-])=O,direct
Modafinil,autoimmune disease,15,0,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,direct
PAROXETINE,mental illness,14,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Thiothixene,cancer (localized),8,0,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1,direct
Lyrica CR,hypersensitivity,313,1,CC(C)C[C@H](CN)CC(O)=O,direct
amlodipine besylate and olmesartan medoxomil,stroke,51,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
erythromycin,chronic kidney disease,3,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Lupron Depot-PED,chronic kidney disease,3,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Nalbuphine hydrochloride,autoimmune disease,15,0,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
Clonidine hydrochloride,hypersensitivity,313,1,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
methylprednisolone acetate,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
PIOGLITAZONEHYDROCHLORIDE,cancer (metastatic),9,0,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
MOVANTIK,liver disease (non-cirrhotic),20,0,COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC=C)[C@H]1O5,direct
Amantadine HCL,stroke,7,0,NC12CC3CC(CC(C3)C1)C2,direct
DESONIDE,hypersensitivity,313,1,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
TIAZAC EXTENDED RELEASE,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
ALVAIZ,liver cirrhosis,4,0,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,direct
Icosapent,anemia,13,0,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,direct
Pregabalin Extended Release,postherpetic neuralgia table,1146,1,CC(C)C[C@H](CN)CC(O)=O,direct
Gablofen,hypersensitivity,313,1,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
MUPIROCIN,hypersensitivity,313,1,C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O,direct
Loperamide Hydrochloride,hypersensitivity,313,1,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Leuprolide Acetate,prostate cancer,265,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Potassium Chloride in Lactated Ringers and Dextrose,chronic kidney disease,3,0,[Cl-].[K+],direct
Alprazolam XR,diabetes mellitus,5,0,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
Depen,aplastic anemia,103,1,[H][C@](N)(C(O)=O)C(C)(C)S,direct
voriconazole,asthma,12,0,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Raloxifene Hydrochloride,asthma,12,0,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,direct
Lidorex,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Vitrexate,myocardial infarction,1,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Carbidopa and Levodopa,hypersensitivity,313,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
EZETIMIBE,liver cirrhosis,4,0,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
metronidazole,AIDS,10,0,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Cinacalcet,anorexia,399,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Integra Plus,hypersensitivity,313,1,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Tolectin,hypersensitivity,313,1,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,fuzzy:tolmetin
Rifadin IV,impaired liver function,918,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
Penciclovir,autoimmune disease,15,0,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,direct
Cetirizine hydrochloride,AIDS,10,0,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
sevelamer carbonate,severe infection,18,0,NCC=C.ClCC1CO1,direct
IPRATROPIUM BROMIDE,severe infection,18,0,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,direct
SUTENT,cancer (metastatic),9,0,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,direct
Dorzolamide Hydrochloride and Timolol Maleate ophthalmic,diabetes mellitus,5,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
AZITHROMYCIN,pneumonia who,1132,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
GEMTESA,hypersensitivity,313,1,[H][C@@]1(CC[C@@H](CC2=CC=C(NC(=O)[C@@H]3CCC4=NC=CC(=O)N34)C=C2)N1)[C@H](O)C1=CC=CC=C1,direct
Sodium Acetate,autoimmune disease,15,0,[Na+].CC([O-])=O,direct
RUBY-FILL,coronary artery disease,37,1,[82Rb+],direct
Dutasteride and tamsulosin hydrochloride,AIDS,10,0,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O,direct
Timolol Maleate,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
INVANZ,the laboratory test,1306,1,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Hydrocodone Bitartrate and Acetaminophen,liver disease (non-cirrhotic),20,0,CC(=O)NC1=CC=C(O)C=C1,direct
Onfi,liver disease (non-cirrhotic),20,0,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,direct
DAPZURA RT,left-sided infective endocarditis,962,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
Niferex,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
TENORETIC,severe infection,18,0,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
ISOSORBIDE MONONITRATE,myocardial infarction,49,1,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,direct
Fycompa,liver disease (non-cirrhotic),20,0,O=C1N(C=C(C=C1C1=CC=CC=C1C#N)C1=NC=CC=C1)C1=CC=CC=C1,direct
COMBIVIR,cancer (localized),8,0,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
TIADYLT ER,chronic stable angina,705,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Hydrocortisone Cream,stroke,7,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
ESZOPICLONE,chronic kidney disease,3,0,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,direct
Cladribine,cancer (localized),8,0,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
1% LIDOCAINE HCI,pregnancy,16,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Allopurinol,anemia,13,0,OC1=NC=NC2=C1C=NN2,direct
Estradiol,cancer (localized),8,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Tafinlar,low-grade glioma who,971,1,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,direct
SSD,pregnancy,16,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
DDAVP,diabetes insipidus,773,1,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE,asthma,12,0,CC(=O)OC1=CC=CC=C1C(O)=O,direct
EXEMESTANE,severe infection,18,0,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C,direct
tizanidine hydrochloride,multiple sclerosis,153,1,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE,cancer (localized),8,0,CC(=O)OC1=CC=CC=C1C(O)=O,direct
Emtricitabine,chronic obstructive pulmonary disease (COPD),6,0,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,direct
Cetirizine Hydrochloride,severe infection,18,0,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
adapalene and benzoyl peroxide,congestive heart failure,2,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Arsenic Trioxide,mental illness,14,0,O=[As]O[As]=O,direct
DEPO-MEDROL,cancer (localized),8,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Levbid,autoimmune disease,15,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
DOCETAXEL,asthma,12,0,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
Mexiletine Hydrochloride,congestive heart failure,2,0,CC(N)COC1=C(C)C=CC=C1C,direct
TORSEMIDE,chronic kidney disease,3,0,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1,direct
Zolmitriptan OD,hypersensitivity,313,1,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
Fluticasone Propionate,pregnancy,16,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Levetiracetam in Sodium Chloride,hypersensitivity,313,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
IYUZEH,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Paclitaxel protein-bound particles,and without neutropenia,595,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Leep RediKit,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Chlorpromazine,sepsis,17,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
Estring,pregnancy,16,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
fluphenazine hydrochloride,psychosis,31,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Prasugrel,stroke,51,1,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,direct
FEBUXOSTAT,gout,147,1,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
LumaSon,cancer (localized),8,0,FS(F)(F)(F)(F)F,direct
Carboplatin,myocardial infarction,1,0,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Paclitaxel protein-bound particles for injectable suspension (albumin-bound),AIDS,10,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
VORICONAZOLE,chronic kidney disease,3,0,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
TOBI Podhaler,hypersensitivity,313,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Levobunolol Hydrochloride,mental illness,14,0,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCCC2=O,direct
Estradiol Vaginal Cream,sepsis,17,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
"Carbidopa Tablets, 25 mg",renal failure,19,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Lidocaine,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Talzenna,congestive heart failure,2,0,CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1,direct
Pioglitazone Hydrochloride and Metformin Hydrochloride,asthma,12,0,CN(C)C(=N)NC(N)=N,direct
MEMANTINE HYDROCHLORIDE,hypersensitivity,313,1,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
FLUDROCORTISONE ACETATE,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
FOSCARNET SODIUM,autoimmune disease,15,0,OC(=O)P(O)(O)=O,direct
Rayaldee,cancer (localized),8,0,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,direct
TEMODAR,myocardial infarction,1,0,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
CHLORDIAZEPOXIDE HYDROCHLORIDE,hypersensitivity,313,1,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
PYLERA,liver disease (non-cirrhotic),20,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
CARBIDOPA,chronic kidney disease,3,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Sorafenib,chronic obstructive pulmonary disease (COPD),6,0,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
Pretrate,stroke,7,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Tetracycline Hydrochloride,liver disease (non-cirrhotic),20,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
CAMCEVI,advanced prostate cancer,567,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Lupron Depot-PED,central precocious puberty,672,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Mycostatin,chronic kidney disease,3,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
ROPIVACAINE HYDROCHLORIDE,hypersensitivity,313,1,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
Diltiazem HCl CD,hypersensitivity,313,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Olumiant,congestive heart failure,2,0,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,direct
Aromasin,mental illness,14,0,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C,direct
cevimeline hydrochloride,asthma,12,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
IXEMPRA,metastatic breast cancer,995,1,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,direct
Emtricitabine,hypersensitivity,313,1,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,direct
AmBisome,other notable reactions,1091,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
FLOLAN,hypersensitivity,313,1,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,direct
Adapalene and benzoyl peroxide,pregnancy,16,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
VIIBRYD,liver cirrhosis,4,0,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,direct
Methylprednisolone Sodium Succinate,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Telmisartan and Amlodipine,mental illness,14,0,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,direct
desmopressin acetate,anemia,13,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
Liothyronine sodium,diabetes mellitus,5,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
Nisoldipine,angina this,598,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C,direct
Midazolam,liver cirrhosis,4,0,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Ertapenem,the laboratory test,1306,1,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Lisinopril,stroke,7,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Emtriva,severe infection,18,0,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,direct
Quinine Sulfate,severe infection,18,0,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12,direct
Ethacrynate Sodium,sepsis,17,0,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Busulfan,mental illness,14,0,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
Regonol,asthma,12,0,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND,chronic kidney disease,3,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Ursodiol,such stones,1278,1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
Protriptyline Hydrochloride,cardiovascular disorders,669,1,CNCCCC1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Levalbuterol,liver disease (non-cirrhotic),20,0,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
Nebivolol Hydrochloride,liver disease (non-cirrhotic),20,0,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
Metyrosine,myocardial infarction,1,0,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,direct
Fluvoxamine Maleate,asthma,12,0,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,direct
diclofenac potassium,cancer (metastatic),9,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
DICYCLOMINE HYDROCHLORIDE,pregnancy,16,0,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,direct
Exjade,decreased egfr,761,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
INVANZ,renal failure,19,0,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Betamethasone dipropionate,mental illness,14,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
MIDAZOLAM,acute narrow-angle glaucoma,546,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
mesalamine,chronic kidney disease,3,0,NC1=CC(C(O)=O)=C(O)C=C1,direct
ULORIC,hyperuricemia and gout,900,1,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
febuxostat,hyperuricemia and gout,900,1,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
AZATHIOPRINE,myocardial infarction,1,0,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Naproxen,impaired renal function,919,1,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O,direct
Ipratropium Bromide,the common cold,1297,1,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,direct
icosapent ethyl,cancer (metastatic),9,0,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Iluvien,anemia,13,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Prenatrix,chronic obstructive pulmonary disease (COPD),6,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Penicillin G Sodium,stroke,7,0,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,direct
thiothixene,myocardial infarction,1,0,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1,direct
omeprazole and sodium bicarbonate,chronic obstructive pulmonary disease (COPD),6,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Cefotaxime,autoimmune disease,15,0,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
omeprazole sodium bicarbonate,diabetes mellitus,5,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
DesOwen,renal failure,19,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Kalydeco,hypertension,11,0,CC(C)(C)C1=CC(=C(O)C=C1NC(=O)C1=CNC2=CC=CC=C2C1=O)C(C)(C)C,direct
Pyrimethamine,cancer (localized),8,0,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1,direct
Carvedilol,autoimmune disease,15,0,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
Lidocaine hydrochloride,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
CANCIDAS,AIDS,10,0,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
PROMETHAZINE HCI,depression,27,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Tramadol HCL ER,chronic non-malignant pain,697,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Armodafinil,anemia,13,0,NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1,direct
SUNOSI,narcolepsy,443,1,N[C@@H](COC(N)=O)CC1=CC=CC=C1,direct
Pentamidine Isethionate,AIDS,10,0,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
"amlodipine,valsartan and hydrochlorothiazide",hypercalcemia,139,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,"fuzzy:amlodipine, valsartan and hydrochlorothiazide"
Arsenic Trioxide,hypersensitivity,313,1,O=[As]O[As]=O,direct
Denavir,cancer (metastatic),9,0,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,direct
JANUMET XR,severe infection,18,0,CN(C)C(=N)NC(N)=N,direct
Etodolac ER,myocardial infarction,1,0,CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1,direct
aripiprazole,diabetes mellitus,5,0,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
GEMCITABINE,anemia,13,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
HALOPERIDOL DECANOATE,dementia,7,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Myoview,AIDS,10,0,CCOCCP(CCOCC)CCP(CCOCC)CCOCC,direct
PEMAZYRE,cancer (localized),8,0,CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F,direct
Granisetron Hydrochloride,cancer (metastatic),9,0,CN1N=C(C(=O)N[C@@H]2C[C@@H]3CCC[C@H](C2)N3C)C2=C1C=CC=C2,direct
Fulvestrant,hypersensitivity,313,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],direct
Hydrochlorothiazide,congestive heart failure,2,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
PAMELOR,stroke,7,0,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Paclitaxel,sepsis,17,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
clobetasol propionate,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Cefadroxil,tics,23,1,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
Vivacaine,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Zonalon,stroke,7,0,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
CYCLOSPORINE,chronic kidney disease,3,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
SUPRANE,chronic obstructive pulmonary disease (COPD),6,0,FC(F)OC(F)C(F)(F)F,direct
CISplatin,asthma,12,0,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
pravastatin sodium,primary dysbetalipoproteinemia who,1172,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
THAM,hyperkalemia,131,1,NC(CO)(CO)CO,direct
MOTPOLY XR,pregnancy,16,0,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
LEVOPHED,acute hypotensive states,540,1,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Triamcinolone Acetonide,cerebral malaria,674,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Ondansetron Hydrochloride,renal failure,19,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Rasuvo,asthma,12,0,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
Hydrocaine,congestive heart failure,2,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,fuzzy:hydroxycine
Gadobutrol,pregnancy,16,0,OC[C@H](O)[C@H](CO)[N+]12CC[N+]3(CC([O-])=O)CC[N+]4(CC([O-])=O)CC[N+](CC([O-])=O)(CC1)[Gd-]234,direct
Diovan,severe infection,18,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Pro-C-Dure 5 Kit,active tuberculosis,535,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
VANFLYTA,long qt syndrome,61,1,CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1,direct
Carbidopa-levodopa,hypersensitivity,313,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution,autoimmune disease,15,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
SUPREP Bowel Prep,severe infection,18,0,[Mg++].[O-]S([O-])(=O)=O,direct
Nebivolol Hydrochloride,hypertension,39,1,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
Prasugrel,liver disease (non-cirrhotic),20,0,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,direct
Atomoxetine,glaucoma,481,1,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
"Testosterone Gel, 1%",hypertension,11,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Fluocinolone Acetonide Oil,hypertension,11,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
pitavastatin calcium,primary hyperlipidemia,1175,1,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
Sumansetron,AIDS,10,0,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,direct
Latanoprost,asthma,12,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Cytalux,severe infection,18,0,CC1(C)\C(=C/C=C2\CCCC(\C=C\C3=[N+](CCCCS(O)(=O)=O)C4=C(C=C(C=C4)S([O-])(=O)=O)C3(C)C)=C2OC2=CC=C(C[C@H](NC(=O)C3=CC=C(NCC4=CN=C5N=C(N)NC(=O)C5=N4)C=C3)C(O)=O)C=C2)N(CCCCS(O)(=O)=O)C2=C1C=C(C=C2)S(O)(=O)=O,direct
ELCYS,sepsis,17,0,N[C@@H](CS)C(O)=O,direct
Vasotec,asthma,12,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
Sotalol,asthma,12,0,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
ACETAMINOPHEN AND CODEINE PHOSPHATE,sepsis,17,0,CC(=O)NC1=CC=C(O)C=C1,direct
Corlanor,pregnancy,16,0,COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1,direct
Nifedipine ER,anemia,13,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Quinidine Sulfate,heart disease,377,1,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
Dabigatran Etexilate,severe infection,18,0,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",liver disease (non-cirrhotic),20,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Metyrosine,arrhythmia,43,1,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,direct
Fluocinolone Acetonide,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Timolol maleate,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
TOPIRAMATE,diabetes mellitus,5,0,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,direct
Irinotecan hydrochloride,pregnancy,16,0,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
BUPIVICAINE HYDROCHLORIDE,chronic obstructive pulmonary disease (COPD),6,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Esomeprazole Sodium,diabetes mellitus,5,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Exelon,these events,1312,1,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,direct
Perphenazine and Amitriptyline Hydrochloride,psychosis,31,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Effer-K 20 mEq Unflavored,autoimmune disease,15,0,[K+].OC([O-])=O,direct
BUTALBITAL AND ACETAMINOPHEN,porphyria warnings butalbital,1142,1,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,direct
Timolol Maleate Ophthalmic Gel Forming Solution,AIDS,10,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
CORDRAN,asthma,12,0,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,direct
Diclofenac Sodium,considerable dehydration,749,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
TOPIRAMATE,epilepsy who,799,1,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,direct
OXBRYTA,diabetes mellitus,5,0,CC(C)N1N=CC=C1C1=C(COC2=CC=CC(O)=C2C=O)C=CC=N1,direct
Thiothixene,psychosis,31,1,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1,direct
JARDIANCE,autoimmune disease,15,0,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C1,direct
JARDIANCE,hypertension,11,0,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C1,direct
SCENESSE,liver cirrhosis,4,0,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,direct
fenofibrate,liver cirrhosis,4,0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
Concept OB,autoimmune disease,15,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide",coronary artery disease,37,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Potassium Chloride,AIDS,10,0,[Cl-].[K+],direct
Memantine HCL,congestive heart failure,2,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
FENOFIBRIC ACID,mental illness,14,0,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
Alclometasone dipropionate,myocardial infarction,1,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])[C@H](Cl)CC2=CC(=O)C=C[C@]12C,direct
Sulfamethoxazole and Trimethoprim,severe infection,18,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Desmopressin Acetate,diabetes insipidus,773,1,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
MLK F4 Kit,asthma,12,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
PARAPLATIN,these outcomes,1313,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
prednisone,congestive heart failure,2,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
TAZORAC,anemia,13,0,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,direct
Clobetasol Propionate ANDA,hypertension,11,0,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Fosinopril Sodium and Hydrochlorothiazide,liver disease (non-cirrhotic),20,0,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,direct
Enalapril Maleate,AIDS,10,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution,diabetes mellitus,5,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
SILODOSIN,congestive heart failure,2,0,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,direct
"Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride",severe renal impairment,1253,1,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
Methylprednisolone Acetate,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Ursodiol 200 mg,autoimmune disease,15,0,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
Deferasorox,deferasirox oral granules,763,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Methenamine Mandelate,gout because it,840,1,C1N2CN3CN1CN(C2)C3,direct
PRAZIQUANTEL,cancer (localized),8,0,O=C(C1CCCCC1)N1CC2N(CCC3=CC=CC=C23)C(=O)C1,direct
Lumason,known or suspected,952,1,FS(F)(F)(F)(F)F,direct
Actoplus Met,severe renal impairment,1253,1,CN(C)C(=N)NC(N)=N,direct
Ala-Scalp,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
CHLORPROMAZINE HYDROCHLORIDE,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
ZIPSOR,renal failure,19,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
NALMEFENE HYDROCHLORIDE,hypersensitivity,313,1,OC1=CC=C2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](OC1=C24)C(=C)CC[C@@]35O,direct
ZOMIG,liver disease (non-cirrhotic),20,0,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
Plerixafor,cancer (metastatic),9,0,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
CHLORTHALIDONE CHLORTHALIDONE,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
QUININE SULFATE,diabetes mellitus,5,0,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12,direct
BENZPHETAMINE HYDROCHLORIDE,heart disease,377,1,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,direct
FULVESTRANT,hypersensitivity,313,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],direct
Physician EZ Use Joint Tunnel and Trigger Kit,liver cirrhosis,4,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Amiloride Hydrochloride,congestive heart failure,2,0,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
Ferrlecit,diabetes mellitus,5,0,[O--].[O--].[O--].[Na+].[Fe+3].[Fe+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,direct
SODIUM ACETATE,hypernatremia,135,1,[Na+].CC([O-])=O,direct
PharmapureRx Lidocaine HCl 4.12%,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
pentazocine and naloxone,cancer (metastatic),9,0,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,direct
Polymyxin B Sulfate and Trimethoprim,hypersensitivity,313,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Spritam,partial seizures,1104,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
PERCOCET,liver disease (non-cirrhotic),20,0,CC(=O)NC1=CC=C(O)C=C1,direct
ibuprofen,hypersensitivity,313,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Jentadueto,pancreatitis,233,1,CN(C)C(=N)NC(N)=N,direct
FASLODEX,diabetes mellitus,5,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],direct
CARBIDOPA AND LEVODOPA,asthma,12,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Afinitor,sega and tsc,1225,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,direct
Dextromethorphan Hydrobromide and Promethazine Hydrochloride,bone-marrow depression,639,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Methylphenidate,renal failure,19,0,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
Nystatin Cream,cancer (metastatic),9,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Imatinib,sepsis,17,0,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
itraconazole,hypersensitivity,313,1,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Azithromycin,pneumonia who,1132,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
INDERAL LA,diabetes mellitus,5,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Keppra,partial seizures,1104,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
Nitrofurantoin,myocardial infarction,1,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
VIIBRYD,chronic kidney disease,3,0,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,direct
Pregabalin,postherpetic neuralgia table,1146,1,CC(C)C[C@H](CN)CC(O)=O,direct
HYDROXYCHLOROQUINE SULFATE,asthma,12,0,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
Zintrexyl-C,anemia,13,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Azathioprine,rheumatoid arthritis,159,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
LAMIVUDINE and ZIDOVUDINE,diabetes mellitus,5,0,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
Multiple Electrolytes pH 5.5,hypersensitivity,313,1,[Cl-].[K+],direct
CAPLYTA,hypersensitivity,313,1,[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C,direct
Mefloquine Hydrochloride,pregnancy,16,0,OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F,direct
E.E.S 400,anemia,13,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
GLYBURIDE,non-insulin-dependent diabetes,1045,1,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,direct
PRAVASTATIN SODIUM,atherosclerosis,357,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
DISOPYRAMIDE PHOSPHATE,mental illness,14,0,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
Lurasidone hydrochloride,AIDS,10,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
zoledronic acid,sepsis,17,0,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
SUNITINIB MALATE,metastatic rcc,1005,1,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,direct
ISOVUE 300,cancer (metastatic),9,0,C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I,direct
MOMETASONE FUROATE,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Metoclopramide,liver disease (non-cirrhotic),20,0,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,direct
Trijardy XR,hypertension,11,0,CN(C)C(=N)NC(N)=N,direct
GEMCITABINE,hypersensitivity,313,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
CitraNatal 90 DHA,AIDS,10,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
LUMIGAN,glaucoma,481,1,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
CLOMID,hypertension,11,0,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
NRG Hemo-Stat,liver disease (non-cirrhotic),20,0,Cl[Al](Cl)Cl,direct
Clomid,severe infection,18,0,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE,hypersensitivity,313,1,CC(=O)OC1=CC=CC=C1C(O)=O,direct
Levobunolol Hydrochloride,severe infection,18,0,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCCC2=O,direct
NITROLINGUAL,myocardial infarction,1,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Betoptic S,sepsis,17,0,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
Tramadol Hydrochloride Extended-Release,anemia,13,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Meropenem and Sodium Chloride,bacterial meningitis,626,1,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
Protonix I.V.,hypertension,11,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Potassium Chloride in Lactated Ringers and Dextrose,brain edema,643,1,[Cl-].[K+],direct
Cartia XT,hypotension,75,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
clofarabine,pediatric patients,13,1,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,direct
Amiloride Hydrochloride and Hydrochlorothiazide,persistent hyperkalemia,1119,1,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
iopamidol,congestive heart failure,2,0,C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I,direct
XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE),tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
TRI-LUMA,anemia,13,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Cartia XT,hypersensitivity,313,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Sumansetron,severe infection,18,0,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,direct
clobazam,chronic obstructive pulmonary disease (COPD),6,0,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,direct
ACCURETIC,impaired liver function,918,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
INSADOL,cancer (localized),8,0,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CC[C@@H](CC)C(C)C,direct
Carbidopa-levodopa,narrow-angle glaucoma,1030,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
AMRIX,diabetes mellitus,5,0,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Oxycodone Hydchloride,asthma,193,1,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C,direct
Norepinephrine bitartrate,acute hypotensive states,540,1,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Travoprost Ophthalmic,chronic kidney disease,3,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Methylphenidate Hydrochloride,psychosis,31,1,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
Phenergan,hypertension,11,0,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
NITROGLYCERIN IN DEXTROSE,asthma,12,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Dihydroergotamine Mesylate Nasal,risk factors,1216,1,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
Namenda XR,hypersensitivity,313,1,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Tranexamic Acid in Sodium Chloride,hypertension,11,0,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE,severe infection,18,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Midazolam,cardiovascular instability,670,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Nitrofurantoin (monohydrate/macrocrystals),sepsis,17,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
DAPZURA RT,prosthetic valve endocarditis,1186,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
Telmisartan and Amlodipine,liver cirrhosis,4,0,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,direct
FENTORA,sepsis,17,0,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
Timolol Maleate,sinus bradycardia,1261,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Xtandi,metastatic crpc who,998,1,CNC(=O)C1=C(F)C=C(C=C1)N1C(=S)N(C(=O)C1(C)C)C1=CC=C(C#N)C(=C1)C(F)(F)F,direct
"Travoprost Ophthalmic Solution USP, 0.004% Travoprost",hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Promethazine Hydrochloride and Phenylephrine Hydrochloride,cancer (metastatic),9,0,CNC[C@H](O)C1=CC(O)=CC=C1,direct
Omnaris,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,direct
CLOMID,chronic obstructive pulmonary disease (COPD),6,0,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
BUDESONIDE,hypertension,11,0,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ALFA 0.9% SODIUM CHLORIDE,hypersensitivity,313,1,[Na+].[Cl-],fuzzy:0.9% sodium chloride
icosapent ethyl,pancreatitis,233,1,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Atomoxetine,chronic kidney disease,3,0,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
Citalopram Hydrobromide,chronic kidney disease,3,0,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
BRIMONIDINE TARTRATE,chronic kidney disease,3,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
TIAZAC EXTENDED RELEASE,severe infection,18,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
METHOTREXATE,non-neoplastic diseases,1051,1,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
Cyclobenzaprine HCL ER,severe infection,18,0,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Tacrolimus,hypersensitivity,313,1,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,direct
Lorazepam,severe infection,18,0,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,direct
Ranitidine Hydrochloride,cancer (metastatic),9,0,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O,direct
PROPAFENONE HYDROCHLORIDE,mental illness,14,0,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,direct
Erlotinib,congestive heart failure,2,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND,renal failure,19,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Vancomycin Hydrochloride for Oral Solution,liver cirrhosis,4,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
ERTAPENEM,hypersensitivity,313,1,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
CAPTOPRIL AND HYDROCHLOROTHIAZIDE,liver cirrhosis,4,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Diclofenac Sodium Delayed Release Delayed Release,cancer (localized),8,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
FENTANYL,anorexia,399,1,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
"CycloSPORINE, Modfied",chronic plaque psoriasis,702,1,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Donepezil hydrochloride,liver disease (non-cirrhotic),20,0,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
Cromolyn Sodium Inhalation Solution,chronic obstructive pulmonary disease (COPD),6,0,OC(COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O)COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O,direct
Dronabinol,autoimmune disease,15,0,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,direct
Cadira Compliant Blood Stat,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
AZACITIDINE AZACITIDINE,pregnancy,16,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Physician EZ Use Joint Tunnel and Trigger Kit II,active tuberculosis,535,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Se-Natal 19 Chewable,pregnancy,16,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Gadobutrol,diabetes mellitus,5,0,OC[C@H](O)[C@H](CO)[N+]12CC[N+]3(CC([O-])=O)CC[N+]4(CC([O-])=O)CC[N+](CC([O-])=O)(CC1)[Gd-]234,direct
nitroglycerin lingual,shock,419,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Fluocinolone Acetonide Oil,anemia,13,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Chlorpromazine Hydrochloride,stroke,7,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
Promethazine,hypertension,11,0,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
ZOLPIDEM TARTRATE,primary insomnia who,1177,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Xylocaine MPF,diabetes mellitus,5,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ENBREL,anemia,13,0,OCC1=CC=CC=C1,direct
FLUOCINONIDE,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,direct
Dihydroergotamine Mesylate,stroke,7,0,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
MYLERAN,hypertension,11,0,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
SUNOSI,liver disease (non-cirrhotic),20,0,N[C@@H](COC(N)=O)CC1=CC=CC=C1,direct
Potassium Chloride,hyperkalemia,131,1,[Cl-].[K+],direct
ZITUVIO,autoimmune disease,15,0,N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F,direct
Hyosyne,chronic kidney disease,3,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Cevimeline Hydrochloride,pregnancy,16,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
Tizanidine,multiple sclerosis,153,1,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
PRENATE DHA,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
0.9% SODIUM CHLORIDE,myocardial infarction,1,0,[Na+].[Cl-],direct
Focalin XR,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,direct
Memantine Hydrochloride,hypersensitivity,313,1,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
AZATHIOPRINE,leukemia,267,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Azelastine hydrochloride and Fluticasone propionate,severe infection,18,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
"Testosterone Gel, 1%",autoimmune disease,15,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Livalo,chronic kidney disease,3,0,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
Zydelig,asthma,12,0,[H][C@@](CC)(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,direct
Ifosfamide,asthma,12,0,ClCCNP1(=O)OCCCN1CCCl,direct
KENALOG-10,unexplained diarrhea,1341,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Tamiflu,hypersensitivity,313,1,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
DOXIL,multiple myeloma,1024,1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
KLAYESTA,congestive heart failure,2,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Nicotrol,anemia,13,0,CN1CCC[C@H]1C1=CN=CC=C1,direct
Pramipexole Dihydrochloride,AIDS,10,0,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
Zyprexa,hypertension,11,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Metoprolol,coronary artery disease,37,1,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
NITRO-BID,stroke,7,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
CLOBAZAM,pregnancy,16,0,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,direct
topotecan hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
APRISO,hypersensitivity,313,1,NC1=CC(C(O)=O)=C(O)C=C1,direct
IPRATROPIUM BROMIDE,diabetes mellitus,5,0,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,direct
Chlorothiazide Sodium,myocardial infarction,1,0,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
ChlorproMAZINE Hydrochloride,chronic kidney disease,3,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
LYVISPAH,hypersensitivity,313,1,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
MINOXIDIL,liver disease (non-cirrhotic),20,0,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1,direct
Sevelamer Hydrochloride,cancer (metastatic),9,0,NCC=C.ClCC1CO1,direct
Diclofenac potassium,stroke,7,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
hydrocortisone acetate pramoxine hcl,autoimmune disease,15,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Paclitaxel,and without neutropenia,595,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
PERPHENAZINE,mental retardation,993,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
CORTEF,severe infection,18,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Methoxsalen,congestive heart failure,2,0,COC1=C2OC(=O)C=CC2=CC2=C1OC=C2,direct
TESTOSTERONE CYPIONATE,asthma,12,0,[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
BETAMETHASONE VALERATE,renal failure,19,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Nitrofurantoin,hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
nystatin,hypersensitivity,313,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
AMIODARONE HCI,AIDS,10,0,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2,direct
ISOPROTERENOL HYDROCHLORIDE,chronic kidney disease,3,0,CC(C)NCC(O)C1=CC(O)=C(O)C=C1,direct
PROCHLORPERAZINE MALEATE,stroke,7,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Nitrofurantoin macrocrystals,severe infection,18,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
CARMUSTINE,cancer (metastatic),9,0,ClCCNC(=O)N(CCCl)N=O,direct
Tri-Legest Fe 28 Day,sepsis,17,0,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],direct
Nesina,hypertension,11,0,CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O,direct
Rubraca,neutropenia,85,1,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,direct
Ranolazine,cancer (metastatic),9,0,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,direct
Labetalol HCL,anemia,13,0,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
BRIDION,hypersensitivity,313,1,O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3O[C@H](CSCCC(O)=O)[C@@H](O[C@H]4O[C@H](CSCCC(O)=O)[C@@H](O[C@H]5O[C@H](CSCCC(O)=O)[C@@H](O[C@H]6O[C@H](CSCCC(O)=O)[C@@H](O[C@H]7O[C@H](CSCCC(O)=O)[C@@H](O[C@H]8O[C@H](CSCCC(O)=O)[C@@H](O[C@H]9O[C@H](CSCCC(O)=O)[C@@H](O[C@H]1O[C@@H]2CSCCC(O)=O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,direct
Meropenem,renal impairment,1211,1,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
Afinitor,tsc-associated partial-onset seizures,1328,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,direct
Hydroxym,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Dorzolamide HCl,hypertension,39,1,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Nitroglycerin Transdermal Infusion System,myocardial infarction,49,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
METRONIDAZOLE,hypersensitivity,313,1,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Butalbital/Acetaminophen/Caffeine,liver disease (non-cirrhotic),20,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Pimozide,diabetes mellitus,5,0,FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1,direct
CORTEF,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
IPRATROPIUM BROMIDE,the common cold,1297,1,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,direct
Pantoprazole,cancer (metastatic),9,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
CIMDUO,mental illness,14,0,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,direct
Mexiletine Hydrochloride,life-threatening ventricular arrhythmia,965,1,CC(N)COC1=C(C)C=CC=C1C,direct
ABRILADA,chronic obstructive pulmonary disease (COPD),6,0,CC(C)O,direct
Dorzolamide and Timolol,myocardial infarction,1,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
LAMICTAL,partial-onset seizures who,1108,1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
Tolectin,chronic obstructive pulmonary disease (COPD),6,0,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,fuzzy:tolmetin
FLUDROCORTISONE ACETATE,active tuberculosis,535,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
BRINZOLAMIDE,hypertension,39,1,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
ONDANSETRON,severe infection,18,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Phenergan,cancer (localized),8,0,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
LAMOTRIGINE,pediatric patients,13,1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
Octreotide,autoimmune disease,15,0,C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=CC=CC=C23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,fuzzy:edotreotide
Hyoscyamine sulfate,severe infection,18,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
TAUVID,liver disease (non-cirrhotic),20,0,[18F]C1=CC=C(C=N1)C1=CC=C2C(NC3=C2C=NC=C3)=C1,direct
Diclofenac potassium,mental illness,14,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
ESTRACE,congestive heart failure,2,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
cefazolin,tics,23,1,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,direct
Latanoprost,autoimmune disease,15,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Methylprednisolone Sodium Succinate,autoimmune disease,15,0,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
INVOKAMET,hypersensitivity,313,1,CN(C)C(=N)NC(N)=N,direct
Protriptyline Hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,CNCCCC1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Solution,AIDS,10,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
PHENYTOIN SODIUM,cancer (localized),8,0,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Foltamin,hypertension,11,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Prednisolone Sodium Phosphate,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Clonidine transdermal system,hypersensitivity,313,1,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
Dexamethasone Sodium Phosphate,cerebral malaria,674,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Cyclogyl,liver disease (non-cirrhotic),20,0,CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1,direct
AMITRIPTYLINE HCL,congestive heart failure,2,0,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
"Brompheniramine, Pseudoephedrine, Dextromethorphan",hypertension,39,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Cotellic,AIDS,10,0,OC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)[C@@H]1CCCCN1,direct
RESTASIS,anemia,13,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Nystatin Cream,renal failure,19,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Deferasirox Oral Granules,decreased egfr,761,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Lidotran,renal failure,19,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE,liver disease (non-cirrhotic),20,0,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3,direct
adenosine,autoimmune disease,15,0,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
Amantadine HCl,autoimmune disease,15,0,NC12CC3CC(CC(C3)C1)C2,direct
Magnesium Sulfate,liver cirrhosis,4,0,[Mg++].[O-]S([O-])(=O)=O,direct
Clindamycin Phosphate and Tretinoin,renal failure,19,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
Albendazole,congestive heart failure,2,0,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,direct
deferasirox,ntdt abbreviation,1070,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Anti Aging Serum,renal failure,257,1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,fuzzy:anti-aging serum
Tolcapone,AIDS,10,0,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,direct
Afinitor,AIDS,10,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,direct
Xylocaine,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
PHENYTOIN SODIUM,osteoporosis,163,1,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Promethazine Hydrochloride and Phenylephrine Hydrochloride,bone marrow depression,637,1,CNC[C@H](O)C1=CC(O)=CC=C1,direct
febuxostat,autoimmune disease,15,0,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
Alclometasone dipropionate,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])[C@H](Cl)CC2=CC(=O)C=C[C@]12C,direct
XACIATO,bacterial vaginosis,627,1,[H][C@@](NC(=O)[C@@H]1C[C@@H](CCC)CN1C)([C@H](C)Cl)[C@@]1([H])O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O,direct
Etodolac,hypersensitivity,313,1,CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1,direct
Dobutamine,hypersensitivity,313,1,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
Caffeine Citrate Oral Solution,autoimmune disease,15,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
bivalirudin,thrombocytopenia,79,1,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,direct
AVYCAZ,hypersensitivity,313,1,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
Vaseline Moisturizing Cream,renal failure,257,1,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,fuzzy:viractin moisturizing cream
Cinacalcet,ckd who,716,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Metronidazole500 mg 500 mg,hypersensitivity,313,1,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Vizamyl,diabetes mellitus,5,0,CNC1=C([18F])C=C(C=C1)C1=NC2=CC=C(O)C=C2S1,direct
LEVALBUTEROL,cancer (metastatic),9,0,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
pentamidine isethionate,hypersensitivity,313,1,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
Diclona,hypersensitivity,313,1,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,fuzzy:diclonina
Metyrosine,pregnancy,16,0,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,direct
Oxaliplatin,chronic obstructive pulmonary disease (COPD),6,0,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,direct
Imipramine hydrochloride,liver cirrhosis,4,0,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
olanzapine,schizophrenia and,1220,1,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
ProAir Digihaler,hypersensitivity,313,1,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Telmisartan and Amlodipine,stroke,51,1,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,direct
Zilretta,mental illness,14,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
BORTEZOMIB,diabetes mellitus,5,0,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
imatinib mesylate,cancer (metastatic),9,0,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Nitrofurantoin Monohydrate/Macrocrystals,hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Fludrocortisone acetate,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
erythromycin,pregnancy,16,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
SUNOSI,narcolepsy or osa,1028,1,N[C@@H](COC(N)=O)CC1=CC=CC=C1,direct
Carbidopa and Levodopa,narrow-angle glaucoma,1030,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Naproxen Sodium,the aspirin triad,1295,1,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O,direct
Zetia,hypersensitivity,313,1,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
ProAir RespiClick,stroke,7,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Zyprexa,schizophrenia and,1220,1,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Korlym,hypertension,11,0,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],direct
Vitrexyl plus Iron,liver cirrhosis,4,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
NIFEdipine,aortic stenosis,55,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Ambien CR,cancer (metastatic),9,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Docetaxel anhydrous,chronic kidney disease,3,0,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
Dialyvite Supreme D,asthma,12,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Chlorothiazide Sodium,hypertension,11,0,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
Dialyvite 5000,hypersensitivity,313,1,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
ORPHENGESIC FORTE,chronic obstructive pulmonary disease (COPD),6,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
spironolactone,severe infection,18,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
Rubraca,liver disease (non-cirrhotic),20,0,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,direct
FLUTICASONE PROPIONATE,diabetes mellitus,5,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
nebivolol,renal failure,19,0,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
caspofungin acetate,concomitant opc,742,1,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
Sulfamethoxazole and Trimethoprim,thrombocytopenia,79,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Leflunomide,liver disease (non-cirrhotic),20,0,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
nifedipine,renal failure,19,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
FLUCONAZOLE,cancer (metastatic),9,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
QUININE SULFATE,congestive heart failure,2,0,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12,direct
Dexatran,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Toronova SUIK,hypertension,11,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Renova,this condition,1315,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
TRIAMCINOLONE ACETONIDE,pregnancy,16,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Simvastatin,myocardial infarction,49,1,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
E-Z-Disk,hypersensitivity,313,1,[Ba++].[O-]S([O-])(=O)=O,direct
Levbid,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
CYCLOPHOSPHAMIDE,anemia,13,0,ClCCN(CCCl)P1(=O)NCCCO1,direct
Diphenoxylate hydrochloride and atropine sulfate,obstructive jaundice,1073,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
Nebivolol Hydrochloride,pregnancy,16,0,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
OXCARBAZEPINE,anorexia,399,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
risedronate sodium,the following conditions,1301,1,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE,chronic obstructive pulmonary disease (COPD),6,0,CC(=O)OC1=CC=CC=C1C(O)=O,direct
Oxycodone Hydrochloride and Acetaminophen,diabetes mellitus,5,0,CC(=O)NC1=CC=C(O)C=C1,direct
Bupivacaine HCl,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Nystatin and triamcinolone acetonide,mental illness,14,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ARGATROBAN,myocardial infarction,1,0,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2,direct
DEFERASIROX,deferasirox tablets,764,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
ERYTHROMYCIN ETHYLSUCCINATE,congestive heart failure,2,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
desmopressin acetate,hyponatremia,137,1,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
Desipramine HCL,impaired renal function,919,1,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
DOFETILIDE,a recent mi,507,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Rifadin IV,anemia,13,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
Hydrocodone Bitartrate And Acetaminophen,hypertension,11,0,CC(=O)NC1=CC=C(O)C=C1,direct
LEVOLEUCOVORIN CALCIUM,myocardial infarction,1,0,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
AMINOPHYLLINE,pregnancy,16,0,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Methocarbamol,mental illness,14,0,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
lenalidomide,asthma,12,0,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
Memantine,sepsis,17,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Aspirin and Extended-Release Dipyridamole,hypersensitivity,313,1,CC(=O)OC1=CC=CC=C1C(O)=O,direct
Sunitinib malate,stroke,7,0,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,direct
vancomycin hydrochloride,hypersensitivity,313,1,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
Mexiletine Hydrochloride,ventricular arrhythmias,1354,1,CC(N)COC1=C(C)C=CC=C1C,direct
CEFEPIME HYDROCHLORIDE AND DEXTROSE,renal failure,19,0,CO\N=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1,direct
nitroglycerin lingual,sepsis,17,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Midazolam in Sodium Chloride,cardiovascular instability,670,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Zestoretic,diabetes mellitus,5,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Aminocaproic Acid,pregnancy,16,0,NCCCCCC(O)=O,direct
GLYCOPYRROLATE 1ML,ileostomy or colostomy,910,1,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
TOPIRAMATE,hypersensitivity,313,1,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,direct
SILVER SULFADIAZINE,liver cirrhosis,4,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
Quinine Sulfate,anemia,13,0,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12,direct
Succinylcholine,mental illness,14,0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,direct
ERLOTINIB,nsclc whose tumors,1069,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
NAROPIN,hypersensitivity,313,1,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
Qbrelis,hypertension,39,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Enalapril maleate and hydrochlorothiazide,diabetes mellitus,5,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
Rectiv,anemia,81,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Progesterone,cancer (metastatic),9,0,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
TRANEXAMIC ACID,severe infection,18,0,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
ASENAPINE,mania,29,1,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
ISOSORBIDE DINITRATE,myocardial infarction,49,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
CELECOXIB,liver disease (non-cirrhotic),20,0,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
XPOVIO,autoimmune disease,15,0,FC(F)(F)C1=CC(=CC(=C1)C1=NN(\C=C/C(=O)NNC2=NC=CN=C2)C=N1)C(F)(F)F,direct
BACLOFEN,congestive heart failure,2,0,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
ANCOBON,bone marrow depression,637,1,NC1=C(F)C=NC(=O)N1,direct
Lidotran,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Albendazole,anemia,13,0,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,direct
Liothyronine Sodium,cancer (metastatic),9,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
Hyoscyamine Sulfate,asthma,12,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Azopt,hypertension,39,1,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Arestin,adult periodontitis,558,1,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,direct
PNV-Select,nutritional deficiencies or,1071,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Doxercalciferol,myocardial infarction,1,0,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
MEROPENEM,renal impairment,1211,1,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
benazepril hydrochloride and hydrochlorothiazide,allergy and asthma,586,1,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,direct
Folcyteine,liver cirrhosis,4,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Definity,diabetes mellitus,5,0,FC(F)(F)C(F)(F)C(F)(F)F,direct
Doxycycline hyclate,myocardial infarction,1,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Nestabs ONE,hypertension,11,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Deferiprone,renal failure,19,0,CN1C=CC(=O)C(O)=C1C,direct
VILAZODONE HYDROCHLORIDE,liver cirrhosis,4,0,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,direct
Betaxolol,renal failure,19,0,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
Irbesartan and Hydrochlorothiazide,hypersensitivity,313,1,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
NITROSTAT,shock,419,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
ACETAZOLAMIDE EXTENDED-RELEASE,autoimmune disease,15,0,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
Lyrica,mental illness,14,0,CC(C)C[C@H](CN)CC(O)=O,direct
Tetracaine HCL,diabetes mellitus,5,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
sevelamer carbonate,pregnancy,16,0,NCC=C.ClCC1CO1,direct
Azelastine hydrochloride and Fluticasone propionate,mental illness,14,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
CYTARABINE,asthma,12,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,direct
TEMOZOLOMIDE,severe infection,18,0,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
Galantamine hydrobromide,stroke,7,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",cancer (metastatic),9,0,CC(N)CC1=CC=CC=C1,direct
thiothixene,psychosis,31,1,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1,direct
LIPIODOL,pelvic inflammatory disease,339,1,COC1=CC=C(C=C1)C(=O)CC(=O)C1=CC=C(C=C1)C(C)(C)C,fuzzy:lipidol
CIDOFOVIR DIHYDRATE,autoimmune disease,15,0,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,direct
Desoximetasone,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Trelstar,advanced prostate cancer,567,1,CC(C)C[C@H](NC(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,direct
Nitroglycerin Transdermal Infusion System,liver cirrhosis,4,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
caspofungin acetate,invasive aspergillosis,944,1,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
Amlodipine and Olmesartan Medoxomil,hypertension,39,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
TIAGABINE HYDROCHLORIDE,myocardial infarction,1,0,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1,direct
Valsartan and Hydrochlorothiazide,severe hypertension,1246,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
VARENICLINE TARTRATE,pregnancy,16,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Methylene blue,pregnancy,16,0,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,direct
"Lansoprazole, Amoxicillin, Clarithromycin",liver cirrhosis,4,0,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
IRBESARTAN AND HYDROCHLOROTHIAZIDE,chronic obstructive pulmonary disease (COPD),6,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
gadobutrol,myocardial infarction,1,0,OC[C@H](O)[C@H](CO)[N+]12CC[N+]3(CC([O-])=O)CC[N+]4(CC([O-])=O)CC[N+](CC([O-])=O)(CC1)[Gd-]234,direct
HYALURONIDASE,renal failure,19,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
prednisone,AIDS,10,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
chlorothiazide sodium,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
Chlorpromazine hydrochloride,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
Differin,chronic obstructive pulmonary disease (COPD),6,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Tafluprost,chronic kidney disease,3,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
Claravis,liver cirrhosis,4,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Analpram HC,hypersensitivity,313,1,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
DALFAMPRIDINE,severe infection,18,0,NC1=CC=NC=C1,direct
Meropenem and Sodium Chloride,renal impairment,1211,1,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
CEFPODOXIME PROXETIL,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]12SCC(COC)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
Allopurinol,diabetes mellitus,5,0,OC1=NC=NC2=C1C=NN2,direct
"Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide",hypersensitivity,313,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Prednisolone Sodium Phosphate,cancer (metastatic),9,0,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Dialyvite with Zinc,cancer (metastatic),9,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
TESTOSTERONE ENANTHATE,AIDS,10,0,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
HULIO,active psoriatic arthritis,533,1,CC(C)O,direct
Deferiprone,hypersensitivity,313,1,CN1C=CC(=O)C(O)=C1C,direct
Bortezomib,anemia,81,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Montelukast Sodium,AIDS,10,0,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
DOXIL,multiple myeloma who,1025,1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
Zingo,severe infection,18,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Spravato,insomnia,441,1,CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl,direct
XYLOCAINE,autoimmune disease,15,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
nebivolol,hypertension,11,0,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
Aubagio,diabetes mellitus,5,0,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
Celontin,hypersensitivity,313,1,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1,direct
LATANOPROST,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Cyclosporine,chronic kidney disease,3,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
abiraterone acetate,liver metastases,967,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Testosterone Cypionate,liver cirrhosis,4,0,[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
DOCETAXEL,pre-existing liver disorders,1151,1,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
Pentamidine Isethionate,pregnancy,16,0,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
Exforge,liver disease (non-cirrhotic),20,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Potassium Chloride Extended-Release,hyperkalemia,131,1,[Cl-].[K+],direct
DOXAPRAM HYDROCHLORIDE,severe cardiovascular diseases,1240,1,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,direct
PROPOFOL,chronic kidney disease,3,0,CC(C)C1=CC=CC(C(C)C)=C1O,direct
NICARDIPINE HYDROCHLORIDE,aortic stenosis,55,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
Terconazole,autoimmune disease,15,0,CC(C)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Lomotil,infectious diarrhea lomotil,933,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
Prevacid,congestive heart failure,2,0,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Edaravone,liver disease (non-cirrhotic),20,0,CC1=NN(C(=O)C1)C1=CC=CC=C1,direct
ZIANA,cancer (localized),8,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
Fluticasone Propionate and Salmeterol,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Adapalene and Benzoyl Peroxide,chronic obstructive pulmonary disease (COPD),6,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Levetiracetam Levetiracetam,anemia,13,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Oxycodone and Aspirin,cancer (localized),8,0,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C,direct
METOPROLOL TARTRATE,arrhythmia,43,1,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
simvastatin,myocardial infarction,49,1,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
ZIANA,acne vulgaris,516,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
captopril,AIDS,10,0,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,direct
Galantamine hydrobromide,myocardial infarction,1,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
FERRIPROX,hypersensitivity,313,1,CN1C=CC(=O)C(O)=C1C,direct
Eucrisa,hypersensitivity,313,1,OB1OCC2=C1C=CC(OC1=CC=C(C=C1)C#N)=C2,direct
lacosamide,pregnancy,16,0,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
Amantadine,severe infection,18,0,NC12CC3CC(CC(C3)C1)C2,direct
PrednisoLONE,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Melphalan Hydrochloride,asthma,12,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
AMLODIPINE and OLMESARTAN medoxomil,stroke,51,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
VELCADE,mental illness,14,0,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Mestinon,bronchial asthma,650,1,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Tadalafil,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]12CC3=C(NC4=CC=CC=C34)[C@H](N1C(=O)CN(C)C2=O)C1=CC2=C(OCO2)C=C1,direct
SULINDAC,asthma,12,0,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O,direct
TRAMADOL HYDROCHLORIDE,gastrointestinal conditions tramadol,830,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
zoledronic acid,bone metastases,638,1,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
Nystatin and triamcinolone acetonide,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Xanax XR,ataxia,465,1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
Imbruvica,sepsis,17,0,NC1=NC=NC2=C1C(=NN2[C@@H]1CCCN(C1)C(=O)C=C)C1=CC=C(OC2=CC=CC=C2)C=C1,direct
HALOPERIDOL LACTATE,dementia,7,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Tilia Fe,liver disease (non-cirrhotic),20,0,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],direct
Lansoprazole,autoimmune disease,15,0,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Protonix Delayed-Release,mental illness,14,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Diclona Patch,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Disopyramide Phosphate,myocardial infarction,49,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
Tazarotene,acne vulgaris,516,1,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,direct
phenelzine sulfate,cancer (metastatic),9,0,NNCCC1=CC=CC=C1,direct
LEVETIRACETAM,autoimmune disease,15,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
ZOCOR,congestive heart failure,2,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
TRAMADOL HYDROCHLORIDE,hypertension,11,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Ropidex,asthma,12,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
Quinidine Gluconate,liver disease (non-cirrhotic),20,0,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
MARINOL,congestive heart failure,2,0,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,direct
ZENATANE,AIDS,10,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Mepivacaine Hydrochloride,stroke,7,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
ethacrynic acid,arrhythmia,43,1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
haloperidol,asthma,12,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Toronova SUIK,autoimmune disease,15,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
BUPIVACAINE HYDROCHLORIDE,anemia,13,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Zytiga,metastatic crpc,997,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Suprane,liver disease (non-cirrhotic),20,0,FC(F)OC(F)C(F)(F)F,direct
SPRYCEL,pediatric patients,13,1,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
Brimonidine Tartrate,cancer (metastatic),9,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Rivastigmine,pregnancy,16,0,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,direct
Diclona Gel,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Ceftriaxone,tics,23,1,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
Lactated Ringers,severe infection,18,0,[Cl-].[K+],direct
Nabumetone,hypersensitivity,313,1,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
"AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE",hypercalcemia,139,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Propranolol Hydrochloride,asthma,12,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
FLEQSUVY,hypersensitivity to baclofen,884,1,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
VIDAZA,hypersensitivity,313,1,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
IQ Dental Mepivacaine,tics,23,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
tofacitinib,congestive heart failure,2,0,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,direct
Valsartan and Hydrochlorothiazide,severe infection,18,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Mycostatin,hypertension,11,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
propofol,liver disease (non-cirrhotic),20,0,CC(C)C1=CC=CC(C(C)C)=C1O,direct
ICOSAPENT ETHYL,myocardial infarction,1,0,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
OXBRYTA,hypersensitivity,313,1,CC(C)N1N=CC=C1C1=C(COC2=CC=CC(O)=C2C=O)C=CC=N1,direct
Proparacaine Hydrochloride,mental illness,14,0,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,direct
NITROFURANTOIN (monohydrate/macrocrystals),AIDS,10,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Molindone Hydrochloride,hypersensitivity,313,1,CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2,direct
Metronidazole500 mg 500 mg,cancer (metastatic),9,0,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Levsin SL,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Kiprofen,myocardial infarction,1,0,CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1,direct
Leflunomide,autoimmune disease,15,0,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
Aripiprazole,hypersensitivity,313,1,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
AMPYRA,sepsis,17,0,NC1=CC=NC=C1,direct
bortezomib,anemia,81,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Lacosamide,severe infection,18,0,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
XACIATO,pregnancy,16,0,[H][C@@](NC(=O)[C@@H]1C[C@@H](CCC)CN1C)([C@H](C)Cl)[C@@]1([H])O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O,direct
Evoxac,other conditions,1087,1,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
DISOPYRAMIDE PHOSPHATE,life-threatening arrhythmias who,964,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
Neoral,chronic plaque psoriasis,702,1,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Pindolol,tics,23,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,direct
"Butalbital, Acetaminophen and Caffeine",chronic obstructive pulmonary disease (COPD),6,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
SODIUM CHLORIDE,chronic obstructive pulmonary disease (COPD),6,0,[Na+].[Cl-],direct
Perphenazine,mental retardation,993,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
pioglitazone,liver disease (non-cirrhotic),20,0,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
citalopram hydrobromide,chronic obstructive pulmonary disease (COPD),6,0,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
Telmisartan and Amlodipine,cancer (localized),8,0,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,direct
NADOLOL,asthma,12,0,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,direct
FLUCYTOSINE,chronic kidney disease,3,0,NC1=C(F)C=NC(=O)N1,direct
Cefuroxime,tics,23,1,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,direct
Nitrofurantoin Monohydrate/Macrocrystals,renal failure,19,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
CISPLATIN,sepsis,17,0,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
Qbrexza,hypertension,11,0,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
voriconazole,liver disease (non-cirrhotic),20,0,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Cevimeline,cancer (localized),8,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
Olanzapine,agitation,21,1,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Tolmetin Sodium,sepsis,17,0,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,direct
Beleodaq,autoimmune disease,15,0,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1,direct
Lodosyn,narrow-angle glaucoma,1030,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Alimta,mpm who,1020,1,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
Amoxapine,depressive symptoms,769,1,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1,direct
ROSUVASTATIN,myocardial infarction,1,0,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Azelastine hydrochloride and Fluticasone propionate,congestive heart failure,2,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Alprazolam Extended Release,congestive heart failure,2,0,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
OLANZAPINE,mental illness,14,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
teriflunomide,AIDS,10,0,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
Sodium Chloride,restricted oral intake,1214,1,[Na+].[Cl-],direct
TOLMETIN SODIUM,anemia,13,0,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,direct
Captopril,skin rash,1262,1,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,direct
FLAVOXATE HYDROCHLORIDE,anemia,13,0,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,direct
Pemetrexed,anemia,13,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
Norgesic Forte,diabetes mellitus,5,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
VIVIMUSTA,nhl who,1039,1,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
SODIUM CHLORIDE,cancer (localized),8,0,[Na+].[Cl-],direct
ERYTHROMYCIN,renal failure,19,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
CAPLYTA,liver cirrhosis,4,0,[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C,direct
Catapres-TTS-1,hypersensitivity,313,1,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE,sepsis,17,0,CC(=O)OC1=CC=CC=C1C(O)=O,direct
Lidocaine Hydrochloride and Hydrocortisone Acetate,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
DOXYCYCLINE,sepsis,17,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Estradiol Valerate,liver disease (non-cirrhotic),20,0,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Dorzolamide hydrochloride,glaucoma,481,1,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Glucagon,anemia,13,0,O,direct
leflunomide,hypersensitivity,313,1,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
Chlordiazepoxide and Amitriptyline Hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Ondansetron,hypertension,11,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Norgesic Forte,stroke,7,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Tobramycin,pseudomonas aeruginosa,1188,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
AcetaZOLAMIDE,pregnancy,16,0,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
ITRACONAZOLE,renal failure,19,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
zolmitriptan,diabetes mellitus,5,0,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
Pentobarbital Sodium,liver cirrhosis,4,0,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,direct
Oseltamivir,severe infection,18,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
Methocarbamol and Aspirin,chronic urticaria,708,1,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
Effer-K Orange,chronic kidney disease,3,0,[K+].OC([O-])=O,direct
ICOSAPENT ETHYL,severe hypertriglyceridemia,1247,1,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Dexlido Kit,pregnancy,16,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
zolpidem tartrate,chronic kidney disease,3,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Dofetilide,long qt syndrome,61,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
ALTAFLUOR,hypersensitivity,313,1,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
Penicillin G Potassium,hypertension,11,0,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,direct
Valsartan,hypersensitivity,313,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Azathioprine,liver cirrhosis,4,0,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Dyural L Kit,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
isosorbide mononitrate,severe infection,18,0,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,direct
Flotrex,hypersensitivity,313,1,NCCCC(N)(C(F)F)C(O)=O,fuzzy:florexa
CLOMID,any visual symptoms,609,1,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
Vancomycin Hydrochloride for Oral Solution,diabetes mellitus,5,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
Colazal,ulcerative colitis,225,1,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,direct
PAMELOR,sepsis,17,0,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
DYMISTA,seasonal allergic rhinitis,1223,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Folixapure,mental illness,14,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Cefotetan,asthma,12,0,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)OC)C(O)=O,direct
Chlorthalidone,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
CALCIUM CHLORIDE,chronic kidney disease,3,0,[Cl-].[Cl-].[Ca++],direct
Bactrim,anemia,13,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Sofosbuvir and Velpatasvir,severe infection,18,0,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
Procto-Med HC,mental illness,14,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
nitrofurantoin macrocrystals,hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Dutasteride and tamsulosin hydrochloride,liver disease (non-cirrhotic),20,0,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O,direct
DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE,hypersensitivity,313,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
PAROXETINE,depressive symptoms,769,1,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Morphine Sulfate,cancer (localized),8,0,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,direct
Cefotan,tics,23,1,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)OC)C(O)=O,direct
DIMETHYL FUMARATE,chronic kidney disease,3,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
"Butalbital, Aspirin, and Caffeine",pregnancy,16,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
SYMPAZAN,hypertension,11,0,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,direct
perphenazine,psychosis,31,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Sunitinib Malate,metastatic rcc,1005,1,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,direct
VENLAFAXINE,chronic kidney disease,3,0,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
Leep RediKit,AIDS,10,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ACETAZOLAMIDE EXTENDED-RELEASE,stroke,7,0,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
Dutasteride and tamsulosin hydrochloride,chronic kidney disease,3,0,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O,direct
IMATINIB MESYLATE,neutropenia,85,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
DISOPYRAMIDE PHOSPHATE,urinary retention,1347,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
PROVAYBLUE,pediatric patients,13,1,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,direct
Fenofibric acid,chronic kidney disease,3,0,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
Omnaris,AIDS,10,0,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,direct
Ambien,chronic insomnia who,690,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Tobramycin Ophthalmic Solution,diabetes mellitus,5,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",the following conditions,1301,1,CC(N)CC1=CC=CC=C1,direct
Irinotecan hydrochloide,diabetes mellitus,5,0,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
XYLOCAINE-MPF WITH EPI,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Galantamine hydrobromide,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
Labetalol HCL,chronic obstructive pulmonary disease (COPD),6,0,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Brimonidine Tartrate,hypersensitivity,313,1,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Aminophylline,hypersensitivity,313,1,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
DISOPYRAMIDE PHOSPHATE,myocardial infarction,49,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
hydrocortisone valerate cream,sepsis,17,0,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Tikosyn,paroxysmal atrial fibrillation,1102,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Deferasirox Oral Granules,advanced malignancies,563,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Quinidine Gluconate,anemia,13,0,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
Hydrochlorothiazide,imparied renal function,922,1,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
VALSARTAN AND HYDROCHLOROTHIAZIDE,severe hypertension,1246,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Cimetidine,asthma,12,0,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N,direct
ACETAZOLAMIDE,cirrhosis,231,1,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
Enalaprilat,renal failure,19,0,[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@@]1([H])C(O)=O,direct
Ceftazidime,severe infection,18,0,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
Buprenorphine Hydrochloride,cancer (localized),8,0,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,direct
Migranow,risk factors,1216,1,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,direct
BETAXOLOL HYDROCHLORIDE,liver cirrhosis,4,0,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
Pravastatin sodium,clinically evident chd,718,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Phenohytro,hypersensitivity,313,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
NOCDURNA,cancer (localized),8,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
DOXEPIN HYDROCHLORIDE,glaucoma,481,1,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
PRENATE Enhance,autoimmune disease,15,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Fluphenazine hydrochloride,dementia,7,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
CitraNatal Assure,sepsis,17,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Etodolac ER,autoimmune disease,15,0,CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1,direct
Dexamethasone Intensol,tuberculosis,213,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ELEPSIA XR 1000 MG,hypersensitivity,313,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
Trecator,hepatic impairment,1,1,CCC1=NC=CC(=C1)C(N)=S,direct
Lidocaine HCl,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Potassium Citrate,liver disease (non-cirrhotic),20,0,[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,direct
ropivacaine hydrochloride,hypersensitivity,313,1,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
"Sodium Sulfate, Potassium Sulfate, and Magnesium Sulfate Bowel Prep kit",pregnancy,16,0,[Mg++].[O-]S([O-])(=O)=O,"fuzzy:sodium sulfate, potassium sulfate and magnesium sulfate oral"
BETAMETHASONE VALERATE,liver cirrhosis,4,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
GaviLyte - C TM,ulcerative colitis,225,1,[Cl-].[K+],direct
Nipent,hairy cell leukemia,845,1,OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CNC[C@H]2O,direct
Vascepa,severe hypertriglyceridemia,1247,1,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Prochlorperazine Maleate,liver disease (non-cirrhotic),20,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Carvedilol,renal failure,19,0,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
Flecainide Acetate,paroxysmal atrial fibrillation,1102,1,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1,direct
Itraconazole Oral,diabetes mellitus,5,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Erythromycin ethylsuccinate,asthma,12,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
DISOPYRAMIDE PHOSPHATE,ventricular arrhythmias,1354,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
Benazepril Hydrochloride and Hydrochlorothiazide,allergy and asthma,586,1,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,direct
benazepril hydrochloride and hydrochlorothiazide,chronic kidney disease,3,0,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,direct
Renvela,cancer (localized),8,0,NCC=C.ClCC1CO1,direct
"SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE",liver disease (non-cirrhotic),20,0,[Mg++].[O-]S([O-])(=O)=O,direct
Aripiprazole,cancer (localized),8,0,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
Clonidine transdermal system,liver cirrhosis,4,0,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
EDECRIN,cancer (localized),8,0,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
bendamustine hydrochloride,chronic lymphocytic leukemia,693,1,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Zytiga,stroke,7,0,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
ZENATANE,tics,23,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Quinapril and Hydrochlorothiazide 10/12.5,pre-existing renal impairment,1152,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Daraprim,myocardial infarction,1,0,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1,direct
Cisatracurium,hypersensitivity,313,1,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,direct
Juxtapid,hypercholesterolemia who,877,1,FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=C(C=CC=C2)C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=CC=CC=C12,direct
NITROGLYCERIN IN DEXTROSE,cancer (metastatic),9,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Zytiga,metastatic crpc who,998,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
ACCOLATE,liver disease (non-cirrhotic),20,0,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,direct
Regadenoson,chronic obstructive pulmonary disease (COPD),6,0,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
Effient,acs undergoing pci,519,1,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,direct
Cevimeline Hydrochloride,diabetes mellitus,5,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
Latuda,liver disease (non-cirrhotic),20,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
PHENERGAN,depression,27,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
MUPIROCIN,congestive heart failure,2,0,C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O,direct
Claravis,disorders of keratinization,779,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Ribavirin,congestive heart failure,2,0,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Venexa FE,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Sinuva,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Levetiracetam,mental illness,14,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Valsartan and Hydrochlorothiazide,hypersensitivity,313,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
THAM,hypertension,11,0,NC(CO)(CO)CO,direct
POLOCAINE(R) -MPF (MEPIVACAINE HCI),chronic kidney disease,3,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
ranolazine,chronic angina,684,1,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,direct
Targretin,hypersensitivity,313,1,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,direct
Omeprazole DR,hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Lenvima,pmmr or,1130,1,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,direct
Aubagio,multiple sclerosis,153,1,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
epoprostenol,congestive heart failure,41,1,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,direct
"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",comorbid depressive symptoms,735,1,CC(N)CC1=CC=CC=C1,direct
BUPIVACAINE HYDROCHLORIDE,chronic kidney disease,3,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
DILTIAZEM HCI,ventricular tachycardia,1357,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Amnesteem,edema,417,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Sotalol Hydrochloride AF,bronchospastic diseases,653,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
COSOPT PF,mental illness,14,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Lidolog Kit,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Sevelamer Hydrochloride,bowel obstruction,641,1,NCC=C.ClCC1CO1,direct
Aztreonam,renal failure,19,0,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(=O)O)\C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O,direct
Lumryz,pediatric patients,13,1,[Na+].OCCCC([O-])=O,direct
bupropion hydrochloride,asthma,12,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Rocklatan,anemia,13,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
TAZVERIK,sepsis,17,0,CCN(C1CCOCC1)C1=C(C)C(=CC(=C1)C1=CC=C(CN2CCOCC2)C=C1)C(=O)NCC1=C(C)C=C(C)NC1=O,direct
VELCADE,anemia,81,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
LAMOTRIGINE Kit,stroke,7,0,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
Hydroxyzine HCL,renal failure,19,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Docetaxel anhydrous,pre-existing liver disorders,1151,1,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
"butalbital, aspirin, and caffeine",hypertension,11,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Litfulo,renal failure,19,0,C[C@H]1CC[C@H](CN1C(=O)C=C)NC1=NC=NC2=C1C=CN2,direct
Hyoscyamine Sulfate TAB,renal failure,19,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Flecainide Acetate,ventricular arrhythmias,1354,1,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1,direct
Ethacrynic Sodium,hypokalemia,133,1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Chemet,hypertension,11,0,OC(=O)[C@@H](S)[C@@H](S)C(O)=O,direct
Fenofibric acid,asthma,12,0,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
Ranitidine,hypertension,11,0,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O,direct
Rifadin IV NOVAPLUS,compromised adrenal function,737,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
Orgovyx,advanced prostate cancer,567,1,CONC(=O)NC1=CC=C(C=C1)C1=C(CN(C)C)C2=C(S1)N(CC1=C(F)C=CC=C1F)C(=O)N(C2=O)C1=CC=C(OC)N=N1,direct
Progesterone,myocardial infarction,1,0,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Triamcinolone Acetonide,autoimmune disease,15,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Benzphetamine Hydrochloride,pregnancy,16,0,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,direct
ZEPZELCA,advanced solid tumors,572,1,[H][C@@]12[C@@H]3SC[C@]4(NCCC5=C4NC4=CC=C(OC)C=C54)C(=O)OC[C@H](N1[C@@H](O)[C@@H]1CC4=CC(C)=C(OC)C(O)=C4[C@@]2([H])N1C)C1=C2OCOC2=C(C)C(OC(C)=O)=C31,direct
Levobunolol Hydrochloride,pregnancy,16,0,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCCC2=O,direct
Ferric Citrate,anemia,81,1,O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,direct
Tradjenta,diabetes mellitus,5,0,CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=C(C=CC=C3)C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1,direct
Promethazine with Codeine,AIDS,10,0,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,direct
Dexamethasone,cerebral malaria,674,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Vivacaine,autoimmune disease,15,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution,liver disease (non-cirrhotic),20,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
NITROGLYCERIN,cancer (metastatic),9,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
SIMBRINZA,glaucoma,481,1,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Terconazole Vaginal Cream 0.8%,diabetes mellitus,5,0,CC(C)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
ProHance,renal failure,257,1,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,direct
Chlorothiazide,sepsis,17,0,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
LEVOLEUCOVORIN CALCIUM,liver cirrhosis,4,0,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
Dobutamine Hydrochloride in Dextrose,myocardial infarction,1,0,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
Latanoprost,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Mepivacaine,mental illness,14,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Lidocaine and prilocaine,pregnancy,16,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
"Brompheniramine, Pseudoephedrine, Dextromethorphan",coronary artery disease,37,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE,liver disease (non-cirrhotic),20,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
METOCLOPRAMIDE hydrochloride,hypersensitivity to metoclopramide,892,1,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,direct
Stendra,hypertension,11,0,COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1,direct
Cinacalcet,primary hpt who,1173,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
atomoxetine,asthma,12,0,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
Cyclobenzaprine Hydrochloride,muscle spasm,457,1,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Dimethyl fumarate,hypersensitivity,313,1,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
Clonidine Hydrochloride,hypersensitivity,313,1,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
pioglitazone,hypersensitivity,313,1,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
Librax,glaucoma,481,1,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Histamine Positive Skin Test Control,chronic obstructive pulmonary disease (COPD),6,0,NCCC1=CNC=N1,direct
oxycodone and acetaminophen,severe infection,18,0,CC(=O)NC1=CC=C(O)C=C1,direct
BUSULFAN,cancer (localized),8,0,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
LORAZEPAM,hypersensitivity,313,1,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,direct
Nifedipine,liver cirrhosis,4,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Alimta,liver disease (non-cirrhotic),20,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
FENOFIBRIC ACID,cancer (metastatic),9,0,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
Norepinephrine Bitartrate,mental illness,14,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Daptomycin,left-sided infective endocarditis,962,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
Delzicol,ulcerative colitis,225,1,NC1=CC(C(O)=O)=C(O)C=C1,direct
Vancomycin Hydrochloride for Oral Solution,mental illness,14,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
CAPRELSA,long qt syndrome,61,1,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,direct
Estring,hypercalcemia,139,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Omnitrope,sleep apnea,3,1,O,direct
PREGABALIN,partial onset seizures,1103,1,CC(C)C[C@H](CN)CC(O)=O,direct
Midazolam hydrochloride,anemia,13,0,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Perphenazine and Amitriptyline Hydrochloride,convulsive disorders,751,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
ALVAIZ,thrombocytopenia,79,1,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,direct
CEFPODOXIME PROXETIL,tics,23,1,[H][C@]12SCC(COC)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
ASMANEX,hypertension,11,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Trileptal,stroke,7,0,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Bexarotene,severe infection,18,0,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,direct
Nizatidine,sepsis,17,0,CNC(NCCSCC1=CSC(CN(C)C)=N1)=C[N+]([O-])=O,direct
POSACONAZOLE,anemia,81,1,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
ACARBOSE,diabetes mellitus,5,0,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,direct
Midazolam in Sodium Chloride,cancer (localized),8,0,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
diclofenac sodium,liver disease (non-cirrhotic),20,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Xalatan,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Sotalol Hydrochloride AF,congestive heart failure,2,0,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Clotrimazole,hypersensitivity,313,1,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Levetiracetam in Sodium Chloride,partial seizures,1104,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
Selegiline Hydrochloride,asthma,12,0,C[C@H](CC1=CC=CC=C1)N(C)CC#C,direct
PROCAINAMIDE HCI,cardiac decompensation,666,1,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
MOTPOLY XR,anemia,13,0,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
Ranexa,myocardial infarction,1,0,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,direct
Brimonidine Tartrate/Timolol Maleate,asthma,193,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Edetate Calcium Disodium,liver cirrhosis,4,0,[Na+].[Na+].[Ca++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O,direct
Fomepizole,pregnancy,16,0,CC1=CNN=C1,direct
NINLARO,cancer (localized),8,0,CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(Cl)=CC=C1Cl)B(O)O,direct
regadenoson,autoimmune disease,15,0,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
DESIPRAMINE HYDROCHLORIDE,depressive symptoms,769,1,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Disopyramide Phosphate,life-threatening ventricular arrhythmias,966,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
Synalar,stroke,7,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
montelukast sodium,liver cirrhosis,4,0,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
MYLERAN,leukemia,267,1,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
Doxy 100,impaired renal function,919,1,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Celontin,liver cirrhosis,4,0,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1,direct
UROCIT-K,severe infection,18,0,[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,direct
Flavoxate Hydrochloride,cancer (metastatic),9,0,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,direct
Diltiazem Hydrochloride EXTENDED RELEASE,liver cirrhosis,4,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
TRUQAP,chronic kidney disease,3,0,NC1(CCN(CC1)C1=C2C=CNC2=NC=N1)C(=O)N[C@@H](CCO)C1=CC=C(Cl)C=C1,direct
DELSTRIGO,congestive heart failure,2,0,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,direct
CardioGen-82,cancer (metastatic),9,0,[82Rb+],direct
VYXEOS,severe infection,18,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,direct
tafluprost,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
VIVIMUSTA,chronic lymphocytic leukemia,693,1,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
MD GASTROVIEW,sepsis,17,0,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Fluphenazine hydrochloride,dementia-related psychosis,766,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Lidotral 3.88% Roll on,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
OSCIMIN,mental illness,14,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Vitafol One,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Vitrexate,liver disease (non-cirrhotic),20,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
AMLODIPINE AND OLMESARTAN MEDOXOMIL,kidney failure,373,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Deferasirox,poor performance status,1139,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Lidocaine Hydrochloride and Epinephrine Bitartrate,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Cystografin,hypersensitivity,313,1,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Dicyclomine HCl,liver cirrhosis,4,0,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,direct
Lenalidomide,mm when pembrolizumab,1014,1,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
Qulipta,hypersensitivity,313,1,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=C4C=CC=N2)C(=O)N1CC(F)(F)F)C1=C(F)C(F)=CC=C1F,direct
Pyridostigmine Bromide,bronchial asthma,650,1,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Hydrocaine,myocardial infarction,1,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,fuzzy:hydroxycine
XYLOCAINE- MPF (LIDOCAINE HCl ),hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
"Albuterol Sulfate Inhalation Solution, 0.5%",hypersensitivity,313,1,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,fuzzy:albuterol sulfate inhalation solution
PERCOCET,gastrointestinal conditions percocet,828,1,CC(=O)NC1=CC=C(O)C=C1,direct
TOBRAMYCIN,pregnancy,16,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Exemestane,hypersensitivity,313,1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C,direct
Synjardy,urinary tract infection,249,1,CN(C)C(=N)NC(N)=N,direct
APREPITANT,autoimmune disease,15,0,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,direct
sorafenib,cancer (metastatic),9,0,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
Xospata,mental illness,14,0,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O,direct
Omeprazole/Bicarbonate,liver disease (non-cirrhotic),20,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Nalbuphine Hydrochloride,depression,27,1,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
SINEMET,chronic kidney disease,3,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Doxercalciferol,ckd on hemodialysis,714,1,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
Rosuvastatin calcium,homozygous familial hypercholesterolemia,872,1,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Mozobil,lymphoma,269,1,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
ATENOLOL,autoimmune disease,15,0,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,direct
Dorzolamide Hydrochloride and Timolol Maleate,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
budesonide,renal failure,19,0,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
POTASSIUM CHLORIDE EXTENDED RELEASE,AIDS,10,0,[Cl-].[K+],direct
Flavoxate Hydrochloride,sepsis,17,0,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,direct
FENTANYL TRANSDERMAL,cancer (localized),8,0,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
Davimet with Fluoride,hypersensitivity,313,1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Antiperspirant,stroke,7,0,O.[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-],direct
FLUOROURACIL,autoimmune disease,15,0,FC1=CNC(=O)NC1=O,direct
Cyltezo,active as,521,1,CC(C)O,direct
toremifene citrate,AIDS,10,0,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,direct
Gemcitabine,hypersensitivity,313,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
Pantoprazole Sodium DR,diabetes mellitus,5,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Levetiracetam in Sodium Chloride,liver disease (non-cirrhotic),20,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Uceris,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ETHOSUXIMIDE,chronic obstructive pulmonary disease (COPD),6,0,CCC1(C)CC(=O)NC1=O,direct
Nystatin and Triamcinolone Acetonide,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
PROPECIA,cancer (localized),8,0,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,direct
Theophylline (Anhydrous),renal failure,19,0,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Clomipramine HCl,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
METHADOSE,gastrointestinal conditions methadose,827,1,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,direct
TRI-LUMA,AIDS,10,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Fluconazole in Sodium Chloride,congestive heart failure,2,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Bupivacaine Hydrochloride,renal failure,19,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
NOCDURNA,cancer (metastatic),9,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
Diltiazem HCL ER,hypersensitivity,313,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Pramosone Cream,chronic kidney disease,3,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
TESTOSTERONE ENANTHATE,mental illness,14,0,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
CINACALCET,these symptoms,1314,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
LYBALVI,reported abnormal shifts,1213,1,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
DEFERASIROX,deferasirox oral granules,763,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Sulfamethox-TMP DS,liver disease (non-cirrhotic),20,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
KENALOG-10,diabetes mellitus,5,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
TRANEXAMIC ACID IN SODIUM CHLORIDE,myocardial infarction,1,0,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Deflazacort,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@]([H])(O)C[C@]3(C)[C@@]1(N=C(C)O2)C(=O)COC(C)=O,direct
lisdexamfetamine dimesylate,autoimmune disease,15,0,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
SODIUM PHENYLACETATE AND SODIUM BENZOATE,congestive heart failure,2,0,OC(=O)C1=CC=CC=C1,direct
Bivalirudin,thrombocytopenia,79,1,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,direct
FOSAMAX PLUS D,hypertension,11,0,CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,direct
Anoro Ellipta,hypersensitivity,313,1,OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2,direct
Vitafol Fe Plus,liver disease (non-cirrhotic),20,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Vascepa,stroke,7,0,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Tramadol Hydrochloride,asthma,193,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Hemox A,congestive heart failure,2,0,Cl[Al](Cl)Cl,direct
CLOMID,pregnancy,16,0,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
TIMOLOL MALEATE,severe infection,18,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Lidorex,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Rozerem,congestive heart failure,2,0,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,direct
Deferasirox,anemia,13,0,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Hyoscyamine ER,severe infection,18,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Lomotil,acute ulcerative colitis,556,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
dicyclomine hydrochloride,prostatic hypertrophy cardiovascular,1184,1,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,direct
carisoprodol,sepsis,17,0,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
ARIMIDEX,severe infection,18,0,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,direct
Lidocaine Hydrochloride and Epinephrine Bitartrate,chronic obstructive pulmonary disease (COPD),6,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
sucralfate,hypersensitivity,313,1,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,direct
Teflaro,autoimmune disease,15,0,[H][C@]12SCC(SC3=NC(=CS3)C3=CC=[N+](C)C=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC)\C1=NSC(NP(O)(O)=O)=N1)C([O-])=O,direct
ELIGARD,metastatic prostate cancer,1004,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Cisatracurium Besylate,pregnancy,16,0,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,direct
Hyoscyamine Sulfate TAB,mental illness,14,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
PAROXETINE,chronic obstructive pulmonary disease (COPD),6,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
DOXORUBICIN HYDROCHLORIDE,multiple myeloma,1024,1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
ZEVTERA,hypertension,39,1,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCN(C1)C(=O)OCC1=C(C)OC(=O)O1,direct
Vyalev,advanced pd,566,1,C[C@@](CC1=CC=C(OP(O)(O)=O)C(O)=C1)(NN)C(O)=O,direct
SUBVENITE,sepsis,17,0,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
Potassium Chloride Extended-Release,significant cardiac arrhythmias,1259,1,[Cl-].[K+],direct
Diclofenac Sodium 1.5%,hypersensitivity,313,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Aridol Bronchial Challenge Test Kit,chronic obstructive pulmonary disease (COPD),6,0,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,direct
Celecoxib,AIDS,10,0,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
"Adenosine Injection, 6mg/2mL (3mg/mL) Vial",congestive heart failure,2,0,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
Adenosine,mental illness,14,0,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
fulvestrant,AIDS,10,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],direct
amiloride hydrochloride,significant cardiac arrhythmias,1259,1,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
"Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg",liver cirrhosis,4,0,CC(=O)OC1=CC=CC=C1C(O)=O,direct
Deferasirox Oral Granules,autoimmune disease,15,0,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Cevimeline Hydrochloride,cancer (localized),8,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
Namenda XR,chronic obstructive pulmonary disease (COPD),6,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
methylprednisolone,hypertension,11,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Xalkori,pregnancy,16,0,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,direct
Atovaquone and Proguanil HCl,malaria,305,1,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,direct
Aspirin and Dipyridamole,hypersensitivity,313,1,CC(=O)OC1=CC=CC=C1C(O)=O,direct
Phenobarbital Sodium,renal failure,19,0,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1,direct
Trileptal,anorexia,399,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Quinidine Gluconate,pregnancy,16,0,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution,sinus bradycardia,1261,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Nuvigil,diabetes mellitus,5,0,NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1,direct
Diclona,severe infection,18,0,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,fuzzy:diclonina
Hydrocortisone Valerate,hypersensitivity,313,1,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Cimetidine Hydrochloride,asthma,12,0,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N,direct
PREDNISONE,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Azulfidine,severe infection,18,0,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,direct
FENOFIBRIC ACID DELAYED-RELEASE,AIDS,10,0,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
Timolol maleate,liver cirrhosis,4,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
DYMISTA,myocardial infarction,1,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Davimet,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Azathioprine,ra appears to,1196,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
CHLORTHALIDONE CHLORTHALIDONE,chronic kidney disease,3,0,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Pantoprazole sodium delayed-release,myocardial infarction,1,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Topotecan,cancer (metastatic),9,0,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE,asthma,12,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Nyamyc,hypersensitivity,313,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Pantoprazole,myocardial infarction,1,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Mepivacaine Hydrochloride,tics,23,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Ezetimibe and Simvastatin,myocardial infarction,49,1,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Gavreto,chronic kidney disease,3,0,CO[C@@]1(CC[C@@H](CC1)C1=NC(NC2=NNC(C)=C2)=CC(C)=N1)C(=O)N[C@@H](C)C1=CC=C(N=C1)N1C=C(F)C=N1,direct
OPFOLDA,congestive heart failure,2,0,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,direct
PANTOPRAZOLE SODIUM I.V.,hypersensitivity,313,1,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Lignospan Forte,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Lisinopril and Hydrochlorothiazide,liver disease (non-cirrhotic),20,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
MLK F4 Kit,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Dorzolamide Hydrochloride Ophthalmic Solution,chronic obstructive pulmonary disease (COPD),6,0,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Isotretinoin,cancer (localized),8,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Niacin,severe hypertriglyceridemia,1247,1,OC(=O)C1=CN=CC=C1,direct
IBUPROFEN,the aspirin triad,1295,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Antiperspirant,asthma,12,0,O.[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-],direct
gemcitabine hydrochloride,various malignancies,1350,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
ibandronate sodium,liver cirrhosis,4,0,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,direct
TIAZAC EXTENDED RELEASE,hypersensitivity,313,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Tetracaine Hydrochloride,hypersensitivity,313,1,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
FOSCARNET SODIUM,sepsis,17,0,OC(=O)P(O)(O)=O,direct
NIFEdipine,tight aortic stenosis,1320,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
temozolomide,stroke,7,0,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
Diflorasone Diacetate,anemia,13,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
MOMETASONE FUROATE MONOHYDRATE,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ERY-TAB,congestive heart failure,2,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound),neutropenia,85,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Imipenem and Cilastatin,meningitis,293,1,CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O,direct
ezetimibe and simvastatin,myocardial infarction,49,1,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Amlodipine and Valsartan,hypersensitivity,313,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Protonix I.V.,hypersensitivity,313,1,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
psorcon,cancer (metastatic),9,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Doxorubicin Hydrochloride,asthma,12,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
Cefaclor,cancer (metastatic),9,0,[H][C@]12SCC(Cl)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
CELESTONE SOLUSPAN,severe infection,18,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
BETHKIS,cancer (localized),8,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Dextroamphetamine Sulfate Extended-Release,sepsis,17,0,C[C@H](N)CC1=CC=CC=C1,direct
VENLAFAXINE,depressive symptoms,769,1,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",congestive heart failure,2,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
MARINOL,renal failure,19,0,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,direct
Ursodiol,liver disease (non-cirrhotic),20,0,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
Fensolvi,diabetes mellitus,5,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Lynparza,prostate cancer,265,1,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1,direct
PAROXETINE,chronic kidney disease,3,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
APREMILAST,stroke,7,0,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,direct
Citalopram Hydrobromide,asthma,12,0,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
POSACONAZOLE,thrombocytopenia,79,1,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
Alcaine,diabetes mellitus,5,0,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,direct
Fioricet,severe infection,18,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
AMITRIPTYLINE HYDROCHLORIDE,severe infection,18,0,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Klonopin,the following conditions,1301,1,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,direct
DEFERASIROX,anemia,13,0,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Rexulti,hypersensitivity,313,1,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,direct
MYLERAN,chronic myelogenous leukemia,695,1,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
Leucovorin Calcium,pneumonia,201,1,[H]C(=O)N1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2,direct
Dobutamine,aortic stenosis,55,1,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
Argatroban,myocardial infarction,1,0,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2,direct
DILTIAZEM HCI,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
CARBIDOPA,severe infection,18,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Acetylcysteine,hypertension,11,0,CC(=O)N[C@@H](CS)C(O)=O,direct
CINACALCET,anorexia,399,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Diovan HCT,severe infection,18,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Toronova II SUIK,the aspirin triad,1295,1,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Quinapril,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Bromocriptine Mesylate,pregnancy,16,0,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
cefdinir,asthma,12,0,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,direct
NOXAFIL,anemia,13,0,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
Carboplatin,these outcomes,1313,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Quflora Pediatric,cancer (localized),8,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Digoxin,chronic atrial fibrillation,685,1,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,direct
Meropenem,bacterial meningitis,626,1,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
TENORMIN,cancer (metastatic),9,0,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,direct
Sotalol Hydrochloride AF,arrhythmia,43,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Paroxetine,depressive symptoms,769,1,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Tizanidine,stroke,7,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Sular,cancer (metastatic),9,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C,direct
rifampin,impaired liver function,918,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
Theophylline,cancer (metastatic),9,0,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Cosyntropin,asthma,12,0,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O,direct
Nadolol,chronic obstructive pulmonary disease (COPD),6,0,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,direct
COMBIGAN,sinus bradycardia,1261,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
SINGULAIR,myocardial infarction,1,0,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
Valsartan and hydrochlorothiazide,hypercalcemia and hypophosphatemia,875,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution,cancer (localized),8,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
E-Z-Paste,hypersensitivity,313,1,[Ba++].[O-]S([O-])(=O)=O,direct
Everolimus,AIDS,10,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,direct
XARELTO,nonvalvular atrial fibrillation,1056,1,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,direct
VIBATIV,hypersensitivity,313,1,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2=C3OC4=CC=C(C=C4Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]4C(C=C2OC2=C(Cl)C=C(C=C2)[C@@H](O)[C@@H]2NC(=O)[C@H](NC4=O)C4=CC(=C(O)C=C4)C4=C(O)C(CNCP(O)(O)=O)=C(O)C=C4[C@H](NC2=O)C(O)=O)=C3)O[C@@H](C)[C@H]1O,direct
Oxymorphone hydrochloride,cancer (metastatic),9,0,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,direct
Carbidopa and levodopa,hypersensitivity,313,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Clobetasol Propionate,hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Azathioprine Sodium,ra appears to,1196,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
NALBUPHINE HCI,stroke,7,0,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
posaconazole,anemia,81,1,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
Busulfan,AIDS,10,0,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
Xofluza,hypersensitivity,313,1,[H][C@@]12COCCN1C(=O)C1=C(OCOC(=O)OC)C(=O)C=CN1N2[C@H]1C2=CC=C(F)C(F)=C2CSC2=CC=CC=C12,direct
Mexiletine hydrochloride,myocardial infarction,49,1,CC(N)COC1=C(C)C=CC=C1C,direct
Deflazacort,cancer (localized),8,0,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@]([H])(O)C[C@]3(C)[C@@]1(N=C(C)O2)C(=O)COC(C)=O,direct
Oraqix,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
tafluprost,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
Jatenzo,AIDS,10,0,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,direct
Carmustine,renal failure,19,0,ClCCNC(=O)N(CCCl)N=O,direct
CELEBREX,chronic obstructive pulmonary disease (COPD),6,0,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
VERELAN,cancer (metastatic),9,0,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,direct
CEFDINIR,mental illness,14,0,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,direct
Ethacrynate Sodium,hypokalemia,133,1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Memantine,liver cirrhosis,4,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
TIAGABINE HYDROCHLORIDE,liver disease (non-cirrhotic),20,0,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1,direct
IHEEZO,asthma,12,0,CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1,direct
Unithroid,diabetes mellitus,5,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
sorafenib,myocardial infarction,1,0,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
Menatrol,hypersensitivity,313,1,CC1=C(O)C(CO)=C(CO)C=N1,direct
LODOCO,diabetes mellitus,5,0,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Pantoprazole sodium delayed-release,autoimmune disease,15,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
NuLev,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Stivarga,asthma,12,0,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,direct
2% LIDOCAINE HCI,chronic kidney disease,3,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
furosemide,hypersensitivity,313,1,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O,direct
Azulfidine,cancer (metastatic),9,0,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,direct
Travatan Z,cancer (metastatic),9,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
CHANTIX,mental illness,14,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Atomoxetine,narrow angle glaucoma,1029,1,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
dabigatran etexilate,severe infection,18,0,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
Bexagliflozin,liver cirrhosis,4,0,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(OCCOC3CC3)C=C2)=C1,direct
Denti-Care Denti-Rinse Neutral Sodium Fluoride Oral Rinse,crowns and restorations,753,1,[F-].[Na+],direct
Atropine Sulfate,brain lesions,644,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
CLOFARABINE,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,direct
Promethazine,anemia,13,0,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
BENZPHETAMINE HYDROCHLORIDE,hypertension,11,0,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,direct
Cortisone Acetate,cataracts,479,1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Olanzapine and Fluoxetine,depression,27,1,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Lovastatin,heart disease,377,1,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC,direct
Mekinist,abnormal lvef,511,1,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1,direct
ILOPERIDONE,myocardial infarction,1,0,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O,direct
CEFAZOLIN,tics,23,1,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,direct
Vimpat,partial-onset seizures generally,1107,1,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
ondansetron hydrochloride,tics,23,1,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
ZOLEDRONIC ACID,bone metastases,638,1,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
Soma,diabetes mellitus,5,0,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,direct
psorcon,sepsis,17,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
TAUVID,cognitive impairment who,733,1,[18F]C1=CC=C(C=N1)C1=CC=C2C(NC3=C2C=NC=C3)=C1,direct
Xenical,chronic kidney disease,3,0,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,direct
AZACITIDINE,chronic obstructive pulmonary disease (COPD),6,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
propranolol hydrochloride,hypersensitivity,313,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
ANCOBON,impaired renal function,919,1,NC1=C(F)C=NC(=O)N1,direct
METHYLPREDNISOLONE ACETATE,severe infection,18,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Betamethasone Dipropionate,hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
lisinopril,liver disease (non-cirrhotic),20,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Tizanidine,impaired hepatic function,915,1,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Hydrocodone/APAP,chronic overdose,698,1,CC(=O)NC1=CC=C(O)C=C1,direct
BETAMETHASONE VALERATE,hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Ondansetron,severe infection,18,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Citalopram Hydrobromide,hypersensitivity,313,1,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
DRONABINOL,hypersensitivity,313,1,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,direct
Melphalan,stroke,7,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Nembutal Sodium,known barbiturate sensitivity,948,1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,direct
Clomipramine HCl,diabetes mellitus,5,0,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
Hydroxyprogesterone Caproate,pregnancy,321,1,[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Ethosuximide,sepsis,17,0,CCC1(C)CC(=O)NC1=O,direct
Venlafaxine hydrochloride,recurrent depression who,1200,1,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
Tizanidine HCL,hypertension,11,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Diltiazem hydrochloride,myocardial infarction,49,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
NIACIN,severe hypertriglyceridemia,1247,1,OC(=O)C1=CN=CC=C1,direct
Nadolol,congestive heart failure,41,1,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,direct
SEVELAMER HYDROCHLORIDE,bowel obstruction,641,1,NCC=C.ClCC1CO1,direct
NITROLINGUAL,hypertension,11,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
"BUPIVACAINE HYDROCHLORIDE injection, solution",sepsis,17,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
SAPHRIS,renal failure,19,0,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
Abiraterone acetate,liver metastases,967,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Granisetron hydrochloride,hypersensitivity,313,1,CN1N=C(C(=O)N[C@@H]2C[C@@H]3CCC[C@H](C2)N3C)C2=C1C=CC=C2,direct
JANUMET XR,pancreatitis,233,1,CN(C)C(=N)NC(N)=N,direct
BORTEZOMIB,mantle cell lymphoma,983,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
VILAZODONE HYDROCHLORIDE,stroke,7,0,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,direct
Foltrate,severe infection,18,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
CARBIDOPA,stroke,7,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Quinapril and Hydrochlorothiazide 10/12.5,impaired liver function,918,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
CEFADROXIL,myocardial infarction,1,0,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
PROPRANOLOL HYDROCHLORIDE,hypersensitivity,313,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Ranolazine,chronic angina,684,1,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,direct
MESALAMINE,renal failure,19,0,NC1=CC(C(O)=O)=C(O)C=C1,direct
Dofetilide,paroxysmal atrial fibrillation,1102,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Reglan,AIDS,10,0,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,direct
Sulfamethox-TMP DS,autoimmune disease,15,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Deferasirox,deferasirox tablets,764,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
DEXAMETHASONE SODIUM PHOSPHATE,cancer (metastatic),9,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
LEVOPHED(R) NOREPINEPHRINE BITARTRATE,AIDS,10,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
LODOCO,anemia,13,0,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Dobutamine,autoimmune disease,15,0,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
CEFTRIAXONE AND DEXTROSE,chlamydia,285,1,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
ERLOTINIB,cancer (localized),8,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
bortezomib,leukopenia,83,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
DesOwen,cancer (metastatic),9,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Plasma-Lyte A,cancer (metastatic),9,0,[Cl-].[K+],direct
ESTRADIOL,asthma,12,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
"Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg",pregnancy,16,0,CC(=O)OC1=CC=CC=C1C(O)=O,direct
ARGATROBAN,autoimmune disease,15,0,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2,direct
ethacrynic acid,severe infection,18,0,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
VILAZODONE HYDROCHLORIDE,mdd including,990,1,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,direct
Valsartan and Hydrochlorothiazide,hypercalcemia and hypophosphatemia,875,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
DOXYCYCLINE HYCLATE,myocardial infarction,1,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Methadone Hydrochloride,gastrointestinal conditions methadone,826,1,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,direct
METHYLPREDNISOLONE ACETATE,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Dimethyl fumarate,renal failure,19,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
MD GASTROVIEW,anemia,13,0,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
DermacinRx Lidotral,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Strong Iodine Solution,tuberculosis because it,1332,1,II,direct
MethylPREDNISolone,sepsis,17,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
3% Sodium Chloride,autoimmune disease,15,0,[Na+].[Cl-],direct
VANCOMYCIN HYDROCHLORIDE,myocardial infarction,1,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
SEREVENT DISKUS,mental illness,14,0,OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1,direct
Potassium Chloride ER,diabetes mellitus,5,0,[Cl-].[K+],direct
Penicillamine,severe infection,18,0,[H][C@](N)(C(O)=O)C(C)(C)S,direct
Clomipramine Hydrochloride,depressive symptoms,769,1,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
isosorbide mononitrate,myocardial infarction,49,1,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,direct
Capecitabine 150mg,cancer (localized),8,0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
dexamethasone,myocardial infarction,1,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
QUINAPRIL,renal failure,19,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Hyoscyamine Sulfate SL,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
BORTEZOMIB,leukopenia,83,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
"Adenosine Injection, 6mg/2mL (3mg/mL) Vial",stroke,7,0,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
FLUOCINONIDE,congestive heart failure,2,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,direct
Flurazepam Hydrochloride,stroke,7,0,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,direct
Naproxen Sodium,sepsis,17,0,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O,direct
0.5% LIDOCAINE HCl,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Phenylephrine Hydrochloride,hypertension,39,1,CNC[C@H](O)C1=CC(O)=CC=C1,direct
FLUCYTOSINE,impaired renal function,919,1,NC1=C(F)C=NC(=O)N1,direct
Timolol Maleate,bronchial asthma,650,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Sotalol Hydrochloride,paroxysmal afib that,1101,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
ILOPERIDONE,renal failure,19,0,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O,direct
PARAPLATIN,normal baseline values,1059,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
OXALIPLATIN,advanced colorectal cancer,560,1,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,direct
Isosorbide dinitrate and hydralazine hydrochloride,AIDS,10,0,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
hydrocortisone,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Triloan II SUIK,autoimmune disease,15,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Irinotecan hydrochloide,renal failure,19,0,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
Diltiazem hydrochloride,liver cirrhosis,4,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
ZOLINZA,asthma,12,0,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,direct
Sensipar,autoimmune disease,15,0,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Alosetron,chronic obstructive pulmonary disease (COPD),6,0,CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2,direct
Minoxidil,anemia,13,0,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1,direct
Labetalol HCL,this tumor,1318,1,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Theophylline,renal failure,19,0,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Propafenone Hydrochloride,mental illness,14,0,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,direct
cevimeline hydrochloride,other conditions,1087,1,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
PERPHENAZINE,psychic depression,1192,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Keveyis,hyperkalemic periodic paralysis,878,1,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O,direct
HYFTOR,hypersensitivity,313,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
Cyanocobalamin,diabetes mellitus,5,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
caspofungin acetate,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
deferasirox,advanced malignancies,563,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
50% MAGNESIUM SULFATE,heart block,59,1,[Mg++].[O-]S([O-])(=O)=O,direct
XELJANZ,rheumatoid arthritis,159,1,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,direct
dimethyl fumarate,myocardial infarction,1,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
Edarbyclor,hypertension,39,1,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
MOTPOLY XR,mental illness,14,0,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
Quinapril HCL and Hydrochlorothiazide,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Azithromycin Monohydrate,pneumonia who,1132,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Atovaquone and Proguanil Hydrochloride,malaria,305,1,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,direct
ROBAXIN,congestive heart failure,2,0,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
Spironolactone and Hydrochlorothiazide,chronic kidney disease,3,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
fomepizole,cancer (localized),8,0,CC1=CNN=C1,direct
UrNeva,renal failure,19,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
AdreView,hypersensitivity,313,1,NC(N)=NCC1=CC(I)=CC=C1,direct
Diclofenac Sodium Delayed Release Delayed Release,chronic kidney disease,3,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
paroxetine hydrochloride,gad and ptsd,822,1,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Tamoxifen Citrate,metastatic breast cancer,995,1,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,direct
Amlodipine besylate and Olmesartan medoxomil,hypertension,39,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Mupirocin,hypersensitivity,313,1,C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O,direct
Fluconazole,cancer (metastatic),9,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Amphetamine Sulfate,cancer (localized),8,0,CC(N)CC1=CC=CC=C1,direct
Spravato,diabetes mellitus,5,0,CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl,direct
CARVEDILOL,liver cirrhosis,4,0,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
Chromagen,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Macrodantin,hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
EXEMESTANE,congestive heart failure,2,0,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C,direct
midazolam,liver disease (non-cirrhotic),20,0,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Estradiol,congestive heart failure,2,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Prochlorperazine Maleate,liver cirrhosis,4,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
CLOBAZAM,hypersensitivity,313,1,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,direct
PIOGLITAZONE HYDROCHLORIDE,congestive heart failure,2,0,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
Paroxetine,renal failure,19,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Azulfidine,renal failure,19,0,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,direct
CIDOFOVIR DIHYDRATE,relapsing cmv retinitis,1206,1,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,direct
MEXILETINE HYDROCHLORIDE,hypertension,11,0,CC(N)COC1=C(C)C=CC=C1C,direct
Cyclobenzaprine HCL ER,muscle spasm,457,1,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
chlorpromazine hydrochloride,sepsis,17,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
Alprazolam XR,AIDS,10,0,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
Ethosuximide,hypersensitivity,313,1,CCC1(C)CC(=O)NC1=O,direct
Sorafenib,rcc or hcc,1198,1,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
HALCINONIDE,renal failure,19,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Tradjenta,diabetes mellitus,111,1,CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=C(C=CC=C3)C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1,direct
ZIANA,asthma,12,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
INLYTA,chronic obstructive pulmonary disease (COPD),6,0,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,direct
Edarbyclor,moderate-to-severe hypertension,1018,1,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Alcaine,hypersensitivity,313,1,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,direct
Sensipar,diabetes mellitus,5,0,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Tizanidne hydrochloride,multiple sclerosis,153,1,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Amlodipine besylate and Olmesartran medoxomil,hypertension,39,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Lactated Ringers and Dextrose,brain edema,643,1,[Cl-].[K+],direct
NEBIVOLOL,asthma,12,0,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
Galantamine,liver cirrhosis,4,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
"Sodium Sulfate, Potassium Sulfate, and Magnesium Sulfate Bowel Prep kit",chronic obstructive pulmonary disease (COPD),6,0,[Mg++].[O-]S([O-])(=O)=O,"fuzzy:sodium sulfate, potassium sulfate and magnesium sulfate oral"
Gloperba,renal failure,19,0,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Flucytosine,bone marrow depression,637,1,NC1=C(F)C=NC(=O)N1,direct
Dextrose And Sodium Chloride,severe infection,18,0,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C=O,direct
"Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral",asthma,12,0,[Mg++].[O-]S([O-])(=O)=O,direct
nebivolol,pregnancy,16,0,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
Tricor,sepsis,17,0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
hydrocortisone acetate pramoxine hcl,pregnancy,16,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE,cancer (localized),8,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Prednisolone Sodium Phosphate,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Accupril,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Nateglinide,hypertension,11,0,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,direct
Trihexyphenidyl Hydrochloride,AIDS,10,0,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1,direct
Glipizide and Metformin Hydrochloride,non-insulin-dependent diabetes,1045,1,CN(C)C(=N)NC(N)=N,direct
Fluvastatin,anemia,13,0,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,direct
PYLERA,severe renal impairment,1253,1,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
Cytarabine,cancer (metastatic),9,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,direct
Azasan,rheumatoid arthritis,159,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Nitrofurantion,hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Trezix,chronic kidney disease,3,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
montelukast sodium,hypersensitivity,313,1,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
Estradiol,cancer (metastatic),9,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
imatinib mesylate,AIDS,10,0,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
CAPTOPRIL AND HYDROCHLOROTHIAZIDE,hypertension who,898,1,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Prenate Elite,hypertension,11,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Imatinib Mesylate,pregnancy,16,0,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Cleviprex,AIDS,10,0,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,direct
NRG Hemo-Stat,congestive heart failure,2,0,Cl[Al](Cl)Cl,direct
Mifepristone,chronic kidney disease,3,0,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],direct
lamivudine,hypersensitivity,313,1,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,direct
Itraconazole Oral,hypersensitivity,313,1,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Lamivudine and Zidovudine,autoimmune disease,15,0,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
VERAPAMIL HYDROCHLORIDE,hypersensitivity,313,1,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,direct
LEUPROLIDE ACETATE,prostate cancer,265,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Cisplatin,renal impairment,1211,1,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
Betamethasone Dipropionate,congestive heart failure,2,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Azelastine hydrochloride and Fluticasone propionate,sepsis,17,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Lenalidomide,hypertension,11,0,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
Lidocaine hydrochloride,asthma,12,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
meloxicam,osteoarthritis,161,1,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O,direct
ANCOBON,myocardial infarction,1,0,NC1=C(F)C=NC(=O)N1,direct
mesalamine,asthma,12,0,NC1=CC(C(O)=O)=C(O)C=C1,direct
Lipofen,asthma,12,0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
MEMANTINE,diabetes mellitus,5,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Stivarga,diabetes mellitus,5,0,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,direct
Hydrocodone/APAP,cancer (localized),8,0,CC(=O)NC1=CC=C(O)C=C1,direct
SOLTAMOX,cancer (metastatic),9,0,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,direct
Potassium Chloride in Sodium Chloride,asthma,12,0,[Cl-].[K+],direct
apixaban,AIDS,10,0,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,direct
Oxycodone Hydrochloride and Acetaminophen,sepsis,17,0,CC(=O)NC1=CC=C(O)C=C1,direct
Chlorthalidone,stroke,7,0,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
memantine hydrochloride,hypersensitivity,313,1,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
VALSARTAN AND HYDROCHLOROTHIAZIDE,chronic obstructive pulmonary disease (COPD),6,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Pamidronate Disodium,hypersensitivity,313,1,NCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Eligard,chronic kidney disease,3,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Arestin,cancer (localized),8,0,[H][C@@]12CC3=C(C(O)=CC=C3N(C)C)C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])C2,direct
ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE,stroke,7,0,CC(=O)OC1=CC=CC=C1C(O)=O,direct
METHSCOPOLAMINE BROMIDE,ileostomy or colostomy,910,1,[Br-].[H][C@@]12O[C@]1([H])[C@H]1C[C@H](C[C@@H]2[N+]1(C)C)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
ESTRADIOL VALERATE,AIDS,10,0,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
HYOSCYAMINE SULFATE,mental illness,14,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
oxycodone hydrochloride and acetaminophen,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
PROPRANOLOL HYDROCHLORIDE,chronic obstructive pulmonary disease (COPD),6,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
memantine,hypersensitivity,313,1,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Dexatran,congestive heart failure,2,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Brimonidine tartrate,hypertension,39,1,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Tobramycin Inhalation Solution,chronic obstructive pulmonary disease (COPD),6,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Rocaltrol,cancer (metastatic),9,0,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,direct
Cortisone Acetate,vertigo,469,1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Tromethamine,hyperkalemia,131,1,NC(CO)(CO)CO,direct
Prenate Mini,severe infection,18,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
AMIODARONE HCI,bradycardia,45,1,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2,direct
Multiple Electrolytes pH 7.4,hypochloremic hypokalemic alkalosis,902,1,[Cl-].[K+],direct
Fycompa,hypertension,11,0,O=C1N(C=C(C=C1C1=CC=CC=C1C#N)C1=NC=CC=C1)C1=CC=CC=C1,direct
Fentanyl system,severe pain,1251,1,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
Xylocaine,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Lidocaine and Prilocaine,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ANAFRANIL,renal failure,19,0,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
Nabumetone,the aspirin triad,1295,1,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
Desonide,hypersensitivity,313,1,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release,liver disease (non-cirrhotic),20,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,fuzzy:pantoprazole sodium delayed-release delayed-release
Caldolor,pregnancy,16,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Signifor LAR,pregnancy,16,0,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,direct
Carbamazepine,depression,27,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
CAFFEINE CITRATE,cancer (localized),8,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Alacort,congestive heart failure,2,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
IMIQUIMOD,cancer (metastatic),9,0,CC(C)CN1C=NC2=C1C1=C(C=CC=C1)N=C2N,direct
Tamoxifen Citrate,stroke,7,0,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,direct
Azathioprine Sodium,rheumatoid arthritis,159,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Varenicline,AIDS,10,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Gemcitabine hydrochloride,hypersensitivity,313,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
Depo-Medrol,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Rubraca,stroke,7,0,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,direct
Sitagliptin and Metformin Hydrochloride,mental illness,14,0,CN(C)C(=N)NC(N)=N,fuzzy:saxagliptin and metformin hydrochloride
BUSULFEX,hypertension,11,0,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
silodosin,hypersensitivity,313,1,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,direct
sevelamer hydrochloride,cancer (metastatic),9,0,NCC=C.ClCC1CO1,direct
AMITRIPTYLINE HYDROCHLORIDE,depressive symptoms,769,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
MYLERAN,pregnancy,16,0,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
DAPZURA RT,congestive heart failure,2,0,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
Propofol Injectable Emulsion,cancer (localized),8,0,CC(C)C1=CC=CC(C(C)C)=C1O,direct
CANCIDAS,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
Teriflunomide,multiple sclerosis,153,1,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
Cyltezo,anti-adalimumab antibody,602,1,CC(C)O,direct
TAVNEOS,pregnancy,16,0,CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C2=CC=C(NC3CCCC3)C=C2)C(=O)C2=C(F)C=CC=C2C)C=C1C(F)(F)F,direct
lisdexamfetamine dimesylate,obesity,149,1,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
Flac Otic Oil,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Lunesta,stroke,7,0,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,direct
Vinorelbine,liver cirrhosis,4,0,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@](CC)([C@@]13[H])[C@@]([H])(OC(C)=O)[C@]2(O)C(=O)OC)[C@]1(C[C@@]2([H])CN(CC(CC)=C2)CC2=C1NC1=CC=CC=C21)C(=O)OC,direct
Bendamustine,diabetes mellitus,5,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Haldol Decanoate,mental illness,14,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
ZAVZPRET,chronic obstructive pulmonary disease (COPD),6,0,CN1CCC(CC1)N1CCN(CC1)C(=O)[C@@H](CC1=CC2=C(NN=C2)C(C)=C1)NC(=O)N1CCC(CC1)C1=CC2=C(NC1=O)C=CC=C2,direct
Adapalene and Benzoyl Peroxide,hypersensitivity,313,1,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Prochlorperazine Maleate,cancer (metastatic),9,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Metronidazole,hypersensitivity,313,1,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
CARBAMAZEPINE,increased intraocular pressure,927,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
AIRSUPRA,mental illness,14,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Cefadroxil,sepsis,17,0,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
PENTAMIDINE ISETHIONATE,hypersensitivity,313,1,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
Rayaldee,AIDS,10,0,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,direct
RECARBRIO,AIDS,10,0,CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O,direct
BRIDION,myocardial infarction,1,0,O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3O[C@H](CSCCC(O)=O)[C@@H](O[C@H]4O[C@H](CSCCC(O)=O)[C@@H](O[C@H]5O[C@H](CSCCC(O)=O)[C@@H](O[C@H]6O[C@H](CSCCC(O)=O)[C@@H](O[C@H]7O[C@H](CSCCC(O)=O)[C@@H](O[C@H]8O[C@H](CSCCC(O)=O)[C@@H](O[C@H]9O[C@H](CSCCC(O)=O)[C@@H](O[C@H]1O[C@@H]2CSCCC(O)=O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,direct
"Clotrimazole Topical Solution USP, 1%",sepsis,17,0,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Abiraterone Acetate,metastatic crpc,997,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
DOBUTAMINE HYDROCHLORIDE,cancer (metastatic),9,0,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
SUPRANE,the event,1298,1,FC(F)OC(F)C(F)(F)F,direct
SIMVASTATIN,pregnancy,16,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Chlorpromazine Hydrochloride,congestive heart failure,2,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
Sofosbuvir and Velpatasvir,autoimmune disease,15,0,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
Promethazine with Codeine,chronic kidney disease,3,0,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,direct
GUANFACINE HYDROCHLORIDE,autoimmune disease,15,0,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,direct
Testosterone Cypionate,hypertension,39,1,[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Cyanocobalamin,congestive heart failure,2,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Auryxia,iron deficiency,405,1,O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,direct
Pradaxa,non-valvular atrial fibrillation,1053,1,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
CANCIDAS,invasive aspergillosis,944,1,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
UrNeva,congestive heart failure,2,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Nortriptyline Hydrochloride,renal failure,19,0,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Morphine Sulfate,mental illness,14,0,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,direct
Aricept,hypersensitivity,313,1,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
Triloan SUIK,active tuberculosis,535,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
LAMIVUDINE AND ZIDOVUDINE,liver disease (non-cirrhotic),20,0,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
cisatracurium besylate,hypersensitivity,313,1,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,direct
Cefuroxime,mental illness,14,0,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,direct
Melphalan,asthma,12,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Clomipramine Hydrochloride,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
HYCAMTIN,cervical cancer,676,1,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
"BUPIVACAINE HYDROCHLORIDE injection, solution",hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Minoxidil,mental illness,14,0,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1,direct
gynazole 1,autoimmune disease,15,0,ClC1=CC=C(CCC(CN2C=CN=C2)SC2=C(Cl)C=CC=C2Cl)C=C1,direct
Amnesteem,these symptoms,1314,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Tigan,pediatric patients,13,1,COC1=CC(=CC(OC)=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1,direct
INGREZZA,hypersensitivity,313,1,COC1=C(OC)C=C2[C@H]3C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN3CCC2=C1,direct
METROGEL,myocardial infarction,1,0,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Oxcarbazepine,ataxia,465,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
DOXIL,sepsis,17,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
Indomethacin ER,hypersensitivity,313,1,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,direct
haloperidol,liver cirrhosis,4,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
epinephrine,hypotension,75,1,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Atovaquone and Proguanil Hydrochloride Pediatric,sepsis,17,0,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,direct
Prilosec,hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
DAPTOMYCIN,left-sided infective endocarditis,962,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
ACETAMINOPHEN AND CODEINE PHOSPHATE,acetaminophen allergy,513,1,CC(=O)NC1=CC=C(O)C=C1,direct
Fluphenazine Hydrochoride,cancer (metastatic),9,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,fuzzy:fluphenazine hydrochloride
Vancomycin Hydrochloride for Oral Solution,hypersensitivity,313,1,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
Cefadroxil,myocardial infarction,1,0,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
TORSEMIDE,cancer (localized),8,0,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1,direct
Finasteride,mental illness,14,0,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,direct
Clobetasol Propionate ANDA,cancer (localized),8,0,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Epclusa,decompensated cirrhosis,759,1,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
DIMETHYL FUMARATE,hypersensitivity,313,1,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
VALSARTAN AND HYDROCHLOROTHIAZIDE,pregnancy,16,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Vitafol One,renal failure,19,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
AMITRIPTYLINE HYDROCHLORIDE,cardiovascular disorders,669,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Flecainide Acetate,supraventricular arrhythmias,1280,1,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1,direct
Amiloride Hydrochloride,significant cardiac arrhythmias,1259,1,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
Diflucan,vaginal candidiasis,1349,1,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Cladribine,cellulitis,297,1,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
Exforge,hypersensitivity,313,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Plasma-Lyte A,hypochloremic hypokalemic alkalosis,902,1,[Cl-].[K+],direct
Anti Aging Serum,mental illness,14,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,fuzzy:anti-aging serum
Famciclovir,asthma,12,0,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O,direct
Azathioprine Sodium,rheumatoid arthritis who,1215,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
ERY-TAB,mental illness,14,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
bendamustine hydrochloride,AIDS,10,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Imatinib,thrombocytopenia,79,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Theophylline Anhydrous,anemia,13,0,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Acetaminophen and Codeine,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
MARINOL,myocardial infarction,1,0,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,direct
Haloperidol Lactate,asthma,12,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Tolmetin Sodium,hypersensitivity,313,1,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,direct
Cefaclor,liver cirrhosis,4,0,[H][C@]12SCC(Cl)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
Imatinib,neutropenia,85,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Tradjenta,severe renal impairment,1253,1,CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=C(C=CC=C3)C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1,direct
Histamine Positive Skin Test Control,liver cirrhosis,4,0,NCCC1=CNC=N1,direct
Cinacalcet,these symptoms,1314,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Trandolapril,mental illness,14,0,[H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC3=CC=CC=C3)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,direct
CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE,chronic obstructive pulmonary disease (COPD),6,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
iopamidol,congenital cardiac conditions,747,1,C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I,direct
LISINOPRIL AND HYDROCHLOROTHIAZIDE,anemia,13,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Amoxicillin and Clavulanate Potassium,diabetes mellitus,5,0,[H][C@@]12CC(=O)N1[C@@H](C(O)=O)\C(O2)=C\CO,direct
PIOGLITAZONE,renal failure,19,0,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
PAROXETINE,marked abnormalities,985,1,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
RUBY-FILL,cancer (localized),8,0,[82Rb+],direct
INDERAL LA,autoimmune disease,15,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Lumryz,anemia,13,0,[Na+].OCCCC([O-])=O,direct
BORTEZOMIB,anemia,81,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
IBUPROFEN,hypertension,11,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Nilutamide,hypersensitivity,313,1,CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,direct
LABETALOL HYDROCHLORIDE,autoimmune disease,15,0,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Cardizem,hypersensitivity,313,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
ZYKADIA,liver disease (non-cirrhotic),20,0,CC(C)OC1=C(NC2=NC=C(Cl)C(N2)=NC2=CC=CC=C2S(=O)(=O)C(C)C)C=C(C)C(=C1)C1CCNCC1,direct
BETIMOL,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Olmesartan Medoxomil and Hydrochlorothiazide,chronic kidney disease,3,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Vascepa,pancreatitis,233,1,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Amnesteem,disorders of keratinization,779,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
EZETIMIBE,hypersensitivity,313,1,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
Dexamethasone 1.5 mg,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
CELESTONE SOLUSPAN,unexplained diarrhea,1341,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
"CycloSPORINE, Modfied",hypersensitivity,313,1,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Diatrizoate Meglumine and Diatrizoate Sodium,cancer (localized),8,0,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Desferal,chronic anemia,683,1,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
AIRSUPRA,autoimmune disease,15,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Tizanidine Hydrochloride,severe infection,18,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Nitrofurantion,autoimmune disease,15,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Diflunisal,anemia,13,0,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,direct
METHYLPREDNISOLONE,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
"PredniSONE Tablets, USP, 20 mg",renal failure,19,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Cisatracurium besylate,hypersensitivity,313,1,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,direct
Methylphenidate Hydrochloride,comorbid depressive symptoms,735,1,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
AVYCAZ,pediatric patients,13,1,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
Azasan,myocardial infarction,1,0,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Tacrolimus,renal failure,19,0,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,direct
levalbuterol inhalation,myocardial infarction,1,0,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
ERTAPENEM SODIUM,AIDS,10,0,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Effer-K Orange,hyperkalemia,131,1,[K+].OC([O-])=O,direct
Paclitaxel protein-bound particles,hypertension,11,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
DEXMETHYLPHENIDATE HYDROCHLORIDE,pediatric patients,13,1,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,direct
Kimyrsa,hypersensitivity,313,1,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
Tolectin,myocardial infarction,1,0,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,fuzzy:tolmetin
DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Metoprolol Tartrate and Hydrochlorothiazide,cancer (metastatic),9,0,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
ProAir Digihaler,myocardial infarction,1,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Tinidazole,hypersensitivity,313,1,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O,direct
Norpace CR,anemia,13,0,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
AZATHIOPRINE,rheumatoid arthritis,159,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Ursodiol 200 mg,diabetes mellitus,5,0,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
pemetrexed,diabetes mellitus,5,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
Quinapril and Hydrochlorothiazide 10/12.5,hypertension,11,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Aubagio,cancer (localized),8,0,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
Oxcarbazepine,edema,417,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Carnitor SF,AIDS,10,0,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
voriconazole,pregnancy,16,0,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Jardiance,urinary tract infection,249,1,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C1,direct
Rykindo extended-release microspheres,tremor,459,1,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,direct
Ethacrynic acid,arrhythmia,43,1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Juxtapid,AIDS,10,0,FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=C(C=CC=C2)C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=CC=CC=C12,direct
Qbrelis,sepsis,17,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Clomipramine hydrochloride,depressive symptoms,769,1,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
TERIFLUNOMIDE,multiple sclerosis,153,1,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
sirolimus,lymphangioleiomyomatosis sirolimus tablets,976,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
MIDAZOLAM HYDROCHLORIDE,acute narrow-angle glaucoma,546,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
LISDEXAMFETAMINE DIMESYLATE,obesity,149,1,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
Lopid,congestive heart failure,2,0,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,direct
BISOPROLOL FUMARATE,stroke,7,0,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,direct
ABRILADA,active as,521,1,CC(C)O,direct
"Desonide Ointment, 0.05%",pregnancy,16,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Diclona Patch,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Labetalol hydrochloride,cancer (localized),8,0,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Lenalidomide,mental illness,14,0,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
Simvastatin,homozygous familial hypercholesterolemia,872,1,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Acarbose,hypersensitivity,313,1,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,direct
CISPLATIN,hypocalcemia and hypomagnesemia,901,1,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
Cetirizine hydrochloride,hypersensitivity,313,1,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Doxercalciferol,liver disease (non-cirrhotic),20,0,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide",coronary artery disease,37,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Tindamax,hypersensitivity,313,1,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O,direct
Hydrocortisone sodium succinate,asthma,12,0,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,fuzzy:hydrocortisone succinate
CISplatin,renal impairment,1211,1,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
Norpace CR,urinary retention,1347,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
Xylocaine MPF,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Lactated Ringers,stroke,7,0,[Cl-].[K+],direct
SODIUM PHENYLACETATE and SODIUM BENZOATE,asthma,12,0,OC(=O)C1=CC=CC=C1,direct
albuterol sulfate,severe infection,18,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Erythromycin ethylsuccinate,sepsis,17,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Solu-Medrol,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Livalo,sepsis,17,0,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
XALATAN,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
CYCLOSET,syncopal migraine,1290,1,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
Fenofibric acid,severe hypertriglyceridemia,1247,1,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
Pitavastatin,primary hyperlipidemia,1175,1,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
ETHOSUXIMIDE,liver disease (non-cirrhotic),20,0,CCC1(C)CC(=O)NC1=O,direct
Pyridostigmine Bromide,asthma,193,1,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
OXCARBAZEPINE,hyponatremia,137,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
HYZAAR,hypertension,11,0,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
metoclopramide hydrochloride,chronic kidney disease,3,0,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,direct
apixaban,nonvalvular atrial fibrillation,1056,1,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,direct
CELECOXIB,post-surgical pain,1145,1,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
Carvedilol,severe hepatic impairment,1245,1,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
Lidocaine Hydrochloride and Dextrose,severe infection,18,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Quazepam,hypersensitivity,313,1,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2,direct
COSOPT PF,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
ALENDRONATE SODIUM,asthma,12,0,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Ezetimibe,renal failure,19,0,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
Clonazepam,AIDS,10,0,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,direct
Methocarbamol and Aspirin,congestive heart failure,2,0,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
Fosinopril Sodium and Hydrochlorothiazide,impaired liver function,918,1,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,direct
FENTANYL TRANSDERMAL,AIDS,10,0,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
Lamotrigine,asthma,12,0,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
EVEROLIMUS,renal failure,19,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,direct
IMURAN,rheumatoid arthritis,159,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Paclitaxel protein-bound particles,cancer (metastatic),9,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
RADICAVA,hypertension,11,0,CC1=NN(C(=O)C1)C1=CC=CC=C1,direct
Procto-Med HC,liver disease (non-cirrhotic),20,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
CORTEF,hypertension,11,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
AmBisome,AIDS,10,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
imatinib mesylate,ph- all who,1121,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Tigan,stroke,7,0,COC1=CC(=CC(OC)=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1,direct
NYSTATIN AND TRIAMCINOLONE ACETONIDE,diabetes mellitus,5,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Levetiracetam Levetiracetam,mental illness,14,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
VELCADE,multiple myeloma,1024,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
XELJANZ,cancer (metastatic),9,0,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,direct
Succinylcholine,stroke,7,0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,direct
Rifampin,compromised adrenal function,737,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
ARIPIPRAZOLE,chronic kidney disease,3,0,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
ISOTRETINOIN,diabetes mellitus,5,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
AMINOPHYLLINE,severe infection,18,0,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Danazol,these symptoms,1314,1,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3,direct
VANFLYTA,liver disease (non-cirrhotic),20,0,CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1,direct
Quflora Pediatric,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Irinotecan hydrochloride,hypersensitivity,313,1,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
IBU,pregnancy,16,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Lidocaine HCl,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Amiloride Hydrochloride and Hydrochlorothiazide,hyperkalemia,131,1,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
Vaseretic,pregnancy,16,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
Levothyroxine Sodium,acute myocardial infarction,545,1,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
Xipere,cancer (localized),8,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
KENALOG-10,chronic kidney disease,3,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Indium In 111 Oxyquinoline,abscess,299,1,[111In+3].[O-]C1=CC=CC2=C1N=CC=C2.[O-]C1=CC=CC2=C1N=CC=C2.[O-]C1=CC=CC2=C1N=CC=C2,direct
Propranolol,shock,419,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Visipaque,AIDS,10,0,CC(=O)N(CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,direct
Celecoxib,renal failure,19,0,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
Sulfamethoxazole and Trimethoprim DS,hypertension,11,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
DermacinRx Lidotral,autoimmune disease,15,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Fluorouracil,hypersensitivity,313,1,FC1=CNC(=O)NC1=O,direct
CitraNatal Assure,congestive heart failure,2,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
NIFEdipine,liver disease (non-cirrhotic),20,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Migranow,uncontrolled hypertension,1337,1,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,direct
Ethacrynic Acid,hypokalemia,133,1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Hydroxyzine Hydrochloride,hypersensitivity,313,1,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Deflazacort,stroke,7,0,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@]([H])(O)C[C@]3(C)[C@@]1(N=C(C)O2)C(=O)COC(C)=O,direct
ERLOTINIB HYDROCHLORIDE,anorexia,399,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
tramadol hydrochloride,sepsis,17,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
ENTERO Vu 24%,liver cirrhosis,4,0,[Ba++].[O-]S([O-])(=O)=O,direct
Fetroja,hypertension,11,0,[H][C@]12SCC(C[N+]3(CCNC(=O)C4=C(Cl)C(O)=C(O)C=C4)CCCC3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(N)=N1)C([O-])=O,direct
SOTALOL HYDROCHLORIDE,cancer (localized),8,0,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Abiraterone,metastatic crpc who,998,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
SPIRONOLACTONE,liver cirrhosis,4,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
QUINIDINE SULFATE,liver cirrhosis,4,0,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
Xylocaine,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Butalbital/Acetaminophen/Caffeine,asthma,12,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Nadolol,angina pectoris,596,1,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,direct
Prenate Pixie,diabetes mellitus,5,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Fareston,AIDS,10,0,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,direct
Ranitidine,cancer (metastatic),9,0,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O,direct
DOXERCALCIFEROL,autoimmune disease,15,0,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
Foltrate,autoimmune disease,15,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Cefuroxime Axetil,AIDS,10,0,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,direct
Chlorpromazine,AIDS,10,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
Lignospan Standard,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
"Amlodipine, Valsartan and Hydrochlorothiazide",hypercalcemia,139,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
rifabutin,hypertension,11,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21,direct
KHAPZORY,metastatic colorectal cancer,996,1,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
Caspofungin Acetate,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Desmopressin Acetate,autoimmune disease,15,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
Deferasirox oral,poor performance status,1139,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
GLYCOPYRROLATE,stroke,7,0,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
glyburide and metformin hydrochloride,chronic kidney disease,3,0,CN(C)C(=N)NC(N)=N,direct
Adasuve,sepsis,17,0,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,direct
Clobetasol Propionate ANDA,hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ACCURETIC,pre-existing renal impairment,1152,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Isosorbide dinitrate and hydralazine hydrochloride,asthma,12,0,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
Argatroban,asthma,12,0,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2,direct
Nefazodone Hydrochloride,autoimmune disease,15,0,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,direct
ASENAPINE,mental illness,14,0,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
pemetrexed,asthma,12,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
Dorzolamide Hydrochloride Ophthalmic Solution,anemia,13,0,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Norpace CR,arrhythmia,43,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
amlodipine besylate and olmesartan medoxomil,chronic kidney disease,3,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Dexamethasone Intensol,unexplained diarrhea,1341,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
FLUDROCORTISONE ACETATE,anemia,13,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
IBUPAK,the aspirin triad,1295,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Auryxia,chronic kidney disease,245,1,O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,direct
Dofetilide,supraventricular arrhythmias,1280,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Liothyronine Sodium,chronic obstructive pulmonary disease (COPD),6,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
XPOVIO,anemia,13,0,FC(F)(F)C1=CC(=CC(=C1)C1=NN(\C=C/C(=O)NNC2=NC=CN=C2)C=N1)C(F)(F)F,direct
Ferrlecit,hypersensitivity,313,1,[O--].[O--].[O--].[Na+].[Fe+3].[Fe+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,direct
"Travoprost Ophthalmic Solution USP, 0.004% Travoprost",sepsis,17,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
atenolol,anemia,13,0,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,direct
SILODOSIN,renal failure,19,0,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,direct
BUPROPION HYDROCHLORIDE,renal failure,19,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Cyclopentolate Hydrochloride,cancer (localized),8,0,CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1,direct
Glipizide and Metformin Hydrochloride,diabetes mellitus,5,0,CN(C)C(=N)NC(N)=N,direct
Caffeine Citrate Oral Solution,AIDS,10,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Brinzolamide,myocardial infarction,1,0,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Oxymorphone hydrochloride,stroke,7,0,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,direct
CIPRODEX,intact tympanic membranes,939,1,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,direct
Hyoscyamine Sulfate ODT,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Dialyvite,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Desipramine Hydrochloride,autoimmune disease,15,0,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
"PREGABALIN capsules, CV",hypersensitivity,313,1,CC(C)C[C@H](CN)CC(O)=O,direct
HYDROCORTISONE VALERATE,cancer (metastatic),9,0,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
XELPROS,severe infection,18,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Deferasirox,autoimmune disease,15,0,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
DICLOFENAC SODIUM,congestive heart failure,2,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Meropenem,cancer (localized),8,0,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
BUPIVACAINE HCI,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Hyosyne,renal failure,19,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
"Butalbita,Acetaminophen and Caffeine",hypertension,11,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Tolmetin Sodium,the aspirin triad,1295,1,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,direct
Gemcitabine hydrochloride,AIDS,10,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
nebivolol,hypertension,39,1,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
olanzapine,liver disease (non-cirrhotic),20,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
BETAMETHASONE DIPROPIONATE,chronic kidney disease,3,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Methotrexate,renal failure,19,0,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
Varenicline tartrate,cancer (metastatic),9,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Nortriptyline Hydrochloride,liver disease (non-cirrhotic),20,0,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
ganciclovir,cmv retinitis,731,1,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,direct
URSODIOL,such stones,1278,1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
"Betamethasone Dipropionate USP, 0.05%",chronic kidney disease,3,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
CLOBETASOL PROPIONATE,liver cirrhosis,4,0,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Zithromax,pneumonia who,1132,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Meropenem,severe infection,18,0,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
"Lansoprazole, Amoxicillin, Clarithromycin",pregnancy,16,0,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Midazolam,hypersensitivity,313,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
IRINOTECAN HYDROCHLORIDE,hypersensitivity,313,1,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
Leucovorin Calcium,sepsis,17,0,[H]C(=O)N1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2,direct
Rivastigmine Transdermal System,chronic obstructive pulmonary disease (COPD),6,0,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,direct
Enalapril Maleate and Hydrochlorothiazide,impaired renal function,919,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND,diabetes mellitus,5,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Fluorescein,cancer (metastatic),9,0,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
dexamethasone,unexplained diarrhea,1341,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
NITROGLYCERIN,increased intracranial pressure,926,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
KENGREAL,asthma,12,0,CSCCNC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC(SCCC(F)(F)F)=N1,direct
Leucovorin calcium,congestive heart failure,2,0,[H]C(=O)N1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2,direct
Mupirocin,chronic obstructive pulmonary disease (COPD),6,0,C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O,direct
Rifadin IV,myocardial infarction,1,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
Trijardy XR,urinary tract infection,249,1,CN(C)C(=N)NC(N)=N,direct
Sodium Phenylacetate and sodium benzoate,myocardial infarction,1,0,OC(=O)C1=CC=CC=C1,direct
ENALAPRILAT,edema,417,1,[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@@]1([H])C(O)=O,direct
carbamazepine,increased intraocular pressure,927,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Betaxolol,hypersensitivity,313,1,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
Etodolac,the aspirin triad,1295,1,CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1,direct
SOLU-CORTEF,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Pfizerpen,AIDS,10,0,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,direct
haloperidol decanoate,dementia,7,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Oseltamivir Phosphate,hypersensitivity,313,1,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
Alosetron,ibs who,907,1,CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2,direct
"Butalbital, Aspirin, and Caffeine",bleeding disorders,635,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE,anemia,13,0,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],direct
CombiPatch (estradiol/norethindrone acetate transdermal system),pregnancy,16,0,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],direct
ERTAPENEM SODIUM,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Arsenic Trioxide,apl who,611,1,O=[As]O[As]=O,direct
Meloxicam,mental illness,14,0,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O,direct
Azathioprine,anemia,13,0,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
pitavastatin calcium,stroke,7,0,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
HALOPERIDOL,liver disease (non-cirrhotic),20,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Phenobarbital Sodium,cancer (localized),8,0,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1,direct
deferasirox,deferasirox oral granules,763,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Dextrose and Electrolyte No. 48,severe renal impairment,1253,1,[Cl-].[K+],direct
Methylprednisolone Sodium Succinate,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Adefovir dipivoxil,asthma,12,0,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C,direct
pramosone,cancer (metastatic),9,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Zolpidem,congestive heart failure,2,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
tooth powder,myocardial infarction,1,0,[F-].[Na+],fuzzy:toothpowder
Diflunisal,liver cirrhosis,4,0,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,direct
Prilosec,AIDS,10,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
hyoscyamine sulfate,asthma,12,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Lacosamide Oral Solution,liver cirrhosis,4,0,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
Amlodipine and olmesartan Medoxomil,hypertension,39,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
mesalamine,renal failure,19,0,NC1=CC(C(O)=O)=C(O)C=C1,direct
VYXEOS,diabetes mellitus,5,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,direct
METOPROLOL TARTRATE,hypertension,11,0,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
Cefuroxime sodium,tics,23,1,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,direct
"Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride",chronic kidney disease,3,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
Tolcapone,dystonia,461,1,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,direct
Melphalan Hydrochloride,anemia,13,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Oraqix,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Hectorol,cancer (localized),8,0,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
Cortisone Acetate,asthma,12,0,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
ROSUVASTATIN CALCIUM,homozygous familial hypercholesterolemia,872,1,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Guanfacine,autoimmune disease,15,0,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,direct
Cetirizine Hydrochloride Oral Solution,hypersensitivity,313,1,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
DOXY 100(TM) DOXYCYCLINE,diabetes mellitus,5,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Fludrocortisone Acetate,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
PAROXETINE,liver cirrhosis,4,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
OSELTAMIVIR PHOSPHATE,hypersensitivity,313,1,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
VORICONAZOLE,acute ia,541,1,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Cefuroxime Axetil,influenza,289,1,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,direct
Liquid Polibar Plus,asthma,12,0,[Ba++].[O-]S([O-])(=O)=O,direct
NINLARO,hypertension,11,0,CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(Cl)=CC=C1Cl)B(O)O,direct
TRANEXAMIC ACID IN SODIUM CHLORIDE,hypertension,11,0,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Sevelamer Carbonate,myocardial infarction,1,0,NCC=C.ClCC1CO1,direct
zolmitriptan,severe infection,18,0,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
COMBIVIR,liver disease (non-cirrhotic),20,0,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
Prenatrix,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Sitagliptin and metformin hydrochloride,pancreatitis,233,1,CN(C)C(=N)NC(N)=N,fuzzy:saxagliptin and metformin hydrochloride
VELCADE,neutropenia,85,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
XPOVIO,myocardial infarction,1,0,FC(F)(F)C1=CC(=CC(=C1)C1=NN(\C=C/C(=O)NNC2=NC=CN=C2)C=N1)C(F)(F)F,direct
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE,hypersensitivity,313,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Colesevelam Hydrochloride,cancer (localized),8,0,NCC=C.ClCC1CO1,fuzzy:sevelamer hydrochloride
CitraNatal Medley,sepsis,17,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Hyoscyamine Sulfate ODT,mental illness,14,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Adalimumab-adbm,anti-adalimumab antibody,602,1,CC(C)O,direct
Carbatrol,increased intraocular pressure,927,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
XYLOCAIN (LIDOCAINE HCl ),tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Morphine Sulfate,myocardial infarction,1,0,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,direct
DEXRAZOXANE,autoimmune disease,15,0,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,direct
Ciprofloxacin and dexamethasone,pregnancy,16,0,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,direct
Mulpleta,sepsis,17,0,CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C1=CSC(NC(=O)C2=CC(Cl)=C(\C=C(/C)C(O)=O)C(Cl)=C2)=N1,direct
Cefotaxime,hypersensitivity,313,1,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
NYSTATIN,AIDS,10,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
ACETAMINOPHEN,pregnancy,16,0,CC(=O)NC1=CC=C(O)C=C1,direct
Raloxifene hydrochloride,an intact uterus,591,1,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,direct
SIMVASTATIN,homozygous familial hypercholesterolemia,872,1,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Carvedilol Phosphate,severe hepatic impairment,1245,1,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
NITROLINGUAL,chronic obstructive pulmonary disease (COPD),6,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Cevimeline,renal failure,19,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
LAMIVUDINE AND ZIDOVUDINE,asthma,12,0,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
OXTELLAR XR,seizure disorders,25,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
"AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE",congestive heart failure,2,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
FUROSEMIDE,hypertension,11,0,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O,direct
Medrol,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
MELOXICAM,myocardial infarction,1,0,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O,direct
ropivacaine hydrochloride,renal failure,19,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
ERLOTINIB HYDROCHLORIDE,mental illness,14,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
CEFPROZIL,sepsis,17,0,[H][C@]12SCC(C=CC)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
pentazocine and naloxone,mental illness,14,0,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,direct
Tretinoin,these symptoms,1314,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
Hydrocortisone Acetate,renal failure,19,0,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
TIZANIDINE HYDROCHLORIDE,myocardial infarction,1,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
LIDO BDK,cancer (metastatic),9,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
RESTASIS,chronic kidney disease,3,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Prolia,hypersensitivity,313,1,OC(=O)[C@@H]1CCCN1,fuzzy:prolina
Nalbuphine hydrochloride,asthma,193,1,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
Erythromycin ethylsuccinate,hypersensitivity,313,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
KENALOG-40,severe infection,18,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Dofetilide,a recent mi,507,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Latuda,congestive heart failure,2,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Nexavar,liver cirrhosis,4,0,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
Vueway,cancer (metastatic),9,0,[Gd+3].OCC(O)CNC(=O)CCC(N1CCN(CC2=CC=CC(CN(CC1)C(CCC(=O)NCC(O)CO)C([O-])=O)=N2)C(CCC(=O)NCC(O)CO)C([O-])=O)C([O-])=O,direct
Flecainide Acetate,myocardial infarction,49,1,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1,direct
Cefaclor,hypertension,11,0,[H][C@]12SCC(Cl)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
POSACONAZOLE,refractory opc,1202,1,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
FENTORA,autoimmune disease,15,0,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
Bimatoprost,hypertension,39,1,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
Lisinopril and hydrochlorothiazide,cancer (localized),8,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Livita Adults,AIDS,10,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Atenolol and Chlorthalidone,liver cirrhosis,4,0,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Saxagliptin,hypersensitivity,313,1,[H][C@@]12C[C@]1([H])N([C@@H](C2)C#N)C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,direct
Cefoxitin and Dextrose,hypersensitivity,313,1,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,direct
Mefloquine Hydrochloride,asthma,12,0,OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F,direct
Konvomep,hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
ESTRACE,breast cancer,263,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Donepezil,hypersensitivity,313,1,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
NIACIN,primary hyperlipidemia,1175,1,OC(=O)C1=CN=CC=C1,direct
nitrofurantoin,liver disease (non-cirrhotic),20,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Losortan Potassium,chronic obstructive pulmonary disease (COPD),6,0,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
Celecoxib 200 mg,chronic obstructive pulmonary disease (COPD),6,0,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
Fulvestrant,severe infection,18,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],direct
Phenelzine Sulfate,liver disease (non-cirrhotic),20,0,NNCCC1=CC=CC=C1,direct
Prochlorperazine Edisylate,hypersensitivity,313,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
GEMFIBROZIL,renal failure,19,0,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,direct
Adapalene and benzoyl peroxide,autoimmune disease,15,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Azulfidine EN-tabs,rheumatoid arthritis who,1215,1,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,direct
Pimozide,hypersensitivity to it,889,1,FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1,direct
NYSTATIN,myocardial infarction,1,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
ZYPITAMAG,primary hyperlipidemia,1175,1,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
Penciclovir,hypersensitivity,313,1,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,direct
PAXIL,hypertension,11,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Armodafinil,diabetes mellitus,5,0,NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1,direct
TESTOSTERONE ENANTHATE,liver cirrhosis,4,0,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
AMLODIPINE AND OLMESARTAN MEDOXOMIL,stroke,51,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
hydrochlorothiazide,renal failure,19,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Methylphenidate Hydrochloride,myocardial infarction,1,0,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
Zytiga,liver metastases,967,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
XALATAN,diabetes mellitus,5,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Midazolam hydrochloride,hemodynamic instability,852,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
leucovorin calcium,advanced colorectal cancer,560,1,[H]C(=O)N1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2,direct
Azasan,cancer (localized),8,0,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
montelukast sodium,anemia,13,0,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
Omeprazole and Sodium Bicarbonate,pregnancy,16,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
CYCLOPHOSPHAMIDE,asthma,12,0,ClCCN(CCCl)P1(=O)NCCCO1,direct
Neuraceq,cognitive impairment who,733,1,CNC1=CC=C(\C=C\C2=CC=C(OCCOCCOCC[18F])C=C2)C=C1,direct
LIDOCAINE HYDROCHLORIDE AND DEXTROSE,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Midodrine hydrochloride,pregnancy,16,0,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,direct
DOXORUBICIN HYDROCHLORIDE,multiple myeloma who,1025,1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
HYCAMTIN,AIDS,10,0,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
Xylocaine,cancer (metastatic),9,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
XARELTO,atrial fibrillation,65,1,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,direct
lamotrigine,liver cirrhosis,4,0,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
Haldol Decanoate,severe infection,18,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Select-OB Plus DHA Prenatal Supplement Plus DHA,AIDS,10,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Dextroamphetamine Sulfate Extended-Release,comorbid depressive symptoms,735,1,C[C@H](N)CC1=CC=CC=C1,direct
Modafinil,diabetes mellitus,5,0,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,direct
TAZVERIK,anemia,13,0,CCN(C1CCOCC1)C1=C(C)C(=CC(=C1)C1=CC=C(CN2CCOCC2)C=C1)C(=O)NCC1=C(C)C=C(C)NC1=O,direct
Diltiazem hydrochloride,hypersensitivity,313,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Tadalafil,diabetes mellitus,5,0,[H][C@]12CC3=C(NC4=CC=CC=C34)[C@H](N1C(=O)CN(C)C2=O)C1=CC2=C(OCO2)C=C1,direct
Levsin,AIDS,10,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Cyanocobalamin,anemia,81,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Methotrexate,congestive heart failure,2,0,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
Pantoprazole Sodium,hypersensitivity,313,1,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
NABUMETONE,renal failure,19,0,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
ibuprofen,myocardial infarction,1,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Dextrose in Lactated Ringers,hypersensitivity,313,1,[Cl-].[K+],direct
Prenate Chewable,pregnancy,16,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
LACTATED RINGERS,chronic kidney disease,3,0,[Cl-].[K+],direct
DOXYCYCLINE,impaired renal function,919,1,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025%,acne vulgaris,516,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
Chlordiazepoxide Hydrochloride and Clidinium Bromide,glaucoma,481,1,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
"Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate",anemia,13,0,[Mg++].[O-]S([O-])(=O)=O,direct
FLUDROCORTISONE ACETATE,mental illness,14,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Olanzapine,schizophrenia and,1220,1,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
EPINEPHRINE,angina pectoris,596,1,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
epinephrine,mental illness,14,0,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
LEXISCAN,functioning artificial pacemakers,821,1,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
Lactated Ringers and Dextrose,mental illness,14,0,[Cl-].[K+],direct
LANOXIN,chronic atrial fibrillation,685,1,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,direct
Dexamethasone 1.5 mg,unexplained diarrhea,1341,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Dextromethorphan Hydrobromide and Promethazine Hydrochloride,cancer (metastatic),9,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Pitavastatin Calcium,congestive heart failure,2,0,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
COMBIGAN,asthma,193,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Pain Relieving Patch,congestive heart failure,2,0,CC(C)C1CCC(C)CC1O,direct
Memantine Hydrochloride,liver disease (non-cirrhotic),20,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
EVOMELA,hypokalemia,133,1,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
ANASPAZ,mental illness,14,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Imipramine Hydrochloride,sepsis,17,0,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
"Brimonidine Tartrate ophthalmic solution, 0.15%",anemia,13,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Ranexa,severe infection,18,0,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,direct
"Lansoprazole, Amoxicillin, Clarithromycin",hypersensitivity,313,1,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
ZOCOR,pregnancy,16,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
CARMUSTINE,cancer (localized),8,0,ClCCNC(=O)N(CCCl)N=O,direct
EPINEPHRINE,AIDS,10,0,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Levalbuterol,asthma,12,0,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
YUPELRI,sepsis,17,0,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1,direct
TRANEXAMIC ACID IN SODIUM CHLORIDE,AIDS,10,0,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
VELCADE,anorexia,399,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Vraylar,renal failure,19,0,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1,direct
Anastrozole,congestive heart failure,2,0,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,direct
Acetylcysteine,chronic kidney disease,3,0,CC(=O)N[C@@H](CS)C(O)=O,direct
Betamethasone Sodium Phosphate and Betamethasone Acetate,stroke,7,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
diflunisal,chronic obstructive pulmonary disease (COPD),6,0,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,direct
LYBALVI,chronic kidney disease,3,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
sevelamer hydrochloride,hypertension,11,0,NCC=C.ClCC1CO1,direct
OXCARBAZEPINE,vaginitis,337,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Oxycodone and Acetaminophen,acetaminophen allergy,513,1,CC(=O)NC1=CC=C(O)C=C1,direct
PROMETHAZINE HCI,asthma,12,0,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Sensipar,these symptoms,1314,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
BUSULFAN,anemia,13,0,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
Gralise,hypersensitivity,313,1,NCC1(CC(O)=O)CCCCC1,direct
Effient,asthma,12,0,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,direct
FLUORESCITE,anemia,13,0,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
ELMIRON,hypertension,11,0,O[C@@H]1CO[C@@H](O[C@@H]2CO[C@@H](O)[C@H](OS(O)(=O)=O)[C@H]2OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O,direct
ELIGARD,advanced prostate cancer,567,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Seizalam,status epilepticus,1274,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
INVOKANA,hypersensitivity,313,1,[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=C(C)C(CC2=CC=C(S2)C2=CC=C(F)C=C2)=C1,direct
Brinzolamide,renal failure,19,0,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
ALPHAGAN P,anemia,13,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
E-Z-Disk,chronic kidney disease,3,0,[Ba++].[O-]S([O-])(=O)=O,direct
"Carisoprodol Tablets, USP, 350 mg",hypersensitivity,313,1,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
FLUOROURACIL,cancer (localized),8,0,FC1=CNC(=O)NC1=O,direct
HYDROCORTISONE ACETATE PRAMOXINE HYDROCHLORIDE,hypersensitivity,313,1,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
LIDOCAINE,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
PROCYSBI,dehydration,395,1,NCCS,direct
BETHKIS,pseudomonas aeruginosa,1188,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
azithromycin,pneumonia who,1132,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
CIPRODEX,diabetes mellitus,5,0,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,direct
FENOFIBRIC ACID,autoimmune disease,15,0,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
Pemfexy,mental illness,14,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
QUININE SULFATE,renal failure,19,0,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12,direct
Magnesium Sulfate,heart block,59,1,[Mg++].[O-]S([O-])(=O)=O,direct
Ketoprofen,pregnancy,16,0,CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1,direct
DoubleDex Kit,inflammatory bowel disease,223,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Mepivacaine Hydrochloride,cancer (localized),8,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
VELCADE,thrombocytopenia,79,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
FLUCONAZOLE,sepsis,17,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
ProAir Digihaler,liver disease (non-cirrhotic),20,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Dexamethasone Sodium Phosphate,unexplained diarrhea,1341,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Timoptic in Ocudose,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Plasma-Lyte A,severe renal impairment,1253,1,[Cl-].[K+],direct
Lydexa 4.12%,myocardial infarction,1,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Brevital Sodium,chronic kidney disease,3,0,CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O,direct
Tafluprost,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
Sitagliptin and metformin hydrochloride,congestive heart failure,2,0,CN(C)C(=N)NC(N)=N,fuzzy:saxagliptin and metformin hydrochloride
CELECOXIB,stroke,7,0,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
FLUVASTATIN SODIUM ER,heart disease,377,1,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,direct
Hydrocodone/APAP,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
Serostim,liver cirrhosis,4,0,O,direct
Levalbuterol,anemia,13,0,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
Zolpidem Tartrate Extended-Release,chronic obstructive pulmonary disease (COPD),6,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Guanfacine Hydrochloride,anemia,13,0,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,direct
Sevelamer Carbonate,autoimmune disease,15,0,NCC=C.ClCC1CO1,direct
Perphenazine,psychic depression,1192,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
HALOPERIDOL LACTATE,severe infection,18,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
chlordiazepoxide hydrochloride and clidinium bromide,glaucoma,481,1,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
XELPROS,cancer (localized),8,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
TIAZAC EXTENDED RELEASE,stroke,7,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
NIACIN,liver disease (non-cirrhotic),20,0,OC(=O)C1=CN=CC=C1,direct
erythromycin lactobionate,sepsis,17,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
FENOFIBRIC ACID,AIDS,10,0,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
Ketorolac tromethamine,hypersensitivity,313,1,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
ACCURETIC,myocardial infarction,1,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
TECFIDERA,pregnancy,16,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
Sumansetron,risk factors,1216,1,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,direct
Trileptal,cancer (metastatic),9,0,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
ASMANEX,AIDS,10,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
"Travoprost Ophthalmic Solution, 0.004%",chronic obstructive pulmonary disease (COPD),6,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Acetaminophen,AIDS,10,0,CC(=O)NC1=CC=C(O)C=C1,direct
Retisert,hypertension,11,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate",autoimmune disease,15,0,CC(N)CC1=CC=CC=C1,direct
Cuprimine,aplastic anemia,103,1,[H][C@](N)(C(O)=O)C(C)(C)S,direct
Carboplatin,impaired kidney function,917,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
VARENICLINE,diabetes mellitus,5,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
QUVIVIQ,cancer (localized),8,0,COC1=CC(C(=O)N2CCC[C@@]2(C)C2=NC3=C(N2)C=CC(Cl)=C3C)=C(C=C1)N1N=CC=N1,direct
EPIVIR,hypersensitivity,313,1,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,direct
Bivalirudin,AIDS,10,0,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,direct
omeprazole sodium bicarbonate,AIDS,10,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Cevimeline,severe infection,18,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
TOBI Podhaler,stroke,7,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Iluvien,AIDS,10,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Indomethacin,these conditions,1310,1,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,direct
OSELTAMIVIR PHOSPHATE,hypertension,11,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
BOSULIF,cml who,729,1,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,direct
Propranolol Hydrochloride,hypersensitivity,313,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Nipent,leukemia,267,1,OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CNC[C@H]2O,direct
Zafirlukast,cirrhosis,231,1,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,direct
Menatrol,diabetes mellitus,5,0,CC1=C(O)C(CO)=C(CO)C=N1,direct
tramadol hydrochloride,asthma,12,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
CISPLATIN,pre-existing renal impairment,1152,1,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
BISOPROLOL FUMARATE,event the following,808,1,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,direct
CHLOROQUINE PHOSPHATE,renal failure,19,0,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,direct
Lidocaine HCl - Hydrocortisone Acetate,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Penicillin G Sodium,autoimmune disease,15,0,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,direct
Polocaine,sepsis,17,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
risperidone,chronic obstructive pulmonary disease (COPD),6,0,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,direct
Epclusa,cirrhosis,231,1,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
PREDNISOLONE,sepsis,17,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
foscarnet sodium,congestive heart failure,2,0,OC(=O)P(O)(O)=O,direct
Donepezil hydrochloride,hypersensitivity,313,1,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
Dicyclomine hydrochloride,prostatic hypertrophy cardiovascular,1184,1,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,direct
Ibuprofen,hypersensitivity,313,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
ertapenem,cancer (localized),8,0,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
olopatadine hydrochloride,liver cirrhosis,4,0,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2,direct
montelukast sodium,stroke,7,0,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
Claravis,these symptoms,1314,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Foltrexyl,myocardial infarction,1,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Glipizide and Metformin Hydrochloride,asthma,12,0,CN(C)C(=N)NC(N)=N,direct
Succinylcholine Chloride,cancer (localized),8,0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,direct
perphenazine,convulsive disorders,751,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Albendazole 200 mg,myocardial infarction,1,0,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,direct
Potassium Citrate,peptic ulcer disease,219,1,[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,direct
Delestrogen,hypersensitivity,313,1,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Trijardy XR,liver cirrhosis,4,0,CN(C)C(=N)NC(N)=N,direct
"PredniSONE Tablets, USP, 20 mg",tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Ropivacaine hydrochloride,mental illness,14,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
metronidazole,pregnancy,16,0,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Glyburide and Metformin Hydrochloride,renal failure,19,0,CN(C)C(=N)NC(N)=N,direct
Daunorubicin Hydrochloride,asthma,12,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,direct
ETHACRYNATE SODIUM,arrhythmia,43,1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
"Butalbital, Acetaminophen and Caffeine",stroke,7,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Olanzapine and Fluoxetine,autoimmune disease,15,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Gadobutrol,hypersensitivity,313,1,OC[C@H](O)[C@H](CO)[N+]12CC[N+]3(CC([O-])=O)CC[N+]4(CC([O-])=O)CC[N+](CC([O-])=O)(CC1)[Gd-]234,direct
Clorazepate Dipotassium,glaucoma,481,1,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,direct
CABERGOLINE,congestive heart failure,2,0,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,direct
"Orphenadrine Citrate, Aspirin and Caffeine",liver cirrhosis,4,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Pantoprazole sodium delayed-release,diabetes mellitus,5,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Mavenclad,hypertension,11,0,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
Adapalene and Benzoyl Peroxide,diabetes mellitus,5,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
TARCEVA,stroke,7,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
AVYCAZ,edema,417,1,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
Trandolapril,renal artery stenosis,1209,1,[H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC3=CC=CC=C3)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,direct
Vitafol Ultra,an overactive thyroid,592,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Carbatrol,autoimmune disease,15,0,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
FENTANYL,severe pain,1251,1,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
Prochlorperazine,mental retardation,993,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
teriflunomide,autoimmune disease,15,0,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
"Testosterone Gel, 1%",depression,27,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Adalimumab-aacf,liver cirrhosis,4,0,CC(C)O,direct
TARCEVA,anorexia,399,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
LODOCO,myocardial infarction,49,1,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
NIZATIDINE,hypersensitivity,313,1,CNC(NCCSCC1=CSC(CN(C)C)=N1)=C[N+]([O-])=O,direct
Gentak,pregnancy,16,0,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,direct
TAUVID,liver cirrhosis,4,0,[18F]C1=CC=C(C=N1)C1=CC=C2C(NC3=C2C=NC=C3)=C1,direct
CELESTONE SOLUSPAN,tuberculosis,213,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Lansoprazole DR,hypersensitivity,313,1,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Pamidronate Disodium,cancer (localized),8,0,NCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Capecitabine,anemia,81,1,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
Pindolol,congestive heart failure,41,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,direct
Dorzolamide Hydrochloride Ophthalmic Solution,liver cirrhosis,4,0,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Dofetilide 0.125mg,liver cirrhosis,4,0,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Azathioprine,rheumatoid arthritis who,1215,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Edluar,insomnia,441,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
BUPROPION HYDROCHLORIDE,myocardial infarction,1,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
"Amlodipine, Valsartan and Hydrochlorothiazide",diabetes mellitus,5,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
dexamethasone,tuberculosis,213,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Bendamustine,chronic obstructive pulmonary disease (COPD),6,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Integra F,liver cirrhosis,4,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
BiDil,tachycardia,47,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
PureVit DualFe Plus,stroke,7,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
NITROGLYCERIN IN DEXTROSE,these conditions,1310,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Adefovir dipivoxil,severe infection,18,0,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C,direct
Azulfidine,mental illness,14,0,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,direct
Leucovorin calcium,advanced colorectal cancer,560,1,[H]C(=O)N1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2,direct
HydrOXYzine Hydrochloride,liver disease (non-cirrhotic),20,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Galantamine,mental illness,14,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
Acetylcysteine,acetaminophen poisoning,514,1,CC(=O)N[C@@H](CS)C(O)=O,direct
QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE,pre-existing renal impairment,1152,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Neomycin Sulfate,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O.[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O,fuzzy:capreomycin sulfate
Lidocaine,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ZOCOR,myocardial infarction,49,1,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
lansoprazole,hypersensitivity,313,1,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Levetiracetam,partial seizures,1104,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
COMBIGAN,cancer (metastatic),9,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Spironolactone and Hydrochlorothiazide,impaired renal function,919,1,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
nitrofurantoin,severe infection,18,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Brimonidine,severe infection,18,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
KETOROLAC TROMETHAMINE,stroke,7,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Indium in 111 Oxyquinoline,abscess,299,1,[111In+3].[O-]C1=CC=CC2=C1N=CC=C2.[O-]C1=CC=CC2=C1N=CC=C2.[O-]C1=CC=CC2=C1N=CC=C2,direct
Marvona SUIK,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
bupropion hydrochloride,sepsis,17,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
"Brimonidine Tartrate ophthalmic solution, 0.15%",glaucoma,481,1,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Vitranol Fe,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
TAVNEOS,vasculitis,183,1,CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C2=CC=C(NC3CCCC3)C=C2)C(=O)C2=C(F)C=CC=C2C)C=C1C(F)(F)F,direct
Urso 250,hypersensitivity,313,1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
NYSTATIN AND TRIAMCINOLONE ACETONIDE,liver disease (non-cirrhotic),20,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Oxcarbazepine,anorexia,399,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate",pregnancy,16,0,CC(N)CC1=CC=CC=C1,direct
latanoprost,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
ACCOLATE,AIDS,10,0,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,direct
Sinuva,sepsis,17,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
TREANDA,chronic lymphocytic leukemia,693,1,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Linezolid,mental illness,14,0,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,direct
TARCEVA,nsclc whose tumors,1069,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
PredniSONE,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Ketoconazole,tinea versicolor,1321,1,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1,direct
Integra Plus,diabetes mellitus,5,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
diflunisal,renal failure,19,0,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,direct
Glimepiride,hypersensitivity,313,1,CCC1=C(C)CN(C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)N[C@H]2CC[C@H](C)CC2)C1=O,direct
FASLODEX,hypersensitivity,313,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],direct
paroxetine hydrochloride,autoimmune disease,15,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
PREDNISOLONE,mental illness,14,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Naropin,hypersensitivity,313,1,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
Symbyax,depression,27,1,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Fluconazole in Sodium Chloride,chronic obstructive pulmonary disease (COPD),6,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
SERTRALINE HYDROCHLORIDE,hypersensitivity,313,1,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,direct
Polocaine-MPF,anemia,13,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
ZEVTERA,anemia,81,1,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCN(C1)C(=O)OCC1=C(C)OC(=O)O1,direct
ATACAND HCT,pregnancy,16,0,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1,direct
Histamine Positive Skin Test Control,asthma,193,1,NCCC1=CNC=N1,direct
"Omeprazole, Sodium bicarbonate",pregnancy,16,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Mirabegron,sepsis,17,0,NC1=NC(CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2)=CS1,direct
CARBIDOPA AND LEVODOPA,hypersensitivity,313,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Diltiazem Hydrochloride EXTENDED RELEASE,hypersensitivity,313,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
NORLIQVA,chronic obstructive pulmonary disease (COPD),6,0,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,direct
Proctosol-HC,mental illness,14,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Clonidine,AIDS,10,0,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
Lipofen,chronic obstructive pulmonary disease (COPD),6,0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
Mycostatin,severe infection,18,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
fulvestrant,liver disease (non-cirrhotic),20,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],direct
Fluocinolone Acetonide Topical,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Prevacid,liver disease (non-cirrhotic),20,0,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Se-Natal 19,liver cirrhosis,4,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
valsartan,diabetes mellitus,5,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
colchicine,hepatic impairment,1,1,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Vitrexyl plus Iron,chronic kidney disease,3,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Galantamine Hydrobromide,cancer (localized),8,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
Penicillin G Potassium,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,direct
HYFTOR,mental illness,14,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
TOBRAMYCIN,hypersensitivity,313,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Polymyxin B Sulfate and Trimethoprim,cancer (metastatic),9,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
LENALIDOMIDE,mm when pembrolizumab,1014,1,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
MB CAPS,cancer (metastatic),9,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,fuzzy:pm caps
TAVALISSE,autoimmune disease,15,0,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC,direct
epiduo forte,hypersensitivity,313,1,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
nitrofurantoin (macrocrystals),cancer (metastatic),9,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Fludrocortisone Acetate,asthma,12,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Budesonide,pregnancy,16,0,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
CLOMIPRAMINE HYDROCHLORIDE,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
Pentazocine and naloxone,acute abdominal conditions,537,1,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,direct
Lenvima,chronic kidney disease,3,0,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,direct
Pentazocine and naloxone,myocardial infarction,1,0,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,direct
Diltiazem Hydrochloride,ventricular tachycardia,1357,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Triasil,asthma,12,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
CAPTOPRIL AND HYDROCHLOROTHIAZIDE,chronic obstructive pulmonary disease (COPD),6,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
NITRO-BID,myocardial infarction,49,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Foscavir,congestive heart failure,2,0,OC(=O)P(O)(O)=O,direct
Glyburide,non-insulin-dependent diabetes,1045,1,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,direct
Rozlytrek,asthma,12,0,CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1,direct
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE,obstructive jaundice,1073,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
Cefuroxime axetil,AIDS,10,0,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,direct
ADEFOVIR DIPIVOXIL,stroke,7,0,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C,direct
Carnitor,edema,417,1,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
Foltamin,hypersensitivity,313,1,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
MALARONE,congestive heart failure,2,0,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,direct
Omeprazole and Sodium Bicarbonate,liver disease (non-cirrhotic),20,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
DEPO-MEDROL,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
TECFIDERA,liver cirrhosis,4,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
TAZICEF,hypersensitivity,313,1,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
prednisone,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
XALATAN,cancer (metastatic),9,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Liquid Polibar Plus,hypersensitivity,313,1,[Ba++].[O-]S([O-])(=O)=O,direct
"Clobetasol Propionate Cream USP, 0.05% Clobetasol Propionate Cream USP, 0.05%",mental illness,14,0,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Deferoxamine Mesylate,AIDS,10,0,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
Pyrimethamine,hypersensitivity,313,1,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1,direct
PRENATE Restore,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
CISplatin,hearing impairment,848,1,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
RADICAVA,renal failure,19,0,CC1=NN(C(=O)C1)C1=CC=CC=C1,direct
Risedronate Sodium,congestive heart failure,2,0,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
Carbidopa-levodopa,glaucoma,481,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Cortisone Acetate,edema,417,1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Pramipexole dihydrochloride,severe infection,18,0,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
Lidocaine,cancer (metastatic),9,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
TOBI,hypersensitivity,313,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
azacitidine for,hypersensitivity,313,1,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Coreg,cancer (metastatic),9,0,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
"Clonidine Transdermal System USP, 0.1 mg/day",anemia,13,0,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
XYWAV,narcolepsy,443,1,OCCCC(O)=O,direct
polymyxin b sulfate and trimethoprim sulfate,hypersensitivity,313,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
LIPIODOL,diabetes mellitus,5,0,COC1=CC=C(C=C1)C(=O)CC(=O)C1=CC=C(C=C1)C(C)(C)C,fuzzy:lipidol
K-Phos No. 2,mental illness,14,0,[K+].OP(O)([O-])=O,direct
Imatinib,cancer (metastatic),9,0,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Meloxicam,osteoarthritis,161,1,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O,direct
Proctosol-HC,congestive heart failure,2,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
RECARBRIO,cancer (localized),8,0,CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O,direct
Stendra,renal failure,19,0,COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1,direct
Famciclovir,laboratory abnormalities that,956,1,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O,direct
NIFEDIPINE,tight aortic stenosis,1320,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Nulibry,liver cirrhosis,4,0,[H][C@@]12COP(O)(=O)O[C@]1([H])C(O)(O)[C@]1([H])NC3=C(NC(N)=NC3=O)N[C@]1([H])O2,direct
Alcaine,congestive heart failure,2,0,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,direct
sevelamer carbonate,cancer (metastatic),9,0,NCC=C.ClCC1CO1,direct
Zydelig,mental illness,14,0,[H][C@@](CC)(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,direct
DDAVP,pregnancy,16,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
bivalirudin,AIDS,10,0,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,direct
TENORETIC,untreated pheochromocytoma,1345,1,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Fentanyl system,asthma,12,0,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
PROGESTERONE,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
PharmapureRx Lidocaine HCl 4.12%,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
SUTENT,renal failure,19,0,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,direct
Erythromycin Ethylsuccinate,asthma,12,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
KLAYESTA,hypertension,11,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",mental illness,14,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
REZZAYO,sepsis,17,0,[H][C@](C)(O)[C@]1([H])\N=C(O)/[C@]([H])(C[C@@]([H])(O)[C@@]([H])(OCC[N+](C)(C)C)\N=C(O)/[C@@]2([H])N(C[C@]([H])(C)[C@]2([H])O)C(=O)[C@@]([H])(\N=C(O)/[C@@]([H])(\N=C(O)/[C@]2([H])C[C@@]([H])(O)CN2C1=O)[C@]([H])(O)[C@@]([H])(O)C1=CC=C(O)C=C1)[C@@]([H])(C)O)\N=C(/O)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CC=C(OCCCCC)C=C1,direct
RESTASIS,hypersensitivity,313,1,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Methoxsalen,severe infection,18,0,COC1=C2OC(=O)C=CC2=CC2=C1OC=C2,direct
Venclexta,AIDS,10,0,CC1(C)CCC(CN2CCN(CC2)C2=CC=C(C(=O)NS(=O)(=O)C3=CC=C(NCC4CCOCC4)C(=C3)[N+]([O-])=O)C(OC3=CN=C4NC=CC4=C3)=C2)=C(C1)C1=CC=C(Cl)C=C1,direct
Cimetidine Hydrochloride,AIDS,10,0,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N,direct
Ziac,myocardial infarction,1,0,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,direct
Rinvoq,non-radiographic axial spondyloarthritis,1052,1,CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F,direct
E.E.S,hypersensitivity,313,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
"Butalbital, aspirin, and caffeine",bleeding disorders,635,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Reltone 200 mg,hypertension,11,0,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
ENDOCET,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
RESTASIS,liver disease (non-cirrhotic),20,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
"butalbital, aspirin, and caffeine",autoimmune disease,15,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Clobetasol Propionate ANDA,diabetes mellitus,5,0,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Dihydroergotamine Mesylate Nasal,cancer (localized),8,0,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
Lisinopril and hydrochlorothiazide,edema,417,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Prepidil,pregnancy,321,1,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,direct
DEPO-MEDROL,stroke,7,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
vilazodone hydrochloride,mdd including,990,1,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,direct
Cyclosporine Modified,severe infection,18,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Capecitabine 500mg,asthma,12,0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
Sodium Chloride,severe renal impairment,1253,1,[Na+].[Cl-],direct
tetracycline hydrochloride,liver failure,371,1,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
Provigil,hypersensitivity,313,1,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,direct
DEFERASIROX,poor performance status,1139,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
SIROLIMUS,renal failure,19,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
Diltiazem Hydrochloride Extended-Release,hypertension,11,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Betoptic S,AIDS,10,0,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
XELPROS,sepsis,17,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
SENSIPAR,chronic obstructive pulmonary disease (COPD),6,0,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
MEXILETINE HYDROCHLORIDE,life-threatening ventricular arrhythmia,965,1,CC(N)COC1=C(C)C=CC=C1C,direct
GLYCOPYRROLATE 1ML,anemia,13,0,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
Methsuximide,chronic obstructive pulmonary disease (COPD),6,0,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1,direct
Deferoxamine mesylate,chronic anemia,683,1,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
omeprazole and sodium bicarbonate,hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Fluvastatin,chronic kidney disease,3,0,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,direct
Fluconazole in Sodium Chloride,diabetes mellitus,5,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Cyclophosphamide,cancer (metastatic),9,0,ClCCN(CCCl)P1(=O)NCCCO1,direct
K Phos Original,elevated urinary ph,790,1,[K+].OP(O)([O-])=O,direct
LISINOPRIL and HYDROCHLOROTHIAZIDE,edema,417,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
ALLOPURINOL,hypersensitivity,313,1,OC1=NC=NC2=C1C=NN2,direct
Prednisone,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Cefotetan,tics,23,1,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)OC)C(O)=O,direct
LISINOPRIL AND HYDROCHLOROTHIAZIDE,edema,417,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
BUTAL/APAP/CAFFEINE,liver disease (non-cirrhotic),20,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,fuzzy:butal/apap/caff
QUELICIN,chronic kidney disease,3,0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,direct
"Desonide Ointment, 0.05%",diabetes mellitus,5,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
budesonide,hypersensitivity,313,1,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Biltricide,cancer (localized),8,0,O=C(C1CCCCC1)N1CC2N(CCC3=CC=CC=C23)C(=O)C1,direct
bupivacaine hydrochloride,stroke,7,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Multiple Electrolytes pH 5.5,brain edema,643,1,[Cl-].[K+],direct
EVOMELA,hypertension,11,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide",hypertension,39,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
OXYCODONE AND ACETAMINOPHEN,AIDS,10,0,CC(=O)NC1=CC=C(O)C=C1,direct
Arava,autoimmune disease,15,0,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
RANOLAZINE,AIDS,10,0,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,direct
Ozempic,cancer (metastatic),9,0,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CN=CN1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O,direct
EMSAM,AIDS,10,0,C[C@H](CC1=CC=CC=C1)N(C)CC#C,direct
Stendra,congestive heart failure,2,0,COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1,direct
CELEBREX,hypertension,11,0,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
PharmapureRx Lidocaine HCl 4.12%,myocardial infarction,1,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
MESALAMINE,ulcerative colitis,225,1,NC1=CC(C(O)=O)=C(O)C=C1,direct
capecitabine,anemia,81,1,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
BORTEZOMIB,anorexia,399,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Zingo,stroke,7,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
GADOTERIDOL,mental illness,14,0,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,direct
Mexiletine Hydrochloride,arrhythmia,43,1,CC(N)COC1=C(C)C=CC=C1C,direct
CLOMID,autoimmune disease,15,0,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
Flagyl,hypersensitivity,313,1,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Levbid,AIDS,10,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Diclofenac potassium,diabetes mellitus,5,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
LACTATED RINGERS,hypertension,11,0,[Cl-].[K+],direct
captopril,hypertension who,898,1,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,direct
Compro,dementia,7,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Glyxambi,urinary tract infection,249,1,CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=C(C=CC=C3)C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1,direct
FENTANYL,insomnia,441,1,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
Diltiazem HCl CD,liver cirrhosis,4,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Glyburide and Metformin Hydrochloride,myocardial infarction,1,0,CN(C)C(=N)NC(N)=N,direct
AZACITIDINE AZACITIDINE,hypersensitivity,313,1,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
CORTEF,congestive heart failure,2,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Pravastatin Sodium,clinically evident chd,718,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Mexiletine hydrochloride,ventricular arrhythmias,1354,1,CC(N)COC1=C(C)C=CC=C1C,direct
Se-Tan PLUS,congestive heart failure,2,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
hydrocortisone acetate pramoxine HCl,chronic kidney disease,3,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Bupivacaine Hydrochloride,asthma,12,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Guanfacine,renal failure,19,0,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,direct
Phenobarbital Sodium,known barbiturate sensitivity,948,1,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1,direct
Ertapenem,pregnancy,16,0,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
RISPERIDONE,diabetes mellitus,5,0,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,direct
Epitol,AIDS,10,0,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Topicort,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
BELRAPZO,chronic lymphocytic leukemia,693,1,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
AIRSUPRA,myocardial infarction,1,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
TAVNEOS,myocardial infarction,1,0,CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C2=CC=C(NC3CCCC3)C=C2)C(=O)C2=C(F)C=CC=C2C)C=C1C(F)(F)F,direct
"Carisoprodol Tablets, USP, 350 mg",chronic kidney disease,3,0,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
ISOSORBIDE MONONITRATE,congestive heart failure,41,1,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,direct
Cefaclor,diabetes mellitus,5,0,[H][C@]12SCC(Cl)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
Sofosbuvir and Velpatasvir,anemia,13,0,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
DIGOX,stroke,7,0,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,direct
Hyoscyamine ER,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Levobunolol Hydrochloride,hypertension,39,1,CC(C)(C)NC[C@H](O)COC1=CC=CC2=C1CCCC2=O,direct
Cimetidine,pre-existing arthritis,1148,1,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N,direct
Citanest Plain,tics,23,1,CCCNC(C)C(=O)NC1=CC=CC=C1C,direct
Edaravone,stroke,7,0,CC1=NN(C(=O)C1)C1=CC=CC=C1,direct
cyanocobalamin,myocardial infarction,1,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Minoxidil,hypersensitivity,313,1,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1,direct
CARBOPLATIN,normal baseline values,1059,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Rosuvastatin,cancer (metastatic),9,0,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Tobramycin,sepsis,17,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Donnatal,cancer (localized),8,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Ropidex,inflammatory bowel disease,223,1,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
Body Wash,AIDS,10,0,OC(=O)C1=CC=CC=C1O,direct
Estradiol Vaginal Cream,breast cancer,263,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
CEFDINIR,congestive heart failure,2,0,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,direct
Xatmep,pregnancy,321,1,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
levoleucovorin,autoimmune disease,15,0,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
XELPROS,stroke,7,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Fluphenazine Hydrochoride,mental retardation,993,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,fuzzy:fluphenazine hydrochloride
Tramadol Hydrochloride,AIDS,10,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
PANRETIN,aids-related ks,579,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,direct
ATAZANAVIR,mental illness,14,0,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,direct
Sumansetron,anemia,13,0,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,direct
ondansetron hydrochloride,liver failure,371,1,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate",pregnancy,16,0,CC(N)CC1=CC=CC=C1,direct
sevelamer carbonate,chronic kidney disease,3,0,NCC=C.ClCC1CO1,direct
Benznidazole,hypersensitivity,313,1,[O-][N+](=O)C1=NC=CN1CC(=O)NCC1=CC=CC=C1,direct
hyoscyamine sulfate,anemia,13,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
ketorolac tromethamine,hypertension,11,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Tizanidine HCl,multiple sclerosis,153,1,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Sirolimus,lymphangioleiomyomatosis safety,974,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
CEFEPIME HYDROCHLORIDE AND DEXTROSE,hypersensitivity,313,1,CO\N=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1,direct
"PREGABALIN capsules, CV",cancer (metastatic),9,0,CC(C)C[C@H](CN)CC(O)=O,direct
Mepivacaine Hydrochloride,congestive heart failure,2,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
CARMUSTINE,hypersensitivity,313,1,ClCCNC(=O)N(CCCl)N=O,direct
SEVELAMER CARBONATE,mental illness,14,0,NCC=C.ClCC1CO1,direct
AMLODIPINE and OLMESARTAN medoxomil,severe infection,18,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Livita Children,hypersensitivity,313,1,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Istalol,chronic kidney disease,3,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
ERYTHROMYCIN ETHYLSUCCINATE,sepsis,17,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Halobetasol Propionate,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
FEBUXOSTAT,hyperuricemia and gout,900,1,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
Harvoni,severe infection,18,0,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
Sevelamer Hydrochloride,sepsis,17,0,NCC=C.ClCC1CO1,direct
Nardil,chronic obstructive pulmonary disease (COPD),6,0,NNCCC1=CC=CC=C1,direct
Ethacrynate Sodium,arrhythmia,43,1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Brimonidine,glaucoma,481,1,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Meropenem,cancer (metastatic),9,0,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
Acetazolamide,cirrhosis,231,1,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
Trisenox,chronic kidney disease,3,0,O=[As]O[As]=O,direct
Gemfibrozil,cancer (localized),8,0,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,direct
ondansetron hydrochloride,cancer (localized),8,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Edarbyclor,chronic kidney disease,3,0,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Scarzen,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Tamoxifen Citrate,increased bone pain,925,1,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,direct
Icosapent,chronic obstructive pulmonary disease (COPD),6,0,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,direct
Acitretin,severe infection,18,0,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1,direct
tacrolimus,pregnancy,16,0,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,direct
Oraqix,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
CASPOFUNGIN ACETATE,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
Select-OB Plus DHA Prenatal Supplement Plus DHA,hypersensitivity,313,1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Xanax XR,poisoning,425,1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
AVYCAZ,hemolytic anemia,107,1,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
Hepzato Kit,asthma,12,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Sumansetron,uncontrolled hypertension,1337,1,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,direct
HALOPERIDOL,anemia,13,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Alprazolam Extended Release,depression,27,1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
Tromethamine,anemia,13,0,NC(CO)(CO)CO,direct
Iclusig,cancer (localized),8,0,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1,direct
Montelukast sodium,autoimmune disease,15,0,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
PROCAINAMIDE HCI,liver cirrhosis,4,0,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
DesOwen,hypersensitivity,313,1,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
NITROGLYCERIN IN DEXTROSE,congestive heart failure,2,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Lialda,ulcerative colitis,225,1,NC1=CC(C(O)=O)=C(O)C=C1,direct
Hectorol,anemia,81,1,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
Vancomycin Hydrochloride for Oral Solution,sepsis,17,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
Sulfameth/Trimeth-DS,hypersensitivity,313,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Amphotericin B,cryptococcal meningitis,754,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Prochlorperazine Edisylate,asthma,12,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Nicardipine hydrochloride,anemia,13,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
tofacitinib,diabetes at baseline,772,1,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,direct
Cyltezo,liver cirrhosis,4,0,CC(C)O,direct
BUFFERED PENICILLIN G POTASSIUM,impaired renal function,919,1,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,direct
deferasirox,deferasirox tablets,764,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Xalatan,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
balsalazide disodium,renal failure,19,0,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,direct
Promethazine Hydrochloride and Phenylephrine Hydrochloride,depression,27,1,CNC[C@H](O)C1=CC(O)=CC=C1,direct
dabigatran etexilate,non-valvular atrial fibrillation,1053,1,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
Dobutamine,hypertension,11,0,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
levoleucovorin,metastatic colorectal cancer,996,1,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
Vancomycin Hydrochloride for Oral Solution,cancer (metastatic),9,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
HALCINONIDE,autoimmune disease,15,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Rubraca,diabetes mellitus,5,0,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,direct
Azulfidine EN-tabs,cancer (metastatic),9,0,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,direct
Xospata,pregnancy,16,0,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O,direct
Sorafenib,mental illness,14,0,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
FUROSEMIDE,chronic kidney disease,3,0,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O,direct
Nitrofurantion Macrocrystals,severe infection,18,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
CitraNatal Medley,myocardial infarction,1,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Amantadine,hypersensitivity,313,1,NC12CC3CC(CC(C3)C1)C2,direct
MLK F1 Kit,renal failure,19,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
methylprednisolone,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Zafirlukast,hepatic impairment,1,1,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,direct
Amcinonide,hypersensitivity,313,1,[H][C@@]12C[C@H]3OC4(CCCC4)O[C@@]3(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Betaxolol,untreated pheochromocytoma,1345,1,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
Uceris,hypersensitivity,313,1,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
LASTACAFT,hypersensitivity,313,1,CN1CCC(CC1)=C1C2=NC=C(C=O)N2CCC2=CC=CC=C12,direct
Olmesartan Medoxomil and Hydrochlorothiazide,autoimmune disease,15,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Fenofibric acid,pregnancy,16,0,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
Escitalopram oxalate,liver disease (non-cirrhotic),20,0,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
Acetaminophen and Codeine,sepsis,17,0,CC(=O)NC1=CC=C(O)C=C1,direct
VANFLYTA,cancer (localized),8,0,CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1,direct
NOXAFIL,severe infection,18,0,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
VIIBRYD,mdd including,990,1,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,direct
BETIMOL,severe infection,18,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Lescol XL,severe infection,18,0,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,direct
Spironolactone,primary hyperaldosteronism,1174,1,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
Ethacrynic acid,cancer (metastatic),9,0,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Carmustine,cancer (localized),8,0,ClCCNC(=O)N(CCCl)N=O,direct
Oseltamivir,hypersensitivity,313,1,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
ISOVUE 300,congenital cardiac conditions,747,1,C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I,direct
CITALOPRAM HYDROBROMIDE,pregnancy,16,0,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
LEXISCAN(R) (REGADENOSON),functioning artificial pacemakers,821,1,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
Cefpodoxime Proxetil,tics,23,1,[H][C@]12SCC(COC)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
pyridostigmine bromide,asthma,12,0,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Medroloan II SUIK,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
TIADYLT ER,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Hydrocodone APAP,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution,diabetes mellitus,5,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Asclera,pregnancy,16,0,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,direct
Indium in 111 Oxyquinoline,AIDS,10,0,[111In+3].[O-]C1=CC=CC2=C1N=CC=C2.[O-]C1=CC=CC2=C1N=CC=C2.[O-]C1=CC=CC2=C1N=CC=C2,direct
BETAXOLOL HYDROCHLORIDE,hypersensitivity,313,1,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
MLK Kit F2,myocardial infarction,1,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Lidorex,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Ery-Ped,stroke,7,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
olopatadine hydrochloride,severe infection,18,0,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2,direct
labetalol hydrochloride,anemia,13,0,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Rifadin IV NOVAPLUS,autoimmune disease,15,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
SIMVASTATIN,liver cirrhosis,4,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Ambien,insomnia,441,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
CINACALCET,hypertension,39,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Acetaminophen And Codeine,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
PROCORT,pregnancy,16,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
SIROLIMUS,liver disease (non-cirrhotic),20,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
Nitrofurantoin (monohydrate/macrocrystals),hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Cinacalcet,anemia,13,0,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
PureVit DualFe Plus,asthma,12,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
PROCRIT,congestive heart failure,2,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,fuzzy:procort
daptomycin,comparator agents,736,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
Tasigna,asthma,12,0,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,direct
SSD,cancer (metastatic),9,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
Sulfameth/Trimeth-DS,anemia,81,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
FLUPHENAZINE HYDROCHLORIDE,mental retardation,993,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Menatrol,cancer (localized),8,0,CC1=C(O)C(CO)=C(CO)C=N1,direct
PACLITAXEL PACLITAXEL,normal baseline and,1057,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Glipizide and Metformin HCl,cancer (metastatic),9,0,CN(C)C(=N)NC(N)=N,direct
Robinul,ileostomy or colostomy,910,1,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
Sevelamer carbonate,bowel obstruction,641,1,NCC=C.ClCC1CO1,direct
Emtriva,anemia,13,0,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,direct
Sucralfate,hypersensitivity,313,1,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,direct
ABRILADA,polyarticular jia who,1137,1,CC(C)O,direct
Omeprazole and Sodium Bicarbonate,hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Lidocaine hydrochloride,AIDS,10,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Theophylline Anhydrous,myocardial infarction,1,0,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Azithromycin Dihydrate,liver disease (non-cirrhotic),20,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
CIMETIDINE,preexisting arthritis,1156,1,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N,direct
Neo-Synalar,pregnancy,16,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Vyalev,renal failure,19,0,C[C@@](CC1=CC=C(OP(O)(O)=O)C(O)=C1)(NN)C(O)=O,direct
DOFETILIDE,hypertension,11,0,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
"SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE",congestive heart failure,2,0,[Mg++].[O-]S([O-])(=O)=O,direct
Rasuvo,sepsis,17,0,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
PROMETHAZINE HCI,liver cirrhosis,4,0,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Olanzapine and Fluoxetine,chronic obstructive pulmonary disease (COPD),6,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Guanfacine Hydrochloride,sepsis,17,0,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,direct
Sevelamer carbonate,chronic kidney disease,3,0,NCC=C.ClCC1CO1,direct
Fluconazole,myocardial infarction,1,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
TOPIRAMATE,autoimmune disease,15,0,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,direct
Cisatracurium Besylate,mental illness,14,0,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,direct
ZEVTERA,chronic kidney disease,3,0,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCN(C1)C(=O)OCC1=C(C)OC(=O)O1,direct
Kyzatrex,chronic kidney disease,3,0,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,direct
VORICONAZOLE,cancer (metastatic),9,0,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Gemfibrozil,stroke,7,0,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,direct
Zolpidem Tartrate,liver cirrhosis,4,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
phenelzine sulfate,mental illness,14,0,NNCCC1=CC=CC=C1,direct
VAFSEO,stroke,7,0,OC(=O)CNC(=O)C1=C(O)C=C(C=N1)C1=CC(Cl)=CC=C1,direct
Marlido Kit,sepsis,17,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Droperidol,long qt syndrome,61,1,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,direct
Clonidine transdermal system,autoimmune disease,15,0,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
Isosorbide Mononitrate,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,direct
CEFPODOXIME PROXETIL,sepsis,17,0,[H][C@]12SCC(COC)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
ZIPSOR,chronic kidney disease,3,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
IBUPROFEN,diabetes mellitus,5,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Cinacalcet,stroke,7,0,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Magnesium Sulfate,chronic kidney disease,3,0,[Mg++].[O-]S([O-])(=O)=O,direct
Select-OB Plus DHA Prenatal Supplement Plus DHA,hypertension,11,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
paroxetine hydrochloride,congestive heart failure,2,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
sucralfate,liver cirrhosis,4,0,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,direct
Rezurock,chronic obstructive pulmonary disease (COPD),6,0,CC(C)NC(=O)COC1=CC=CC(=C1)C1=NC2=C(C=CC=C2)C(NC2=CC=C3NN=CC3=C2)=N1,direct
RISEDRONATE SODIUM,renal failure,19,0,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
VOQUEZNA DUAL PAK,hypersensitivity,313,1,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
Zetonna,myocardial infarction,1,0,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,direct
SUCRALFATE,congestive heart failure,2,0,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,direct
XALATAN,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
OMEPRAZOLE,hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Glycopyrrolate,ileostomy or colostomy,910,1,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
Isotretinoin,these symptoms,1314,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
ERYTHROMYCIN,stroke,7,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
IMIQUIMOD,pre-existing autoimmune conditions,1149,1,CC(C)CN1C=NC2=C1C1=C(C=CC=C1)N=C2N,direct
acamprosate calcium,cancer (metastatic),9,0,CC(=O)NCCCS(O)(=O)=O,direct
ZEVTERA,leukopenia,83,1,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCN(C1)C(=O)OCC1=C(C)OC(=O)O1,direct
Daunorubicin Hydrochloride,bone marrow suppression,101,1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,direct
Diacomit,pediatric patients,13,1,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1,direct
Synjardy XR,urinary tract infection,249,1,CN(C)C(=N)NC(N)=N,direct
varenicline tartrate,hypersensitivity,313,1,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
SSD Cream,anemia,13,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
Ciprofloxacin and Dexamethasone,non-intact tympanic membranes,1046,1,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,direct
CETIRIZINE HYDROCHLORIDE,congestive heart failure,2,0,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Esomeprazole Sodium,sepsis,17,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Serostim,mental illness,14,0,O,direct
PureVit DualFe Plus,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
ERYTHROMYCIN ETHYLSUCCINATE,hypersensitivity,313,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Nefazodone Hydrochloride,major depression who,978,1,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,direct
Timoptic,diabetes mellitus,5,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
GADOTERIDOL,renal failure,257,1,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,direct
NALMEFENE HYDROCHLORIDE,severe infection,18,0,OC1=CC=C2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](OC1=C24)C(=C)CC[C@@]35O,direct
VABOMERE,cancer (metastatic),9,0,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
carbamazepine,chronic kidney disease,3,0,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Sulfameth/Trimeth-DS,anemia,13,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Tetracaine Hydrochloride,stroke,7,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
Isosorbide,myocardial infarction,1,0,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
Harvoni,liver failure,371,1,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
Methylene Blue INJ,hypersensitivity,313,1,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,direct
Auryxia,diabetes mellitus,5,0,O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,direct
Tarpeyo,hypersensitivity,313,1,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Hydrocodone APAP,pregnancy,16,0,CC(=O)NC1=CC=C(O)C=C1,direct
Reglan,anemia,13,0,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,direct
Vueway,hypersensitivity,313,1,[Gd+3].OCC(O)CNC(=O)CCC(N1CCN(CC2=CC=CC(CN(CC1)C(CCC(=O)NCC(O)CO)C([O-])=O)=N2)C(CCC(=O)NCC(O)CO)C([O-])=O)C([O-])=O,direct
LAMOTRIGINE Kit,pregnancy,16,0,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
DIAZEPAM,glaucoma,481,1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,direct
MLK F3 Kit,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ADAPALENE AND BENZOYL PEROXIDE,hypersensitivity,313,1,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Mexiletine hydrochloride,asthma,12,0,CC(N)COC1=C(C)C=CC=C1C,direct
Norepinephrine bitartrate,severe infection,18,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
UROCIT-K,autoimmune disease,15,0,[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,direct
Chlordiazepoxide Hydrochloride,hypersensitivity,313,1,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Atomoxetine Hydrochloride,glaucoma,481,1,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
Azelastine Hydrochloride and Fluticasone Propionate,seasonal allergic rhinitis,1223,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Clomipramine hydrochloride,myocardial infarction,1,0,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
Donnatal,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE",renal failure,19,0,CC(N)CC1=CC=CC=C1,direct
Silodosin,hypersensitivity,313,1,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,direct
FLUPHENAZINE HYDROCHLORIDE,dementia,7,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Imatinib Mesylate,thrombocytopenia,79,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Colchicine,cancer (metastatic),9,0,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Priftin,active pulmonary tuberculosis,534,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(\C=N\N1CCN(CC1)C1CCCC1)=C2O,direct
TUKYSA,anemia,81,1,CC1=CC(NC2=NC=NC3=CC=C(NC4=NC(C)(C)CO4)C=C23)=CC=C1OC1=CC2=NC=NN2C=C1,direct
azithromycin dihydrate,pneumonia,201,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
DOCETAXEL,other tumor types,1093,1,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
memantine hydrochloride,hypertension,11,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Timoptic-XE,cancer (metastatic),9,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
ENBREL,pso and jia,1190,1,OCC1=CC=CC=C1,direct
Iclusig,liver cirrhosis,4,0,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1,direct
AMPHETAMINE SULFATE,liver cirrhosis,4,0,CC(N)CC1=CC=CC=C1,direct
metoclopramide hydrochloride,pregnancy,16,0,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,direct
PLERIXAFOR,nhl or mm,1038,1,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
Focalin XR,myocardial infarction,1,0,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,direct
nitrofurantoin,cancer (metastatic),9,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
BUDESONIDE,hypersensitivity,313,1,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
APREPITANT,chronic kidney disease,3,0,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,direct
Edetate Calcium Disodium,stroke,7,0,[Na+].[Na+].[Ca++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O,direct
Olanzapine,mental illness,14,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Leflunomide,myocardial infarction,1,0,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
Asenapine,bipolar mania,634,1,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
Amphotericin B,visceral leishmaniasis who,1359,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Thalitone,myocardial infarction,1,0,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Cefprozil,autoimmune disease,15,0,[H][C@]12SCC(C=CC)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
SULINDAC,marginal cardiac function,984,1,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O,direct
Irinotecan hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
Gablofen,liver disease (non-cirrhotic),20,0,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
Plasma-Lyte A,brain edema,643,1,[Cl-].[K+],direct
TIMOLOL MALEATE,sepsis,17,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
ENTERO Vu 24%,liver disease (non-cirrhotic),20,0,[Ba++].[O-]S([O-])(=O)=O,direct
Thioridazine Hydrochloride,renal failure,19,0,CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1,direct
Diclofenac potassium,hypersensitivity,313,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Tranexamic acid,subarachnoid hemorrhage,1275,1,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
ORLISTAT,pediatric patients,13,1,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,direct
"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",acetaminophen allergy,513,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
CAPECITABINE,metastatic colorectal cancer,996,1,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
leuprolide acetate,asthma,12,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
venlafaxine,pregnancy,16,0,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
Solu-Cortef,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Antiperspirant,liver disease (non-cirrhotic),20,0,O.[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-],direct
hyoscyamine sulfate,severe infection,18,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Rocaltrol,asthma,12,0,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,direct
Body Scrub,renal failure,257,1,O.O.[Al+3].[Al+3].[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-],direct
Leucovorin calcium,cancer (metastatic),9,0,[H]C(=O)N1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2,direct
Chloroquine Phosphate,preexisting auditory damage,1157,1,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,direct
KENALOG-10,cerebral malaria,674,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
toremifene citrate,chronic obstructive pulmonary disease (COPD),6,0,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,direct
Fluphenazine Decanoate,dementia-related psychosis,766,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Levsin SL,sepsis,17,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
"BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE",severe renal impairment,1253,1,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
Propofol,congestive heart failure,2,0,CC(C)C1=CC=CC(C(C)C)=C1O,direct
Spravato,suicidal ideation,9,1,CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl,direct
Diovan HCT,cancer (localized),8,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Vasotec,chronic kidney disease,3,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
timolol maleate ophthalmic gel forming solution,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Varenicline,hypersensitivity,313,1,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Prenate Elite,stroke,7,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
BRIMONIDINE TARTRATE,hypertension,39,1,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Rosuvastatin Calcium,diabetes mellitus,5,0,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
ARSENIC TRIOXIDE,hypersensitivity,313,1,O=[As]O[As]=O,direct
Dexamethasone,sepsis,17,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
FERRIPROX,thalassemia syndromes,1293,1,CN1C=CC(=O)C(O)=C1C,direct
Stivarga,autoimmune disease,15,0,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,direct
Namenda XR,pregnancy,16,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
sucralfate,stroke,7,0,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,direct
Risedronate Sodium,chronic obstructive pulmonary disease (COPD),6,0,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
Ipratropium bromide,perennial rhinitis,1112,1,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,direct
amlodipine and valsartan,cancer (localized),8,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
CHLOROTHIAZIDE SODIUM,autoimmune disease,15,0,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
LIDOCAINE AND PRILOCAINE,renal failure,19,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
doxycycline,impaired renal function,919,1,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
pentazocine and naloxone,pregnancy,16,0,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,direct
CARVEDILOL,pregnancy,16,0,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
GUANFACINE,hypersensitivity,313,1,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,direct
Lacosamide,partial-onset seizures generally,1107,1,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
OSELTAMIVIR PHOSPHATE,myocardial infarction,1,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
Lescol XL,cancer (localized),8,0,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,direct
Potassium Chloride in Sodium Chloride,autoimmune disease,15,0,[Cl-].[K+],direct
Lansoprazole DR,AIDS,10,0,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Ibuprofen,known hypersensitivityto ibuprofen,951,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution,liver disease (non-cirrhotic),20,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Nexletol,hypersensitivity,313,1,CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O,direct
Propofol Injectable Emulsion,diabetes mellitus,5,0,CC(C)C1=CC=CC(C(C)C)=C1O,direct
Lidotran,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Apixaban,nonvalvular atrial fibrillation,1056,1,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,direct
VANFLYTA,hypokalemia,133,1,CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1,direct
Memantine HCL,liver cirrhosis,4,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
0.9% SODIUM CHLORIDE,brain edema,643,1,[Na+].[Cl-],direct
Multaq,anemia,13,0,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,direct
GEMTESA,sepsis,17,0,[H][C@@]1(CC[C@@H](CC2=CC=C(NC(=O)[C@@H]3CCC4=NC=CC(=O)N34)C=C2)N1)[C@H](O)C1=CC=CC=C1,direct
BUTAL/APAP/CAFFEINE,hypersensitivity,313,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,fuzzy:butal/apap/caff
lamivudine,mental illness,14,0,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,direct
Mycobutin,active tuberculosis,535,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21,direct
Diovan HCT,liver disease (non-cirrhotic),20,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
brexpiprazole,autoimmune disease,15,0,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,direct
Desmopressin acetate,cancer (metastatic),9,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
Pemetrexed,congestive heart failure,2,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
CHLOROTHIAZIDE SODIUM,sepsis,17,0,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
CLOBAZAM,hypertension,11,0,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,direct
Alclometasone dipropionate,chronic kidney disease,3,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])[C@H](Cl)CC2=CC(=O)C=C[C@]12C,direct
Fluorescein,hypertension,11,0,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
Octreotide,bradycardia,45,1,C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=CC=CC=C23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,fuzzy:edotreotide
Omeprazole,mental illness,14,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Nulibry,autoimmune disease,15,0,[H][C@@]12COP(O)(=O)O[C@]1([H])C(O)(O)[C@]1([H])NC3=C(NC(N)=NC3=O)N[C@]1([H])O2,direct
Succinylcholine,AIDS,10,0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,direct
amantadine hydrochloride,suicidal ideation,9,1,NC12CC3CC(CC(C3)C1)C2,direct
Rubraca,anemia,81,1,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,direct
Lidocaine Hydrochloride,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
fluphenazine decanoate,congestive heart failure,2,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
"Travoprost Ophthalmic Solution USP, 0.004% Travoprost",cancer (localized),8,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Carbocaine,hypersensitivity,313,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Alkindi Sprinkle,stroke,7,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
BETIMOL,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Oxymorphone hydrochloride,low back pain,969,1,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,direct
DOFETILIDE,long qt syndrome,61,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Desflurane,pediatric patients,13,1,FC(F)OC(F)C(F)(F)F,direct
ONDANSETRON,stroke,7,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Epirubicin Hydrochloride,breast cancer,263,1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
ARIMIDEX,ldl elevations,959,1,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,direct
Lidocort,renal failure,19,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Zetonna,hypertension,11,0,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,direct
Lovastatin,atherosclerosis,357,1,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC,direct
latanoprost,stroke,7,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Foscavir,pregnancy,16,0,OC(=O)P(O)(O)=O,direct
Dorzolamide hydrochloride,cancer (metastatic),9,0,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Fluphenazine Hydrochoride,asthma,12,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,fuzzy:fluphenazine hydrochloride
Propranolol,hypersensitivity,313,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
LABETALOL HYDROCHLORIDE,chronic obstructive pulmonary disease (COPD),6,0,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Lidocaine and prilocaine,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
lisinopril,liver cirrhosis,4,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
SERTRALINE HYDROCHLORIDE,chronic obstructive pulmonary disease (COPD),6,0,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,direct
Adapalene and benzoyl peroxide,hypersensitivity,313,1,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
LYVISPAH,autoimmune disease,15,0,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
"Albuterol Sulfate Inhalation Solution, 0.5%",pregnancy,16,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,fuzzy:albuterol sulfate inhalation solution
SINEMET,narrow-angle glaucoma,1030,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Polocaine,chronic kidney disease,3,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Ethacrynic Sodium,arrhythmia,43,1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Metopirone,sepsis,17,0,CC(C)(C(=O)C1=CN=CC=C1)C1=CC=CN=C1,direct
LOPERAMIDE HYDROCHLORIDE,chronic obstructive pulmonary disease (COPD),6,0,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
ELUCIREM,hypersensitivity,313,1,[Gd+3].OCC(O)CNC(=O)CCC(N1CCN(CC2=CC=CC(CN(CC1)C(CCC(=O)NCC(O)CO)C([O-])=O)=N2)C(CCC(=O)NCC(O)CO)C([O-])=O)C([O-])=O,direct
Hydromorphone Hydrochloride,diabetes mellitus,5,0,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O,direct
Irinotecan Hydrochloride 100 mg/5 mL,sepsis,17,0,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
Propafenone HCl,mental illness,14,0,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,direct
Methotrexate,diabetes mellitus,5,0,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
NITROSTAT,liver cirrhosis,4,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
NEXIUM,chronic obstructive pulmonary disease (COPD),6,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
ILOPERIDONE,AIDS,10,0,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O,direct
ENDOCET,severe infection,18,0,CC(=O)NC1=CC=C(O)C=C1,direct
Glipizide,sepsis,17,0,CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,direct
Cefotaxime,pregnancy,16,0,[H][C@]12SCC(COC(C)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
Theophylline (Anhydrous),myocardial infarction,1,0,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
DOFETILIDE,supraventricular arrhythmias,1280,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Zintrexyl-C,chronic obstructive pulmonary disease (COPD),6,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Rocaltrol,hypercalcemia,139,1,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,direct
Lidocaine,cancer (localized),8,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Cytarabine,autoimmune disease,15,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,direct
Nitrofurantoin Monohydrate/Macrocrystal,hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
ARIMIDEX,pregnancy,16,0,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,direct
CYCLOSET,liver cirrhosis,4,0,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
Desferal,mental illness,14,0,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
Calcitrene,diabetes mellitus,5,0,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
Tretinoin,severe infection,18,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
Zestoretic,mental illness,14,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
ZOLINZA,lymphoma,269,1,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,direct
RISPERIDONE,AIDS,10,0,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,direct
Dorzolamide Hydrochloride Ophthalmic,hypertension,39,1,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
XYOSTED,hypertension,39,1,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
ceftriaxone,pregnancy,16,0,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
Tobramycin Inhalation Solution,hypersensitivity,313,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Propranolol Hydrochloride,angina pectoris,596,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Methocarbamol,sepsis,17,0,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
SOLU-MEDROL,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Irinotecan hydrochloride,anemia,13,0,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
Desonide,congestive heart failure,2,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Clindamycin Phosphate 1.2% and Tretinoin 0.025%,acne vulgaris,516,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
Vyalev,chronic obstructive pulmonary disease (COPD),6,0,C[C@@](CC1=CC=C(OP(O)(O)=O)C(O)=C1)(NN)C(O)=O,direct
TIADYLT ER,myocardial infarction,49,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Travatan Z,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Daunorubicin Hydrochloride,liver cirrhosis,4,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,direct
PENTAMIDINE ISETHIONATE,sepsis,17,0,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
Marlido Kit,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Rhopressa,glaucoma,481,1,CC1=CC(C)=C(C=C1)C(=O)OCC1=CC=C(C=C1)[C@@H](CN)C(=O)NC1=CC=C2C=NC=CC2=C1,direct
METHADOSE,renal failure,19,0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,direct
CARMUSTINE,severe infection,18,0,ClCCNC(=O)N(CCCl)N=O,direct
PRAVASTATIN SODIUM,stroke,7,0,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Nitrofurantion Macrocrystals,chronic kidney disease,3,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Corvert,severe infection,18,0,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Carbidopa and levodopa,glaucoma,481,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
IBU,known hypersensitivityto ibuprofen,951,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Losortan Potassium,liver disease (non-cirrhotic),20,0,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
Colcrys,hepatic impairment,1,1,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Prolia,postmenopausal osteoporosis,1147,1,OC(=O)[C@@H]1CCCN1,fuzzy:prolina
Amoxicillin and Clavulanate Potassium,pediatric patients,13,1,[H][C@@]12CC(=O)N1[C@@H](C(O)=O)\C(O2)=C\CO,direct
Brimonidine Tartrate and Timolol Maleate,myocardial infarction,1,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Timolol Maleate Ophthalmic Gel Forming Solution,sepsis,17,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
TAZVERIK,epithelioid sarcoma,800,1,CCN(C1CCOCC1)C1=C(C)C(=CC(=C1)C1=CC=C(CN2CCOCC2)C=C1)C(=O)NCC1=C(C)C=C(C)NC1=O,direct
deferasirox,poor performance status,1139,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
LANSOPRAZOLE,hypersensitivity,313,1,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Ifosfamide,mental illness,14,0,ClCCNP1(=O)OCCCN1CCCl,direct
ACETAZOLAMIDE EXTENDED-RELEASE,liver cirrhosis,4,0,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
Nalbuphine Hydrochloride,sepsis,17,0,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
ERLOTINIB HYDROCHLORIDE,pancreatic cancer,1097,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
Potassium Chloride,whom there,1362,1,[Cl-].[K+],direct
Diprivan,hypersensitivity,313,1,CC(C)C1=CC=CC(C(C)C)=C1O,direct
LEVALBUTEROL,hypersensitivity,313,1,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
Acetaminophen And Codeine,stroke,7,0,CC(=O)NC1=CC=C(O)C=C1,direct
hydrocortisone acetate pramoxine hcl,hypersensitivity,313,1,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Sotalol,stroke,7,0,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Lidocaine Hydrochloride and Epinephrine,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Cisplatin,hearing impairment,848,1,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
Emtriva,liver disease (non-cirrhotic),20,0,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,direct
Albuterol Sulfate,chronic kidney disease,3,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
OSELTAMIVIR,chronic kidney disease,3,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
CAMCEVI,chronic kidney disease,3,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Norepinephrine,cancer (localized),8,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
ABILIFY MAINTENA,anemia,13,0,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
0.5% LIDOCAINE HCl,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
bupropion hydrochloride,cancer (localized),8,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Delestrogen,myocardial infarction,1,0,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Carbamazepine,anemia,13,0,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
ESZOPICLONE,asthma,12,0,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,direct
Dicyclomine Hydrochloride,prostatic hypertrophy cardiovascular,1184,1,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,direct
Glyxambi,mental illness,14,0,CC#CCN1C(=NC2=C1C(=O)N(CC1=NC3=C(C=CC=C3)C(C)=N1)C(=O)N2C)N1CCC[C@@H](N)C1,direct
INDOMETHACIN,these conditions,1310,1,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,direct
Tiagabine Hydrochloride,liver cirrhosis,4,0,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1,direct
Chlorpromazine hydrochloride,diabetes mellitus,5,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
Deferoxamine,asthma,12,0,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
calcium chloride,acute symptomatic hypocalcemia,554,1,[Cl-].[Cl-].[Ca++],direct
Metyrosine,malignant pheochromocytoma metyrosine,981,1,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,direct
Rexulti,mental illness,14,0,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,direct
Lidocaine Hydrochloride and Epinephrine,mental illness,14,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Foltamin,cancer (localized),8,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
"SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE",liver disease (non-cirrhotic),20,0,[Mg++].[O-]S([O-])(=O)=O,direct
DICYCLOMINE HYDROCHLORIDE,prostatic hypertrophy cardiovascular,1184,1,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,direct
Rectiv,autoimmune disease,15,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Phenelzine Sulfate,depressive symptoms,769,1,NNCCC1=CC=CC=C1,direct
Hepzato Kit,liver disease (non-cirrhotic),20,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Donepezil,anemia,13,0,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
Venlafaxine,depressive symptoms,769,1,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
Vyvanse,obesity,149,1,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
fluconazole,AIDS,10,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Regadenoson,functioning artificial pacemakers,821,1,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
Enalapril Maleate,liver disease (non-cirrhotic),20,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
VERAPAMIL HYDROCHLORIDE,diabetes mellitus,5,0,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,direct
Diclofenac Sodium Delayed Release,the aspirin triad,1295,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Zonalon,severe infection,18,0,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
Penicillamine,anemia,81,1,[H][C@](N)(C(O)=O)C(C)(C)S,direct
ISTODAX,mental illness,14,0,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,direct
Promethazine Hydrochloride and Phenylephrine Hydrochloride,severe infection,18,0,CNC[C@H](O)C1=CC(O)=CC=C1,direct
GADOTERIDOL,severe infection,18,0,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,direct
temozolomide,anaplastic astrocytoma are,593,1,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
RIBAVIRIN,bradycardia,45,1,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
RELAFEN DS,hypersensitivity,313,1,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
Lisdexamfetamine dimesylate,mental illness,14,0,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
RAPAFLO,liver disease (non-cirrhotic),20,0,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,direct
PROCTOFOAM HC,sepsis,17,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Foltamin,autoimmune disease,15,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Oseltamivir,cancer (localized),8,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
Medrol,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Glipizide and Metformin HCl,stroke,7,0,CN(C)C(=N)NC(N)=N,direct
Methyldopa,diabetes mellitus,5,0,C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O,direct
Imipramine hydrochloride,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
LONSURF,post-baseline samples which,1144,1,OC[C@H]1O[C@H](C[C@@H]1O)N1C=C(C(=O)NC1=O)C(F)(F)F,direct
Bexagliflozin,renal failure,19,0,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(OCCOC3CC3)C=C2)=C1,direct
Bromocriptine Mesylate,unexplained pleuropulmonary disorders,1342,1,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
Prochlorperazine Maleate,mental retardation,993,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
AMITRIPTYLINE HCL,depressive symptoms,769,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Mirtazapine,renal failure,19,0,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1,direct
Carafate,renal failure,19,0,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,direct
Sotalol hydrochloride,arrhythmia,43,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
PRENATE DHA,cancer (metastatic),9,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Dobutamine,sepsis,17,0,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
DURYSTA,liver disease (non-cirrhotic),20,0,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
Tranexamic Acid,active intravascular clotting,526,1,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
HydrOXYzine Hydrochloride,hypersensitivity,313,1,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Tobramycin Inhalation,pseudomonas aeruginosa,1188,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
IRBESARTAN AND HYDROCHLOROTHIAZIDE,chronic kidney disease,3,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
2% LIDOCAINE HCI,sepsis,17,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Synjardy,stroke,7,0,CN(C)C(=N)NC(N)=N,direct
Epitol,symptomatic hyponatremia,1286,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Indomethacin,diabetes mellitus,5,0,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,direct
Prochlorperazine Maleate,hypersensitivity,313,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
FERRIPROX,chronic obstructive pulmonary disease (COPD),6,0,CN1C=CC(=O)C(O)=C1C,direct
Abiraterone acetate,cancer (localized),8,0,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Clindamycin Phosphate 1.2% and Tretinoin 0.025%,anemia,13,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
CABOMETYX,advanced hepatocellular carcinoma,561,1,COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,direct
Nadolol,bronchospastic diseases,653,1,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,direct
gadobutrol,hypersensitivity,313,1,OC[C@H](O)[C@H](CO)[N+]12CC[N+]3(CC([O-])=O)CC[N+]4(CC([O-])=O)CC[N+](CC([O-])=O)(CC1)[Gd-]234,direct
Telmisartan and Amlodipine,kidney failure,373,1,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,direct
Triasil,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Nestabs ONE,stroke,7,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Calcium Chloride,ventricular fibrillation,63,1,[Cl-].[Cl-].[Ca++],direct
Cartia XT,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
CLOBETASOL PROPIONATE,hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
cevimeline hydrochloride,severe infection,18,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
perphenazine,mental retardation,993,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
BOSULIF,bp cml,642,1,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,direct
PROCHLORPERAZINE EDISYLATE,previous brain damage,1166,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Aridol Bronchial Challenge Test Kit,hypersensitivity,313,1,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,direct
Isosorbide Mononitrate,myocardial infarction,49,1,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,direct
NUPLAZID,mental illness,14,0,CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C2CCN(C)CC2)C=C1,direct
Nystatin and triamcinolone acetonide,autoimmune disease,15,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Tasmar,dystonia,461,1,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,direct
Dofetilide 0.125mg,paroxysmal atrial fibrillation,1102,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Methoxsalen,melanoma,273,1,COC1=C2OC(=O)C=CC2=CC2=C1OC=C2,direct
APREPITANT,mental illness,14,0,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,direct
Xalkori,edema,417,1,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,direct
TOBI,this symptom,1317,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
NITROLINGUAL,shock,419,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
"PredniSONE Tablets, USP, 20 mg",cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Metoprolol tartrate,arrhythmia,43,1,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
Melphalan Hydrochloride,renal damage,1210,1,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Nateglinide,cancer (metastatic),9,0,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,direct
PROCAINAMIDE HCI,life-threatening ventricular arrhythmias,966,1,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
Risperidone,hypersensitivity,313,1,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,direct
HUMIRA,polyarticular jia who,1137,1,CC(C)O,direct
Prevacid,cancer (localized),8,0,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
"brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide",coronary artery disease,37,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
PACLITAXEL PACLITAXEL,solid tumors,1264,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Dichlorphenamide,chronic kidney disease,3,0,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O,direct
itraconazole,diabetes mellitus,5,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Topotecan Hydrochloride,cervical cancer,676,1,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
Aspirin and Extended-Release Dipyridamole,pregnancy,16,0,CC(=O)OC1=CC=CC=C1C(O)=O,direct
NOXAFIL,pregnancy,16,0,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
NITROFURANTOIN,liver cirrhosis,4,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Trifluoperazine Hydrochloride,liver disease (non-cirrhotic),20,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Febuxostat,gout,147,1,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
Triazolam,hypersensitivity,313,1,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,direct
Tolcapone,elevated enzymes,788,1,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,direct
Fluphenazine Hydrochloride,psychosis,31,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Rifadin IV NOVAPLUS,cancer (metastatic),9,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
Isordil Titradose,congestive heart failure,41,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
PARSABIV,sepsis,17,0,C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O)C(=O)N[C@H](CCCNC(N)=N)C(N)=O,direct
Nitrofurantion,hypertension,11,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Adalimumab-adbm,active psa,532,1,CC(C)O,direct
KENALOG-40,cerebral malaria,674,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
itraconazole,stroke,7,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
epinephrine,hypertension,11,0,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Ipratropium bromide,renal failure,19,0,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,direct
RAPAFLO,liver cirrhosis,4,0,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,direct
Latanoprost,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
olmesartan medoxomil-hydrochlorothiazide,hypertension,11,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
AZATHIOPRINE,rheumatoid arthritis who,1215,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Dorzolamide Hydrochloride,asthma,12,0,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
nicardipine hydrochloride,advanced aortic stenosis,559,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
prochlorperazine maleate,autoimmune disease,15,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Chlordiazepoxide and Amitriptyline Hydrochloride,myocardial infarction,1,0,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
0.9% SODIUM CHLORIDE,edema,417,1,[Na+].[Cl-],direct
aspirin-dipyridamole,hypertension,11,0,CC(=O)OC1=CC=CC=C1C(O)=O,direct
Timolol Maleate Ophthalmic Gel Forming Solution,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Enalapril Maleate and Hydrochlorothiazide,pregnancy,16,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
fluocinonide,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,direct
CHLORPROMAZINE HCI,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
Cortisone Acetate,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Nadolol,congestive heart failure,2,0,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,direct
gemcitabine,diabetes mellitus,5,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
Estradiol valerate,hypersensitivity,313,1,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Azacitidine,autoimmune disease,15,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Phenergan,liver cirrhosis,4,0,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
azithromycin monohydrate,liver disease (non-cirrhotic),20,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
KENALOG-40,active tuberculosis,535,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Quinapril and Hydrochlorothiazide,pre-existing renal impairment,1152,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
PROCAINAMIDE HCI,severe infection,18,0,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
SUPREP Bowel Prep,anemia,13,0,[Mg++].[O-]S([O-])(=O)=O,direct
Benazepril Hydrochloride,liver cirrhosis,4,0,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,direct
ProHance,myocardial infarction,1,0,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,direct
SINGULAIR,liver cirrhosis,4,0,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
balsalazide disodium,active ulcerative colitis,536,1,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,direct
Sevelamer Carbonate for Oral Suspension,bowel obstruction,641,1,NCC=C.ClCC1CO1,direct
XYLOCAINE- MPF (LIDOCAINE HCl ),AIDS,10,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
FENTANYL TRANSDERMAL,anorexia,399,1,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
MACI,severe infection,18,0,COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1,fuzzy:mac
Pramipexole Dihydrochloride,pregnancy,16,0,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
RECARBRIO,liver disease (non-cirrhotic),20,0,CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O,direct
TOPIRAMATE,asthma,12,0,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,direct
Lomotil,autoimmune disease,15,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
ESTRADIOL,congestive heart failure,2,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
FIRMAGON,advanced prostate cancer,567,1,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(N)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(=O)[C@@H]2CC(=O)NC(=O)N2)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,direct
ITRACONAZOLE,hypersensitivity,313,1,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Diacomit,renal failure,19,0,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1,direct
Flavoxate Hydrochloride,renal failure,19,0,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,direct
Zolpidem Tartrate,primary insomnia who,1177,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
CARISOPRODOL,hypersensitivity,313,1,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
"Butalbital, Acetaminophen, Caffeine",hypertension,11,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
QUVIVIQ,stroke,7,0,COC1=CC(C(=O)N2CCC[C@@]2(C)C2=NC3=C(N2)C=CC(Cl)=C3C)=C(C=C1)N1N=CC=N1,direct
Mefenamic Acid,chronic kidney disease,3,0,CC1=C(C)C(NC2=CC=CC=C2C(O)=O)=CC=C1,direct
ELIQUIS,nonvalvular atrial fibrillation,1056,1,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,direct
BRENZAVVY,renal failure,19,0,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(OCCOC3CC3)C=C2)=C1,direct
chlorothiazide sodium,congestive heart failure,2,0,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
Cortisone Acetate,liver disease (non-cirrhotic),20,0,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Cayston,severe infection,18,0,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(=O)O)\C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O,direct
Zafirlukast,asthma on zafirlukast,618,1,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,direct
Propranolol hydrochloride,hypersensitivity,313,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Integra F,hypersensitivity,313,1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
"Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide",ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
ganciclovir,myocardial infarction,1,0,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,direct
Depo-Estradiol,severe infection,18,0,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1,direct
Cosyntropin,severe infection,18,0,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O,direct
PNV-Omega,sepsis,17,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
VITRASE,hypersensitivity,313,1,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,fuzzy:vitrasert
TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE),hypersensitivity,313,1,COC1=CC(=CC(OC)=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1,direct
PANTOPRAZOLE SODIUM,hypersensitivity,313,1,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Carvedilol,bradycardia,45,1,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
ACETAZOLAMIDE EXTENDED-RELEASE,cirrhosis,231,1,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
chlorpromazine hydrochloride,anemia,13,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
Bupivacaine Hydrochloride,congestive heart failure,2,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
theophylline,cancer (metastatic),9,0,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Dorzolamide hydrochloride and timolol maleate,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Bactrim,pregnancy,16,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
MITIGARE,sepsis,17,0,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Colcrys,autoimmune disease,15,0,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Kit for the Preparation of Technetium Tc 99m Sulfur Colloid,cancer (metastatic),9,0,[99Tc].S1SSSSSSS1,direct
Butalbital/Acetaminophen/Caffeine,chronic obstructive pulmonary disease (COPD),6,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Hyosyne,mental illness,14,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Travoprost Ophthalmic Solution,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Aztreonam,hypersensitivity,313,1,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(=O)O)\C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O,direct
RETEVMO,solid tumors,1264,1,COC1=NC=C(CN2C3CC2CN(C3)C2=CC=C(C=N2)C2=CC(OCC(C)(C)O)=CN3N=CC(C#N)=C23)C=C1,direct
BELBUCA,renal failure,19,0,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,direct
Claravis,sepsis,17,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
"Brompheniramine maleate, pseudoephedrine hydrochloride,",stroke,7,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
KETOROLAC TROMETHAMINE,hypersensitivity,313,1,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
PROMETHAZINE HCI,bone-marrow depression,639,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
ganciclovir,asthma,12,0,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,direct
ASMANEX,asthma,193,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Ertapenem,asthma,12,0,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Lenvima,endometrial carcinoma that,795,1,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,direct
azithromycin monohydrate,renal failure,19,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
VFEND,acute ia,541,1,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Benznidazole,asthma,12,0,[O-][N+](=O)C1=NC=CN1CC(=O)NCC1=CC=CC=C1,direct
rifampin,sepsis,17,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
ROSUVASTATIN CALCIUM,myocardial infarction,1,0,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
LEFLUNOMIDE,hypersensitivity,313,1,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
LEXISCAN(R) (REGADENOSON),severe infection,18,0,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
Cleviprex,perioperative hypertension,1114,1,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,direct
Methenamine Mandelate,chronic pyelonephritis,704,1,C1N2CN3CN1CN(C2)C3,direct
acetazolamide,cirrhosis,231,1,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
AMIODARONE HCI,liver disease (non-cirrhotic),20,0,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2,direct
Mometasone Furoate,congestive heart failure,2,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Diltiazem Hydrochloride,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Folcyteine,chronic kidney disease,3,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Ventrixyl Fe,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Clindamycin Phosphate and Tretinoin,acne vulgaris,516,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
Tramadol Hydrochloride and Acetaminophen,mental illness,14,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
ERLOTINIB HYDROCHLORIDE,congestive heart failure,2,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
Dextroamphetamine Sulfate Extended-Release,diabetes mellitus,5,0,C[C@H](N)CC1=CC=CC=C1,direct
Depo-Estradiol,pregnancy,16,0,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1,direct
Zonalon,glaucoma,481,1,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
SULFATRIM,pregnancy,16,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Adalimumab-adbm,active psoriatic arthritis,533,1,CC(C)O,direct
Citanest Forte DENTAL,AIDS,10,0,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Alosetron Hydrochloride,AIDS,10,0,CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2,direct
gemcitabine hydrochloride,myocardial infarction,1,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
Teflaro,cancer (localized),8,0,[H][C@]12SCC(SC3=NC(=CS3)C3=CC=[N+](C)C=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC)\C1=NSC(NP(O)(O)=O)=N1)C([O-])=O,direct
VIVIMUSTA,pregnancy,16,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
VENLAFAXINE,hypertension,11,0,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
Texacort,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Erythromycin Ethylsuccinate,congestive heart failure,2,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Betoptic S,myocardial infarction,1,0,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
CALQUENCE,mcl who,987,1,CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1,direct
Tigan,hypersensitivity,313,1,COC1=CC(=CC(OC)=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1,direct
CAFCIT,renal failure,19,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Fensolvi,mental illness,14,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Topotecan hydrochloride,cervical cancer,676,1,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
Imatinib,ph- all who,1121,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
ZOMIG,mental illness,14,0,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
OSCIMIN,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Estradiol Vaginal Cream,cancer (metastatic),9,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Caldolor,anemia,13,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Topotecan Hydrochloride,pregnancy,16,0,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
Clonidine hydrochloride,liver cirrhosis,4,0,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
Epidiolex,tsc on placebo,1327,1,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1,direct
Telmisartan and Amlodipine,chronic obstructive pulmonary disease (COPD),6,0,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,direct
Potassium Chloride in Dextrose and Sodium Chloride,hypersensitivity,313,1,[Cl-].[K+],direct
LIDOCAINE,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
OZOBAX DS,renal failure,19,0,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
Demser,renal failure,19,0,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,direct
PRAZIQUANTEL,ocular cysticercosis,1075,1,O=C(C1CCCCC1)N1CC2N(CCC3=CC=CC=C23)C(=O)C1,direct
Bortezomib,sepsis,17,0,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Nitroglycerin In Dextrose,asthma,12,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Jatenzo,hypertension,39,1,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,direct
CARBOplatin,asthma,12,0,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Betamethasone dipropionate,stroke,7,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Desmopressin Acetate,hyponatremia,137,1,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
Amitriptyline Hydrochloride,cardiovascular disorders,669,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Asenapine,diabetes mellitus,5,0,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
NITROFURANTOIN (monohydrate/macrocrystals),asthma,12,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Orbactiv,hypersensitivity,313,1,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
Azithromycin Monohydrate,mental illness,14,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Tobramycin Inhalation,hypersensitivity,313,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Fludrocortisone Acetate,pregnancy,16,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Zyvox,chronic kidney disease,3,0,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,direct
Levetiracetam ER,cancer (metastatic),9,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Betamethasone Sodium Phosphate and Betamethasone Acetate,tuberculosis,213,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Cardizem,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Veklury,hypersensitivity,313,1,CCC(CC)COC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@](C#N)([C@H](O)[C@@H]1O)C1=CC=C2N1N=CN=C2N)OC1=CC=CC=C1,direct
Fluphenazine hydrochloride,psychosis,31,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Nitrofurantoin Monohydrate/Macrocrystal,diabetes mellitus,5,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Flucytosine,mental illness,14,0,NC1=C(F)C=NC(=O)N1,direct
Lipofen,cancer (localized),8,0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
gemcitabine,hypersensitivity,313,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
Lidocaine Hydrochloride and Epinephrine,anemia,13,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
FENOFIBRIC ACID,severe hypertriglyceridemia,1247,1,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
Sorafenib,asthma,12,0,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
Cladribine,anxiety,19,1,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
NeuLumEX,myocardial infarction,1,0,[Ba++].[O-]S([O-])(=O)=O,direct
Dialyvite with Zinc,stroke,7,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Rinvoq,psoriatic arthritis,1191,1,CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F,direct
Torsemide,congestive heart failure,2,0,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1,direct
Lurasidone hydrochloride,bipolar depression,632,1,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
AKEEGA,hypertension,11,0,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Clomid,normal liver function,1063,1,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
LIDOCAINE HCI AND EPINEPHRINE,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Diltiazem Hydrochloride EXTENDED RELEASE,AIDS,10,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Zingo,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Haloperidol Decanoate,dementia,7,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Diovan HCT,severe hypertension,1246,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Metolazone,hypertension,39,1,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,direct
CAMCEVI,prostate cancer,265,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
NITROGLYCERIN IN DEXTROSE,increased intracranial pressure,926,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Zintrexyl-C,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Paroxetine,gad and ptsd,822,1,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Amiloride Hydrochloride,severe infection,18,0,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
Heparin Sodium in Dextrose,sepsis,17,0,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C=O,direct
Polocaine,tics,23,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
BUSULFAN,chronic obstructive pulmonary disease (COPD),6,0,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
Amantadine Hydrochloride,hypersensitivity,313,1,NC12CC3CC(CC(C3)C1)C2,direct
Gemcitabine,AIDS,10,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
HALOPERIDOL LACTATE,psychosis,31,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Theophylline,asthma,12,0,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Hydrocortisone,autoimmune disease,15,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
metronidazole,mental illness,14,0,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
olmesartan medoxomil-hydrochlorothiazide,stroke,7,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
AZACITIDINE,myocardial infarction,1,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
FLOLAN,mental illness,14,0,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,direct
UDSxMP Medicated System,AIDS,10,0,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O,direct
ICOSAPENT ETHYL,anemia,13,0,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Physicians EZ Use M-pred,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
METHYLPREDNISOLONE,myocardial infarction,1,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Visudyne,hypersensitivity,313,1,COC(=O)CCC1=C2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(CCC(O)=O)=C5C)C(C=C)=C4C)C2=CC=C([C@@H](C(=O)OC)[C@@]32C)C(=O)OC)=C1C,direct
Lisdexamfetamine dimesylate,liver disease (non-cirrhotic),20,0,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
DISOPYRAMIDE PHOSPHATE,life-threatening ventricular arrhythmias,966,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound),sepsis,291,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Galantamine hydrobromide,AIDS,10,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
melphalan hydrochloride,hypertension,11,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Marcaine,anemia,13,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Concept OB,myocardial infarction,1,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Gentak,hypersensitivity,313,1,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,direct
Oxcarbazepine,urinary tract infection,249,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral,renal failure,19,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
PANTOPRAZOLE SODIUM I.V.,renal failure,19,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
KENALOG-40,unexplained diarrhea,1341,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
HYZAAR,sepsis,17,0,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",the following conditions,1301,1,CC(N)CC1=CC=CC=C1,direct
Ketorocaine LM Kit,the aspirin triad,1295,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
amlodipine and valsartan,hypersensitivity,313,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Enalapril Maleate and Hydrochlorothiazide,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
Nateglinide,autoimmune disease,15,0,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,direct
Prolia,glucocorticoid-induced osteoporosis,839,1,OC(=O)[C@@H]1CCCN1,fuzzy:prolina
liothyronine sodium,diabetes mellitus,5,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
CEVIMELINE,myocardial infarction,1,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
Analpram HC,sepsis,17,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide",stroke,7,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Plasma-Lyte 148,hypochloremic hypokalemic alkalosis,902,1,[Cl-].[K+],direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release",the following conditions,1301,1,CC(N)CC1=CC=CC=C1,direct
benzphetamine hydrochloride,stroke,7,0,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,direct
ACETAZOLAMIDE EXTENDED-RELEASE,hypertension,11,0,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
Cortisone Acetate,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
CAPLYTA,sepsis,17,0,[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C,direct
Losartan Potassium and Hydrochlorothiazide,such a history,1277,1,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
doxycycline,cancer (metastatic),9,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
VIBATIV,AIDS,10,0,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2=C3OC4=CC=C(C=C4Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]4C(C=C2OC2=C(Cl)C=C(C=C2)[C@@H](O)[C@@H]2NC(=O)[C@H](NC4=O)C4=CC(=C(O)C=C4)C4=C(O)C(CNCP(O)(O)=O)=C(O)C=C4[C@H](NC2=O)C(O)=O)=C3)O[C@@H](C)[C@H]1O,direct
Trileptal,vaginitis,337,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Proctocort,cancer (localized),8,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Topotecan hydrochloride,autoimmune disease,15,0,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
SALICYLIC ACID,chronic kidney disease,3,0,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,direct
Proparacaine Hydrochloride,hypersensitivity,313,1,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,direct
Erlotinib Hydrochloride,anorexia,399,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
FOSAMAX PLUS D,the following conditions,1301,1,CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,direct
Progesterone,congestive heart failure,2,0,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
"Butalbital, Acetaminophen, and Caffeine",asthma,12,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
NORLIQVA,sensitivity to amlodipine,1227,1,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,direct
Trimipramine Maleate,depression symptoms,768,1,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Lovastatin,sepsis,17,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC,direct
ADEFOVIR DIPIVOXIL,hypersensitivity,313,1,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C,direct
Azelastine Hydrochloride and Fluticasone Propionate,severe infection,18,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Dorzolamide Hydrochloride and Timolol Maleate ophthalmic,mental illness,14,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Phenergan,bone-marrow depression,639,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Valsartan and hydrochlorothiazide,liver cirrhosis,4,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
LEUKERAN,cancer (localized),8,0,OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl,direct
0.5% LIDOCAINE HCl,liver cirrhosis,4,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
AMANTADINE HYDROCHLORIDE,severe infection,18,0,NC12CC3CC(CC(C3)C1)C2,direct
Pirnuo,hypersensitivity,313,1,C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O,direct
CaroSpir,myocardial infarction,1,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
nicardipine hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
DIANEAL Low Calcium with Dextrose,lactic acidosis,129,1,[Cl-].[Cl-].[Ca++],direct
Neomycin and Polymyxin B Sulfates,stroke,7,0,[H][C@]1(NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CCN)NC(=O)[C@H](CCNC1=O)NC(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)CCCCC(C)CC)[C@@H](C)O)[C@@H](C)O,direct
Spravato,liver disease (non-cirrhotic),20,0,CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl,direct
PRENATE DHA,diabetes mellitus,5,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
BETHKIS,renal failure,19,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Epitol,increased intraocular pressure,927,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Zingo,cancer (metastatic),9,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Levoleucovorin,chronic obstructive pulmonary disease (COPD),6,0,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
LEUPROLIDE ACETATE,renal failure,19,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
URSODIOL,primary biliary cholangitis,1170,1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
Chlordiazepoxide hydrochloride and clidinium bromide,AIDS,10,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Pramipexole dihydrochloride,mental illness,14,0,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
Clorazepate Dipotassium,autoimmune disease,15,0,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,direct
Flagyl,cancer (metastatic),9,0,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Cefotetan,sepsis,17,0,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)OC)C(O)=O,direct
PROCTOZONE-HC,pregnancy,16,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
bupropion hydrochloride,anorexia,399,1,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Propranolol Hydrochloride,mental illness,14,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Loperamide Hydrochloride,asthma,12,0,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Pentobarbital Sodium,myocardial infarction,1,0,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,direct
Betamethasone Valerate,hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Dorzolamide Hydrochloride and Timolol Maleate,hypertension,11,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Levetiracetam Extended-Release,chronic obstructive pulmonary disease (COPD),6,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Zyvox,hypertension,11,0,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,direct
Flucytosine,impaired renal function,919,1,NC1=C(F)C=NC(=O)N1,direct
MEPIVACAINE HYDROCHLORIDE,hypersensitivity,313,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Mavenclad,pregnancy,16,0,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
Rivaroxaban,nonvalvular atrial fibrillation,1056,1,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,direct
Imatinib Mesylate,liver disease (non-cirrhotic),20,0,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
NATEGLINIDE,AIDS,10,0,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,direct
Epinephrine,angina pectoris,596,1,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Prednisolone Sodium Phosphate Oral Solution,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Vancomycin Hydrochloride,hypersensitivity,313,1,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
Paroxetine,liver cirrhosis,4,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Tobramycin Inhalation Solution Pak,hypersensitivity,313,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
IXEMPRA,sepsis,17,0,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,direct
Acamprosate Calcium,alcohol dependence who,580,1,CC(=O)NCCCS(O)(=O)=O,direct
FLUPHENAZINE DECANOATE,mental retardation,993,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Camptosar,cancer (localized),8,0,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
TECFIDERA,stroke,7,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
Bisoprolol fumarate,autoimmune disease,15,0,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,direct
Prednisolone Sodium Phosphate Oral Solution,renal failure,19,0,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
DILTIAZEM HYDROCHLORIDE,supraventricular arrhythmias,1280,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
VALSARTAN,hypersensitivity,313,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
ACCOLATE,sepsis,17,0,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,direct
Abiraterone Acetate,metastatic crpc who,998,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Reltone 200 mg,such stones,1278,1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
Prometrium,liver cirrhosis,4,0,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
ULORIC,gout,147,1,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
potassium chloride,hyperkalemia,131,1,[Cl-].[K+],direct
Fosfomycin Tromethamine,hypersensitivity,313,1,C[C@@H]1O[C@@H]1P(O)(O)=O,direct
Mesalamine,anemia,13,0,NC1=CC(C(O)=O)=C(O)C=C1,direct
nebivolol,AIDS,10,0,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
Arsenic trioxide,hypersensitivity,313,1,O=[As]O[As]=O,direct
Carbidopa and levodopa,narrow-angle glaucoma,1030,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
diflunisal,cancer (localized),8,0,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,direct
Imatinib Mesylate,sepsis,17,0,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
ALVAIZ,cancer (localized),8,0,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,direct
Cyclopentolate Hydrochloride,glaucoma,481,1,CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1,direct
Metolazone,liver cirrhosis,4,0,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,direct
CARVEDILOL,AIDS,10,0,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
"brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide",anemia,13,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
PRAVASTATIN SODIUM,stroke,51,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Virazole,bradycardia,45,1,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
AKEEGA,brca m mcrpc,647,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Kyzatrex,liver cirrhosis,4,0,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,direct
VOQUEZNA,hypersensitivity,313,1,CNCC1=CN(C(=C1)C1=CC=CC=C1F)S(=O)(=O)C1=CC=CN=C1,direct
Compro,psychosis,31,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
pravastatin sodium,clinically evident chd,718,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Fluocinolone Acetonide Topical,myocardial infarction,1,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
TENORETIC,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Adalimumab-adbm,active ankylosing spondylitis,520,1,CC(C)O,direct
Body Scrub,stroke,7,0,O.O.[Al+3].[Al+3].[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-],direct
oseltamivir phosphate,liver cirrhosis,4,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
QUVIVIQ,diabetes mellitus,5,0,COC1=CC(C(=O)N2CCC[C@@]2(C)C2=NC3=C(N2)C=CC(Cl)=C3C)=C(C=C1)N1N=CC=N1,direct
Aminocaproic Acid,cancer (metastatic),9,0,NCCCCCC(O)=O,direct
PHENYTOIN SODIUM,hypertension,11,0,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Priftin,sepsis,17,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(\C=N\N1CCN(CC1)C1CCCC1)=C2O,direct
Imbruvica,b-cell malignancies,624,1,NC1=NC=NC2=C1C(=NN2[C@@H]1CCCN(C1)C(=O)C=C)C1=CC=C(OC2=CC=CC=C2)C=C1,direct
Doxorubicin Hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
oxaliplatin,cancer (metastatic),9,0,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,direct
Citanest Plain,hypersensitivity,313,1,CCCNC(C)C(=O)NC1=CC=CC=C1C,direct
"Clonidine Transdermal System USP, 0.1 mg/day",hypersensitivity,313,1,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
CARBIDOPA AND LEVODOPA,glaucoma,481,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
CITRANATAL B-CALM,hypersensitivity,313,1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
potassium chloride,asthma,12,0,[Cl-].[K+],direct
Levothyroxine sodium,thyrotoxicosis,113,1,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
Pregabalin,hypersensitivity,313,1,CC(C)C[C@H](CN)CC(O)=O,direct
Bortezomib,leukopenia,83,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Metoprolol,myocardial infarction,49,1,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
Prenate Mini,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Azithromycin,AIDS,10,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
NITRO-DUR,myocardial infarction,49,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Alacort,anemia,13,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
ANASPAZ,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
regadenoson,functioning artificial pacemakers,821,1,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
Timolol maleate,asthma,12,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
K Phos Original,cancer (localized),8,0,[K+].OP(O)([O-])=O,direct
Dorzolamide Hydrochloride and Timolol Maleate Preservative Free,mental illness,14,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Uro-MP,myocardial infarction,1,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
CHLOROQUINE PHOSPHATE,diabetes mellitus,5,0,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,direct
Forfivo XL,anorexia,399,1,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Nitrofurantoin Mono,hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
TEMODAR,anaplastic astrocytoma are,593,1,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
Cyklokapron,severe infection,18,0,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
ZITUVIO,stroke,7,0,N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F,direct
AirDuo RespiClick,liver cirrhosis,4,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
CISplatin,preexisting renal impairment,1162,1,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
Aldactone,primary hyperaldosteronism,1174,1,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
Demser,malignant pheochromocytoma demser,980,1,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,direct
Mirtazapine,mental illness,14,0,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1,direct
Kimyrsa,hypertension,11,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
RADICAVA,hypersensitivity,313,1,CC1=NN(C(=O)C1)C1=CC=CC=C1,direct
Methocarbamol and Aspirin,edema,417,1,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
TIAZAC EXTENDED RELEASE,congestive heart failure,2,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
VITRAKVI,liver disease (non-cirrhotic),20,0,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1,direct
TRANEXAMIC ACID,active intravascular clotting,526,1,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Zingo,pregnancy,16,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
DROXIA,hypertension,11,0,NC(=O)NO,direct
midazolam,cardiovascular instability,670,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Trifluoperazine Hydrochloride,previous brain damage,1166,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
PACLITAXEL PACLITAXEL,cancer (localized),8,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Trifluoperazine Hydrochloride,mental retardation,993,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Hydroxyzine HCL,sepsis,17,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
PROCHLORPERAZINE,hypersensitivity,313,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Clomipramine HCl,cancer (localized),8,0,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
Procainamide Hydrochloride,life-threatening ventricular arrhythmias,966,1,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
ertapenem,hypersensitivity,313,1,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Amiloride Hydrochloride,AIDS,10,0,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
LEVALBUTEROL,pregnancy,16,0,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
Caldolor,stroke,7,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
CLORAZEPATE DIPOTASSIUM,pregnancy,16,0,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,direct
INVOKANA,myocardial infarction,1,0,[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=C(C)C(CC2=CC=C(S2)C2=CC=C(F)C=C2)=C1,direct
ESTRADIOL VALERATE,hypersensitivity,313,1,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
CHLOROTHIAZIDE SODIUM,hypertension,11,0,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
Lisinopril and hydrochlorothiazide,impaired renal function,919,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
LATANOPROST,congestive heart failure,2,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Methylphenidate,sepsis,17,0,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
Bactrim DS,renal failure,19,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Ojjaara,autoimmune disease,15,0,O=C(NCC#N)C1=CC=C(C=C1)C1=CC=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1,direct
Galantamine,autoimmune disease,15,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
Travoprost Ophthalmic Solution,AIDS,10,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Azulfidine,chronic kidney disease,3,0,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,direct
PERPHENAZINE,dementia,7,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Vancomycin,hypersensitivity,313,1,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",mental illness,14,0,CC(N)CC1=CC=CC=C1,direct
BETAMETHASONE VALERATE,cancer (localized),8,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Doxycycline,impaired renal function,919,1,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Teflaro,hypersensitivity,313,1,[H][C@]12SCC(SC3=NC(=CS3)C3=CC=[N+](C)C=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC)\C1=NSC(NP(O)(O)=O)=N1)C([O-])=O,direct
Alprazolam XR,poisoning,425,1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
itraconazole,cancer (metastatic),9,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Mirtazapine,pregnancy,16,0,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1,direct
Leucovorin Calcium,advanced colorectal cancer,560,1,[H]C(=O)N1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2,direct
Solu-Medrol,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Cisatracurium Besylate,hypersensitivity,313,1,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,direct
AZITHROMYCIN DIHYDRATE,pneumonia who,1132,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Cyclobenzaprine HCL ER,asthma,12,0,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
BRIMONIDINE TARTRATE and TIMOLOL MALEATE,chronic kidney disease,3,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Deferoxamine Mesylate,cancer (localized),8,0,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
Everolimus,tsc-associated partial-onset seizures,1328,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,direct
Radiaura Skin Recovery,stroke,7,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Signifor LAR,acromegaly who,518,1,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,direct
Otezla,liver cirrhosis,4,0,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,direct
Kitabis Pak,mental illness,14,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Pazopanib,liver disease (non-cirrhotic),20,0,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,direct
OXALIPLATIN,myocardial infarction,1,0,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,direct
AZACITIDINE AZACITIDINE,myocardial infarction,1,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Cuprimine,mental illness,14,0,[H][C@](N)(C(O)=O)C(C)(C)S,direct
Sodium phenylacetate and Sodium benzoate,otc and cps,1083,1,OC(=O)C1=CC=CC=C1,direct
Dorzolamide Hydrochloride and Timolol Maleate Preservative Free,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Xalatan,hypertension,11,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Levothyroxine sodium,cancer (metastatic),9,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
Proctosol-HC,renal failure,19,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
IYUZEH,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
VALSARTAN AND HYDROCHLOROTHIAZIDE,hypersensitivity,313,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
ABILIFY,liver disease (non-cirrhotic),20,0,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
Phenobarbital Sodium,severe infection,18,0,CCC1(C(=O)NC(=O)NC1=O)C1=CC=CC=C1,direct
KLAYESTA,stroke,7,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Levetiracetam ER,diabetes mellitus,5,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
"Carbidopa Tablets, 25 mg",sepsis,17,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Cefazolin Sodium,anemia,13,0,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,direct
Rivastigmine Transdermal System,these events,1312,1,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,direct
Qulipta,AIDS,10,0,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=C4C=CC=N2)C(=O)N1CC(F)(F)F)C1=C(F)C(F)=CC=C1F,direct
Levetiracetam Extended-Release,asthma,12,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
AZATHIOPRINE,ra appears to,1196,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Diphenoxylate hydrochloride and atropine sulfate,hypersensitivity,313,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
Strovite One Caplets,anemia,13,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Glycate,stroke,7,0,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
Venlafaxine hydrochloride,asthma,12,0,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
FLAVOXATE HYDROCHLORIDE,stroke,7,0,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,direct
esomeprazole,hypersensitivity,313,1,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Mekinist,solid tumors,1264,1,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1,direct
Seizalam,mental illness,14,0,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
SAPHRIS,bipolar mania,634,1,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
Lumryz,cancer (localized),8,0,[Na+].OCCCC([O-])=O,direct
Ribavirin,myocardial infarction,1,0,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Rasuvo,hypersensitivity,313,1,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
PNV-DHA,chronic obstructive pulmonary disease (COPD),6,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
EVOMELA,cancer (localized),8,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
BUTALBITAL and ACETAMINOPHEN,acetaminophen allergy,513,1,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,direct
Tikosyn,supraventricular arrhythmias,1280,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
OZOBAX DS,liver disease (non-cirrhotic),20,0,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
TORSEMIDE,AIDS,10,0,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1,direct
DermacinRx Lidotral,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Integra Plus,anemia,13,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Heparin Sodium in Dextrose,the following conditions,1301,1,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C=O,direct
XYLOCAINE,congestive heart failure,2,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
MUPIROCIN,liver cirrhosis,4,0,C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O,direct
MOMETASONE FUROATE,stroke,7,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
FLUCONAZOLE,hypersensitivity,313,1,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Lidocaine hydrochloride,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Deferasirox oral,decreased egfr,761,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Jalyn,prostate cancer,265,1,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O,direct
Leflunomide,hypersensitivity,313,1,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
BUPIVACAINE HCI AND EPINEPHRINE,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
BUSULFEX,hypersensitivity,313,1,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
Lactated Ringers and Dextrose,anemia,13,0,[Cl-].[K+],direct
ethacrynic acid,hypokalemia,133,1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Desferal,chronic obstructive pulmonary disease (COPD),6,0,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
Cyclomydril,hypersensitivity,313,1,CNC[C@H](O)C1=CC(O)=CC=C1,direct
Trimethoprim sulfate and Polymyxin B sulfate,hypersensitivity,313,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release",congestive heart failure,2,0,CC(N)CC1=CC=CC=C1,direct
Salsalate,the aspirin triad,1295,1,OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O,direct
Nortriptyline Hydrochloride,myocardial infarction,1,0,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Meclofenamate Sodium,hypertension,11,0,CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1,direct
SULFATRIM,hypersensitivity,313,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Pemfexy,cancer (metastatic),9,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
Disopyramide Phosphate,urinary retention,1347,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
XYOSTED,cancer (metastatic),9,0,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
JANUMET,pancreatitis,233,1,CN(C)C(=N)NC(N)=N,direct
Proctosol-HC,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
PLERIXAFOR,cancer (metastatic),9,0,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
pentobarbital sodium,known barbiturate sensitivity,948,1,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,direct
TAVALISSE,chronic itp who,692,1,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC,direct
Dutasteride and Tamsulosin Hydrochloride,prostate cancer,265,1,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O,direct
"SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE",renal failure,19,0,[Mg++].[O-]S([O-])(=O)=O,direct
Tasigna,severe infection,18,0,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,direct
diltiazem hydrochloride,hypotension,75,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
CABOMETYX,epnet in cabinet,801,1,COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,direct
Nilandron,hypersensitivity,313,1,CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,direct
Telmisartan and Hydrochlorothiazide,such a history,1277,1,CCCC1=NC2=C(C=C(C=C2C)C2=NC3=CC=CC=C3N2C)N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O,direct
ACCRUFER,a history of,502,1,[Fe+3].CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1,direct
Esomeprazole DR,severe infection,18,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
nifedipine,tight aortic stenosis,1320,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
ACETAMINOPHEN AND CODEINE,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
Ryaltris,seasonal allergic rhinitis,1223,1,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2,direct
EDECRIN,hypokalemia,133,1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
midazolam,congestive heart failure,2,0,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Sensipar,hypertension,11,0,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
calcium chloride,liver disease (non-cirrhotic),20,0,[Cl-].[Cl-].[Ca++],direct
SINEMET,cancer (localized),8,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
RETEVMO,stroke,7,0,COC1=NC=C(CN2C3CC2CN(C3)C2=CC=C(C=N2)C2=CC(OCC(C)(C)O)=CN3N=CC(C#N)=C23)C=C1,direct
ROPIVACAINE HYDROCHLORIDE,liver cirrhosis,4,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
Oxymorphone hydrochloride,mental illness,14,0,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,direct
Fluocinolone Acetonide Oil,sepsis,17,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
XACIATO,chronic kidney disease,3,0,[H][C@@](NC(=O)[C@@H]1C[C@@H](CCC)CN1C)([C@H](C)Cl)[C@@]1([H])O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O,direct
EZETIMIBE,liver disease (non-cirrhotic),20,0,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
"PredniSONE Tablets, USP, 5 mg",cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Integra Plus,autoimmune disease,15,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Estradiol Vaginal,hypercalcemia,139,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Flagyl,sepsis,17,0,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Veletri,congestive heart failure,41,1,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,direct
pentamidine isethionate,congestive heart failure,2,0,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
Cleviprex,pregnancy,16,0,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,direct
XELPROS,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Tetracaine Hydrochloride,severe infection,18,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
Isosorbide Mononitrate,congestive heart failure,2,0,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,direct
PROCHLORPERAZINE EDISYLATE,cancer (metastatic),9,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
ELUCIREM,cancer (localized),8,0,[Gd+3].OCC(O)CNC(=O)CCC(N1CCN(CC2=CC=CC(CN(CC1)C(CCC(=O)NCC(O)CO)C([O-])=O)=N2)C(CCC(=O)NCC(O)CO)C([O-])=O)C([O-])=O,direct
3% Sodium Chloride,severe renal impairment,1253,1,[Na+].[Cl-],direct
Idarubicin Hydrochloride,asthma,12,0,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O,direct
Chlordiazepoxide Hydrochloride and Clidinium Bromide,hypertension,11,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Travoprost Ophthalmic,stroke,7,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Ibandronate Sodium,apr-like events,613,1,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Desipramine Hydrochloride,impaired renal function,919,1,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Progesterone,severe infection,18,0,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
KLAYESTA,AIDS,10,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
nitrofurantoin macrocrystals,stroke,7,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Fluocinolone Acetonide Topical,diabetes mellitus,5,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
ISOPROTERENOL HYDROCHLORIDE,asthma,12,0,CC(C)NCC(O)C1=CC(O)=C(O)C=C1,direct
Diflorasone Diacetate,hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
AVYCAZ,neutropenia,85,1,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
toremifene citrate,cancer (localized),8,0,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,direct
"Clotrimazole Topical Solution USP, 1%",hypersensitivity,313,1,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Foscavir,mental illness,14,0,OC(=O)P(O)(O)=O,direct
Tobramycin Inhalation Solution Pak,pregnancy,16,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Adalimumab-aacf,anti-adalimumab antibody,602,1,CC(C)O,direct
Nicotrol,diabetes mellitus,5,0,CN1CCC[C@H]1C1=CN=CC=C1,direct
Xalkori,AIDS,10,0,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,direct
Cyclophosphamide,asthma,12,0,ClCCN(CCCl)P1(=O)NCCCO1,direct
Zyprexa,autoimmune disease,15,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Corvert,AIDS,10,0,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Diatrizoate Meglumine and Diatrizoate Sodium,hypersensitivity,313,1,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Daraprim,hypersensitivity,313,1,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1,direct
CAPTOPRIL AND HYDROCHLOROTHIAZIDE,stroke,7,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Icosapent Ethyl,diabetes mellitus,5,0,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Aridol Bronchial Challenge Test Kit,pregnancy,16,0,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,direct
ConZip,osteoarthritis,161,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
fluphenazine hydrochloride,dementia,7,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Nitrofurantion Macrocrystals,hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
FULVESTRANT,AIDS,10,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],direct
Gadobutrol,chronic kidney disease,3,0,OC[C@H](O)[C@H](CO)[N+]12CC[N+]3(CC([O-])=O)CC[N+]4(CC([O-])=O)CC[N+](CC([O-])=O)(CC1)[Gd-]234,direct
Fosfomycin Tromethamine,hypertension,11,0,C[C@@H]1O[C@@H]1P(O)(O)=O,direct
Accucaine,cancer (localized),8,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Dobutamine,AIDS,10,0,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
adenosine,asthma,193,1,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
MOVANTIK,renal failure,19,0,COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC=C)[C@H]1O5,direct
Avalide,hypersensitivity,313,1,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Dextrose And Sodium Chloride,myocardial infarction,1,0,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C=O,direct
Ciprofloxacin and dexamethasone,cancer (metastatic),9,0,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,direct
CLONAZEPAM,the following conditions,1301,1,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,direct
Folixapure,hypersensitivity,313,1,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Nicardipine hydrochloride,advanced aortic stenosis,559,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
XYWAV,sepsis,17,0,OCCCC(O)=O,direct
PROCHLORPERAZINE EDISYLATE,sepsis,17,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
ISTODAX,renal failure,19,0,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,direct
Polocaine,hypertension,11,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
LEXISCAN(R) (REGADENOSON),lung disease,375,1,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
Pramipexole Dihydrochloride,or without levodopa,1082,1,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
Dialyvite 3000,hypersensitivity,313,1,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Lyrica,hypersensitivity,313,1,CC(C)C[C@H](CN)CC(O)=O,direct
Omnitrope,stroke,7,0,O,direct
ertapenem,the laboratory test,1306,1,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
K Phos Original,chronic kidney disease,3,0,[K+].OP(O)([O-])=O,direct
OZOBAX DS,hypersensitivity,313,1,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
"Clobetasol Propionate Cream, 0.05% Clobetasol Propionate Cream, 0.05%",hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,"fuzzy:clobetasol propionate cream usp, 0.05% clobetasol propionate cream usp, 0.05%"
PRIALT,congestive heart failure,2,0,[H][C@]12CSSC[C@]3([H])NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@]([H])(NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC3=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N2,direct
XALATAN,sepsis,17,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Norepinephrine bitartrate,chronic obstructive pulmonary disease (COPD),6,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Epidiolex,sepsis,17,0,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1,direct
Normosol-R and Dextrose,myocardial infarction,1,0,[Cl-].[K+],direct
Procainamide Hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
PROCHLORPERAZINE MALEATE,hypersensitivity,313,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Dexmethylphenidate Hydrochloride Extended-Release,pediatric patients,13,1,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,direct
GALZIN,hypersensitivity,313,1,[Zn++].CC([O-])=O.CC([O-])=O,direct
Timolol Maleate Ophthalmic Gel Forming Solution 0.25%,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
ROBAXIN,cancer (localized),8,0,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
Betaxolol Hydrochloride,diabetes mellitus,5,0,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
Clomipramine Hydrochloride,congestive heart failure,2,0,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
Macrobid,liver cirrhosis,4,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Sulfamethoxazole and Trimethoprim,pneumonia who,1132,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
"PredniSONE Tablets, USP, 20 mg",unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Quinidine Gluconate,heart disease,377,1,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
Hyoscyamine Sulfate SL,diabetes mellitus,5,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
NADOLOL,bronchospastic diseases,653,1,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,direct
ACETAMINOPHEN AND CODEINE,hypertension,11,0,CC(=O)NC1=CC=C(O)C=C1,direct
AMPHETAMINE SULFATE,cancer (metastatic),9,0,CC(N)CC1=CC=CC=C1,direct
MARINOL,sepsis,17,0,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,direct
"BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, AND TETRACYCLINE HYDROCHLORIDE",congestive heart failure,2,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
Lydexa 4.12%,sepsis,17,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
posaconazole,hypertension,11,0,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
"Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide",hypersensitivity,313,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
AIRSUPRA,severe infection,18,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Butal/APAP/Caff,acetaminophen allergy,513,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
HydrOXYzine Hydrochloride,severe infection,18,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
CASPOFUNGIN ACETATE,concomitant opc,742,1,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
DOXY 100(TM) DOXYCYCLINE,cancer (metastatic),9,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
ALBENDAZOLE,hypersensitivity,313,1,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,direct
VALCHLOR,hypersensitivity,313,1,CN(CCCl)CCCl,direct
AGAMREE,hypersensitivity,313,1,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@@]1(O)C(=O)CO,direct
Pemetrexed disodium,congestive heart failure,2,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
Atenolol,myocardial infarction,1,0,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,direct
Promethazine Hydrochloride,bone marrow depression,637,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Scandonest 3% Plain,tics,23,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Norepinephrine Bitartrate,acute hypotensive states,540,1,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Halog,myocardial infarction,1,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Tobramycin Inhalation Solution,this symptom,1317,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
BUPROPION HYDROCHLORIDE,depressive symptoms,769,1,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Cyclobenzaprine Hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
AGAMREE,hypertension,11,0,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@@]1(O)C(=O)CO,direct
Tetracaine HCL,tics,23,1,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
EMFLAZA,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@]([H])(O)C[C@]3(C)[C@@]1(N=C(C)O2)C(=O)COC(C)=O,direct
Proctocort,myocardial infarction,1,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Clomipramine HCl,hypertension,11,0,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
Febuxostat,autoimmune disease,15,0,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
Amphotericin B,normal neutrophil counts,1064,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
VITRAKVI,pediatric patients,13,1,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1,direct
PRUDOXIN,diabetes mellitus,5,0,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
FLUORESCITE,asthma,12,0,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
SOTYLIZE,life-threatening ventricular arrhythmias,966,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Depen,renal failure,19,0,[H][C@](N)(C(O)=O)C(C)(C)S,direct
Denavir,anemia,13,0,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,direct
Lidocaine Hydrochloride and Dextrose,liver cirrhosis,4,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
AZATHIOPRINE,AIDS,10,0,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
ARIPIPRAZOLE,cancer (metastatic),9,0,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
SIROLIMUS,lymphangioleiomyomatosis safety,974,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
Rubraca,leukopenia,83,1,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,direct
Doxepin HCL,stroke,7,0,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
Cromolyn Sodium Inhalation Solution,asthma,12,0,OC(COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O)COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O,direct
Nilutamide,chronic obstructive pulmonary disease (COPD),6,0,CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,direct
Venlafaxine Hydrochloride,mood disorders who,1019,1,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
Labetalol hydrochloride,sepsis,17,0,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
metolazone,congestive heart failure,2,0,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,direct
Bystolic,autoimmune disease,15,0,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
thiothixene,mental retardation,993,1,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1,direct
Clofarabine,hypertension,11,0,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,direct
BIVALIRUDIN,liver disease (non-cirrhotic),20,0,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,direct
Chlorothiazide,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
Deferoxamine mesylate,myocardial infarction,1,0,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
Cytalux,ovarian cancer,1094,1,CC1(C)\C(=C/C=C2\CCCC(\C=C\C3=[N+](CCCCS(O)(=O)=O)C4=C(C=C(C=C4)S([O-])(=O)=O)C3(C)C)=C2OC2=CC=C(C[C@H](NC(=O)C3=CC=C(NCC4=CN=C5N=C(N)NC(=O)C5=N4)C=C3)C(O)=O)C=C2)N(CCCCS(O)(=O)=O)C2=C1C=C(C=C2)S(O)(=O)=O,direct
Ketorocaine L Kit,autoimmune disease,15,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Metoprolol tartrate,myocardial infarction,49,1,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
Bimatoprost,glaucoma,481,1,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
Potassium Chloride,chronic obstructive pulmonary disease (COPD),6,0,[Cl-].[K+],direct
Carvedilol Phosphate,shock,419,1,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
ertapenem sodium,mental illness,14,0,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Amantadine HCl,cancer (localized),8,0,NC12CC3CC(CC(C3)C1)C2,direct
Octreotide,renal failure,19,0,C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=CC=CC=C23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,fuzzy:edotreotide
Doxepin hydrochloride,glaucoma,481,1,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
VIVIMUSTA,sepsis,17,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
PHENYLEPHRINE HYDROCHLORIDE,hypertension or thyrotoxicosis,897,1,CNC[C@H](O)C1=CC(O)=CC=C1,direct
Alkindi Sprinkle,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
ranolazine,autoimmune disease,15,0,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,direct
Dihydroergotamine mesylate,diabetes mellitus,5,0,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE,sepsis,17,0,CC(=O)OC1=CC=CC=C1C(O)=O,direct
isosorbide dinitrate and hydralazine hydrochloride,tachycardia,47,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
SILODOSIN,pregnancy,16,0,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,direct
TENORMIN,untreated pheochromocytoma,1345,1,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,direct
AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE,seasonal allergic rhinitis,1223,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Quinidine gluconate,cancer (metastatic),9,0,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
methylprednisolone,pregnancy,16,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Tricor,severe hypertriglyceridemia,1247,1,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
OLANZAPINE,schizophrenia and,1220,1,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Erlotinib,chronic kidney disease,3,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
VFEND,hypersensitivity,313,1,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Zanaflex,renal failure,19,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
ArmonAir Digihaler,cancer (metastatic),9,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution,chronic kidney disease,3,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Lidogel,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ROSUVASTATIN CALCIUM,hypersensitivity,313,1,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
ATAZANAVIR,ldl-cholesterol measured,960,1,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,direct
Famotidine,liver disease (non-cirrhotic),20,0,NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1,direct
Diclona,hypertension,11,0,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,fuzzy:diclonina
Hydrocortisone,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
MEPIVACAINE HYDROCHLORIDE,chronic obstructive pulmonary disease (COPD),6,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Pamidronate Disodium,hypercalcemia of malignancy,876,1,NCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
ChlorproMAZINE Hydrochloride,cancer (localized),8,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
Levocarnitine,bronchospasm,197,1,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
"PREGABALIN capsules, CV",myocardial infarction,1,0,CC(C)C[C@H](CN)CC(O)=O,direct
FIRMAGON,chronic kidney disease,3,0,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(N)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(=O)[C@@H]2CC(=O)NC(=O)N2)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,direct
Carbatrol,depression,27,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
methylprednisolone,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Marinol,hypersensitivity,313,1,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,direct
Ropidex,severe infection,18,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
NABUMETONE,hypersensitivity,313,1,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
Ravicti,hypersensitivity,313,1,O=C(CCCC1=CC=CC=C1)OCC(COC(=O)CCCC1=CC=CC=C1)OC(=O)CCCC1=CC=CC=C1,direct
PHENYLEPHRINE HYDROCHLORIDE,chronic kidney disease,3,0,CNC[C@H](O)C1=CC(O)=CC=C1,direct
valsartan,hypersensitivity,313,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Chlordiazepoxide Hydrochloride,sepsis,17,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Captopril,mental illness,14,0,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,direct
Travoprost,chronic kidney disease,3,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Clocortolone Pivalate,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
FENTANYL TRANSDERMAL,insomnia,441,1,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
citalopram hydrobromide,liver disease (non-cirrhotic),20,0,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
XELSTRYM,pregnancy,16,0,C[C@H](N)CC1=CC=CC=C1,direct
Donepezil,liver disease (non-cirrhotic),20,0,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
Liothyronine Sodium,pediatric patients,13,1,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
DIURIL,renal failure,19,0,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
Sirolimus,lymphangioleiomyomatosis sirolimus tablets,976,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
ATAZANAVIR,hypertension,11,0,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,direct
Ranolazine,autoimmune disease,15,0,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,direct
TRUQAP,hypersensitivity,313,1,NC1(CCN(CC1)C1=C2C=CNC2=NC=N1)C(=O)N[C@@H](CCO)C1=CC=C(Cl)C=C1,direct
OXCARBAZEPINE,edema,417,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Diovan,mental illness,14,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Dihydroergotamine Mesylate,risk factors,1216,1,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
Famciclovir,recurrent genital herpes,1201,1,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O,direct
Apixaban,autoimmune disease,15,0,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,direct
Capecitabine,myocardial infarction,1,0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
Sulindac,anemia,13,0,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O,direct
Trijardy XR,AIDS,10,0,CN(C)C(=N)NC(N)=N,direct
ATENOLOL AND CHLORTHALIDONE,untreated pheochromocytoma,1345,1,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
esomeprazole,mental illness,14,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
CEFTRIAXONE AND DEXTROSE,pelvic inflammatory disease,339,1,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
Levoleucovorin,metastatic colorectal cancer,996,1,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
Carbamazepine ER,symptomatic hyponatremia,1286,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Timolol Maleate Ophthalmic Gel Forming Solution 0.25%,severe infection,18,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Telmisartan and Amlodipine,hypertension,39,1,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,direct
PRASUGREL,stroke,51,1,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,direct
BELBUCA,chronic moderate-to-severe pain,694,1,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,direct
Mavenclad,mental illness,14,0,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
Nabumetone 500 mg,hypersensitivity,313,1,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
Plenvu,asthma,12,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Marinol,sepsis,17,0,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,direct
Dextrose And Sodium Chloride,diabetes mellitus,5,0,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C=O,direct
Xipere,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Bacitracin,liver disease (non-cirrhotic),20,0,CC[C@H](C)[C@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC,direct
NADOLOL,congestive heart failure,41,1,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,direct
Keppra,hypersensitivity,313,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
NITROFURANTOIN,chronic obstructive pulmonary disease (COPD),6,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Potassium Chloride Extended-release,sepsis,17,0,[Cl-].[K+],direct
KETOROLAC TROMETHAMINE,the aspirin triad,1295,1,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Thioridazine Hydrochloride,long qt syndrome,61,1,CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1,direct
Dichlorphenamide,hyperkalemic periodic paralysis,878,1,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O,direct
Levothyroxine sodium,myocardial infarction,49,1,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
Nitrofurantion,myocardial infarction,1,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Anoro Ellipta,pregnancy,16,0,OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2,direct
Dextrose and Electrolyte No. 48,brain edema,643,1,[Cl-].[K+],direct
fluocinolone acetonide,AIDS,10,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Bortezomib,cancer (localized),8,0,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Zetonna,cancer (metastatic),9,0,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,direct
Diclofenac sodium,the aspirin triad,1295,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
MethylPREDNISolone,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
azithromycin,AIDS,10,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
AVODART,stroke,7,0,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)NC1=CC(=CC=C1C(F)(F)F)C(F)(F)F,direct
Bexarotene,sexual partners who,1256,1,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,direct
Accucaine,diabetes mellitus,5,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
"Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg",hypersensitivity,313,1,CC(=O)OC1=CC=CC=C1C(O)=O,direct
sevelamer hydrochloride,chronic kidney disease,3,0,NCC=C.ClCC1CO1,direct
Bendeka,asthma,12,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
ezetimibe,chronic kidney disease,3,0,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
carisoprodol,hypersensitivity,313,1,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
ULORIC,gout who,842,1,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
Doxepin Hydrochloride,congestive heart failure,2,0,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
BUTAL/APAP/CAFFEINE,cancer (localized),8,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,fuzzy:butal/apap/caff
Pantoprazole sodium,hypersensitivity,313,1,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Sotalol Hydrochloride,ventricular arrhythmias are,1355,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Azithromycin Dihydrate,pneumonia who,1132,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
0.5% LIDOCAINE HCl,stroke,7,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Fluticasone Propionate,anemia,13,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Prolate,severe infection,18,0,CC(=O)NC1=CC=C(O)C=C1,direct
benzphetamine hydrochloride,renal failure,19,0,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,direct
Humira,active ankylosing spondylitis,520,1,CC(C)O,direct
VITRASE,liver disease (non-cirrhotic),20,0,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,fuzzy:vitrasert
Imipramine Hydrochloride,depressive symptoms,769,1,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Dichlorphenamide,congestive heart failure,2,0,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O,direct
Konvomep,chronic kidney disease,3,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Phenergan,mental illness,14,0,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Acetaminophen And Codeine,acetaminophen allergy,513,1,CC(=O)NC1=CC=C(O)C=C1,direct
Bupivacaine HCl,pregnancy,16,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
FOSCARNET SODIUM,liver disease (non-cirrhotic),20,0,OC(=O)P(O)(O)=O,direct
Amlodipine and olmesartan Medoxomil,stroke,51,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Humira,anti-adalimumab antibody,602,1,CC(C)O,direct
AMANTADINE HYDROCHLORIDE,cancer (metastatic),9,0,NC12CC3CC(CC(C3)C1)C2,direct
Coreg CR,severe hepatic impairment,1245,1,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
Cortisone Acetate,glaucoma,481,1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Teriflunomide,cancer (metastatic),9,0,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
timolol maleate,congestive heart failure,2,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
FIRMAGON,prostate cancer,265,1,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(N)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(=O)[C@@H]2CC(=O)NC(=O)N2)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,direct
Diazoxide,autoimmune disease,15,0,CC1=NS(=O)(=O)C2=C(N1)C=CC(Cl)=C2,direct
Pyridostigmine,asthma,193,1,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Potassium Chloride,hypertension,11,0,[Cl-].[K+],direct
Diltiazem Hydrochloride,autoimmune disease,15,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Ammonia N-13,liver cirrhosis,4,0,[13NH3],direct
IHEEZO,anemia,13,0,CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1,direct
prochlorperazine edisylate,hypersensitivity,313,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Prolate,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
METHYLPREDNISOLONE ACETATE,liver disease (non-cirrhotic),20,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Phenergan,renal failure,19,0,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
CARBAMAZEPINE ER,renal failure,19,0,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
PRIMAXIN IV,chronic obstructive pulmonary disease (COPD),6,0,CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O,direct
Dorzolamide Hydrochloride Ophthalmic Solution,glaucoma,481,1,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Vitrexyl,stroke,7,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Fluphenazine Hydrochloride,dementia,7,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
DABIGATRAN,asthma,12,0,CN1C(CNC2=CC=C(C=C2)C(N)=N)=NC2=C1C=CC(=C2)C(=O)N(CCC(O)=O)C1=NC=CC=C1,direct
3% Sodium Chloride,hypertension,11,0,[Na+].[Cl-],direct
Telmisartan and Hydrochlorothiazide,myocardial infarction,1,0,CCCC1=NC2=C(C=C(C=C2C)C2=NC3=CC=CC=C3N2C)N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O,direct
Sevelamer Carbonate For Oral Suspension,bowel obstruction,641,1,NCC=C.ClCC1CO1,direct
SPRYCEL,sepsis,17,0,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
Nebivolol Hydrochloride,liver cirrhosis,4,0,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
NALBUPHINE HCI,depression,27,1,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
Focalin XR,pediatric patients,13,1,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,direct
Butalbital and Acetaminophen,acetaminophen allergy,513,1,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,direct
Liquid Polibar Plus,cancer (metastatic),9,0,[Ba++].[O-]S([O-])(=O)=O,direct
QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Topicort,congestive heart failure,2,0,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
SODIUM CHLORIDE,hypernatremia,135,1,[Na+].[Cl-],direct
Capecitabine 150mg,mental illness,14,0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
Mekinist,autoimmune disease,15,0,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1,direct
DOXAPRAM HYDROCHLORIDE,hypersensitivity,313,1,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Carbidopa-levodopa,anemia,13,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Tetracycline Hydrochloride,renal impairment,1211,1,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
HALOPERIDOL LACTATE,mental illness,14,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
CABOMETYX,pnet in cabinet,1131,1,COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,direct
Timoptic in Ocudose,sepsis,17,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Adenosine,asthma,193,1,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
ConZip,hypertension,11,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Prochlorperazine Maleate,mental illness,14,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
PROGESTERONE,asthma,12,0,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Aminophylline,liver cirrhosis,4,0,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Lidogel,renal failure,19,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Fluocinolone Acetonide Topical,liver cirrhosis,4,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Lacosamide,AIDS,10,0,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
Rinvoq,cancer (localized),8,0,CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F,direct
NEBIVOLOL,hypertension,39,1,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
Acebutolol Hydrochloride,tics,23,1,CCCC(=O)NC1=CC=C(OCC(O)CNC(C)C)C(=C1)C(C)=O,direct
INPEFA,hypersensitivity,313,1,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@@H]2O[C@H](SC)[C@@H](O)[C@H](O)[C@H]2O)C=C1,direct
Adrenalin,shock,419,1,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Lidocaine and prilocaine,sepsis,17,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Cleviprex,autoimmune disease,15,0,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,direct
Midodrine Hydrochloride,cancer (localized),8,0,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,direct
Dialyvite Supreme D,AIDS,10,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
PROMETHAZINE DM,sepsis,17,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
TRANEXAMIC ACID IN SODIUM CHLORIDE,active intravascular clotting,526,1,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
HYDROCHLOROTHIAZIDE,autoimmune disease,15,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Tranexamic acid,active intravascular clotting,526,1,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Tramadol Hydrochloride and Acetaminophen,cancer (metastatic),9,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Kit for the Preparation of Technetium Tc 99m Sulfur Colloid,autoimmune disease,15,0,[99Tc].S1SSSSSSS1,direct
Halog,diabetes mellitus,5,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Corvert,atrial fibrillation,65,1,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Venexa FE,diabetes mellitus,5,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Colazal,active ulcerative colitis,536,1,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,direct
Lisinopril,AIDS,10,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
MOMETASONE FUROATE,hypertension,11,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Vaseretic,impaired renal function,919,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
Glyburide and Metformin Hydrochloride,non-insulin-dependent diabetes,1045,1,CN(C)C(=N)NC(N)=N,direct
oxycodone hydrochloride and acetaminophen,autoimmune disease,15,0,CC(=O)NC1=CC=C(O)C=C1,direct
"Carbidopa Tablets, 25 mg",stroke,7,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
leuprolide acetate,metastatic prostate cancer,1004,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
donepezil hydrochloride,stroke,7,0,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
METHOCARBAMOL,renal impairment,1211,1,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
fluocinolone acetonide,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Losortan Potassium,liver cirrhosis,4,0,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
latanoprost,renal failure,19,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
capecitabine,liver cirrhosis,4,0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
ISOSORBIDE DINITRATE,severe infection,18,0,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
Vimpat,partial-onset seizures who,1108,1,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
Propranolol,bradycardia,45,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Gastrografin,pregnancy,16,0,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Spironolactone,the following conditions,1301,1,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
VARENICLINE TARTRATE,hypersensitivity,313,1,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
"Travoprost Ophthalmic Solution USP, 0.004% Travoprost",glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
XYLOCAINE-MPF WITH EPI,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Rubraca,ovarian cancer,1094,1,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,direct
Timoptic-XE,autoimmune disease,15,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
OXTELLAR XR,hypertension,11,0,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Betamethasone dipropionate,anemia,13,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Tafinlar,abnormal lvef,511,1,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,direct
Doxycyclate Hyclate,impaired renal function,919,1,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Clonazepam,relative risk,1208,1,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,direct
SINEMET,autoimmune disease,15,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Lignospan Standard,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Atovaquone and Proguanil Hydrochloride Pediatric,cancer (metastatic),9,0,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,direct
NOXAFIL,refractory opc,1202,1,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
Cinacalcet Hydrochloride,these symptoms,1314,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Keppra XR,chronic obstructive pulmonary disease (COPD),6,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
VOQUEZNA,AIDS,10,0,CNCC1=CN(C(=C1)C1=CC=CC=C1F)S(=O)(=O)C1=CC=CN=C1,direct
Glucagon,hypersensitivity,313,1,O,direct
Asenapine,chronic kidney disease,3,0,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
Avalide,mental illness,14,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Dopram,severe cardiovascular diseases,1240,1,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,direct
FloLipid,myocardial infarction,49,1,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
HYDROXYCHLOROQUINE SULFATE,porphyria the condition,1141,1,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
Carteolol Hydrochloride,hypertension,39,1,CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2,direct
Erythrocin Lactobionate,diabetes mellitus,5,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
SOTALOL HYDROCHLORIDE,chronic kidney disease,3,0,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Oraqix,hypertension,11,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
UROCIT-K,AIDS,10,0,[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,direct
CEVIMELINE HYDROCHLORIDE,other conditions,1087,1,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
UltraCare Anesthetic Gel,tics,23,1,CCOC(=O)C1=CC=C(N)C=C1,direct
Diflunisal,sepsis,17,0,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,direct
ZOLPIDEM TARTRATE,hypersensitivity,313,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
LOTRONEX,ibs who,907,1,CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2,direct
ERYTHROMYCIN,chronic obstructive pulmonary disease (COPD),6,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Ropivacaine hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
Ezetimibe,homozygous familial sitosterolemia,873,1,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
TAVNEOS,chronic kidney disease,3,0,CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C2=CC=C(NC3CCCC3)C=C2)C(=O)C2=C(F)C=CC=C2C)C=C1C(F)(F)F,direct
Harvoni,liver cirrhosis,4,0,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
Kitabis Pak,AIDS,10,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Loperamide Hydrochloride,acute ulcerative colitis,556,1,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Minoxidil,cancer (localized),8,0,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1,direct
Azacitidine,asthma,12,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Lunesta,cancer (localized),8,0,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,direct
BUTALBITAL and ACETAMINOPHEN,liver cirrhosis,4,0,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,direct
TORSEMIDE,hypersensitivity,313,1,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1,direct
LIDO BDK,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
CELEBREX,post-surgical pain,1145,1,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
Betoptic S,bradycardia,45,1,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
Imiquimod,myocardial infarction,1,0,CC(C)CN1C=NC2=C1C1=C(C=CC=C1)N=C2N,direct
HUMIRA,active psoriatic arthritis,533,1,CC(C)O,direct
Eligard,advanced prostate cancer,567,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
METROGEL,autoimmune disease,15,0,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
PRYIDOSTIGMINE BROMIDE,asthma,12,0,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
FARXIGA,renal failure,19,0,CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1,direct
METROGEL,hypersensitivity,313,1,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Halobetasol Propionate,hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
PROCHLORPERAZINE EDISYLATE,mental illness,14,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Norgesic Forte,anemia,13,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Zolpidem tartrate sublingual,asthma,12,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Venclexta,anemia,13,0,CC1(C)CCC(CN2CCN(CC2)C2=CC=C(C(=O)NS(=O)(=O)C3=CC=C(NCC4CCOCC4)C(=C3)[N+]([O-])=O)C(OC3=CN=C4NC=CC4=C3)=C2)=C(C1)C1=CC=C(Cl)C=C1,direct
toremifene citrate,severe infection,18,0,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,direct
Dicyclomine Hydrochloride,AIDS,10,0,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,direct
PRIMAXIN IV,meningitis,293,1,CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O,direct
MELOXICAM,osteoarthritis,161,1,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O,direct
MELPHALAN HYDROCHLORIDE,asthma,12,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
VOTRIENT,stroke,7,0,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,direct
PENCICLOVIR,hypertension,11,0,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,direct
TESTOSTERONE ENANTHATE,uncontrolled hypertension,1337,1,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Potassium Chloride,significant cardiac arrhythmias,1259,1,[Cl-].[K+],direct
Lidotral 3.88% Roll on,chronic kidney disease,3,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
NITRO-DUR,congestive heart failure,41,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
ProAir RespiClick,hypersensitivity,313,1,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Absorica LD,myocardial infarction,1,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Carbatrol,mental illness,14,0,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
lenalidomide,liver cirrhosis,4,0,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
VYTORIN,asthma,12,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Clomiphene Citrate,pregnancy,16,0,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
HYDROCHLOROTHIAZIDE,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Venexa FE,congestive heart failure,2,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Nilutamide,hepatic impairment,1,1,CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,direct
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE,hypertension,39,1,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
OXCARBAZEPINE,ataxia,465,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Pazopanib,sepsis,17,0,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,direct
Diflucan,serious underlying diseases,1232,1,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
PHENYLEPHRINE HYDROCHLORIDE,hypertension,39,1,CNC[C@H](O)C1=CC(O)=CC=C1,direct
Polocaine-MPF,hypersensitivity,313,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Ketorolac tromethamine,liver disease (non-cirrhotic),20,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
"Butalbita,Acetaminophen and Caffeine",severe infection,18,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Esomeprazole Sodium,renal failure,19,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Kit for the Prepartion of Technetium Tc99m Sulfur Colloid,breast cancer,263,1,[99Tc].S1SSSSSSS1,direct
Pentobarbital Sodium,chronic obstructive pulmonary disease (COPD),6,0,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,direct
POSACONAZOLE,AIDS,10,0,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
Hydrocortisone sodium succinate,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,fuzzy:hydrocortisone succinate
Arava,diabetes mellitus,5,0,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
Neomycin Sulfate,myocardial infarction,1,0,[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O.[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O,fuzzy:capreomycin sulfate
"Testosterone Gel, 1%",diabetes mellitus,5,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Prenate Pixie,autoimmune disease,15,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Pravastatin sodium,atherosclerosis,357,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
NITROFURANTOIN,hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
PANTOPRAZOLE SODIUM,liver disease (non-cirrhotic),20,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
LIDOCAINE HCl and EPINEPHRINE,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
DOXERCALCIFEROL,liver cirrhosis,4,0,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
Sodium Acetate,stroke,7,0,[Na+].CC([O-])=O,direct
NEXIUM,hypersensitivity,313,1,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Perindopril Erbumine,autoimmune disease,15,0,[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,direct
KOURZEQ,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Desferal,severe infection,18,0,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
amlodipine besylate and olmesartan medoxomil,kidney failure,373,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Matulane,asthma,12,0,CNNCC1=CC=C(C=C1)C(=O)NC(C)C,direct
Ultramicrosize Griseofulvin,autoimmune disease,15,0,COC1=CC(OC)=C(Cl)C2=C1C(=O)[C@]1(O2)[C@H](C)CC(=O)C=C1OC,direct
Nateglinide,AIDS,10,0,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,direct
DONEPEZIL HYDROCHLORIDE,anemia,13,0,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
"Butalbital, aspirin, and caffeine",anemia,13,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
ERYTHROMYCIN,hypersensitivity,313,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Paclitaxel protein-bound particles for injectable suspension (albumin-bound),diabetes mellitus,5,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Cinacalcet Hydrochloride,ckd who,716,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Mepivacaine,hypersensitivity,313,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Loxapine,dementia,7,1,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,direct
chlordiazepoxide hydrochloride and clidinium bromide,liver disease (non-cirrhotic),20,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
bupivacaine hydrochloride,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Xarelto,atrial fibrillation,65,1,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,direct
CLOFARABINE,asthma,12,0,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,direct
HYDROCORTISONE,autoimmune disease,15,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
FOSAMAX,the following conditions,1301,1,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Allopurinol,stroke,7,0,OC1=NC=NC2=C1C=NN2,direct
KOURZEQ,anemia,13,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
DICLOFENAC SODIUM,the aspirin triad,1295,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Doxycycline hyclate,congestive heart failure,2,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Fluphenazine hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
XYLOCAINE,cancer (metastatic),9,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
imatinib mesylate,neutropenia,85,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride and DextromethorphanHydrobromide",cancer (metastatic),9,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Ceftriaxone,severe infection,18,0,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
FENTANYL TRANSDERMAL,severe pain,1251,1,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
Kalydeco,cf who,679,1,CC(C)(C)C1=CC(=C(O)C=C1NC(=O)C1=CNC2=CC=CC=C2C1=O)C(C)(C)C,direct
Plerixafor,nhl or mm,1038,1,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
Irinotecan Hydrochloride 100 mg/5 mL,congestive heart failure,2,0,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
Deferasirox Oral Granules,deferasirox oral granules,763,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Losartan Potassium and Hydrochlorothiazide,liver cirrhosis,4,0,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
Lidocaine Hydrochloride and Dextrose,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
lenalidomide,hypertension,11,0,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
Plasma-Lyte A,hypersensitivity,313,1,[Cl-].[K+],direct
"Amlodipine, Valsartan and Hydrochlorothiazide",hypercalcemia and hypophosphatemia,875,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
CALCIUM CHLORIDE,ventricular fibrillation,63,1,[Cl-].[Cl-].[Ca++],direct
Vitrexyl,myocardial infarction,1,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Diphenoxylate Hydrochloride and Atropine Sulfate,hypersensitivity,313,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
SSD Cream,sepsis,291,1,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
DOXEPIN HYDROCHLORIDE,sepsis,17,0,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
Alprazolam XR,ataxia,465,1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
Zingo,myocardial infarction,1,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
spironolactone,cancer (metastatic),9,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
Doxepin Hydrochloride,glaucoma,481,1,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
TARGADOX,sepsis,17,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Prepidil,congestive heart failure,2,0,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,direct
Dorzolamide Hydrochloride Ophthalmic,glaucoma,481,1,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Trisenox,apl who,611,1,O=[As]O[As]=O,direct
Exforge HCT,hypercalcemia and hypophosphatemia,875,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Depo-Medrol,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
PENICILLIN G POTASSIUM,myocardial infarction,1,0,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,direct
Inflammacin,considerable dehydration,749,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
DESOXIMETASONE,anemia,13,0,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ACCUTANE,myocardial infarction,1,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Potassium Chloride in Sodium Chloride,mental illness,14,0,[Cl-].[K+],direct
Midazolam,acute narrow-angle glaucoma,546,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
latanoprost,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Zyvox,pediatric patients,13,1,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,direct
SENSORCAINE MPF,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Mavenclad,current malignancy,756,1,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
Ropivacaine hydrochloride,cancer (metastatic),9,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
PrednisoLONE,AIDS,10,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Otezla,chronic kidney disease,3,0,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,direct
ETOPOPHOS,lung cancer,215,1,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@@H]1O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O,direct
YUPELRI,hypersensitivity,313,1,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1,direct
CAMCEVI,pregnancy,16,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND,cancer (localized),8,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Triamcinolone acetonide,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
tooth powder,renal failure,257,1,[F-].[Na+],fuzzy:toothpowder
ELIGARD,prostate cancer,265,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Levoleucovorin Calcium,metastatic colorectal cancer,996,1,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
abiraterone acetate,metastatic crpc who,998,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Motofen,diabetes mellitus,5,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
Multi-Specialty Kit,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Edetate Calcium Disodium,mental illness,14,0,[Na+].[Na+].[Ca++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O,direct
Docetaxel anhydrous,liver disease (non-cirrhotic),20,0,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
Edaravone,liver cirrhosis,4,0,CC1=NN(C(=O)C1)C1=CC=CC=C1,direct
Voriconazole,acute ia,541,1,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
NINLARO,multiple myeloma who,1025,1,CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(Cl)=CC=C1Cl)B(O)O,direct
VIIBRYD,renal failure,19,0,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,direct
LISINOPRIL AND HYDROCHLOROTHIAZIDE,impaired renal function,919,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
PEMRYDI RTU,asthma,12,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
Prochlorperazine Maleate,chronic obstructive pulmonary disease (COPD),6,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
DELSTRIGO,liver cirrhosis,4,0,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,direct
Desipramine HCL,congestive heart failure,2,0,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
PREDNISOLONE,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Flumazenil,chronic kidney disease,3,0,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,direct
Kalydeco,liver disease (non-cirrhotic),20,0,CC(C)(C)C1=CC(=C(O)C=C1NC(=O)C1=CNC2=CC=CC=C2C1=O)C(C)(C)C,direct
Carbamazepine ER,increased intraocular pressure,927,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
PERPHENAZINE,dementia-related psychosis,766,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Fareston,chronic obstructive pulmonary disease (COPD),6,0,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,direct
topotecan hydrochloride,mental illness,14,0,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
Bupivilog Kit,active tuberculosis,535,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
ZITUVIO,hypersensitivity,313,1,N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F,direct
Urso 250,cancer (metastatic),9,0,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
Gemcitabine hydrochloride,sepsis,17,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
PEMRYDI RTU,mpm who,1020,1,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
memantine hydrochloride,chronic kidney disease,3,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Pro-C-Dure 6 Kit,active tuberculosis,535,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Diovan HCT,hypercalcemia and hypophosphatemia,875,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
APRISO,myocardial infarction,1,0,NC1=CC(C(O)=O)=C(O)C=C1,direct
Nipent,pregnancy,16,0,OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CNC[C@H]2O,direct
voriconazole,hypersensitivity,313,1,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
gentamicin sulfate,chronic kidney disease,3,0,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,direct
IBANDRONATE SODIUM,autoimmune disease,15,0,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Albuterol sulfate,chronic kidney disease,3,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
CABERGOLINE,hyperprolactinemic disorders,880,1,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",comorbid depressive symptoms,735,1,CC(N)CC1=CC=CC=C1,direct
YUTIQ,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
HydrOXYzine Hydrochloride,mental illness,14,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
CIDOFOVIR DIHYDRATE,hypersensitivity to cidofovir,886,1,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,direct
pitavastatin calcium,hyperlipidemia,143,1,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
Vaseline Moisturizing Cream,hypertension,11,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,fuzzy:viractin moisturizing cream
Triamcinolone acetonide,pregnancy,16,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE,cancer (metastatic),9,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ORPHENGESIC FORTE,myasthenia gravis,151,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Omeprazole DR,sepsis,17,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Neo-Synalar,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Rifampin,cancer (metastatic),9,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
ZEPZELCA,cancer (localized),8,0,[H][C@@]12[C@@H]3SC[C@]4(NCCC5=C4NC4=CC=C(OC)C=C54)C(=O)OC[C@H](N1[C@@H](O)[C@@H]1CC4=CC(C)=C(OC)C(O)=C4[C@@]2([H])N1C)C1=C2OCOC2=C(C)C(OC(C)=O)=C31,direct
Losortan Potassium,sepsis,17,0,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
Balsalazide Disodium,chronic kidney disease,3,0,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,direct
Dasatinib,pediatric patients,13,1,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
PROSCAR,hypertension,11,0,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,direct
methylphenidate hydrochloride,pediatric patients,13,1,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
Levothyroxine Sodium,myocardial infarction,49,1,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
Balsalazide Disodium,active ulcerative colitis,536,1,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,direct
Pramipexole Dihydrochloride,liver cirrhosis,4,0,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
Escitalopram oxalate,hypersensitivity,313,1,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
PRYIDOSTIGMINE BROMIDE,bronchial asthma,650,1,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Omeprazole/Sodium Bicarbonate,hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Solu-Medrol,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Ventrixyl,liver disease (non-cirrhotic),20,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
CYTARABINE,bone marrow suppression,101,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,direct
PROCRIT,hypertension,11,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,fuzzy:procort
DIURIL,AIDS,10,0,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
Atelvia,the following conditions,1301,1,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE,liver cirrhosis,4,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
Foltrate,hypertension,11,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
TIADYLT ER,hypersensitivity,313,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Deferasorox,liver disease (non-cirrhotic),20,0,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Pramipexole Dihydrochloride Extended-Release,or without levodopa,1082,1,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
POLOCAINE(R) -MPF (MEPIVACAINE HCI),hypersensitivity,313,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Caffeine Citrate Oral Solution,pregnancy,16,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Azulfidine,porphyria as sulfonamides,1140,1,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,direct
Texacort,renal failure,19,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Rivaroxaban,autoimmune disease,15,0,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,direct
Rapamune,stroke,7,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
Chemet,sepsis,17,0,OC(=O)[C@@H](S)[C@@H](S)C(O)=O,direct
OSCIMIN,congestive heart failure,2,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Hydrocortisone,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Hyoscyamine Sulfate TAB,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Fluphenazine Hydrochloride,dementia-related psychosis,766,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Amlodipine besylate and Olmesartran medoxomil,kidney failure,373,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Fluocinonide,cancer (localized),8,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,direct
SORILUX,liver cirrhosis,4,0,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
METHYLPHENIDATE HYDROCHLORIDE,comorbid depressive symptoms,735,1,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
CaroSpir,the following conditions,1301,1,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
Tazarotene,chronic obstructive pulmonary disease (COPD),6,0,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,direct
Dexlido Kit,inflammatory bowel disease,223,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
GUANFACINE HYDROCHLORIDE,chronic obstructive pulmonary disease (COPD),6,0,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,direct
Lyrica CR,postherpetic neuralgia table,1146,1,CC(C)C[C@H](CN)CC(O)=O,direct
Erythromycin,hypersensitivity,313,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
celecoxib,post-surgical pain,1145,1,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
metyrosine,pheochromocytoma for,1125,1,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,direct
LEVOLEUCOVORIN CALCIUM,metastatic colorectal cancer,996,1,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
Dexmethylphenidate Hydrochloride Extended-Release,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,direct
KLOR-Con/EF,congestive heart failure,2,0,[K+].OC([O-])=O,direct
Diacomit,autoimmune disease,15,0,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1,direct
Diflorasone Diacetate,pregnancy,16,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Ammonul,otc and cps,1083,1,OC(=O)C1=CC=CC=C1,direct
PERPHENAZINE,liver disease (non-cirrhotic),20,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Venlafaxine Hydrochloride,chronic kidney disease,3,0,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
tizanidine,impaired hepatic function,915,1,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Istalol,cancer (localized),8,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
LANREOTIDE ACETATE,mental illness,14,0,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],direct
KETOROLAC TROMETHAMINE,mental illness,14,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
NIACIN,hyperlipidemia,143,1,OC(=O)C1=CN=CC=C1,direct
Tetracycline Hydrochloride,cancer (localized),8,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
Betaxolol,asthma,12,0,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
Cetirizine Hydrochloride Oral Solution,AIDS,10,0,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
CARBOplatin,poor performance status,1139,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Dihydroergotamine Mesylate,uncontrolled hypertension,1337,1,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
Imipramine Pamoate,depressive symptoms,769,1,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
DIGOXIN,atrial fibrillation,65,1,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,direct
Positive Skin Test Control - Histamine,asthma,193,1,NCCC1=CNC=N1,direct
Dorzolamide hydrochloride,hypertension,39,1,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
HALCINONIDE,hypersensitivity,313,1,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Istalol,asthma,193,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
PROPRANOLOL HYDROCHLORIDE,angina pectoris,596,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Nystatin,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
SEREVENT DISKUS,asthma who,619,1,OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1,direct
"SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE",mental illness,14,0,[Mg++].[O-]S([O-])(=O)=O,direct
PIOGLITAZONEHYDROCHLORIDE,sepsis,17,0,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
SULINDAC,chronic obstructive pulmonary disease (COPD),6,0,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O,direct
Doxycycline hyclate,impaired renal function,919,1,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
HYOSCYAMINE SULFATE,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
MAGNESIUM SULFATE,asthma,12,0,[Mg++].[O-]S([O-])(=O)=O,direct
ATACAND HCT,cancer (metastatic),9,0,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1,direct
Kyzatrex,diabetes mellitus,5,0,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,direct
Leuprolide Acetate,sepsis,17,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Gastrografin,hypersensitivity,313,1,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Diflunisal,the aspirin triad,1295,1,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,direct
Dexrazoxane,breast cancer,263,1,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,direct
Bupivacaine Hydrochloride and Epinephrine,mental illness,14,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Dyanavel XR,adhd there,557,1,CC(N)CC1=CC=CC=C1,direct
fenofibrate,mental illness,14,0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
Carbidopa-levodopa,cancer (metastatic),9,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
PROPAFENONE HYDROCHLORIDE,chronic atrial fibrillation,685,1,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,direct
ARSENIC TRIOXIDE,hypersensitivity to arsenic,883,1,O=[As]O[As]=O,direct
Prograf,myocardial infarction,1,0,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,direct
Amlodipine besylate and Olmesartan medoxomil,AIDS,10,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Medrol,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
CARDENE IV,myocardial infarction,1,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
Rifadin IV NOVAPLUS,impaired liver function,918,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
Cayston,cf known to,678,1,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(=O)O)\C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O,direct
SODIUM PHENYLACETATE AND SODIUM BENZOATE,otc and cps,1083,1,OC(=O)C1=CC=CC=C1,direct
Linezolid,diabetes mellitus,5,0,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,direct
Tobramycin Inhalation,chronic obstructive pulmonary disease (COPD),6,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
pyridostigmine bromide,diabetes mellitus,5,0,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Varenicline tartrate,hypersensitivity,313,1,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Conray,asthma,12,0,CNC(=O)C1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Reyvow,congestive heart failure,2,0,CN1CCC(CC1)C(=O)C1=CC=CC(NC(=O)C2=C(F)C=C(F)C=C2F)=N1,direct
Body Scrub,chronic kidney disease,3,0,O.O.[Al+3].[Al+3].[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-],direct
Gloperba,congestive heart failure,2,0,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
ROSUVASTATIN,severe infection,18,0,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Norepinephrine bitartrate,arrhythmia,43,1,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Timolol Maleate Ophthalmic Gel Forming Solution 0.25%,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
LIDOCAINE,anemia,13,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
LAMIVUDINE AND ZIDOVUDINE,hypersensitivity,313,1,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
NUPLAZID,hypersensitivity,313,1,CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C2CCN(C)CC2)C=C1,direct
LIPIODOL,hcc lipiodol use,846,1,COC1=CC=C(C=C1)C(=O)CC(=O)C1=CC=C(C=C1)C(C)(C)C,fuzzy:lipidol
Doxycyclate Hyclate,liver cirrhosis,4,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
ENDOCET,autoimmune disease,15,0,CC(=O)NC1=CC=C(O)C=C1,direct
psorcon,hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
EXEMESTANE,hypersensitivity,313,1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C,direct
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE,stroke,7,0,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3,direct
ANAFRANIL,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
Hydrocodone Bitartrate and Acetaminophen,chronic overdose,698,1,CC(=O)NC1=CC=C(O)C=C1,direct
Hydrocodone/APAP,congestive heart failure,2,0,CC(=O)NC1=CC=C(O)C=C1,direct
Vitafol One,an overactive thyroid,592,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
PROMETHAZINE DM,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Erythromycin,chronic obstructive pulmonary disease (COPD),6,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Liothyronine Sodium,liver disease (non-cirrhotic),20,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
Droperidol,renal failure,19,0,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,direct
Loperamide hydrochloride,hypersensitivity,313,1,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Azathioprine,leukemia,267,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
olopatadine hydrochloride,perennial allergic rhinitis,1111,1,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2,direct
Mepivacaine,cancer (localized),8,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Tetracycline Hydrochloride,liver failure,371,1,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
Lidolog Kit,renal failure,19,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
MB CAPS,hypertension,11,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,fuzzy:pm caps
Fluocinolone Acetonide,autoimmune disease,15,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Toronova II SUIK,cancer (localized),8,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Stivarga,hyponatremia,137,1,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,direct
Glipizide,cancer (metastatic),9,0,CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,direct
BRENZAVVY,diabetes mellitus,111,1,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(OCCOC3CC3)C=C2)=C1,direct
Betaxolol Hydrochloride,bradycardia,45,1,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
Isolyte P in Dextrose,hypersensitivity,313,1,[Cl-].[K+],direct
Glipizide and Metformin Hydrochloride,sepsis,17,0,CN(C)C(=N)NC(N)=N,direct
Methotrexate,non-hodgkin lymphoma,1043,1,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
SUBVENITE,cancer (localized),8,0,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
Midodrine Hydrochloride,diabetes mellitus,5,0,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,direct
Adalimumab,active ankylosing spondylitis,520,1,CC(C)O,direct
fluphenazine decanoate,autoimmune disease,15,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
ISOSORBIDE MONONITRATE,myocardial infarction,1,0,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,direct
Prograf,hypersensitivity,313,1,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,direct
PROPECIA,prostate cancer,265,1,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,direct
VIVIMUSTA,lymphoma,269,1,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Spironolactone and Hydrochlorothiazide,liver cirrhosis,4,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
Folixate,cancer (metastatic),9,0,CN1[C@@H](CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)N=C(N)N2,direct
Ethacrynic Sodium,congestive heart failure,2,0,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Amphotericin B,systemic fungal infections,1292,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Pitavastatin,hyperlipidemia,143,1,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
Dorzolamide Hydrochloride Ophthalmic,chronic obstructive pulmonary disease (COPD),6,0,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
XELJANZ,AIDS,10,0,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,direct
balsalazide disodium,ulcerative colitis,225,1,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,direct
Deferasirox,deferasirox oral granules,763,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
CARNITOR,edema,417,1,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE,sepsis,17,0,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],direct
Levocarnitine,hypertension,11,0,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
Cystografin Dilute,congestive heart failure,2,0,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Dextrose and Electrolyte No. 48,severe infection,18,0,[Cl-].[K+],direct
PRIALT,anemia,13,0,[H][C@]12CSSC[C@]3([H])NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@]([H])(NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC3=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N2,direct
Gentamicin Sulfate Opth Solution,severe infection,18,0,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,direct
Quinapril and Hydrochlorothiazide 10/12.5,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Alosetron Hydrochloride,ibs who,907,1,CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2,direct
NRG Hemo-Stat,hypersensitivity,313,1,Cl[Al](Cl)Cl,direct
BUPIVICAINE HYDROCHLORIDE,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Vitafol Ultra,myocardial infarction,1,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Litfulo,hypersensitivity,313,1,C[C@H]1CC[C@H](CN1C(=O)C=C)NC1=NC=NC2=C1C=CN2,direct
Ferric Citrate,chronic kidney disease,245,1,O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,direct
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride and DextromethorphanHydrobromide",mental illness,14,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
BELRAPZO,pregnancy,16,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Prenatryl,renal failure,19,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
GEMFIBROZIL,significantly elevated triglycerides,1260,1,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,direct
APREMILAST,liver disease (non-cirrhotic),20,0,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,direct
Diclofenac Sodium Delayed Release,sepsis,17,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
TRANEXAMIC ACID,subarachnoid hemorrhage,1275,1,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Clofarabine,liver disease (non-cirrhotic),20,0,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,direct
fenofibrate,renal failure,19,0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
Bexagliflozin,hypertension,11,0,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(OCCOC3CC3)C=C2)=C1,direct
Rasuvo,cancer (metastatic),9,0,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
Diazoxide,AIDS,10,0,CC1=NS(=O)(=O)C2=C(N1)C=CC(Cl)=C2,direct
AMPYRA,ms as follows,1022,1,NC1=CC=NC=C1,direct
Cytarabine,hypertension,11,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,direct
Sevelamer Carbonate,anemia,13,0,NCC=C.ClCC1CO1,direct
Protonix Delayed-Release,myocardial infarction,1,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
leflunomide,cancer (metastatic),9,0,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
thiothixene,dementia,7,1,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1,direct
Hydromorphone Hydrochloride,cancer (localized),8,0,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O,direct
esomeprazole magnesium,hypersensitivity,313,1,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Polocaine,hypersensitivity,313,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Danazol,renal failure,19,0,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3,direct
Pro-C-Dure 5 Kit,pregnancy,16,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Adrenalin,autoimmune disease,15,0,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
erythromycin lactobionate,hypersensitivity,313,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Bendeka,cancer (localized),8,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Aminocaproic Acid,stroke,7,0,NCCCCCC(O)=O,direct
Sitagliptin and Metformin Hydrochloride,myocardial infarction,1,0,CN(C)C(=N)NC(N)=N,fuzzy:saxagliptin and metformin hydrochloride
Amiloride Hydrochloride and Hydrochlorothiazide,significant cardiac arrhythmias,1259,1,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
nystatin,stroke,7,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
APREPITANT,pregnancy,16,0,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,direct
silodosin,chronic kidney disease,3,0,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,direct
Lidotral 3.88% Roll on,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Renvela,bowel obstruction,641,1,NCC=C.ClCC1CO1,direct
Vraylar,mental illness,14,0,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1,direct
caspofungin acetate,anemia,13,0,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
cisatracurium besylate,cancer (localized),8,0,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,direct
EVOMELA,severe infection,18,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
tafluprost,severe infection,18,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
Zilretta,stroke,7,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Procto-Med HC,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Dialyvite,hypersensitivity,313,1,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
HULIO,active psa,532,1,CC(C)O,direct
Triasil,sepsis,17,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Qbrelis,congestive heart failure,2,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Prednisolone,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Amlodipine besylate and Olmesartran medoxomil,sepsis,17,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Plasma-Lyte 148,liver disease (non-cirrhotic),20,0,[Cl-].[K+],direct
"Fluocinolone Acetonide Topical Solution USP, 0.01%",hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
PREDNISOLONE,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
CARBAMAZEPINE ER,sepsis,17,0,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Ketorocaine L Kit,anemia,13,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
aspirin-dipyridamole,congestive heart failure,2,0,CC(=O)OC1=CC=CC=C1C(O)=O,direct
CARBOplatin,normal baseline values,1059,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Bacitracin,myocardial infarction,1,0,CC[C@H](C)[C@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC,direct
Methylphenidate Hydrochloride,severe infection,18,0,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
XELJANZ,diabetes at baseline,772,1,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,direct
Paricalcitol,chronic kidney disease,3,0,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1)[C@H](C)\C=C\[C@H](C)C(C)(C)O,direct
Bupivacaine Hydrochloride and Epinephrine,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Olmesartan Medoxomil and Hydrochlorothiazide,hypertension,11,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Foltamin,congestive heart failure,2,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Provigil,cancer (metastatic),9,0,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,direct
Guanfacine Hydrochloride,autoimmune disease,15,0,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,direct
zoledronic acid,the following conditions,1301,1,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
DDAVP,cancer (metastatic),9,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
Rubraca,thrombocytopenia,79,1,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,direct
Omidria,hypersensitivity,313,1,CNC[C@H](O)C1=CC(O)=CC=C1,direct
Multaq,af or afl,576,1,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,direct
"Betamethasone Dipropionate USP, 0.05%",AIDS,10,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Tilia Fe,renal failure,19,0,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],direct
ASPRUZYO SPRINKLE,chronic angina,684,1,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,direct
Humira,polyarticular jia who,1137,1,CC(C)O,direct
Sulfamethoxazole and Trimethoprim,hypersensitivity,313,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
LURASIDONE HYDROCHLORIDE,cancer (metastatic),9,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Zestoretic,edema,417,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Gastrografin,chronic obstructive pulmonary disease (COPD),6,0,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Deferiprone,thalassemia syndromes,1293,1,CN1C=CC(=O)C(O)=C1C,direct
QUININE SULFATE,sepsis,17,0,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12,direct
LIDOCAINE,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
SORILUX,known hypercalcemia,950,1,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
ASMANEX HFA,hypertension,11,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Trileptal,insomnia,441,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
ABILIFY MAINTENA,congestive heart failure,2,0,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
prednisone,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Nystatin Cream,hypersensitivity,313,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE",pregnancy,16,0,CC(N)CC1=CC=CC=C1,direct
Prenatryl,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
TUKYSA,asthma,12,0,CC1=CC(NC2=NC=NC3=CC=C(NC4=NC(C)(C)CO4)C=C23)=CC=C1OC1=CC2=NC=NN2C=C1,direct
Fluphenazine hydrochloride,mental retardation,993,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Diltiazem HCl CD,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Spironolactone and Hydrochlorothiazide,asthma,12,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
GUANFACINE HYDROCHLORIDE,hypersensitivity,313,1,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,direct
SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE),liver cirrhosis,4,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
FENOFIBRATE,congestive heart failure,2,0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
Zingo,chronic kidney disease,3,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
RYDAPT,advanced sm,571,1,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O)N(C)C(=O)C1=CC=CC=C1,direct
Irinotecan Hydrochloride 100 mg/5 mL,hypersensitivity,313,1,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
DAPTOMYCIN,prosthetic valve endocarditis,1186,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
Bortezomib,mantle cell lymphoma,983,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
DRONABINOL,renal failure,19,0,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,direct
AMLODIPINE and OLMESARTAN medoxomil,hypertension,39,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Quinidine Gluconate,mental illness,14,0,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
Argatroban,chronic obstructive pulmonary disease (COPD),6,0,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2,direct
Fluorescein,anemia,13,0,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
Icosapent ethyl,pancreatitis,233,1,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Zingo,anemia,13,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Epinephrine,hypotension,75,1,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
AMITRIPTYLINE HYDROCHLORIDE,cancer (metastatic),9,0,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
CLONAZEPAM,liver disease (non-cirrhotic),20,0,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,direct
Dihydroergotamine mesylate,liver cirrhosis,4,0,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
albuterol sulfate,liver disease (non-cirrhotic),20,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
SAPHRIS,mental illness,14,0,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
Perphenazine and Amitriptyline Hydrochloride,congestive heart failure,2,0,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
tramadol hydrochloride,depression,27,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
LEUKERAN,leukemia,267,1,OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl,direct
Carbamazepine ER,depression,27,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
imatinib mesylate,stroke,7,0,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
METHOCARBAMOL,sepsis,17,0,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
PHENERGAN,bone-marrow depression,639,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
hydrocortisone,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Dofetilide 0.125mg,congestive heart failure,2,0,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Niferex,chronic kidney disease,3,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Lurasidone hydrochloride,hypertension,11,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Icosapent,pancreatitis,233,1,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,direct
Effer-K 20 mEq Unflavored,hyperkalemia,131,1,[K+].OC([O-])=O,direct
Clonazepam,the following conditions,1301,1,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,direct
Oxaliplatin,sepsis,17,0,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,direct
Cotellic,histiocytic neoplasms,868,1,OC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)[C@@H]1CCCCN1,direct
Imiquimod,xeroderma pigmentosum,1366,1,CC(C)CN1C=NC2=C1C1=C(C=CC=C1)N=C2N,direct
LENALIDOMIDE,congestive heart failure,2,0,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
Nystatin Topical Powder,cancer (metastatic),9,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
DESIPRAMINE HYDROCHLORIDE,impaired renal function,919,1,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Theophylline (Anhydrous),liver cirrhosis,4,0,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Signifor LAR,chronic kidney disease,3,0,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,direct
ALVAIZ,pediatric patients,13,1,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,direct
Ferric Citrate,iron deficiency,405,1,O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,direct
Reclast,underlying risk factors,1340,1,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
PROCAINAMIDE HCI,liver disease (non-cirrhotic),20,0,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
Trandolapril,edema,417,1,[H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC3=CC=CC=C3)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,direct
MB CAPS,pregnancy,16,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,fuzzy:pm caps
METHOTREXATE,non-hodgkin lymphoma,1043,1,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
Sucralfate,autoimmune disease,15,0,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,direct
PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release,pregnancy,16,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,fuzzy:pantoprazole sodium delayed-release delayed-release
Fareston,hypersensitivity,313,1,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,direct
NATEGLINIDE,sepsis,17,0,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,direct
PROCYSBI,renal failure,19,0,NCCS,direct
Cyclopentolate Hydrochloride,severe infection,18,0,CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1,direct
LAMOTRIGINE Kit,cancer (localized),8,0,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
Methylphenidate,AIDS,10,0,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
Linezolid,asthma,12,0,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,direct
Atovaquone and Proguanil Hydrochloride Pediatric,stroke,7,0,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,direct
Rinvoq,congestive heart failure,2,0,CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F,direct
ONDANSETRON,sepsis,17,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Carvedilol,shock,419,1,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
Raloxifene Hydrochloride,an intact uterus,591,1,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,direct
Body Wash,renal failure,257,1,OC(=O)C1=CC=CC=C1O,direct
Doxorubicin Hydrochloride Liposome,multiple myeloma,1024,1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
ADAPALENE AND BENZOYL PEROXIDE,liver disease (non-cirrhotic),20,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Vyvanse,anemia,13,0,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
Capecitabine 150mg,hypersensitivity,313,1,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
Methylphenidate HCl,asthma,12,0,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
Dextrose And Sodium Chloride,cancer (metastatic),9,0,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C=O,direct
clobetasol propionate,hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Rivastigmine Transdermal System,mental illness,14,0,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,direct
BETAPACE,arrhythmia,43,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Marinol,cancer (localized),8,0,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,direct
Propranolol Hydrochloride ER,hypersensitivity,313,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
LORAZEPAM,severe infection,18,0,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,direct
SUPRANE,stroke,7,0,FC(F)OC(F)C(F)(F)F,direct
Alendronate Sodium,the following conditions,1301,1,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Pryidostigmine Bromide,asthma,193,1,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Nitrofurantoin Monohydrate/ Macrocrystalline,hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
TRIAMCINOLONE ACETONIDE,cerebral malaria,674,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
LIDOCAINE HCl,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
BETAPACE,life-threatening ventricular arrhythmias,966,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Niacin,primary hyperlipidemia,1175,1,OC(=O)C1=CN=CC=C1,direct
ProAir RespiClick,anemia,13,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
RISEDRONATE SODIUM,the following conditions,1301,1,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
LIDOCAINE HCI AND DEXTROSE,hypertension,11,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
BENDAMUSTINE HYDROCHLORIDE,anemia,13,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
OSELTAMIVIR,pregnancy,16,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
Methylprednisolone,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,congestive heart failure,2,0,CC(=O)NC1=CC=C(O)C=C1,direct
Clobetasol Propionate,congestive heart failure,2,0,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Methocarbamol,renal impairment,1211,1,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
MD GASTROVIEW,hypersensitivity,313,1,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Alcaine,asthma,12,0,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,direct
E.E.S 400,pregnancy,16,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Pyridostigmine Bromide,renal failure,19,0,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
"Adenosine Injection, 6mg/2mL (3mg/mL) Vial",anemia,13,0,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
INDERAL LA,chronic obstructive pulmonary disease (COPD),6,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Caspofungin Acetate,anemia,13,0,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
CINACALCET,ckd who,716,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
ATACAND HCT,such a history,1277,1,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1,direct
ProAir Digihaler,liver cirrhosis,4,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
"Butalbital, Acetaminophen and Caffeine",asthma,12,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Simvastatin,myocardial infarction,1,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Coreg,shock,419,1,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
Rectiv,cancer (metastatic),9,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
CORTEF,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Bendeka,anemia,13,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Serostim,hypersensitivity,313,1,O,direct
Stendra,hypersensitivity,313,1,COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1,direct
Clomipramine HCl,depressive symptoms,769,1,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
Lidocaine HCl - Hydrocortisone Acetate with Aloe,diabetes mellitus,5,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Calcipotriene,stroke,7,0,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
carisoprodol,autoimmune disease,15,0,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
Doxycycline,sepsis,17,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
TIADYLT ER,severe infection,18,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
XYLOCAINE MPF,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
COSOPT PF,stroke,7,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
VENTOLIN HFA,liver cirrhosis,4,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
azithromycin,myocardial infarction,1,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
DISOPYRAMIDE PHOSPHATE,arrhythmia,43,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
Voltaren,stroke,7,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Montelukast,pregnancy,16,0,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
Diclofenac Sodium Delayed Release,chronic kidney disease,3,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Cefprozil,AIDS,10,0,[H][C@]12SCC(C=CC)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
cyanocobalamin,pernicious anemia who,1117,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Migranow,severe hepatic impairment,1245,1,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,direct
Biltricide,renal failure,19,0,O=C(C1CCCCC1)N1CC2N(CCC3=CC=CC=C23)C(=O)C1,direct
dihydroergotamine mesylate,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
OMEPRAZOLE,liver cirrhosis,4,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
FLUOCINONIDE,AIDS,10,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,direct
Brexpiprazole,asthma,12,0,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,direct
NRG Hemo-Stat,renal failure,19,0,Cl[Al](Cl)Cl,direct
bortezomib,thrombocytopenia,79,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
VYTORIN,myocardial infarction,49,1,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Flecainide Acetate,stroke,7,0,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1,direct
TESTOSTERONE CYPIONATE,uncontrolled hypertension,1337,1,[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
potassium chloride,chronic kidney disease,3,0,[Cl-].[K+],direct
Daptomycin in Sodium Chloride,left-sided infective endocarditis,962,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
Phenohytro,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
SULFATRIM,thrombocytopenia,79,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Albuterol Sulfate,pregnancy,16,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Adalimumab-adbm,polyarticular jia who,1137,1,CC(C)O,direct
Nifedipine ER,mental illness,14,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Sorafenib,myocardial infarction,1,0,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
Cefaclor,tics,23,1,[H][C@]12SCC(Cl)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
MLK F3 Kit,cancer (metastatic),9,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
rifampin,compromised adrenal function,737,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
CARVEDILOL,shock,419,1,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
DESOXIMETASONE,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
venlafaxine,hypertension,11,0,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
Cartia XT,myocardial infarction,1,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Brexpiprazole,hypersensitivity,313,1,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,direct
VIDAZA,chronic kidney disease,3,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Lidocaine Hydrochloride,asthma,12,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Amantadine Hydrochloride,hypertension,11,0,NC12CC3CC(CC(C3)C1)C2,direct
"amlodipine,valsartan and hydrochlorothiazide",autoimmune disease,15,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,"fuzzy:amlodipine, valsartan and hydrochlorothiazide"
tafluprost,cancer (metastatic),9,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
ATENOLOL,untreated pheochromocytoma,1345,1,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,direct
Pioglitazone,anemia,13,0,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
Emtricitabine,pregnancy,16,0,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,direct
ERYTHROMYCIN,asthma,12,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Actos,hypersensitivity,313,1,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
Ventrixyl,AIDS,10,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
DASATINIB,chronic phase cml,701,1,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
ZOLINZA,diabetes mellitus,5,0,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,direct
Itraconazole,autoimmune disease,15,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Dialyvite Supreme D,hypersensitivity,313,1,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Nardil,anemia,13,0,NNCCC1=CC=CC=C1,direct
LumaSon,anemia,13,0,FS(F)(F)(F)(F)F,direct
Benazepril Hydrochloride and Hydrochlorothiazide,hypersensitivity,313,1,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,direct
PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE,acute abdominal conditions,537,1,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,direct
LIDOCAINE HCl and EPINEPHRINE,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Tegretol,depression,27,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Fluphenazine Hydrochoride,psychosis,31,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,fuzzy:fluphenazine hydrochloride
DIGOXIN,congestive heart failure,2,0,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,direct
FENOFIBRATE,severe hypertriglyceridemia,1247,1,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Solution,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
IBU,the aspirin triad,1295,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Otrexup,AIDS,10,0,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
Ibutilide Fumarate,autoimmune disease,15,0,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Nexavar,stroke,7,0,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
PROCAINAMIDE HYDROCHLORIDE,heart block,59,1,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
Betamethasone Valerate,liver disease (non-cirrhotic),20,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
PROCTOFOAM HC,hypersensitivity,313,1,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Nexavar,hypersensitivity,313,1,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
Enalapril Maleate,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
Normosol-R and Dextrose,sepsis,17,0,[Cl-].[K+],direct
Nicotrol,sepsis,17,0,CN1CCC[C@H]1C1=CN=CC=C1,direct
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE,coronary artery disease,37,1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3,direct
LIDOCAINE HCI AND DEXTROSE,mental illness,14,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Ambien,asthma,12,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
HALOG,hypersensitivity,313,1,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
DESMOPRESSIN ACETATE,autoimmune disease,15,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
Nyamyc,diabetes mellitus,5,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
CISPLATIN,hearing impairment,848,1,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
Isosorbide dinitrate and hydralazine hydrochloride,liver cirrhosis,4,0,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
EVEROLIMUS,sega and tsc,1225,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,direct
MD GASTROVIEW,myocardial infarction,1,0,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Sular,hypersensitivity,313,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C,direct
OSELTAMIVIR,chronic obstructive pulmonary disease (COPD),6,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
Irbesartan,anemia,13,0,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
Lenvima,myocardial infarction,1,0,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,direct
Solu-Cortef,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
butalbital and acetaminophen,autoimmune disease,15,0,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,direct
Epitol,depression,27,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Lipofen,severe hypertriglyceridemia,1247,1,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
Sevelamer Carbonate,chronic kidney disease,3,0,NCC=C.ClCC1CO1,direct
PROCAINAMIDE HCI,ventricular arrhythmias,1354,1,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
TREANDA,asthma,12,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Chlordiazepoxide hydrochloride and clidinium bromide,glaucoma,481,1,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Venlafaxine hydrochloride,depressive symptoms,769,1,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
Finasteride,autoimmune disease,15,0,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,direct
bendamustine hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Benicar HCT,diabetes mellitus,5,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
IHEEZO,hypersensitivity,313,1,CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1,direct
TARGADOX,pregnancy,16,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Dexamethasone 1.5 mg,renal failure,19,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
dexamethasone,cerebral malaria,674,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
TEMODAR,mental illness,14,0,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
Tikosyn,long qt syndrome,61,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
PHENYLEPHRINE HYDROCHLORIDE,thyrotoxicosis,113,1,CNC[C@H](O)C1=CC(O)=CC=C1,direct
Protriptyline Hydrochloride,depressive symptoms,769,1,CNCCCC1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
VARENICLINE TARTRATE,diabetes mellitus,5,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Dyanavel XR,pediatric patients,13,1,CC(N)CC1=CC=CC=C1,direct
ZYPITAMAG,diabetes mellitus,5,0,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
Ezetimibe and Simvastatin,chronic kidney disease,3,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Halog,hypersensitivity,313,1,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Celecoxib,severe infection,18,0,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
DEXAMETHASONE SODIUM PHOSPHATE,cerebral malaria,674,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Risperidone,bipolar mania,634,1,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,direct
ITRACONAZOLE,AIDS,10,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
TIGAN(R) (TRIMETHOBENZAMIDE HYDROCHLORIDE),chronic obstructive pulmonary disease (COPD),6,0,COC1=CC(=CC(OC)=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1,direct
XYOSTED,asthma,12,0,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
FLAVOXATE HYDROCHLORIDE,chronic kidney disease,3,0,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,direct
pemetrexed,mpm who,1020,1,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
LEVETIRACETAM,partial seizures,1104,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
Diovan,pregnancy,16,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Albuterol sulfate,anemia,13,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Melphalan hydrochloride,renal damage,1210,1,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
TRANEXAMIC ACID IN SODIUM CHLORIDE,chronic obstructive pulmonary disease (COPD),6,0,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Avalide,congestive heart failure,2,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
deferasirox,congestive heart failure,2,0,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Venlafaxine Hydrochloride,depressive symptoms,769,1,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
Timolol GFS,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Benzphetamine Hydrochloride,severe infection,18,0,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,direct
CARBAMAZEPINE ER,symptomatic hyponatremia,1286,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Gleevec,thrombocytopenia,79,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Actonel,sepsis,17,0,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
Denti-Care Denti-Rinse Neutral Sodium Fluoride Oral Rinse,myocardial infarction,1,0,[F-].[Na+],direct
SOLU-MEDROL,AIDS,10,0,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Galantamine,asthma,12,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
Carnitor SF,bronchospasm,197,1,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
GALZIN,mental illness,14,0,[Zn++].CC([O-])=O.CC([O-])=O,direct
Quinidine Sulfate,pregnancy,16,0,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
Diltiazem Hydrochloride Extended-Release,AIDS,10,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Erythromycin Ethylsuccinate,hypersensitivity,313,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
RAMELTEON,stroke,7,0,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,direct
REZZAYO,asthma,12,0,[H][C@](C)(O)[C@]1([H])\N=C(O)/[C@]([H])(C[C@@]([H])(O)[C@@]([H])(OCC[N+](C)(C)C)\N=C(O)/[C@@]2([H])N(C[C@]([H])(C)[C@]2([H])O)C(=O)[C@@]([H])(\N=C(O)/[C@@]([H])(\N=C(O)/[C@]2([H])C[C@@]([H])(O)CN2C1=O)[C@]([H])(O)[C@@]([H])(O)C1=CC=C(O)C=C1)[C@@]([H])(C)O)\N=C(/O)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CC=C(OCCCCC)C=C1,direct
Cephalexin,hypersensitivity,313,1,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
VABOMERE,baseline bacteremia,628,1,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
DermacinRx Lidotral,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
DICLOFENAC SODIUM,anemia,13,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Sodium Phenylacetate and Sodium Benzoate,stroke,7,0,OC(=O)C1=CC=CC=C1,direct
Mifepristone,liver cirrhosis,4,0,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],direct
TAZVERIK,follicular lymphoma,817,1,CCN(C1CCOCC1)C1=C(C)C(=CC(=C1)C1=CC=C(CN2CCOCC2)C=C1)C(=O)NCC1=C(C)C=C(C)NC1=O,direct
VENTOLIN HFA,hypersensitivity,313,1,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Ziac,impaired renal function,919,1,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,direct
LumaSon,mental illness,14,0,FS(F)(F)(F)(F)F,direct
Kitabis Pak,chronic obstructive pulmonary disease (COPD),6,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
CALCITRIOL,AIDS,10,0,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,direct
Ferric Citrate,sepsis,17,0,O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,direct
Prochlorperazine,psychosis,31,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Enalaprilat,diabetes mellitus,5,0,[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@@]1([H])C(O)=O,direct
bupropion hydrochloride,bulimia,401,1,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
DILTIAZEM HCI,supraventricular arrhythmias,1280,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
ELEPSIA XR 1000 MG,diabetes mellitus,5,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Pravastatin Sodium,atherosclerosis,357,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Actonel,pregnancy,16,0,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release",stroke,7,0,CC(N)CC1=CC=CC=C1,direct
Diltiazem Hydrochloride Extended-Release,hypersensitivity,313,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Dofetilide,mental illness,14,0,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Bupivilog Kit,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Tazarotene,plaque psoriasis,1128,1,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,direct
BUTALBITAL AND ACETAMINOPHEN,acetaminophen allergy,513,1,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,direct
"Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride",cancer (localized),8,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
Azasan,leukemia,267,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Vyalev,severe infection,18,0,C[C@@](CC1=CC=C(OP(O)(O)=O)C(O)=C1)(NN)C(O)=O,direct
QUVIVIQ,autoimmune disease,15,0,COC1=CC(C(=O)N2CCC[C@@]2(C)C2=NC3=C(N2)C=CC(Cl)=C3C)=C(C=C1)N1N=CC=N1,direct
Lamotrigine,stroke,7,0,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
DEXAMETHASONE SODIUM PHOSPHATE,tuberculosis,213,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
lisinopril,mental illness,14,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
CARTIA XT,hypotension,75,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
HYDROXYCHLOROQUINE SULFATE,autoimmune disease,15,0,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
Aminophylline,diabetes mellitus,5,0,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Cyclomydril,anemia,13,0,CNC[C@H](O)C1=CC(O)=CC=C1,direct
Nifedipine ER,aortic stenosis,55,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
CitraNatal Medley,hypersensitivity,313,1,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Mesalamine,impaired renal function,919,1,NC1=CC(C(O)=O)=C(O)C=C1,direct
tizanidine hydrochloride,chronic kidney disease,3,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Pemetrexed,diabetes mellitus,5,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE,liver disease (non-cirrhotic),20,0,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],direct
ProHance,chronic kidney disease,3,0,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,direct
Radiaura Skin Recovery,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
TUKYSA,breast cancer,263,1,CC1=CC(NC2=NC=NC3=CC=C(NC4=NC(C)(C)CO4)C=C23)=CC=C1OC1=CC2=NC=NN2C=C1,direct
HYDROCHLOROTHIAZIDE,imparied renal function,922,1,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Lisinopril and Hydrochlorothiazide,mental illness,14,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Dichlorphenamide,stroke,7,0,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O,direct
ONDANSETRON,liver failure,371,1,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
MIDAZOLAM,cardiovascular instability,670,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Desflurane,hyperthermia,423,1,FC(F)OC(F)C(F)(F)F,direct
Vasotec,chronic obstructive pulmonary disease (COPD),6,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
Oseltamivir phosphate,hypersensitivity,313,1,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
Sodium phenylacetate and Sodium benzoate,liver cirrhosis,4,0,OC(=O)C1=CC=CC=C1,direct
foscarnet sodium,hypersensitivity,313,1,OC(=O)P(O)(O)=O,direct
Tretinoin,hypertension,11,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
Nalbuphine hydrochloride,hypertension,11,0,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
BIMATOPROST,pregnancy,16,0,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
PIOGLITAZONE HYDROCHLORIDE,hypersensitivity,313,1,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
METOLAZONE,cancer (metastatic),9,0,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,direct
Prasugrel,acs undergoing pci,519,1,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,direct
Tolcapone,renal failure,19,0,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,direct
Granisetron Hydrochloride,hypersensitivity,313,1,CN1N=C(C(=O)N[C@@H]2C[C@@H]3CCC[C@H](C2)N3C)C2=C1C=CC=C2,direct
VENLAFAXINE,anemia,13,0,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
PENTAMIDINE ISETHIONATE,cancer (localized),8,0,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
sorafenib,hypersensitivity,313,1,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
Xatmep,non-malignant diseases,1048,1,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
Bendeka,chronic lymphocytic leukemia,693,1,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Icosapent Ethyl,pancreatitis,233,1,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Effient,stroke,51,1,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,direct
AVYCAZ,anemia,81,1,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
CARMUSTINE,myocardial infarction,1,0,ClCCNC(=O)N(CCCl)N=O,direct
Pyrimethamine,liver disease (non-cirrhotic),20,0,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1,direct
Lactated Ringers,pregnancy,16,0,[Cl-].[K+],direct
METHSCOPOLAMINE BROMIDE,stroke,7,0,[Br-].[H][C@@]12O[C@]1([H])[C@H]1C[C@H](C[C@@H]2[N+]1(C)C)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
VANCOMYCIN HYDROCHLORIDE,hypersensitivity,313,1,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
gemcitabine,various malignancies,1350,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
GADOTERIDOL,hypertension,11,0,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,direct
Mexiletine hydrochloride,arrhythmia,43,1,CC(N)COC1=C(C)C=CC=C1C,direct
TIAGABINE HYDROCHLORIDE,stroke,7,0,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1,direct
Lamivudine,hypersensitivity,313,1,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,direct
metolazone,hypertension,39,1,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,direct
Dofetilide 0.125mg,long qt syndrome,61,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Galantamine hydrobromide,diabetes mellitus,5,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
Dexamethasone Intensol,liver disease (non-cirrhotic),20,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
dasatinib,myocardial infarction,1,0,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
Norepinephrine,acute hypotensive states,540,1,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
zolpidem tartrate,hypertension,11,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
"Omeprazole, Sodium bicarbonate",renal failure,19,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Regadenoson,liver cirrhosis,4,0,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
Nexavar,rcc or hcc,1198,1,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
Cadira Compliant Blood Stat,stroke,7,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
DROXIA,anemia,81,1,NC(=O)NO,direct
Hydrocodone Bitartrate And Acetaminophen,acetaminophen allergy,513,1,CC(=O)NC1=CC=C(O)C=C1,direct
Paclitaxel protein-bound particles,anemia,13,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
citalopram hydrobromide,depressive symptoms,769,1,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
Quinapril and Hydrochlorothiazide,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Lisdexamfetamine Dimesylate,cancer (metastatic),9,0,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
RIFAMPIN,impaired liver function,918,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
Methylprednisolone Acetate,renal failure,19,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
TARCEVA,diabetes mellitus,5,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
PROMETHAZINE DM,liver cirrhosis,4,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Temozolomide,renal failure,19,0,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
ProAir Digihaler,anemia,13,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Sertraline,severe infection,18,0,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,direct
Indomethacin ER,stroke,7,0,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,direct
Claravis,autoimmune disease,15,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
PROCTOZONE-HC,liver cirrhosis,4,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
METHYLPREDNISOLONE,stroke,7,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
FAMCICLOVIR,recurrent genital herpes,1201,1,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O,direct
DASATINIB,sepsis,17,0,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
Proctosol-HC,hypertension,11,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
IBANDRONATE SODIUM,the following conditions,1301,1,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Cetirizine Hydrochloride,hypersensitivity,313,1,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Sensipar,ckd who,716,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
cytarabine,bone marrow suppression,101,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,direct
Dextrose and Electrolyte No. 48,chronic obstructive pulmonary disease (COPD),6,0,[Cl-].[K+],direct
Mozobil,insomnia,441,1,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
Tobramycin,asthma,12,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Ambien,autoimmune disease,15,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
FLUCONAZOLE,serious underlying diseases,1232,1,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
"Butalbital, Acetaminophen and Caffeine",acetaminophen allergy,513,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Hyoscyamine Sulfate SL,chronic obstructive pulmonary disease (COPD),6,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Lidolog Kit,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Zolpidem Tartrate Extended-Release,insomnia,441,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Trihexyphenidyl Hydrochloride,hypersensitivity,313,1,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1,direct
Lansoprazole,hypersensitivity,313,1,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Fentanyl Buccal,breakthrough pain,649,1,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,sepsis,17,0,CC(=O)NC1=CC=C(O)C=C1,direct
Cyklokapron,liver cirrhosis,4,0,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Kit for the Prepartion of Technetium Tc99m Sulfur Colloid,melanoma,273,1,[99Tc].S1SSSSSSS1,direct
Paclitaxel,solid tumors,1264,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Rifampin,impaired liver function,918,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
Betaxolol Hydrochloride,shock,419,1,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
Metoprolol tartrate,coronary artery disease,37,1,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
Propafenone Hydrochloride,stroke,7,0,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,direct
Minoxidil,myocardial infarction,1,0,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1,direct
Hydrocortisone Valerate,pregnancy,16,0,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Strovite One Caplets,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Pantoprazole,hypertension,11,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Dalfampridine,liver cirrhosis,4,0,NC1=CC=NC=C1,direct
CARMUSTINE,diabetes mellitus,5,0,ClCCNC(=O)N(CCCl)N=O,direct
Fluconazole,vaginal candidiasis,1349,1,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
ZIPSOR,hypersensitivity,313,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Thiothixene,dementia,7,1,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1,direct
Nebivolol,hypertension,39,1,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
pravastatin sodium,liver cirrhosis,4,0,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution,asthma,12,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
zolpidem tartrate,diabetes mellitus,5,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
simvastatin,homozygous familial hypercholesterolemia,872,1,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Loperamide Hydrochloride,acute diarrhea,538,1,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Azor,mental illness,14,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
CLOMID,normal liver function,1063,1,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
Carisoprodol,hypersensitivity,313,1,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
CASPOFUNGIN ACETATE,invasive aspergillosis,944,1,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
"Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride",chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
Vitafol Ultra,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
ELIGARD,diabetes mellitus,5,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
IMURAN,ra appears to,1196,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Doxepin HCL,severe infection,18,0,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
Icosapent ethyl,renal failure,19,0,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Nifedipine,aortic stenosis,55,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Morphine Sulfate,pregnancy,16,0,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,direct
topotecan hydrochloride,cervical cancer,676,1,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
Simvastatin,renal failure,19,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Sitagliptin and Metformin Hydrochloride,cancer (metastatic),9,0,CN(C)C(=N)NC(N)=N,fuzzy:saxagliptin and metformin hydrochloride
LEFLUNOMIDE,liver cirrhosis,4,0,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
Oxycodone and Aspirin,chronic urticaria,708,1,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C,direct
Sotalol Hydrochloride,ventricular arrhythmias,1354,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Lamotrigine,partial seizures who,1105,1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
hydrochlorothiazide,chronic obstructive pulmonary disease (COPD),6,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Suprane,renal failure,19,0,FC(F)OC(F)C(F)(F)F,direct
Metyrosine,pheochromocytoma for,1125,1,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,direct
Lidocaine Hydrochloride,cancer (localized),8,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
SUNOSI,liver cirrhosis,4,0,N[C@@H](COC(N)=O)CC1=CC=CC=C1,direct
Avanafil,hypersensitivity,313,1,COC1=C(Cl)C=C(CNC2=C(C=NC(=N2)N2CCC[C@H]2CO)C(=O)NCC2=NC=CC=N2)C=C1,direct
epiduo forte,cancer (metastatic),9,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Mepivacaine,tics,23,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
ESTRADIOL VALERATE,stroke,7,0,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Labetalol HCL,congestive heart failure,41,1,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Dyural L Kit,congestive heart failure,2,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
memantine hydrochloride,liver disease (non-cirrhotic),20,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
temozolomide,congestive heart failure,2,0,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
Orbactiv,renal failure,19,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
haloperidol,psychosis,31,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Tetracaine,chronic kidney disease,3,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
Hepzato Kit,sepsis,17,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Visudyne,anemia,13,0,COC(=O)CCC1=C2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(CCC(O)=O)=C5C)C(C=C)=C4C)C2=CC=C([C@@H](C(=O)OC)[C@@]32C)C(=O)OC)=C1C,direct
ZOLPIDEM TARTRATE,chronic insomnia who,690,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
linezolid,pediatric patients,13,1,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,direct
Diltiazem Hydrochloride Extended-Release,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Iluvien,pregnancy,16,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
SINGULAIR,cancer (localized),8,0,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
Lisinopril,hypertension,39,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Nisoldipine,renal failure,19,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C,direct
ZEGERID,liver cirrhosis,4,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Ertapenem,hypersensitivity,313,1,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Alimta,anemia,13,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
diflunisal,hypertension,11,0,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,direct
Nicardipine Hydrochloride,advanced aortic stenosis,559,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
BUSULFEX,renal failure,19,0,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
Actos,pregnancy,16,0,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
Nulibry,congestive heart failure,2,0,[H][C@@]12COP(O)(=O)O[C@]1([H])C(O)(O)[C@]1([H])NC3=C(NC(N)=NC3=O)N[C@]1([H])O2,direct
PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE,asthma,12,0,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,direct
Acetaminophen and Codeine Phosphate,acetaminophen allergy,513,1,CC(=O)NC1=CC=C(O)C=C1,direct
Fensolvi,liver disease (non-cirrhotic),20,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Itraconazole,renal failure,19,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
metoclopramide hydrochloride,documented lesions,784,1,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,direct
FLUOCINOLONE ACETONIDE,stroke,7,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
BENDAMUSTINE HYDROCHLORIDE,chronic lymphocytic leukemia,693,1,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Ferric Citrate,cancer (localized),8,0,O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,direct
"butalbital, aspirin, and caffeine",renal failure,19,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
DORZOLAMIDE HYDROCHLORIDE,myocardial infarction,1,0,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
AK-FLUOR,hypersensitivity,313,1,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
"Testosterone Gel, 1%",chronic kidney disease,3,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Venexa,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Hyronan,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ENALAPRILAT,autoimmune disease,15,0,[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@@]1([H])C(O)=O,direct
VYXEOS,liver disease (non-cirrhotic),20,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,direct
bupivacaine hydrochloride,anemia,13,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
DESMOPRESSIN ACETATE,sepsis,17,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
SPRYCEL,chronic phase cml,701,1,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
Sotalol Hydrochloride,arrhythmia,43,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
TAVNEOS,severe infection,18,0,CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C2=CC=C(NC3CCCC3)C=C2)C(=O)C2=C(F)C=CC=C2C)C=C1C(F)(F)F,direct
Tasigna,cml-cp and cml-ap,730,1,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,direct
Sotalol,ventricular arrhythmias are,1355,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
XELSTRYM,chronic obstructive pulmonary disease (COPD),6,0,C[C@H](N)CC1=CC=CC=C1,direct
valsartan,sepsis,17,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Nitrofurantoin Mono,liver cirrhosis,4,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
DOBUTAMINE HYDROCHLORIDE,anemia,13,0,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
LAMIVUDINE and ZIDOVUDINE,severe infection,18,0,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
"Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate",autoimmune disease,15,0,[Mg++].[O-]S([O-])(=O)=O,direct
Chemet,myocardial infarction,1,0,OC(=O)[C@@H](S)[C@@H](S)C(O)=O,direct
PHENDIMETRAZINE TARTRATE,autoimmune disease,15,0,C[C@H]1[C@@H](OCCN1C)C1=CC=CC=C1,direct
Vitramyn,myocardial infarction,1,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
LISDEXAMFETAMINE DIMESYLATE,myocardial infarction,1,0,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
RIFAMPIN,liver cirrhosis,4,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
Ranexa,cancer (metastatic),9,0,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,direct
Hydromorphone Hydrochloride,acute abdominal conditions,537,1,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O,direct
Amitriptyline HCL,cardiovascular disorders,669,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
ACETAMINOPHEN AND CODEINE,myocardial infarction,1,0,CC(=O)NC1=CC=C(O)C=C1,direct
CHLORTHALIDONE CHLORTHALIDONE,renal failure,19,0,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Fioricet,liver disease (non-cirrhotic),20,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
voriconazole,diabetes mellitus,5,0,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
"Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide",ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Cleviprex,myocardial infarction,1,0,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,direct
ezetimibe and simvastatin,anemia,13,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Neomycin and Polymyxin B Sulfates,asthma,12,0,[H][C@]1(NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CCN)NC(=O)[C@H](CCNC1=O)NC(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)CCCCC(C)CC)[C@@H](C)O)[C@@H](C)O,direct
Erythromycin Lactobionate,stroke,7,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Davimet-M,AIDS,10,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
URIMAR-T CAPS,severe infection,18,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Tetracaine HCL,liver disease (non-cirrhotic),20,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
SOLTAMOX,autoimmune disease,15,0,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,direct
Humira,active psoriatic arthritis,533,1,CC(C)O,direct
Esomeprazole Magnesium DR,hypersensitivity,313,1,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Norepinephrine,liver disease (non-cirrhotic),20,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Spironolactone and Hydrochlorothiazide,cancer (metastatic),9,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
FLUOCINONIDE,diabetes mellitus,5,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,direct
Promethazine with Codeine,bone marrow depression,637,1,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,direct
Denavir,chronic obstructive pulmonary disease (COPD),6,0,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,direct
Progesterone,hypersensitivity,313,1,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Nexletol,AIDS,10,0,CC(C)(CCCCCC(O)CCCCCC(C)(C)C(O)=O)C(O)=O,direct
Niferex,pregnancy,16,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
CARVEDILOL,renal failure,19,0,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
LURASIDONE HYDROCHLORIDE,bipolar depression,632,1,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
ARISTADA INITIO,mental illness,14,0,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12,direct
Prolate,congestive heart failure,2,0,CC(=O)NC1=CC=C(O)C=C1,direct
Nitroglycerin Transdermal Infusion System,congestive heart failure,41,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
HYALURONIDASE,stroke,7,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Nefazodone Hydrochloride,depressive symptoms,769,1,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,direct
Clomiphene Citrate,hypersensitivity,313,1,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
hydrochlorothiazide,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Cyclosporine,pregnancy,16,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Rosuvastatin Calcium,cancer (localized),8,0,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Paricalcitol,mental illness,14,0,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1)[C@H](C)\C=C\[C@H](C)C(C)(C)O,direct
PRAVASTATIN SODIUM,primary dysbetalipoproteinemia who,1172,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Fluphenazine Hydrochloride,mental retardation,993,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
midazolam,hemodynamic instability,852,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Imiquimod,stroke,7,0,CC(C)CN1C=NC2=C1C1=C(C=CC=C1)N=C2N,direct
LAMIVUDINE and ZIDOVUDINE,myocardial infarction,1,0,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
Thiothixene,chronic kidney disease,3,0,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1,direct
Ribavirin,the following characteristics,1300,1,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
LIDOCAINE HYDROCHLORIDE,AIDS,10,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
amantadine,chronic kidney disease,3,0,NC12CC3CC(CC(C3)C1)C2,direct
Zarontin,AIDS,10,0,CCC1(C)CC(=O)NC1=O,direct
TESTOSTERONE CYPIONATE,liver cirrhosis,4,0,[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
HALOPERIDOL DECANOATE,chronic obstructive pulmonary disease (COPD),6,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
hyoscyamine sulfate,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Pentobarbital Sodium,AIDS,10,0,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,direct
GLYBURIDE,autoimmune disease,15,0,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,direct
Ala-Scalp,asthma,12,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Kitabis Pak,stroke,7,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
LABETALOL HYDROCHLORIDE,congestive heart failure,41,1,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
TRIAMCINOLONE ACETONIDE,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
PERPHENAZINE,psychosis,31,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Triloan SUIK,severe infection,18,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ERY-TAB,hypersensitivity,313,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
ACCOLATE,asthma,12,0,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,direct
SERTRALINE HYDROCHLORIDE,depressive symptoms,769,1,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,direct
Galantamine,anemia,13,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
Se-Tan PLUS,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Zoledronic acid,the following conditions,1301,1,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
ETHOSUXIMIDE,cancer (metastatic),9,0,CCC1(C)CC(=O)NC1=O,direct
Proctocort,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
BUTALBITAL AND ACETAMINOPHEN,anemia,13,0,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,direct
LATANOPROST,pregnancy,16,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Spritam,hypersensitivity,313,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
MIDAZOLAM HYDROCHLORIDE,cardiovascular instability,670,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
bortezomib,relapsed multiple myeloma,1205,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Bromocriptine Mesylate,renal failure,19,0,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
Cefazolin,congestive heart failure,2,0,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,direct
Dobutamine in Dextrose,aortic stenosis,55,1,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
omeprazole sodium bicarbonate,hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
tooth powder,congestive heart failure,2,0,[F-].[Na+],fuzzy:toothpowder
Diltiazem HCl CD,hypotension,75,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
ZIOPTAN,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
Methscopolamine Bromide,ileostomy or colostomy,910,1,[Br-].[H][C@@]12O[C@]1([H])[C@H]1C[C@H](C[C@@H]2[N+]1(C)C)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Hydrocodone Bitartrate And Acetaminophen,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
Methenamine Mandelate,liver disease (non-cirrhotic),20,0,C1N2CN3CN1CN(C2)C3,direct
Levalbuterol Inhalation Solution,hypersensitivity,313,1,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
Enalaprilat,liver disease (non-cirrhotic),20,0,[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@@]1([H])C(O)=O,direct
Enalaprilat,chronic kidney disease,3,0,[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@@]1([H])C(O)=O,direct
Lisinopril and Hydrochlorothiazide,edema,417,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
MEXILETINE HYDROCHLORIDE,arrhythmia,43,1,CC(N)COC1=C(C)C=CC=C1C,direct
Lisinopril with Hydrochlorothiazide,impaired renal function,919,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Adenosine,liver disease (non-cirrhotic),20,0,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
Nardil,depressive symptoms,769,1,NNCCC1=CC=CC=C1,direct
Nystop,renal failure,19,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
SOLU-MEDROL,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Alprazolam XR,anorexia,399,1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
captopril,hypertension,39,1,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,direct
Epidiolex,stroke,7,0,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1,direct
Amlodipine and Valsartan,chronic obstructive pulmonary disease (COPD),6,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Ranitidine Hydrochloride,chronic kidney disease,3,0,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O,direct
QUININE SULFATE,severe infection,18,0,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12,direct
2% LIDOCAINE HCI,severe infection,18,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
HUMIRA,active ankylosing spondylitis,520,1,CC(C)O,direct
Dicyclomine hydrochloride,renal failure,19,0,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,direct
Midazolam hydrochloride,stroke,7,0,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Irinotecan hydrochloide,hypersensitivity,313,1,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
Gloperba,hepatic impairment,1,1,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Positive Skin Test Control - Histamine,renal failure,19,0,NCCC1=CNC=N1,direct
DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE,liver disease (non-cirrhotic),20,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Ganciclovir,cmv retinitis,731,1,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,direct
COSELA,newly diagnosed es-sclc,1035,1,CN1CCN(CC1)C1=CN=C(NC2=NC3=C(C=C4N3C3(CCCCC3)CNC4=O)C=N2)C=C1,direct
TENORETIC,stroke,7,0,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Rosuvastatin,homozygous familial hypercholesterolemia,872,1,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Iodixanol,coronary artery disease,37,1,CC(=O)N(CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,direct
CISPLATIN,renal impairment,1211,1,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
Cromolyn Sodium Inhalation Solution,bronchial asthma,650,1,OC(COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O)COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O,direct
ARISTADA,hypersensitivity,313,1,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12,direct
GIMOTI,hypersensitivity to metoclopramide,892,1,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,direct
Nilutamide,AIDS,10,0,CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,direct
LumaSon,known or suspected,952,1,FS(F)(F)(F)(F)F,direct
ACARBOSE,renal failure,19,0,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,direct
ibandronate sodium,the following conditions,1301,1,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,direct
ChlorproMAZINE Hydrochloride,dementia-related psychos,765,1,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
"PREGABALIN capsules, CV",chronic kidney disease,3,0,CC(C)C[C@H](CN)CC(O)=O,direct
Methylphenidate HCl,psychosis,31,1,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
BRIMONIDINE TARTRATE,sepsis,17,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
LIDOCAINE HCI AND DEXTROSE,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Enalapril Maleate and Hydrochlorothiazide,renal failure,19,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
Metoclopramide,hypersensitivity to metoclopramide,892,1,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,direct
ROSUVASTATIN,asthma,12,0,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Marvona SUIK,AIDS,10,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
SALICYLIC ACID,impaired blood circulation,912,1,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,direct
haloperidol,AIDS,10,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
candesartan cilexetil and hydrochlorothiazide,mental illness,14,0,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1,direct
"AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE",hypercalcemia and hypophosphatemia,875,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
aripiprazole,hypersensitivity,313,1,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
LEUKERAN,anemia,13,0,OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl,direct
Amphotericin B,severe infection,18,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Ceftriaxone Sodium,liver cirrhosis,4,0,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
ESZOPICLONE,autoimmune disease,15,0,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,direct
Prometrium,hypersensitivity,313,1,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
EOVIST,anemia,13,0,[Gd+3].[H][C@@](CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)(CC1=CC=C(OCC)C=C1)N(CC(O)=O)CC(O)=O,direct
Diltiazem Hydrochloride EXTENDED RELEASE,myocardial infarction,49,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Timolol Maleate Ophthalmic Gel Forming Solution 0.25%,congestive heart failure,2,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
VOTRIENT,available laboratory data,623,1,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,direct
Propofol,sepsis,17,0,CC(C)C1=CC=CC(C(C)C)=C1O,direct
Nicardipine hydrochloride,hypersensitivity,313,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
ethacrynic acid,AIDS,10,0,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
TIMOLOL MALEATE,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
TRANEXAMIC ACID IN SODIUM CHLORIDE,subarachnoid hemorrhage,1275,1,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Quinine Sulfate,the following,1299,1,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12,direct
Irinotecan hydrochloide,autoimmune disease,15,0,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
Cleviprex,severe hypertension,1246,1,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,direct
Oxcarbazepine,myocardial infarction,1,0,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Abiraterone acetate,metastatic crpc who,998,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Potassium Chloride Extended-release,hyperkalemia,131,1,[Cl-].[K+],direct
Ertapenem,congestive heart failure,2,0,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Ledipasvir and Sofosbuvir,renal failure,19,0,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
Diazepam Intensol,open-angle glaucoma who,1081,1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,direct
Pregabalin,partial onset seizures,1103,1,CC(C)C[C@H](CN)CC(O)=O,direct
Disopyramide Phosphate,life-threatening arrhythmias who,964,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
Tranexamic acid,hypertension,11,0,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
FOSFOMYCIN TROMETHAMINE,AIDS,10,0,C[C@@H]1O[C@@H]1P(O)(O)=O,direct
Aridol Bronchial Challenge Test Kit,anemia,13,0,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,direct
ERTAPENEM SODIUM,liver disease (non-cirrhotic),20,0,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Bupivacaine Hydrochloride,liver disease (non-cirrhotic),20,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Promethazine Hydrochloride and Dextromethorphan Hydrobromide,depression,27,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Tetracaine Hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
PROCRIT,autoimmune disease,15,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,fuzzy:procort
Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution,severe infection,18,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Zetonna,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,direct
LEFLUNOMIDE,myocardial infarction,1,0,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
Vaseretic,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
CYCLOSPORINE,hypersensitivity,313,1,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Zolmitriptan OD,chronic kidney disease,3,0,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
CitraNatal Harmony 3.0,hypersensitivity,313,1,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
proparacaine hydrochloride,hypersensitivity,313,1,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,direct
MAGNESIUM SULFATE,chronic obstructive pulmonary disease (COPD),6,0,[Mg++].[O-]S([O-])(=O)=O,direct
Normosol-R,moderate blood loss,1015,1,[Cl-].[K+],direct
Brinzolamide,mental illness,14,0,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
K Phos Original,hypertension,11,0,[K+].OP(O)([O-])=O,direct
LANREOTIDE ACETATE,hypersensitivity,313,1,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],direct
DESOXIMETASONE,AIDS,10,0,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Carnitor,bronchospasm,197,1,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
Indomethacin,stroke,7,0,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,direct
XACIATO,diabetes mellitus,5,0,[H][C@@](NC(=O)[C@@H]1C[C@@H](CCC)CN1C)([C@H](C)Cl)[C@@]1([H])O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O,direct
Doxorubicin Hydrochloride,multiple myeloma who,1025,1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
Aridol Bronchial Challenge Test Kit,diabetes mellitus,5,0,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,direct
Levothyroxine sodium,acute myocardial infarction,545,1,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
PROGESTERONE,autoimmune disease,15,0,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Thioridazine Hydrochloride,arrhythmia,43,1,CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1,direct
dabigatran etexilate,stroke,7,0,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
Icosapent ethyl,severe hypertriglyceridemia,1247,1,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Zestril,hypertension,39,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
KLOR-CON M,myocardial infarction,1,0,[Cl-].[K+],direct
Lupron Depot-PED,pediatric patients,13,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
edaravone,hypersensitivity,313,1,CC1=NN(C(=O)C1)C1=CC=CC=C1,direct
Zolpidem,liver cirrhosis,4,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Ipratropium bromide,cancer (localized),8,0,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,direct
Erlotinib,anorexia,399,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
Chlorothiazide sodium,chronic obstructive pulmonary disease (COPD),6,0,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
Oseltamivir,autoimmune disease,15,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
Cyltezo,stroke,7,0,CC(C)O,direct
OXALIPLATIN,cancer (metastatic),9,0,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,direct
Procardia XL,tight aortic stenosis,1320,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Nitrostat,liver cirrhosis,4,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Esterified Estrogens and Methyltestosterone,AIDS,10,0,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3,direct
PNV-Select,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Ery-Ped,autoimmune disease,15,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
CANCIDAS,concomitant opc,742,1,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
Nortriptyline Hydrochloride,liver cirrhosis,4,0,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
CardioGen-82,coronary artery disease,37,1,[82Rb+],direct
Metronidazole250 mg 250 mg,hypersensitivity,313,1,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Theophylline Anhydrous,hypersensitivity,313,1,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Fluvoxamine Maleate,pregnancy,16,0,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,direct
Cabergoline,hyperprolactinemic disorders,880,1,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,direct
Vyalev,stroke,7,0,C[C@@](CC1=CC=C(OP(O)(O)=O)C(O)=C1)(NN)C(O)=O,direct
Effer-K 20 mEq Unflavored,diabetes mellitus,5,0,[K+].OC([O-])=O,direct
Ezetimibe,mixed hyperlipidemia,1013,1,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
Desferal,cancer (localized),8,0,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
Tetracaine Hydrochloride,hypertension,11,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
Mozobil,mental illness,14,0,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
Dexamethasone 1.5 mg,autoimmune disease,15,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
venlafaxine,recurrent depression who,1200,1,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
APTENSIO XR,pediatric patients,13,1,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
ARSENIC TRIOXIDE,mental illness,14,0,O=[As]O[As]=O,direct
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE,glaucoma,481,1,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Sulfasalazine,porphyria as sulfonamides,1140,1,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,direct
Oxycodone and Aspirin,high frequency loss,863,1,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C,direct
nitroglycerin lingual,severe infection,18,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Nitroglycerin In Dextrose,increased intracranial pressure,926,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Ribavirin,hypertension,11,0,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Diltiazem Hydrochloride,supraventricular arrhythmias,1280,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Davimet with Fluoride,liver cirrhosis,4,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Phenelzine Sulfate,congestive heart failure,2,0,NNCCC1=CC=CC=C1,direct
Prolia,chronic kidney disease,3,0,OC(=O)[C@@H]1CCCN1,fuzzy:prolina
Nipent,stroke,7,0,OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CNC[C@H]2O,direct
"Butalbital, Acetaminophen, and Caffeine",acetaminophen allergy,513,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Pramosone Cream,renal failure,19,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Zolpidem tartrate sublingual,anemia,13,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Dialyvite with Zinc,cancer (localized),8,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Synalar,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
AMMONIA N-13,pregnancy,16,0,[13NH3],direct
posaconazole,diabetes mellitus,5,0,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
Alendronate,AIDS,10,0,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Multiple Electrolytes pH 7.4,brain edema,643,1,[Cl-].[K+],direct
LIDOCAINE HCl AND EPINEPHRINE,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Lynparza,cancer (metastatic),9,0,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1,direct
Naproxen Sodium,chronic obstructive pulmonary disease (COPD),6,0,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O,direct
RAMELTEON,severe infection,18,0,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,direct
TOBI Podhaler,pseudomonas aeruginosa,1188,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
ACETAMINOPHEN AND CODEINE,chronic obstructive pulmonary disease (COPD),6,0,CC(=O)NC1=CC=C(O)C=C1,direct
PROVAYBLUE,acquired methemoglobinemia,517,1,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,direct
XELJANZ XR,lung disease,375,1,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,direct
Flurandrenolide,autoimmune disease,15,0,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,direct
Paricalcitol,evidence of,811,1,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1)[C@H](C)\C=C\[C@H](C)C(C)(C)O,direct
Dorzolamide Hydrochloride and Timolol Maleate ophthalmic,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
POTASSIUM CHLORIDE EXTENDED RELEASE,hyperkalemia,131,1,[Cl-].[K+],direct
Estradiol,hypersensitivity,313,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Lisinopril with Hydrochlorothiazide,edema,417,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
VERAPAMIL HYDROCHLORIDE,mental illness,14,0,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,direct
BUTALBITAL and ACETAMINOPHEN,pregnancy,16,0,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,direct
Tranexamic Acid in Sodium Chloride,severe infection,18,0,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
K Phos Original,anemia,13,0,[K+].OP(O)([O-])=O,direct
Amnesteem,liver disease (non-cirrhotic),20,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
CIDOFOVIR,chronic kidney disease,3,0,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,direct
Plasma-Lyte A,sepsis,17,0,[Cl-].[K+],direct
GLYCOPYRROLATE,ileostomy or colostomy,910,1,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
Diclona Gel,myocardial infarction,1,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
AZASITE,hypersensitivity,313,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Lumason,autoimmune disease,15,0,FS(F)(F)(F)(F)F,direct
Solu-Medrol,anemia,13,0,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
"Butalbital, Acetaminophen and Caffeine",porphyria warnings butalbital,1142,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Ethamolin,esophageal varices that,805,1,NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O,direct
Bortezomib,anorexia,399,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
SULFATRIM,cancer (metastatic),9,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Cleviprex,essential hypertension,806,1,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,direct
LUMIGAN,cancer (metastatic),9,0,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
QUELICIN,hypersensitivity,313,1,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,direct
Zoledronic acid,chronic kidney disease,3,0,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
TIAZAC EXTENDED RELEASE,chronic stable angina,705,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Sulfameth/Trimeth-DS,thrombocytopenia,79,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Nitrostat,shock,419,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Cinacalcet Hydrochloride,chronic kidney disease,3,0,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
MIDODRINE HYDROCHLORIDE,diabetes mellitus,5,0,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,direct
Imatinib Mesylate,neutropenia,85,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Dabigatran etexilate,AIDS,10,0,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
hydrocodone bitartrate and acetaminophen,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
GaviLyte - C TM,autoimmune disease,15,0,[Cl-].[K+],direct
DOFETILIDE,renal failure,19,0,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Oxycodone Hydchloride,depression,27,1,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C,direct
LOPERAMIDE HYDROCHLORIDE,hypersensitivity,313,1,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Depo-Estradiol,hypersensitivity,313,1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1,direct
betamethasone dipropionate,sepsis,17,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
SUCCINYLCHOLINE CHLORIDE,severe infection,18,0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,direct
Zoledronic Acid,sepsis,17,0,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE,stroke,7,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Varenicline,pregnancy,16,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
UltraCare Anesthetic Gel,hypersensitivity,313,1,CCOC(=O)C1=CC=C(N)C=C1,direct
Levetiracetam,hypersensitivity,313,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
DIGOXIN,sepsis,17,0,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,direct
Hydrocortisone Valerate,mental illness,14,0,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Nalbuphine hydrochloride,cancer (localized),8,0,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
Lyrica CR,myocardial infarction,1,0,CC(C)C[C@H](CN)CC(O)=O,direct
Trisenox,asthma,12,0,O=[As]O[As]=O,direct
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE,anemia,13,0,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3,direct
MultiHance,chronic obstructive pulmonary disease (COPD),6,0,[Gd+3].OC(=O)CN(CCN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)C(COCC1=CC=CC=C1)C(O)=O,direct
POTASSIUM CITRATE EXTENDED RELEASE,chronic obstructive pulmonary disease (COPD),6,0,[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,direct
Nascobal,liver cirrhosis,4,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
cyanocobalamin,severe infection,18,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Bendeka,lymphoma,269,1,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
ArmonAir Digihaler,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Lidolog Kit,liver cirrhosis,4,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
PROCRIT,cancer procrit,660,1,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,fuzzy:procort
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,chronic overdose,698,1,CC(=O)NC1=CC=C(O)C=C1,direct
Esomeprazole Magnesium,hypersensitivity,313,1,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
hydrochlorothiazide,chronic kidney disease,3,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
TriStart DHA,hypertension,11,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Benazepril Hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,direct
Nitazoxanide,hypersensitivity,313,1,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,direct
TIAZAC EXTENDED RELEASE,diabetes mellitus,5,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
nitroglycerin,mental illness,14,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
venlafaxine,depressive symptoms,769,1,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
MINOXIDIL,autoimmune disease,15,0,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1,direct
Delestrogen,cancer (metastatic),9,0,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Theophylline,hypersensitivity,313,1,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Capecitabine 150mg,metastatic colorectal cancer,996,1,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
Azacitidine,sepsis,17,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
IMATINIB MESYLATE,liver disease (non-cirrhotic),20,0,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
"Timolol Maleate Ophthalmic Gel Forming Solution, 0.25%",glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
XYWAV,cancer (metastatic),9,0,OCCCC(O)=O,direct
Enalapril maleate and hydrochlorothiazide,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
HICON,vomiting and diarrhea,1360,1,[131I-],direct
Propafenone Hydrochloride,pregnancy,16,0,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,direct
Cyanocobalamin,pernicious anemia who,1117,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
EUTHYROX,pediatric patients,13,1,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
FLUOROURACIL,hypersensitivity,313,1,FC1=CNC(=O)NC1=O,direct
NICARDIPINE HYDROCHLORIDE,advanced aortic stenosis,559,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
LANREOTIDE ACETATE,documented hepatic impairment,783,1,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],direct
Gavreto,myocardial infarction,1,0,CO[C@@]1(CC[C@@H](CC1)C1=NC(NC2=NNC(C)=C2)=CC(C)=N1)C(=O)N[C@@H](C)C1=CC=C(N=C1)N1C=C(F)C=N1,direct
ISOTRETINOIN,AIDS,10,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Catapres-TTS-1,renal failure,19,0,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
Amoxapine,chronic obstructive pulmonary disease (COPD),6,0,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1,direct
50% MAGNESIUM SULFATE,hypertension,11,0,[Mg++].[O-]S([O-])(=O)=O,direct
Imatinib Mesylate,ph- all who,1121,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
"Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide",cancer (metastatic),9,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Diprivan,cancer (localized),8,0,CC(C)C1=CC=CC(C(C)C)=C1O,direct
DIAZEPAM,cancer (localized),8,0,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,direct
Klonopin,stroke,7,0,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,direct
Pantoprazole Sodium DR,chronic obstructive pulmonary disease (COPD),6,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Pramipexole Dihydrochloride,cancer (metastatic),9,0,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
Targretin,sexual partners who,1256,1,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,direct
Ursodiol,primary biliary cholangitis,1170,1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
VITRAKVI,myocardial infarction,1,0,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1,direct
Fentanyl system,severe infection,18,0,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
Ojjaara,chronic kidney disease,3,0,O=C(NCC#N)C1=CC=C(C=C1)C1=CC=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1,direct
Pantoprazole,hypersensitivity,313,1,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
diclofenac potassium,hypersensitivity,313,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
ALVAIZ,hepatitis c,279,1,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,direct
Lansoprazole DR,pregnancy,16,0,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
PROPOFOL,hypersensitivity,313,1,CC(C)C1=CC=CC(C(C)C)=C1O,direct
Granisetron hydrochloride,autoimmune disease,15,0,CN1N=C(C(=O)N[C@@H]2C[C@@H]3CCC[C@H](C2)N3C)C2=C1C=CC=C2,direct
ZEVTERA,respiratory distress,191,1,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCN(C1)C(=O)OCC1=C(C)OC(=O)O1,direct
Mirtazapine,depressive symptoms,769,1,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1,direct
SULFATRIM,anemia,81,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Mexiletine hydrochloride,chronic kidney disease,3,0,CC(N)COC1=C(C)C=CC=C1C,direct
OXCARBAZEPINE,anxiety,19,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
AirDuo RespiClick,myocardial infarction,1,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Mestinon,asthma,193,1,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Nystatin,myocardial infarction,1,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Amyvid,sepsis,17,0,[H]N(C1=C([H])C([H])=C(\C([H])=C(/[H])C2=C([H])N=C(OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])[18F])C([H])=C2[H])C([H])=C1[H])C([H])([H])[H],direct
Fluocinolone Acetonide Topical,autoimmune disease,15,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
glyburide and metformin hydrochloride,non-insulin-dependent diabetes,1045,1,CN(C)C(=N)NC(N)=N,direct
tizanidine hydrochloride,diabetes mellitus,5,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Prochlorperazine,anemia,13,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
captopril,liver disease (non-cirrhotic),20,0,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,direct
Moexipril Hydrochloride,stroke,7,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O,direct
PROGESTERONE,hypertension,11,0,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Tafinlar,cancer (localized),8,0,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,direct
Dofetilide,congestive heart failure,2,0,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Trifluoperazine Hydrochloride,psychosis,31,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
ABRAXANE,neutropenia,85,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Adefovir dipivoxil,hypersensitivity,313,1,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C,direct
MALARONE,renal failure,19,0,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,direct
Reyvow,chronic kidney disease,3,0,CN1CCC(CC1)C(=O)C1=CC=CC(NC(=O)C2=C(F)C=C(F)C=C2F)=N1,direct
METHYLPREDNISOLONE ACETATE,stroke,7,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
TOBRAMYCIN,this symptom,1317,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
SULFATRIM,mental illness,14,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Cisatracurium,liver disease (non-cirrhotic),20,0,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,direct
Denavir,AIDS,10,0,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,direct
CHLORDIAZEPOXIDE HYDROCHLORIDE,renal failure,19,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Dexlansoprazole,asthma,12,0,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1,direct
gemcitabine hydrochloride,stroke,7,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
Motofen,acute ulcerative colitis,556,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
PROGESTERONE,hypersensitivity,313,1,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Dexamethasone sodium phosphate,liver cirrhosis,4,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Methyldopa,cancer (localized),8,0,C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O,direct
TIADYLT ER,hypertension,11,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
DOXY 100(TM) DOXYCYCLINE,impaired renal function,919,1,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
leuprolide acetate,cancer (localized),8,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
LEUPROLIDE ACETATE,metastatic prostate cancer,1004,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Clomipramine hydrochloride,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
raloxifene hydrochloride,an intact uterus,591,1,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,direct
Cinacalcet Hydrochloride,autoimmune disease,15,0,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Fioricet,acetaminophen allergy,513,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
gabapentin,hypersensitivity,313,1,NCC1(CC(O)=O)CCCCC1,direct
Vancomycin Hydrochloride,autoimmune disease,15,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
Pramosone,hypersensitivity,313,1,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
toremifene citrate,hypersensitivity,313,1,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,direct
Diazepam,open-angle glaucoma who,1081,1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,direct
Metoprolol Tartrate and Hydrochlorothiazide,impaired renal function,919,1,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
OPFOLDA,lopd who,968,1,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,direct
FABHALTA,renal failure,19,0,CCO[C@H]1CCN(CC2=C(OC)C=C(C)C3=C2C=CN3)[C@@H](C1)C1=CC=C(C=C1)C(O)=O,direct
SOTYLIZE,myocardial infarction,1,0,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Sodium Acetate,pregnancy,16,0,[Na+].CC([O-])=O,direct
leuprolide acetate,prostate cancer,265,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Nitazoxanide,congestive heart failure,2,0,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,direct
XYLOCAINE-MPF WITH EPI,chronic kidney disease,3,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Accucaine,sepsis,17,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Edetate Calcium Disodium,hepatitis,229,1,[Na+].[Na+].[Ca++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O,direct
XYLOCAIN (LIDOCAINE HCl ),cancer (metastatic),9,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
CABOMETYX,AIDS,10,0,COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,direct
"brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide",severe infection,18,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Amlodipine besylate and Olmesartran medoxomil,mental illness,14,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Fioricet,anemia,13,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
NeuLumEX,anemia,13,0,[Ba++].[O-]S([O-])(=O)=O,direct
TRIDERM,chronic kidney disease,3,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Desipramine HCL,depressive symptoms,769,1,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Bisoprolol Fumarate and Hydrochlorothiazide,impaired renal function,919,1,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,direct
Varenicline,sepsis,17,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Timolol GFS,congestive heart failure,2,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
pioglitazone,anemia,13,0,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
Cyclophosphamide,rapidly growing tumors,1197,1,ClCCN(CCCl)P1(=O)NCCCO1,direct
Losortan Potassium,left ventricular hypertrophy,961,1,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
Sulindac,the aspirin triad,1295,1,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O,direct
bupivacaine hydrochloride,cancer (localized),8,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
NYSTATIN AND TRIAMCINOLONE ACETONIDE,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Nitrofurantoin Macrocrystals,stroke,7,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Pravastatin sodium,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Doxycycline Monohydrate,myocardial infarction,1,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Prednisolone Sodium Phosphate Oral Solution,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
MIDAZOLAM HYDROCHLORIDE,hypersensitivity,313,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
INVEGA TRINZA,tics,23,1,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,direct
Pentamidine Isethionate,cancer (localized),8,0,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
Levetiracetam ER,hypersensitivity,313,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
VIDAZA,hypertension,11,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
"Desonide Ointment, 0.05%",hypersensitivity,313,1,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Nabumetone 500 mg,impaired renal function,919,1,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
Glipizide and Metformin HCl,non-insulin-dependent diabetes,1045,1,CN(C)C(=N)NC(N)=N,direct
Deferasirox Oral Granules,poor performance status,1139,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Bacitracin,hypersensitivity,313,1,CC[C@H](C)[C@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC,direct
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE HALF STRENGTH,coronary artery disease,37,1,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,fuzzy:esterified estrogens and methyltestosterone half-strength
PROCAINAMIDE HYDROCHLORIDE,ventricular arrhythmias,1354,1,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
Methyldopa,anemia,81,1,C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O,direct
tetracycline hydrochloride,renal impairment,1211,1,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
HULIO,polyarticular jia who,1137,1,CC(C)O,direct
Carbidopa,cancer (localized),8,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
ABRILADA,active psoriatic arthritis,533,1,CC(C)O,direct
Cardene IV,aortic stenosis,55,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
AMPYRA,chronic obstructive pulmonary disease (COPD),6,0,NC1=CC=NC=C1,direct
FOSFOMYCIN TROMETHAMINE,hypersensitivity,313,1,C[C@@H]1O[C@@H]1P(O)(O)=O,direct
TAZORAC,pregnancy,16,0,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,direct
VALSARTAN AND HYDROCHLOROTHIAZIDE,hypercalcemia and hypophosphatemia,875,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Nitroglycerin In Dextrose,these conditions,1310,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
fluconazole,vaginal candidiasis,1349,1,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Definity,pregnancy,16,0,FC(F)(F)C(F)(F)C(F)(F)F,direct
ELEPSIA XR 1000 MG,pregnancy,16,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Meclofenamate Sodium,the aspirin triad,1295,1,CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1,direct
Deflazacort,renal failure,19,0,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@]([H])(O)C[C@]3(C)[C@@]1(N=C(C)O2)C(=O)COC(C)=O,direct
ATENOLOL AND CHLORTHALIDONE,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Cisatracurium Besylate,hypertension,11,0,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,direct
PENTAZOCINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE,severe infection,18,0,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,direct
Tramadol Hydrochloride,gastrointestinal conditions tramadol,830,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Caldolor,chronic obstructive pulmonary disease (COPD),6,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
NALFON,the aspirin triad,1295,1,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,direct
TRIAMCINOLONE ACETONIDE,unexplained diarrhea,1341,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Perindopril Erbumine,edema,417,1,[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,direct
Lignospan Forte,cancer (metastatic),9,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Demser,pheochromocytoma for,1125,1,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,direct
Robinul,AIDS,10,0,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
K Phos Original,infected phosphate stones,932,1,[K+].OP(O)([O-])=O,direct
LAMIVUDINE,liver disease (non-cirrhotic),20,0,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,direct
Revlimid,mm when pembrolizumab,1014,1,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
VITRASE,liver cirrhosis,4,0,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,fuzzy:vitrasert
Zithromax,severe infection,18,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
PROCAINAMIDE HCI,heart block,59,1,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
glyburide and metformin hydrochloride,diabetes mellitus,5,0,CN(C)C(=N)NC(N)=N,direct
Alprazolam Extended Release,ataxia,465,1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
OXBRYTA,severe infection,18,0,CC(C)N1N=CC=C1C1=C(COC2=CC=CC(O)=C2C=O)C=CC=N1,direct
VENLAFAXINE,severe infection,18,0,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
Xalkori,autoimmune disease,15,0,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,direct
STEGLATRO,cancer (localized),8,0,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1,direct
tofacitinib,rheumatoid arthritis,159,1,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,direct
Indium In 111 Oxyquinoline,stroke,7,0,[111In+3].[O-]C1=CC=CC2=C1N=CC=C2.[O-]C1=CC=CC2=C1N=CC=C2.[O-]C1=CC=CC2=C1N=CC=C2,direct
Finasteride,liver disease (non-cirrhotic),20,0,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,direct
"Butalbita,Acetaminophen and Caffeine",liver cirrhosis,4,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Litfulo,severe infection,18,0,C[C@H]1CC[C@H](CN1C(=O)C=C)NC1=NC=NC2=C1C=CN2,direct
bortezomib,multiple myeloma,1024,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Betaxolol Hydrochloride,pregnancy,16,0,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
NITROGLYCERIN,chronic obstructive pulmonary disease (COPD),6,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
CIMETIDINE HYDROCHLORIDE,preexisting arthritis,1156,1,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N,direct
Norpace CR,life-threatening ventricular arrhythmias,966,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
CitraNatal Assure,stroke,7,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Pro-C-Dure 6 Kit,AIDS,10,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Amlodipine and Olmesartan Medoxomil,stroke,51,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Lurasidone hydrochloride,another indication,601,1,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Theophylline (Anhydrous),hypersensitivity,313,1,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Toronova II SUIK,mental illness,14,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
CITALOPRAM HYDROBROMIDE,depressive symptoms,769,1,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
VYXEOS,the following,1299,1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,direct
NIZATIDINE,liver disease (non-cirrhotic),20,0,CNC(NCCSCC1=CSC(CN(C)C)=N1)=C[N+]([O-])=O,direct
Tramadol Hydrochloride Extended-Release,osteoarthritis,161,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Diclofenac Sodium Delayed Release Delayed Release,considerable dehydration,749,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Cleviprex,aortic stenosis,55,1,CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC(Cl)=C1Cl)C(=O)OC,direct
CORTEF,liver cirrhosis,4,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Pegasys,chronic obstructive pulmonary disease (COPD),6,0,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O,fuzzy:pearsys
Pravastatin sodium,stroke,51,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Estradiol Vaginal Cream,hypercalcemia,139,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
ATAZANAVIR,diabetes mellitus,5,0,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,direct
Lidocaine hydrochloride,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Promethazine with Codeine,chronic ulcerative colitis,707,1,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,direct
Nalbuphine Hydrochloride,mental illness,14,0,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
Trihexyphenidyl Hydrochloride,narrow angle glaucoma,1029,1,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1,direct
"LIDOCAINE HYDROCHLORIDE, HYDROCORTISONE ACETATE",hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
CARBAMAZEPINE ER,liver cirrhosis,4,0,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Motofen,ulcerative colitis,225,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
toremifene citrate,renal failure,19,0,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,direct
FLUVASTATIN SODIUM ER,renal failure,19,0,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,direct
Normosol-R,severe infection,18,0,[Cl-].[K+],direct
Pantoprazole Sodium DR,congestive heart failure,2,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Foltrate,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
ESTRACE,hypercalcemia,139,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Mestinon,AIDS,10,0,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
OSELTAMIVIR,hypersensitivity,313,1,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
Azasan,rheumatoid arthritis who,1215,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
abiraterone acetate,metastatic crpc,997,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
gadobutrol,congestive heart failure,2,0,OC[C@H](O)[C@H](CO)[N+]12CC[N+]3(CC([O-])=O)CC[N+]4(CC([O-])=O)CC[N+](CC([O-])=O)(CC1)[Gd-]234,direct
Cyclosporine,chronic plaque psoriasis,702,1,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Atovaquone and Proguanil HCl,autoimmune disease,15,0,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,direct
OPFOLDA,stroke,7,0,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,direct
LABETALOL HYDROCHLORIDE,this tumor,1318,1,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
VFEND,hypertension,11,0,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Cyanocobalamin,vitamin b12 deficiency,407,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Carisoprodol,sepsis,17,0,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
Nortriptyline HCL,depressive symptoms,769,1,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
VUITY,hypersensitivity,313,1,CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O,direct
Betaxolol Hydrochloride,chronic kidney disease,3,0,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
TIZANIDINE HYDROCHLORIDE,multiple sclerosis,153,1,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
ceftriaxone,cancer (localized),8,0,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
Propranolol hydrochloride,angina pectoris,596,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Methylprednisolone sodium succinate,pregnancy,16,0,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
XYLOCAIN (LIDOCAINE HCl ),chronic obstructive pulmonary disease (COPD),6,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
POTASSIUM CHLORIDE,edema,417,1,[Cl-].[K+],direct
Ammonia N 13,renal failure,19,0,[13NH3],direct
Zoledronic acid,hypertension,11,0,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
Irinotecan hydrochloride,liver disease (non-cirrhotic),20,0,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
CEFDINIR,anemia,13,0,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,direct
EDECRIN,arrhythmia,43,1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Fluocinolone Acetonide,asthma,12,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Lodosyn,mental illness,14,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
AMLODIPINE and OLMESARTAN medoxomil,kidney failure,373,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
thiothixene,chronic kidney disease,3,0,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1,direct
dabigatran etexilate,sepsis,17,0,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
Lyrica,diabetes mellitus,5,0,CC(C)C[C@H](CN)CC(O)=O,direct
pregabalin,hypersensitivity,313,1,CC(C)C[C@H](CN)CC(O)=O,direct
sirolimus,mental illness,14,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
CitraNatal Harmony 3.0,hypertension,11,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
DILTIAZEM HYDROCHLORIDE,severe infection,18,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Niacor,hypersensitivity,313,1,OC(=O)C1=CN=CC=C1,direct
Leuprolide Acetate,congestive heart failure,2,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Estradiol Valerate,AIDS,10,0,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
LACTATED RINGERS,severe renal impairment,1253,1,[Cl-].[K+],direct
DORZOLAMIDE HYDROCHLORIDE,hypertension,39,1,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Omlonti,severe infection,18,0,CC(C)OC(=O)CNC1=CC=CC(CN(CC2=CC=C(C=C2)N2C=CC=N2)S(=O)(=O)C2=CC=CN=C2)=N1,direct
fluconazole,hypersensitivity,313,1,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Ibuprofen,myocardial infarction,1,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
SIMBRINZA,hypertension,39,1,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
TECFIDERA,diabetes mellitus,5,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
SAPHRIS,AIDS,10,0,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
DMT SUIK,pregnancy,16,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Adrenalin,hypotension,75,1,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
DesOwen,congestive heart failure,2,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Meloxicam,the aspirin triad,1295,1,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O,direct
OXYCODONE AND ACETAMINOPHEN,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
Qbrelis,chronic obstructive pulmonary disease (COPD),6,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
hydrocodone bitartrate and acetaminophen,liver cirrhosis,4,0,CC(=O)NC1=CC=C(O)C=C1,direct
PNV-DHA,cancer (metastatic),9,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Hydroxychloroquine sulfate,porphyria the condition,1141,1,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
Doxepin HCL,congestive heart failure,2,0,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
VITRAKVI,sepsis,17,0,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1,direct
Pregabalin,myocardial infarction,1,0,CC(C)C[C@H](CN)CC(O)=O,direct
Mepivacaine,hypertension,11,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Haloperidol Lactate,psychosis,31,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Ipratropium Bromide,sepsis,17,0,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,direct
LAMPIT,adverse reactions,575,1,CC1CS(=O)(=O)CCN1\N=C\C1=CC=C(O1)[N+]([O-])=O,direct
Gemfibrozil,liver disease (non-cirrhotic),20,0,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,direct
HUMIRA,anti-adalimumab antibody,602,1,CC(C)O,direct
CIMDUO,autoimmune disease,15,0,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,direct
LIDO BDK,autoimmune disease,15,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Dabigatran Etexilate,non-valvular atrial fibrillation,1053,1,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
Prednisolone Sodium Phosphate,sepsis,17,0,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ALPHAGAN P,hypertension,39,1,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Nystop,pregnancy,16,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Methsuximide,hypersensitivity,313,1,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1,direct
INDERAL LA,hypertrophic subaortic stenosis,899,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Stivarga,anemia,81,1,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,direct
CYTARABINE,liver cirrhosis,4,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,direct
Plerixafor,AIDS,10,0,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
atomoxetine,diabetes mellitus,5,0,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
Tetracaine HCL,congestive heart failure,2,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
Ondansetron,liver failure,371,1,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Multi-Specialty Kit,hypertension,11,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Phenelzine Sulfate,renal failure,19,0,NNCCC1=CC=CC=C1,direct
IMURAN,chronic kidney disease,3,0,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Etodolac ER,hypersensitivity,313,1,CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1,direct
CHLOROQUINE PHOSPHATE,preexisting auditory damage,1157,1,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,direct
Idarubicin Hydrochloride,severe infection,18,0,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O,direct
varenicline,asthma,12,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
ELIXOPHYLLIN,hypersensitivity,313,1,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Timolol GFS,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
APREPITANT,dehydration,395,1,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,direct
Hemox A,hypersensitivity,313,1,Cl[Al](Cl)Cl,direct
Korlym,mental illness,14,0,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],direct
Rezurock,chronic gvhd,687,1,CC(C)NC(=O)COC1=CC=CC(=C1)C1=NC2=C(C=CC=C2)C(NC2=CC=C3NN=CC3=C2)=N1,direct
Bexarotene,hypersensitivity,313,1,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,direct
Rubraca,myocardial infarction,1,0,CNCC1=CC=C(C=C1)C1=C2CCNC(=O)C3=C2C(N1)=CC(F)=C3,direct
Lidocaine HCl - Hydrocortisone Acetate,congestive heart failure,2,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Pramipexole Dihydrochloride,concomitant levodopa,741,1,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
Depo-Estradiol,myocardial infarction,1,0,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1,direct
Norco,myocardial infarction,1,0,CC(=O)NC1=CC=C(O)C=C1,direct
Ezetimibe,hypersensitivity,313,1,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
Cefotetan,anemia,81,1,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)OC)C(O)=O,direct
DORZOLAMIDE HYDROCHLORIDE,glaucoma,481,1,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
RUBY-FILL,sepsis,17,0,[82Rb+],direct
Humira,renal failure,19,0,CC(C)O,direct
LIDOCAINE HCI,mental illness,14,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
azacitidine for,myocardial infarction,1,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Select-OB Plus DHA Prenatal Supplement Plus DHA,severe infection,18,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide",liver disease (non-cirrhotic),20,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
LAMIVUDINE and ZIDOVUDINE,hypersensitivity,313,1,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
DOXIL,cancer (metastatic),9,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
Topotecan,cervical cancer,676,1,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
MEXILETINE HYDROCHLORIDE,chronic kidney disease,3,0,CC(N)COC1=C(C)C=CC=C1C,direct
Dexlansoprazole delayed release,stroke,7,0,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1,direct
Levetiracetam Extended-Release,hypersensitivity,313,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
CLOMIPRAMINE HYDROCHLORIDE,pregnancy,16,0,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
LISINOPRIL,hypertension,39,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
METOPROLOL TARTRATE,coronary artery disease,37,1,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
LEFLUNOMIDE,severe infection,18,0,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
BIMATOPROST,hypertension,11,0,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
Lunesta,liver cirrhosis,4,0,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,direct
Kiprofen,anemia,13,0,CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1,direct
Promethazine,bone-marrow depression,639,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Cyclomydril,liver disease (non-cirrhotic),20,0,CNC[C@H](O)C1=CC(O)=CC=C1,direct
STEGLATRO,hypersensitivity,313,1,CCOC1=CC=C(CC2=CC(=CC=C2Cl)[C@]23OC[C@](CO)(O2)[C@@H](O)[C@H](O)[C@H]3O)C=C1,direct
"Lansoprazole, Amoxicillin, Clarithromycin",cancer (localized),8,0,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Rifampin,chronic obstructive pulmonary disease (COPD),6,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
BENDAMUSTINE HYDROCHLORIDE,asthma,12,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Fluocinolone acetonide,cancer (localized),8,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
UROGESIC BLUE,hypersensitivity,313,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Hyosyne,stroke,7,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Multitam,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Methylphenidate,cancer (localized),8,0,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
Dexamethasone,tuberculosis,213,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Caffeine Citrate,liver cirrhosis,4,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Abiraterone,liver metastases,967,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Nitroglycerin,shock,419,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
PARSABIV,cancer (localized),8,0,C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O)C(=O)N[C@H](CCCNC(N)=N)C(N)=O,direct
HYZAAR,severe infection,18,0,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
Zolmitriptan,hypersensitivity,313,1,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
LIDOCAINE AND PRILOCAINE,mental illness,14,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
LANREOTIDE ACETATE,myocardial infarction,1,0,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],direct
Azor,stroke,51,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
zolpidem tartrate,insomnia,441,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Proparacaine Hydrochloride,chronic kidney disease,3,0,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,direct
GLYCOPYRROLATE,liver disease (non-cirrhotic),20,0,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
Celecoxib,autoimmune disease,15,0,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
ERLEADA,prostate cancer,265,1,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F,direct
Lyrica,stroke,7,0,CC(C)C[C@H](CN)CC(O)=O,direct
DYMISTA,congestive heart failure,2,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Hydroxychloroquine sulfate,hypertension,11,0,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
BIVALIRUDIN,thrombocytopenia,79,1,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,direct
Synalar,sepsis,17,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
PAROXETINE,gad and ptsd,822,1,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Methylprednisolone acetate,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
teriflunomide,stroke,7,0,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
Bupivilog Kit,stroke,7,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Rapivab,hypersensitivity,313,1,[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O,direct
azithromycin dihydrate,chronic obstructive pulmonary disease (COPD),6,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Lumryz,cancer (metastatic),9,0,[Na+].OCCCC([O-])=O,direct
BORTEZOMIB,neutropenia,85,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Carnitor SF,hypersensitivity,313,1,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
Ketorocaine L Kit,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
TIAGABINE HYDROCHLORIDE,pregnancy,16,0,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1,direct
adapalene and benzoyl peroxide,hypersensitivity,313,1,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
ketorolac tromethamine,hypersensitivity,313,1,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
TRI-LUMA,darker skin cannot,758,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
MEPIVACAINE HYDROCHLORIDE,tics,23,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Pemetrexed,cancer (metastatic),9,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
MLK F3 Kit,myocardial infarction,1,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ACCOLATE,stroke,7,0,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,direct
Revlimid,hypertension,11,0,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
Ammonia N-13,coronary artery disease,37,1,[13NH3],direct
GEMFIBROZIL,stroke,7,0,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,direct
"SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE",cancer (metastatic),9,0,[Mg++].[O-]S([O-])(=O)=O,direct
DALFAMPRIDINE,chronic obstructive pulmonary disease (COPD),6,0,NC1=CC=NC=C1,direct
Prometrium,congestive heart failure,2,0,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Nilandron,diabetes mellitus,5,0,CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,direct
TRIESENCE,asthma,12,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Ionite H,hypersensitivity,313,1,[F-].[Na+],direct
Vitafol One,myocardial infarction,1,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
ethacrynic acid,liver disease (non-cirrhotic),20,0,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Virazole,heart disease,377,1,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
INDOMETHACIN,diabetes mellitus,5,0,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,direct
Angiomax,sepsis,17,0,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,direct
Cefazolin,tics,23,1,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,direct
perphenazine,dementia,7,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Itraconazole,hypersensitivity,313,1,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Spironolactone and Hydrochlorothiazide,renal failure,19,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
Dexrazoxane,sepsis,17,0,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,direct
ACCURETIC,renal failure,19,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Tramadol Hydrochloride and Acetaminophen,anemia,13,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Halcinonide,hypersensitivity,313,1,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
DOXEPIN HYDROCHLORIDE,depressive symptoms,769,1,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
Carafate,mental illness,14,0,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,direct
Bromocriptine Mesylate,severe infection,18,0,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
PHENYLEPHRINE HYDROCHLORIDE,renal failure,19,0,CNC[C@H](O)C1=CC(O)=CC=C1,direct
Argatroban,hypersensitivity,313,1,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2,direct
Compro,asthma,12,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Hectorol,edema,417,1,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
CAFFEINE CITRATE,necrotizing enterocolitis,1032,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Meclofenamate Sodium,hypersensitivity,313,1,CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1,direct
ASENAPINE,asthma,12,0,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
TESTOSTERONE CYPIONATE,hypertension,39,1,[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Zolpidem Tartrate,AIDS,10,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
PEMETREXED,mpm who,1020,1,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
bivalirudin,hypertension,11,0,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,direct
DROPERIDOL,sepsis,17,0,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,direct
propafenone hydrochloride,arrhythmia,43,1,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,direct
erythromycin,hypersensitivity,313,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Xatmep,cancer (metastatic),9,0,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
Neomycin and Polymyxin B Sulfates,indwelling catheters,929,1,[H][C@]1(NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](CCN)NC(=O)[C@H](CCNC1=O)NC(=O)[C@H](CCN)NC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)CCCCC(C)CC)[C@@H](C)O)[C@@H](C)O,direct
DEFERASIROX,advanced malignancies,563,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Estrace,hypersensitivity,313,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Hectorol,leukopenia,83,1,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
Brinzolamide,hypertension,39,1,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Prenate Elite,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
"Orphenadrine Citrate, Aspirin and Caffeine",myasthenia gravis,151,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Mexiletine Hydrochloride,cancer (localized),8,0,CC(N)COC1=C(C)C=CC=C1C,direct
Terconazole Vaginal Cream 0.8%,AIDS,10,0,CC(C)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Dexlansoprazole delayed release,hypersensitivity,313,1,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1,direct
CitraNatal Medley,diabetes mellitus,5,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
CARBAMAZEPINE ER,increased intraocular pressure,927,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
COLCHICINE,hepatic impairment,1,1,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Tizanidine hydrochloride,asthma,12,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
CEFPODOXIME PROXETIL,asthma,12,0,[H][C@]12SCC(COC)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
Zydelig,cll and inhl,721,1,[H][C@@](CC)(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,direct
PROCRIT,cancer (localized),8,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,fuzzy:procort
Oxcarbazepine,vaginitis,337,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Xalatan,pregnancy,16,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
TRIHEXYPHENIDYL HYDROCHLORIDE,diabetes mellitus,5,0,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1,direct
sirolimus,severe infection,18,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
cisatracurium besylate,severe infection,18,0,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,direct
Inflammacin,hypersensitivity,313,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Dihydroergotamine Mesylate Nasal,hypertension,39,1,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
Pimozide,asthma,12,0,FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1,direct
ArmonAir Digihaler,renal failure,19,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Pyrimethamine,liver cirrhosis,4,0,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1,direct
Esomeprazole DR,congestive heart failure,2,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
"Butalbital, Acetaminophen, Caffeine",hypersensitivity,313,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
LAMICTAL,anemia,13,0,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
BUPIVICAINE HYDROCHLORIDE,anemia,13,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Rosuvastatin,hypersensitivity,313,1,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
SPRYCEL,AIDS,10,0,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
DELSTRIGO,hypersensitivity,313,1,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,direct
Imiquimod,pre-existing autoimmune conditions,1149,1,CC(C)CN1C=NC2=C1C1=C(C=CC=C1)N=C2N,direct
Hydroxyprogesterone Caproate,liver disease (non-cirrhotic),20,0,[H][C@@]12CC[C@](OC(=O)CCCCC)(C(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Lidocort,sepsis,17,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Indomethacin ER,cancer (metastatic),9,0,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,direct
Lamotrigine,sepsis,17,0,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
Bexagliflozin,chronic obstructive pulmonary disease (COPD),6,0,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(OCCOC3CC3)C=C2)=C1,direct
Tindazole,liver disease (non-cirrhotic),20,0,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O,direct
Benzphetamine Hydrochloride,liver disease (non-cirrhotic),20,0,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,direct
Rexulti,mdd and schizophrenia,989,1,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,direct
Vitafol Ultra,autoimmune disease,15,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
nystatin,cancer (localized),8,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
SODIUM PHENYLACETATE AND SODIUM BENZOATE,cancer (metastatic),9,0,OC(=O)C1=CC=CC=C1,direct
TOBREX,hypersensitivity,313,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Tasigna,myocardial infarction,1,0,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)=CC(=C1)C(F)(F)F,direct
Naproxen,the aspirin triad,1295,1,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O,direct
CERIANNA,AIDS,10,0,[H][C@@]12C[C@@H]([18F])[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Iodixanol,liver disease (non-cirrhotic),20,0,CC(=O)N(CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,direct
BUTAL/APAP/CAFFEINE,hypertension,11,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,fuzzy:butal/apap/caff
febuxostat,gout who,842,1,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
CEFDINIR,tics,23,1,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,direct
perphenazine,mental illness,14,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Carbatrol,liver disease (non-cirrhotic),20,0,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Timoptic in Ocudose,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
DILTIAZEM HYDROCHLORIDE,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Kiprofen,renal failure,19,0,CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1,direct
LISINOPRIL and HYDROCHLOROTHIAZIDE,AIDS,10,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
VELCADE,autoimmune disease,15,0,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Doxy 100,autoimmune disease,15,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
bisoprolol fumarate and hydrochlorothiazide,impaired renal function,919,1,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,direct
"CycloSPORINE, Modfied",autoimmune disease,15,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
VYXEOS,AIDS,10,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,direct
LISINOPRIL AND HYDROCHLOROTHIAZIDE,myocardial infarction,1,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
CASPOFUNGIN ACETATE,myocardial infarction,1,0,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
Azor,hypertension,39,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Silver Sulfadiazine,severe infection,18,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
Promethazine Hydrochloride,depression,27,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
omeprazole sodium bicarbonate,asthma,12,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Pazopanib,available laboratory data,623,1,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,direct
VIVIMUSTA,cancer (localized),8,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
LEVOPHED,chronic kidney disease,3,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Sertraline,depressive symptoms,769,1,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,direct
Norpace CR,ventricular arrhythmias,1354,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
Memantine Hydrochloride,sepsis,17,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
CYTARABINE,liver disease (non-cirrhotic),20,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,direct
hydrocort,sepsis,17,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
methylprednisolone,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Cefdinir,cancer (metastatic),9,0,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,direct
ethacrynic acid,chronic obstructive pulmonary disease (COPD),6,0,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Flucytosine,hypersensitivity,313,1,NC1=C(F)C=NC(=O)N1,direct
Amiloride Hydrochloride,persistent hyperkalemia,1119,1,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
Deferasorox,poor performance status,1139,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Hydroxyzine hydrochloride,hypersensitivity,313,1,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Vimpat,partial-onset seizures,1106,1,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
Hydrocortisone Acetate Pramoxine Hcl,hypersensitivity,313,1,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Ribotin-E,liver disease (non-cirrhotic),20,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Silver Sulfadiazine,congestive heart failure,2,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
desmopressin acetate,asthma,12,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
amantadine,chronic obstructive pulmonary disease (COPD),6,0,NC12CC3CC(CC(C3)C1)C2,direct
HYFTOR,hypertension,11,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
OXCARBAZEPINE,chronic kidney disease,3,0,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
CAPRELSA,mental illness,14,0,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,direct
Cortisone Acetate,cancer (localized),8,0,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Atenolol,liver cirrhosis,4,0,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,direct
Memantine HCL,chronic kidney disease,3,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Armodafinil,hypersensitivity,313,1,NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1,direct
SEREVENT DISKUS,AIDS,10,0,OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1,direct
FLUORESCITE,renal failure,19,0,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
Lacosamide,partial-onset seizures,1106,1,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
Levetiracetam Extended-release,hypersensitivity,313,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
PRYIDOSTIGMINE BROMIDE,pregnancy,16,0,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Docetaxel,preexisting liver disorders,1161,1,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
Triazolam,hypertension,11,0,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,direct
ENALAPRILAT,chronic kidney disease,3,0,[H][C@@](C)(N[C@@]([H])(CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@@]1([H])C(O)=O,direct
chlordiazepoxide hydrochloride and clidinium bromide,myocardial infarction,1,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
olanzapine,chronic kidney disease,3,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
PredniSONE,liver cirrhosis,4,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE,mental illness,14,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
PARSABIV,hypersensitivity,313,1,C[C@@H](NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](C)NC(=O)[C@@H](CSSC[C@H](N)C(O)=O)NC(C)=O)C(=O)N[C@H](CCCNC(N)=N)C(N)=O,direct
Albuterol Sulfate,asthma,12,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
AMITRIPTYLINE HCL,cancer (metastatic),9,0,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Abiraterone acetate,severe infection,18,0,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Rexulti,liver cirrhosis,4,0,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,direct
Enalapril maleate and hydrochlorothiazide,severe infection,18,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
Isosorbide,congestive heart failure,41,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
Azithromycin Dihydrate,cancer (metastatic),9,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
ganciclovir,renal failure,19,0,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,direct
AmBisome,congestive heart failure,2,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Cefazolin,perioperative prophylaxis,1115,1,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,direct
PRIALT,stroke,7,0,[H][C@]12CSSC[C@]3([H])NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@]([H])(NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC3=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N2,direct
DORZOLAMIDE HYDROCHLORIDE,renal failure,19,0,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Benicar HCT,mental illness,14,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Priftin,renal failure,19,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(\C=N\N1CCN(CC1)C1CCCC1)=C2O,direct
Lisinopril with Hydrochlorothiazide,chronic kidney disease,3,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Dalfampridine,mental illness,14,0,NC1=CC=NC=C1,direct
Cyltezo,chronic obstructive pulmonary disease (COPD),6,0,CC(C)O,direct
Tafluprost Ophthalmic,mental illness,14,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
HALCINONIDE,congestive heart failure,2,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
LYVISPAH,hypersensitivity to baclofen,884,1,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide",hypertension,39,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
lacosamide,severe infection,18,0,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
Risedronate Sodium,renal failure,19,0,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
"Butalbita,Acetaminophen and Caffeine",acetaminophen allergy,513,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
DIANEAL Low Calcium with Dextrose,anemia,13,0,[Cl-].[Cl-].[Ca++],direct
AMRIX,muscle spasm,457,1,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
VYXEOS,mental illness,14,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,direct
INDERAL LA,angina pectoris,596,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Doxycycline Hyclate,impaired renal function,919,1,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Oseltamivir Phosphate for Oral Suspension,hypersensitivity,313,1,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
Oxycodone/APAP,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
Moexipril Hydrochloride,diabetes mellitus,5,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O,direct
LOTRONEX,hypertension,11,0,CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2,direct
omeprazole,hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Lamotrigine,partial-onset seizures who,1108,1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
ZYKADIA,alk-positive nsclc,582,1,CC(C)OC1=C(NC2=NC=C(Cl)C(N2)=NC2=CC=CC=C2S(=O)(=O)C(C)C)C=C(C)C(=C1)C1CCNCC1,direct
Abiraterone,AIDS,10,0,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Edetate Calcium Disodium,chronic obstructive pulmonary disease (COPD),6,0,[Na+].[Na+].[Ca++].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O,direct
caffeine citrate,congestive heart failure,2,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Tobramycin,this symptom,1317,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Methylphenidate HCl,comorbid depressive symptoms,735,1,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
risperidone,hypersensitivity,313,1,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,direct
Diclofenac Sodium Delayed Release Delayed Release,stroke,7,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Demser,hypertension,11,0,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,direct
DOXYCYCLINE HYCLATE,autoimmune disease,15,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Citalopram,hypersensitivity,313,1,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
Risedronate Sodium,the following conditions,1301,1,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
EMSAM,pheochromocytoma because maois,1124,1,C[C@H](CC1=CC=CC=C1)N(C)CC#C,direct
Doxepin Hydrochloride,depressive symptoms,769,1,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
MESALAMINE,anemia,13,0,NC1=CC(C(O)=O)=C(O)C=C1,direct
Capecitabine 500mg,diabetes mellitus,5,0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
Triloan SUIK,liver disease (non-cirrhotic),20,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Metoprolol tartrate,diabetes mellitus,5,0,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
INDERAL LA,cancer (localized),8,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
"BUTALBITAL, ACETAMINOPHEN AND CAFFEINE",acetaminophenm allergy,515,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Xtandi,myocardial infarction,1,0,CNC(=O)C1=C(F)C=C(C=C1)N1C(=S)N(C(=O)C1(C)C)C1=CC=C(C#N)C(=C1)C(F)(F)F,direct
Chromagen,cancer (metastatic),9,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
HydrOXYzine Hydrochloride,pregnancy,16,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Caldolor,malaria,305,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Disopyramide Phosphate,arrhythmia,43,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE,cancer (localized),8,0,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
Albuterol sulfate,sepsis,17,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Imatinib,anemia,13,0,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Emtriva,hypersensitivity,313,1,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,direct
Potassium Chloride in Sodium Chloride,brain edema,643,1,[Cl-].[K+],direct
Flumazenil,chronic obstructive pulmonary disease (COPD),6,0,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,direct
Tikosyn,a recent mi,507,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Estradiol Vaginal,breast cancer,263,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
NALFON,congestive heart failure,2,0,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,direct
Nefazodone Hydrochloride,anemia,13,0,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,direct
Fenofibric Acid,pregnancy,16,0,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
Doxorubicin Hydrochloride Liposome,congestive heart failure,2,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
METHYLPREDNISOLONE ACETATE,autoimmune disease,15,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Nabumetone 500 mg,anemia,13,0,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
Cytomel,mental illness,14,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
SOAANZ,hypersensitivity,313,1,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1,direct
LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
LAMIVUDINE AND ZIDOVUDINE,chronic obstructive pulmonary disease (COPD),6,0,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
Olanzapine and Fluoxetine,myocardial infarction,1,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
GaviLyte - C TM,sepsis,17,0,[Cl-].[K+],direct
Binosto,the following conditions,1301,1,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Cefazolin,anemia,13,0,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,direct
DEXRAZOXANE,severe infection,18,0,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,direct
Promethazine Hydrochloride and Dextromethorphan Hydrobromide,bone-marrow depression,639,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
cephalexin,AIDS,10,0,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
Sevelamer Carbonate For Oral Suspension,autoimmune disease,15,0,NCC=C.ClCC1CO1,direct
"Travoprost Ophthalmic Solution, 0.004%",glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Seizalam,hypersensitivity,313,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Calcitrene,hypersensitivity,313,1,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
Olanzapine,hypertension,11,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Trecator,liver cirrhosis,4,0,CCC1=NC=CC(=C1)C(N)=S,direct
Zilretta,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Amlodipine and Valsartan,hypertension,11,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Mupirocin,autoimmune disease,15,0,C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O,direct
CIMDUO,hypersensitivity,313,1,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,direct
REGIOCIT,asthma,12,0,[Na+].[Cl-],direct
PROCHLORPERAZINE EDISYLATE,autoimmune disease,15,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Proctosol-HC,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
RANOLAZINE,chronic angina,684,1,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,direct
"Butalbital, Acetaminophen and Caffeine",AIDS,10,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Prednisolone,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Diclofenac Sodium Delayed Release Delayed Release,the aspirin triad,1295,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
BRIMONIDINE TARTRATE and TIMOLOL MALEATE,congestive heart failure,2,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Sensorcaine,stroke,7,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Lorazepam,glaucoma,481,1,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,direct
amlodipine besylate and olmesartan medoxomil,hypertension,39,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Heparin Sodium and Dextrose,stroke,7,0,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C=O,fuzzy:heparin sodium in dextrose
CAFCIT,congestive heart failure,2,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
MIDODRINE HYDROCHLORIDE,mental illness,14,0,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,direct
TOLMETIN SODIUM,the aspirin triad,1295,1,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,direct
Montelukast sodium,congestive heart failure,2,0,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
Hydrocodone APAP,chronic overdose,698,1,CC(=O)NC1=CC=C(O)C=C1,direct
CEVIMELINE,other conditions,1087,1,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
Nardil,endogenous features,793,1,NNCCC1=CC=CC=C1,direct
Zithromax,anemia,13,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Testosterone Cypionate,pregnancy,16,0,[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
desoximetasone,anemia,13,0,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Dabigatran etexilate,cancer (localized),8,0,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
Cefuroxime sodium,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,direct
Voriconazole,hypersensitivity,313,1,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
NOREPINEPHRINE BITARTRATE,chronic kidney disease,3,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Cefdinir,tics,23,1,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,direct
Omeprazole/Sodium Bicarbonate,hypertension,11,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Lactated Ringers,hypersensitivity,313,1,[Cl-].[K+],direct
amiloride hydrochloride,congestive heart failure,2,0,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
Zolpidem tartrate,sepsis,17,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
pravastatin sodium,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Varenicline tartrate,pregnancy,16,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Dihydroergotamine mesylate,risk factors,1216,1,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
Lorazepam,sepsis,17,0,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,direct
Tamiflu,anemia,13,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE,impaired liver function,918,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
DEFINITY RT,sickle cell disease,89,1,FC(F)(F)C(F)(F)C(F)(F)F,direct
NITROGLYCERIN IN DEXTROSE,liver cirrhosis,4,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Soma,liver disease (non-cirrhotic),20,0,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,direct
DEFENCATH,kidney failure,373,1,O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1,direct
Deferasorox,decreased egfr,761,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Ciprofloxacin and Dexamethasone,pregnancy,16,0,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,direct
Clocortolone Pivalate,sepsis,17,0,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
NAROPIN,liver cirrhosis,4,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
COSOPT,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Icosapent ethyl,congestive heart failure,2,0,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
ERLOTINIB,pancreatic cancer,1097,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
DURYSTA,sepsis,17,0,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
Diltiazem Hydrochloride EXTENDED RELEASE,hypotension,75,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Sulfamethox-TMP DS,anemia,81,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Forfivo XL,liver disease (non-cirrhotic),20,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
oseltamivir phosphate,hypersensitivity,313,1,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
CARBIDOPA,hypersensitivity,313,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Promethazine,depression,27,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Molindone Hydrochloride,stroke,7,0,CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2,direct
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE,pregnancy,16,0,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],direct
Oseltamivir phosphate,hypertension,11,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
Revlimid,congestive heart failure,2,0,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
Travatan Z,mental illness,14,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
VOTRIENT,cancer (localized),8,0,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,direct
Midazolam hydrochloride,hypersensitivity,313,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
POTASSIUM CITRATE EXTENDED RELEASE,sepsis,17,0,[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,direct
AMLODIPINE AND OLMESARTAN MEDOXOMIL,hypertension,39,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
LEXISCAN,chronic kidney disease,3,0,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
Cyclomydril,AIDS,10,0,CNC[C@H](O)C1=CC(O)=CC=C1,direct
Amphotericin B,presumed fungal infections,1165,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Estradiol,anemia,13,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Perindopril Erbumine,essential hypertension,806,1,[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,direct
ConZip,severe infection,18,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Prednisone,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Exelon,cancer (localized),8,0,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,direct
Alprazolam,glaucoma,481,1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
Conray,cancer (metastatic),9,0,CNC(=O)C1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
TAUVID,alzheimer's disease,35,1,[18F]C1=CC=C(C=N1)C1=CC=C2C(NC3=C2C=NC=C3)=C1,direct
NOREPINEPHRINE BITARTRATE,congestive heart failure,2,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
CIMDUO,liver disease (non-cirrhotic),20,0,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,direct
penicillamine,anemia,81,1,[H][C@](N)(C(O)=O)C(C)(C)S,direct
Venlafaxine,recurrent depression who,1200,1,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
INDOMETHACIN,the aspirin triad,1295,1,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,direct
PEMRYDI RTU,pregnancy,16,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
Mepivacaine Hydrochloride,hypersensitivity,313,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
PureVit DualFe Plus,diabetes mellitus,5,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Positive Skin Test Control - Histamine,congestive heart failure,2,0,NCCC1=CNC=N1,direct
Flurandrenolide,hypersensitivity,313,1,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,direct
BUPIVACAINE HCI,diabetes mellitus,5,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
BETAMETHASONE DIPROPIONATE,hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Nalbuphine hydrochloride,pregnancy,16,0,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
Epclusa,liver cirrhosis,4,0,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
Indomethacin,the aspirin triad,1295,1,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,direct
Clonidine Hydrochloride,asthma,12,0,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
RIFAMPIN,diabetes mellitus,5,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
ISOVUE 300,hyperthyroidism,117,1,C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I,direct
Diazoxide,congestive heart failure,41,1,CC1=NS(=O)(=O)C2=C(N1)C=CC(Cl)=C2,direct
Body Wash,congestive heart failure,2,0,OC(=O)C1=CC=CC=C1O,direct
AMLODIPINE and OLMESARTAN medoxomil,chronic obstructive pulmonary disease (COPD),6,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Clomid,hypersensitivity,313,1,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
Dorzolamide and Timolol,cancer (localized),8,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Prednisolone,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Phenylephrine Hydrochloride,hypertension or thyrotoxicosis,897,1,CNC[C@H](O)C1=CC(O)=CC=C1,direct
cephalexin,cancer (metastatic),9,0,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
Potassium Chloride in Dextrose and Sodium Chloride,autoimmune disease,15,0,[Cl-].[K+],direct
Exforge HCT,hypercalcemia,139,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Fulvestrant,myocardial infarction,1,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],direct
Tindamax,congestive heart failure,2,0,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O,direct
Rhopressa,hypertension,39,1,CC1=CC(C)=C(C=C1)C(=O)OCC1=CC=C(C=C1)[C@@H](CN)C(=O)NC1=CC=C2C=NC=CC2=C1,direct
Timoptic,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Otrexup,chronic kidney disease,3,0,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
Citalopram Hydrobromide,depressive symptoms,769,1,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
ASENAPINE,anemia,13,0,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
Norepinephrine,chronic kidney disease,3,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
memantine,autoimmune disease,15,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
NADOLOL,pregnancy,16,0,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,direct
Cortisone Acetate,congestive heart failure,41,1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Cefazolin Sodium,perioperative prophylaxis,1115,1,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,direct
Doxorubicin Hydrochloride Liposome,multiple myeloma who,1025,1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
teriflunomide,mental illness,14,0,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
CIDOFOVIR DIHYDRATE,hypersensitivity,313,1,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,direct
Beleodaq,lymphoma,269,1,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1,direct
zolmiptriptan,hypersensitivity,313,1,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
Arsenic Trioxide,cancer (localized),8,0,O=[As]O[As]=O,direct
Flavoxate Hydrochloride,hypertension,11,0,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,direct
Estradiol valerate,mental illness,14,0,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
DALFAMPRIDINE,ms as follows,1022,1,NC1=CC=NC=C1,direct
Pain Relieving Patch,pregnancy,16,0,CC(C)C1CCC(C)CC1O,direct
Vascepa,pregnancy,16,0,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
MOMETASONE FUROATE,cancer (localized),8,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Vimpat,chronic kidney disease,3,0,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
DOFETILIDE,chronic kidney disease,3,0,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
DEPO-MEDROL,hypertension,11,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
ALVAIZ,renal failure,19,0,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,direct
Tafluprost,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
VIDAZA,myocardial infarction,1,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Zoledronic acid,underlying risk factors,1340,1,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
Liothyronine sodium,cancer (localized),8,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
Oxycodone Hydrochloride and Acetaminophen,chronic kidney disease,3,0,CC(=O)NC1=CC=C(O)C=C1,direct
CHLORTHALIDONE,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Aminophylline,mental illness,14,0,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
CYSTEINE HYDROCHLORIDE,hypersensitivity,313,1,N[C@@H](CS)C(O)=O,direct
ZALDYON,myocardial infarction,1,0,NC1=CC(C(O)=O)=C(O)C=C1,direct
Sulfameth/Trimeth-DS,diabetes mellitus,5,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
ABILIFY MAINTENA,chronic kidney disease,3,0,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
lurasidone hydrochloride,cancer (metastatic),9,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Varenicline,diabetes mellitus,5,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
HUMIRA,active psa,532,1,CC(C)O,direct
Tobramycin Inhalation,congestive heart failure,2,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Leep RediKit,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
butalbital and acetaminophen,mental illness,14,0,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,direct
bortezomib,mantle cell lymphoma,983,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Prilosec,congestive heart failure,2,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
AMLODIPINE AND VALSARTAN,liver disease (non-cirrhotic),20,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Metopirone,severe infection,18,0,CC(C)(C(=O)C1=CN=CC=C1)C1=CC=CN=C1,direct
Potassium Chloride Extended-release,anemia,13,0,[Cl-].[K+],direct
Bromocriptine Mesylate,myocardial infarction,49,1,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
ACCRUFER,renal failure,19,0,[Fe+3].CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1,direct
Pramipexole Dihydrochloride Extended-Release,asthma,12,0,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
SILVADENE,chronic kidney disease,3,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
Cefuroxime Axetil,mental illness,14,0,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,direct
XYLOCAIN (LIDOCAINE HCl ),hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Doxepin HCL,glaucoma,481,1,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
SORILUX,hypercalcemia,139,1,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
DOBUTAMINE HYDROCHLORIDE,autoimmune disease,15,0,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE,glaucoma,481,1,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
ARISTADA INITIO,myocardial infarction,1,0,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12,direct
Ezetimibe,autoimmune disease,15,0,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
Liquid Polibar Plus,severe infection,18,0,[Ba++].[O-]S([O-])(=O)=O,direct
FLOLAN,renal failure,19,0,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,direct
Erythromycin Lactobionate,hypersensitivity,313,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Sunitinib malate,chronic obstructive pulmonary disease (COPD),6,0,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,direct
Kyzatrex,severe infection,18,0,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,direct
Ammonium Lactate,hypersensitivity,313,1,[NH4+].CC(O)C([O-])=O,direct
Fluphenazine Decanoate,mental retardation,993,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Oxaliplatin,advanced colorectal cancer,560,1,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,direct
Klonopin,pregnancy,16,0,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,direct
Galantamine Hydrobromide,hypersensitivity,313,1,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
DIMETHYL FUMARATE,congestive heart failure,2,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
POLOCAINE (MEPIVACAINE HCl),liver cirrhosis,4,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Citanest Forte DENTAL,hypersensitivity,313,1,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
ONDANSETRON,diabetes mellitus,5,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Protonix Delayed-Release,hypersensitivity,313,1,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
SEVELAMER HYDROCHLORIDE,cancer (metastatic),9,0,NCC=C.ClCC1CO1,direct
Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution,liver cirrhosis,4,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Romidepsin,liver disease (non-cirrhotic),20,0,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,direct
"Butalbital, Acetaminophen, Caffeine",acetaminophen allergy,513,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Amlodipine and olmesartan Medoxomil,kidney failure,373,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Dexlansoprazole,hypersensitivity,313,1,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1,direct
clobazam,hypersensitivity,313,1,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,direct
Rocklatan,cancer (metastatic),9,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Ionite H,cancer (localized),8,0,[F-].[Na+],direct
LEVOXYL,pediatric patients,13,1,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
Methylphenidate,comorbid depressive symptoms,735,1,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
Bupropion hydrochloride,hypertension,11,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Regadenoson,autoimmune disease,15,0,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
DIURIL,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
RIFAMPIN,congestive heart failure,2,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
Kit for the Preparation of Technetium Tc 99m Sulfur Colloid,breast cancer,263,1,[99Tc].S1SSSSSSS1,direct
Itraconazole,pregnancy,16,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
SEVELAMER HYDROCHLORIDE,stroke,7,0,NCC=C.ClCC1CO1,direct
Dofetilide 0.125mg,supraventricular arrhythmias,1280,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Zoledronic acid,bone metastases,638,1,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
Rocaltrol,hypertension,11,0,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,direct
Alclometasone Dipropionate,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])[C@H](Cl)CC2=CC(=O)C=C[C@]12C,direct
CIPRODEX,non-intact tympanic membranes,1046,1,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,direct
Dorzolamide hydrochloride and timolol maleate,autoimmune disease,15,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Sodium Phenylacetate and Sodium Benzoate,chronic kidney disease,3,0,OC(=O)C1=CC=CC=C1,direct
Glycopyrrolate,severe infection,18,0,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
SELEGILINE HYDROCHLORIDE,asthma,12,0,C[C@H](CC1=CC=CC=C1)N(C)CC#C,direct
Ery-Ped,hypersensitivity,313,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Deferasirox oral,severe infection,18,0,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Chromagen,stroke,7,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Lynparza,congestive heart failure,2,0,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1,direct
ITRACONAZOLE,severe infection,18,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Clonidine transdermal system,AIDS,10,0,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
"Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide",hypertension,11,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Bupropion hydrochloride,chronic kidney disease,3,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Mirabegron,pediatric patients,13,1,NC1=NC(CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2)=CS1,direct
METHYLPREDNISOLONE,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
SORILUX,myocardial infarction,1,0,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
nitroglycerin,shock,419,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
LIDOCAINE HCl,anemia,13,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Lidocaine Hydrochloride,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
BORTEZOMIB,relapsed multiple myeloma,1205,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Timolol Maleate Ophthalmic Gel Forming Solution,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Dofetilide 0.125mg,a recent mi,507,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
NEBIVOLOL,renal failure,19,0,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
Fluvastatin Sodium,hypersensitivity,313,1,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,direct
SIMVASTATIN,myocardial infarction,49,1,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
VIVJOA,pregnancy,16,0,O[C@@](CN1C=NN=N1)(C1=CC=C(F)C=C1F)C(F)(F)C1=CC=C(C=N1)C1=CC=C(OCC(F)(F)F)C=C1,direct
Penicillamine,aplastic anemia,103,1,[H][C@](N)(C(O)=O)C(C)(C)S,direct
Gentak,asthma,12,0,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,direct
Perphenazine and Amitriptyline Hydrochloride,cardiovascular disorders,669,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
NINLARO,diabetes mellitus,5,0,CC(C)C[C@H](NC(=O)CNC(=O)C1=CC(Cl)=CC=C1Cl)B(O)O,direct
Trijardy XR,asthma,12,0,CN(C)C(=N)NC(N)=N,direct
Oxycodone Hydchloride,cancer (metastatic),9,0,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C,direct
Dutasteride and tamsulosin hydrochloride,pregnancy,16,0,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O,direct
LAMOTRIGINE,partial-onset seizures who,1108,1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
RAPAFLO,hypersensitivity,313,1,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,direct
Forfivo XL,hypertension,11,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Suprane,hypertension,11,0,FC(F)OC(F)C(F)(F)F,direct
Istalol,bronchial asthma,650,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
VENLAFAXINE,recurrent depression who,1200,1,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
fomepizole,mental illness,14,0,CC1=CNN=C1,direct
CIDOFOVIR DIHYDRATE,peripheral cmv retinitis,1116,1,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,direct
nystatin,chronic kidney disease,3,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Plenvu,severe renal impairment,1253,1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
SOLTAMOX,severe infection,18,0,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,direct
Renvela,chronic obstructive pulmonary disease (COPD),6,0,NCC=C.ClCC1CO1,direct
Prenate Chewable,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
pramosone,chronic kidney disease,3,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Levocarnitine,edema,417,1,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
ERTAPENEM,the laboratory test,1306,1,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
PARAPLATIN,chronic kidney disease,3,0,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Cetirizine Hydrochloride,pregnancy,16,0,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Galantamine,diabetes mellitus,5,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
Norepinephrine,mental illness,14,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Nitrofurantoin Macrocrystals,chronic kidney disease,3,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Zoledronic acid,stroke,7,0,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
Evista,an intact uterus,591,1,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,direct
FLUTICASONE PROPIONATE,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
ACCURETIC,diabetes mellitus,5,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
CHLOROTHIAZIDE SODIUM,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
Caspofungin Acetate,invasive aspergillosis,944,1,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
Capecitabine 150mg,chronic obstructive pulmonary disease (COPD),6,0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
Adalimumab,polyarticular jia who,1137,1,CC(C)O,direct
CLOFARABINE,pediatric patients,13,1,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,direct
polymyxin b sulfate and trimethoprim sulfate,chronic obstructive pulmonary disease (COPD),6,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Tranexamic Acid,subarachnoid hemorrhage,1275,1,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Dexamethasone sodium phosphate,a stressed myocardium,508,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
pazopanib,available laboratory data,623,1,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=CC=NC(NC2=CC=C(C)C(=C2)S(N)(=O)=O)=N1,direct
Nystatin Cream,congestive heart failure,2,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Cytarabine,cancer (localized),8,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,direct
Irinotecan Hydrochloride 100 mg/5 mL,mental illness,14,0,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
lisinopril,myocardial infarction,1,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Desmopressin acetate,AIDS,10,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
TOBRAMYCIN,anemia,13,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
gynazole 1,hypersensitivity,313,1,ClC1=CC=C(CCC(CN2C=CN=C2)SC2=C(Cl)C=CC=C2Cl)C=C1,direct
Sodium Iodide I-131,vomiting and diarrhea,1360,1,[131I-],direct
DoubleDex Kit,sepsis,17,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
HydrOXYzine Hydrochloride,congestive heart failure,2,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Marcaine,severe infection,18,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
TOLCAPONE,elevated enzymes,788,1,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,direct
Lidocaine Hydrochloride and Epinephrine,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ALBENZA,cancer (metastatic),9,0,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,direct
Gastrografin,autoimmune disease,15,0,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Chlordiazepoxide and Amitriptyline Hydrochloride,mental illness,14,0,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Clomiphene Citrate,normal liver function,1063,1,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
Amlodipine and Olmesartan Medoxomil,myocardial infarction,1,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
epinephrine,shock,419,1,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Famciclovir,chronic obstructive pulmonary disease (COPD),6,0,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O,direct
Travoprost,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Methylprednisolone acetate,renal failure,19,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Ziac,autoimmune disease,15,0,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,direct
ESOMEPRAZOLE STRONTIUM,sepsis,17,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
E.E.S 400,hypersensitivity,313,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
CEFADROXIL,anemia,13,0,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
varenicline,hypersensitivity,313,1,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
zolmitriptan,anemia,13,0,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
ATAZANAVIR,anemia,13,0,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,direct
PYLERA,AIDS,10,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
LAMICTAL,pediatric patients,13,1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
Pantoprazole Sodium,hypertension,11,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Amlodipine besylate and Olmesartan medoxomil,hypertension,11,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
DermacinRx Purefoltin,liver cirrhosis,4,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
"Orphenadrine Citrate, Aspirin and Caffeine",cancer (metastatic),9,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Voriconazole,sepsis,17,0,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Doxepin hydrochloride,depressive symptoms,769,1,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
HYALURONIDASE,hypersensitivity,313,1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
meloxicam,mental illness,14,0,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O,direct
methylphenidate hydrochloride CD,comorbid depressive symptoms,735,1,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
imatinib mesylate,congestive heart failure,2,0,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
"Testosterone Gel, 1%",cancer (metastatic),9,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Juxtapid,renal failure,19,0,FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=C(C=CC=C2)C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=CC=CC=C12,direct
Venlafaxine hydrochloride,anemia,13,0,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
TIAGABINE HYDROCHLORIDE,epilepsy who,799,1,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1,direct
Docetaxel,pre-existing liver disorders,1151,1,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
COLCHICINE,asthma,12,0,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
INVEGA TRINZA,pregnancy,16,0,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release",mental illness,14,0,CC(N)CC1=CC=CC=C1,direct
NITROGLYCERIN IN DEXTROSE,diabetes mellitus,5,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
PROMETHAZINE HYDROCHLORIDE,depression,27,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
DOXERCALCIFEROL,stroke,7,0,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
Budesonide,asthma,12,0,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Fluconazole in Sodium Chloride,hypersensitivity,313,1,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Aztreonam,hypertension,11,0,C[C@H]1[C@H](NC(=O)C(=N/OC(C)(C)C(=O)O)\C2=CSC([NH3+])=N2)C(=O)N1S([O-])(=O)=O,direct
Omeprazole/Bicarbonate,hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Epclusa,anemia,13,0,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
Pravastatin Sodium,primary dysbetalipoproteinemia who,1172,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Imbruvica,anemia,81,1,NC1=NC=NC2=C1C(=NN2[C@@H]1CCCN(C1)C(=O)C=C)C1=CC=C(OC2=CC=CC=C2)C=C1,direct
Topiramate,epilepsy who,799,1,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,direct
Dialyvite with Zinc,hypertension,11,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Valsartan and Hydrochlorothiazide,asthma,12,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Adalimumab-aacf,mental illness,14,0,CC(C)O,direct
Buprenorphine Hydrochloride,depression,27,1,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,direct
MANNITOL,renal failure,19,0,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,direct
Olumiant,rheumatoid arthritis,159,1,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,direct
Memantine Hydrochloride,chronic kidney disease,3,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Sodium Phenylacetate and sodium benzoate,otc and cps,1083,1,OC(=O)C1=CC=CC=C1,direct
Tafluprost,congestive heart failure,2,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
EPOPROSTENOL,diabetes mellitus,5,0,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,direct
Everolimus,renal failure,19,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,direct
Omeprazole/Bicarbonate,asthma,12,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
ELIQUIS,the following conditions,1301,1,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,direct
Ropivacaine hydrochloride,hypersensitivity,313,1,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
PHENDIMETRAZINE TARTRATE,heart disease,377,1,C[C@H]1[C@@H](OCCN1C)C1=CC=CC=C1,direct
CardioGen-82,sepsis,17,0,[82Rb+],direct
Nalbuphine Hydrochloride,diabetes mellitus,5,0,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
PNV-Select,liver disease (non-cirrhotic),20,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Nicardipine hydrochloride,hypertension,11,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
Exforge HCT,liver disease (non-cirrhotic),20,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Cortisone Acetate,inflammatory bowel disease,223,1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Lidocaine and Prilocaine,myocardial infarction,1,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Liothyronine Sodium,severe infection,18,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride and DextromethorphanHydrobromide",coronary artery disease,37,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Desmopressin acetate,hyponatremia,137,1,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
Ammonium Lactate,cancer (localized),8,0,[NH4+].CC(O)C([O-])=O,direct
candesartan cilexetil and hydrochlorothiazide,symptomatic hypotension,1287,1,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1,direct
ibandronate sodium,diabetes mellitus,5,0,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Pentam 300,diabetes mellitus,5,0,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
Methylene Blue,acquired methemoglobinemia,517,1,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,direct
PROCAINAMIDE HYDROCHLORIDE,cardiac decompensation,666,1,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
Dextromethorphan Hydrobromide and Promethazine Hydrochloride,depression,27,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
perphenazine,congestive heart failure,2,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Lisdexamfetamine dimesylate,obesity,149,1,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
paroxetine hydrochloride,cancer (metastatic),9,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Lisinopril and Hydrochlorothiazide,AIDS,10,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
LACOSAMIDE,partial-onset seizures generally,1107,1,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
ertapenem sodium,liver disease (non-cirrhotic),20,0,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Toronova SUIK,the aspirin triad,1295,1,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Otezla,plaque psoriasis who,1129,1,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,direct
NIFEDIPINE,cancer (metastatic),9,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Ambien CR,insomnia,441,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
lurasidone hydrochloride,another indication,601,1,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Anusol HC,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
RUBY-FILL,stroke,7,0,[82Rb+],direct
Niferex,anemia,13,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
K-Phos No. 2,pregnancy,16,0,[K+].OP(O)([O-])=O,direct
Cardizem,myocardial infarction,49,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Synalar,diabetes mellitus,5,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
EOVIST,hypertension,11,0,[Gd+3].[H][C@@](CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)(CC1=CC=C(OCC)C=C1)N(CC(O)=O)CC(O)=O,direct
deferasirox,hypertension,11,0,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
LEVETIRACETAM,hypersensitivity,313,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE,autoimmune disease,15,0,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3,direct
DROPERIDOL,asthma,12,0,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,direct
Betamethasone Sodium Phosphate and Betamethasone Acetate,unexplained diarrhea,1341,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Multi-Specialty Kit,mental illness,14,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Regonol,asthma,193,1,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Flac Otic Oil,liver cirrhosis,4,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Celecoxib,liver cirrhosis,4,0,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
Dexilant,AIDS,10,0,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1,direct
SIMVASTATIN,AIDS,10,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
LIDOCAINE HYDROCHLORIDE,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Ibuprofen,the aspirin triad,1295,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Tramadol Hydrochloride,liver cirrhosis,4,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Valsartan and Hydrochlorothiazide,cancer (localized),8,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Metoprolol,arrhythmia,43,1,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
METRONIDAZOLE,myocardial infarction,1,0,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
acamprosate calcium,alcohol dependence who,580,1,CC(=O)NCCCS(O)(=O)=O,direct
FOSCARNET SODIUM,cancer (localized),8,0,OC(=O)P(O)(O)=O,direct
Flumazenil,hypersensitivity,313,1,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,direct
BRIMONIDINE TARTRATE and TIMOLOL MALEATE,sinus bradycardia,1261,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Sotalol Hydrochloride,life-threatening ventricular arrhythmias,966,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Tetracaine,liver disease (non-cirrhotic),20,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
NITROFURANTOIN (monohydrate/macrocrystals),hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
lurasidone hydrochloride,myocardial infarction,1,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE",comorbid depressive symptoms,735,1,CC(N)CC1=CC=CC=C1,direct
Lyrica CR,anemia,13,0,CC(C)C[C@H](CN)CC(O)=O,direct
Multiple Electrolytes pH 5.5,hypochloremic hypokalemic alkalosis,902,1,[Cl-].[K+],direct
Flavoxate Hydrochloride,congestive heart failure,2,0,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,direct
ORSERDU,hypertension,11,0,CCNCCC1=CC=C(CN(CC)C2=C(C=CC(OC)=C2)[C@@H]2CCC3=CC(O)=CC=C3C2)C=C1,direct
FABHALTA,hypersensitivity,313,1,CCO[C@H]1CCN(CC2=C(OC)C=C(C)C3=C2C=CN3)[C@@H](C1)C1=CC=C(C=C1)C(O)=O,direct
DILTIAZEM HYDROCHLORIDE,hypertension,11,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Bupivacaine HCl,diabetes mellitus,5,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
CLOFARABINE,AIDS,10,0,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,direct
Telmisartan and Amlodipine,myocardial infarction,1,0,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,direct
Minoxidil,renal failure,19,0,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1,direct
Clindamycin Phosphate 1.2% and Tretinoin 0.025%,congestive heart failure,2,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
"Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride",cancer (metastatic),9,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
MB CAPS,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,fuzzy:pm caps
Rinvoq,moderate-to-severe atopic dermatitis,1017,1,CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F,direct
Antiperspirant,renal failure,257,1,O.[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-],direct
Lurasidone Hydrochloride,liver cirrhosis,4,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Dorzolamide Hydrochloride and Timolol Maleate ophthalmic,liver disease (non-cirrhotic),20,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
tizanidine,cancer (localized),8,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Liothyronine sodium,hypertension,11,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
IBUPROFEN,severe infection,18,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Fenofibrate,severe hypertriglyceridemia,1247,1,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
Alprazolam Extended Release,poisoning,425,1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
Ertapenem,renal failure,19,0,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Orphenadrine Citrate Aspirin Caffeine,myasthenia gravis,151,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Midazolam Hydrochloride,hemodynamic instability,852,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Pentam 300,hypersensitivity,313,1,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
Mekinist,low-grade glioma who,971,1,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1,direct
Ledipasvir and Sofosbuvir,liver failure,371,1,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
Albuterol Sulfate Inhalation Solution,hypersensitivity,313,1,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Foscavir,hypersensitivity,313,1,OC(=O)P(O)(O)=O,direct
Sirolimus,liver cirrhosis,4,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
TARCEVA,pancreatic cancer,1097,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
Nitrofurantoin macrocrystals,hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Lidocaine Hydrochloride,severe infection,18,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Hectorol,dehydration,395,1,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
Lansoprazole DR,chronic kidney disease,3,0,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Valium,glaucoma,481,1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,direct
atomoxetine,narrow angle glaucoma,1029,1,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
pentazocine and naloxone,cancer (localized),8,0,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,direct
Amyvid,myocardial infarction,1,0,[H]N(C1=C([H])C([H])=C(\C([H])=C(/[H])C2=C([H])N=C(OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])[18F])C([H])=C2[H])C([H])=C1[H])C([H])([H])[H],direct
apixaban,the following conditions,1301,1,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,direct
POLOCAINE (MEPIVACAINE HCl),anemia,13,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Lurasidone Hydrochloride,pregnancy,16,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
ROBAXIN,diabetes mellitus,5,0,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
Cyclomydril,glaucoma,481,1,CNC[C@H](O)C1=CC(O)=CC=C1,direct
Rosuvastatin calcium,anemia,13,0,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Effient,autoimmune disease,15,0,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,direct
ENBREL,pediatric patients,13,1,OCC1=CC=CC=C1,direct
METHOCARBAMOL,cancer (metastatic),9,0,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
PROCHLORPERAZINE MALEATE,mental retardation,993,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
LAMOTRIGINE Kit,congestive heart failure,2,0,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
Cephalexin,stroke,7,0,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
"butalbital, aspirin, and caffeine",bleeding disorders,635,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
PEMETREXED,mental illness,14,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
Azor,kidney failure,373,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
pramosone,diabetes mellitus,5,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Claravis,mental illness,14,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Sulfamethox-TMP DS,thrombocytopenia,79,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Lisinopril,chronic obstructive pulmonary disease (COPD),6,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Nystatin and triamcinolone acetonide,liver cirrhosis,4,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Dorzolamide Hydrochloride and Timolol Maleate,diabetes mellitus,5,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Carbidopa and levodopa,anemia,13,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
oseltamavir phosphate,chronic kidney disease,3,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
PROSCAR,prostate cancer,265,1,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,direct
Linezolid,pediatric patients,13,1,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,direct
PACLITAXEL PACLITAXEL,solid tumors who,1266,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
AMITRIPTYLINE HCL,chronic obstructive pulmonary disease (COPD),6,0,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Methsuximide,mental illness,14,0,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1,direct
"PredniSONE Tablets, USP, 5 mg",unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Namenda,hypersensitivity,313,1,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE,hypersensitivity,313,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
VIVIMUSTA,liver cirrhosis,4,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
KLAYESTA,hypersensitivity,313,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
epiduo forte,cancer (localized),8,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Docetaxel,liver disease (non-cirrhotic),20,0,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
Nystatin,hypersensitivity,313,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Dorzolamide hydrochloride,sepsis,17,0,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Flurazepam Hydrochloride,hypersensitivity,313,1,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,direct
Benicar HCT,hypersensitivity,313,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Albuterol sulfate,hypersensitivity,313,1,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Methadone Hydrochloride,diabetes mellitus,5,0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Ropidex,pancreatitis,233,1,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
potassium chloride,liver cirrhosis,4,0,[Cl-].[K+],direct
Liothyronine sodium,pediatric patients,13,1,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
Cefuroxime axetil,influenza,289,1,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,direct
Rifabutin,active tuberculosis,535,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21,direct
Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound),and without neutropenia,595,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
"Clotrimazole Topical Solution USP, 1%",AIDS,10,0,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Candesartan Cilexetil and Hydrochlorothiazide,liver cirrhosis,4,0,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1,direct
olopatadine hydrochloride,liver disease (non-cirrhotic),20,0,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2,direct
calcipotriene,myocardial infarction,1,0,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
ROBAXIN,liver disease (non-cirrhotic),20,0,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
iopamidol,hyperthyroidism,117,1,C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I,direct
Stivarga,AIDS,10,0,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,direct
Diclofenac Sodium,hypersensitivity,313,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
LUMIGAN,hypertension,39,1,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
Fluconazole,hypersensitivity,313,1,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Nebivolol,cancer (localized),8,0,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
Xanax XR,congestive heart failure,2,0,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
CAPECITABINE,anemia,81,1,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
INDERAL LA,hypersensitivity,313,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
GEMCITABINE,cancer (metastatic),9,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
DEXRAZOXANE,diabetes mellitus,5,0,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,direct
Reltone 200 mg,cancer (localized),8,0,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
SIMVASTATIN,chronic kidney disease,3,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Donepezil Hydrochloride,asthma,12,0,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
Losortan Potassium,pregnancy,16,0,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE,stroke,7,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Nalbuphine hydrochloride,liver cirrhosis,4,0,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
PLERIXAFOR,liver cirrhosis,4,0,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
Sitagliptin,cancer (metastatic),9,0,N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F,direct
FENTORA,liver cirrhosis,4,0,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
ELMIRON,interstitial cystitis who,941,1,O[C@@H]1CO[C@@H](O[C@@H]2CO[C@@H](O)[C@H](OS(O)(=O)=O)[C@H]2OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O,direct
LIDOCAINE HCI,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
PNV-Select,congestive heart failure,2,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Dasatinib,chronic phase cml,701,1,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
Cromolyn Sodium,asthma,193,1,OC(COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O)COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O,direct
Xylocaine MPF,chronic kidney disease,3,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Carbamazepine,myocardial infarction,1,0,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
bupropion hydrochloride,diabetes mellitus,5,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Busulfan,hypersensitivity,313,1,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
Se-Natal 19 Chewable,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
IMATINIB MESYLATE,ph-all who,1122,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Galantamine hydrobromide,pregnancy,16,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
Isosorbide dinitrate,pregnancy,16,0,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
Propafenone Hydrochloride,arrhythmia,43,1,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,direct
ARSENIC TRIOXIDE,apl who,611,1,O=[As]O[As]=O,direct
HYDROCORTISONE,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
mesalamine,ulcerative colitis,225,1,NC1=CC(C(O)=O)=C(O)C=C1,direct
FLUPHENAZINE HYDROCHLORIDE,anemia,13,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Epidiolex,severe infection,18,0,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1,direct
Dutasteride and tamsulosin hydrochloride,stroke,7,0,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O,direct
ARGATROBAN,hypersensitivity,313,1,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2,direct
Bupivilog Kit,sepsis,17,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
BORTEZOMIB,insomnia,441,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Diclofenac Sodium 1.5%,asthma,12,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Glyburide and Metformin Hydrochloride,severe infection,18,0,CN(C)C(=N)NC(N)=N,direct
DDAVP,hyponatremia,137,1,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
TAZAROTENE,plaque psoriasis,1128,1,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,direct
DEFERASIROX,high-risk mds,865,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Rozlytrek,sepsis,17,0,CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1,direct
Modafinil,hypersensitivity,313,1,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,direct
ANAFRANIL,stroke,7,0,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
Lunesta,renal failure,19,0,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,direct
DIGOX,ventricular fibrillation,63,1,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,direct
Marvona SUIK,renal failure,19,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Enalapril maleate and hydrochlorothiazide,impaired renal function,919,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
EOVIST,pancreatitis,233,1,[Gd+3].[H][C@@](CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)(CC1=CC=C(OCC)C=C1)N(CC(O)=O)CC(O)=O,direct
Ketorolac tromethamine,the aspirin triad,1295,1,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Mefloquine Hydrochloride,acute p,551,1,OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F,direct
Perindopril Erbumine,hypertension in u,895,1,[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,direct
TIBSOVO,newly diagnosed aml,1033,1,[H][C@@](N(C(=O)[C@]1([H])CCC(=O)N1C1=NC=CC(=C1)C#N)C1=CC(F)=CN=C1)(C(=O)NC1CC(F)(F)C1)C1=C(Cl)C=CC=C1,direct
Azacitidine,hypersensitivity,313,1,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Chlordiazepoxide and Amitriptyline Hydrochloride,cardiovascular disorders,669,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Diatrizoate Meglumine and Diatrizoate Sodium,anemia,13,0,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
SSD,sepsis,291,1,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
Abiraterone Acetate,liver metastases,967,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Ipratropium bromide,pregnancy,16,0,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,direct
methocarbamol,pregnancy,16,0,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
Plasma-Lyte 148,brain edema,643,1,[Cl-].[K+],direct
Paclitaxel protein-bound particles for injectable suspension (albumin-bound),myocardial infarction,1,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Ammonul,myocardial infarction,1,0,OC(=O)C1=CC=CC=C1,direct
risperidone,myocardial infarction,1,0,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,direct
Plasma-Lyte 148,mental illness,14,0,[Cl-].[K+],direct
Fluphenazine Hydrochoride,dementia-related psychosis,766,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,fuzzy:fluphenazine hydrochloride
Chlorothiazide sodium,pregnancy,16,0,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
Methylene blue,liver cirrhosis,4,0,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,direct
Polymyxin B Sulfate and Trimethoprim,diabetes mellitus,5,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
CITRANATAL B-CALM,stroke,7,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
ondansetron,long qt syndrome,61,1,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Oxycodone Hydchloride,pregnancy,16,0,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C,direct
"Clotrimazole Topical Solution USP, 1%",mental illness,14,0,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Pramipexole dihydrochloride,concomitant levodopa,741,1,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
ADENOSINE,asthma,193,1,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
Aubagio,pregnancy,16,0,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
"brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide",mental illness,14,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
NITRO-DUR,renal failure,19,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Dihydroergotamine Mesylate Nasal,uncontrolled hypertension,1337,1,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
Lisdexamfetamine Dimesylate,obesity,149,1,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
Tindazole,hypersensitivity,313,1,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O,direct
ZYPITAMAG,hyperlipidemia,143,1,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
Esomeprazole sodium,mental illness,14,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
AMANTADINE HYDROCHLORIDE,hypersensitivity,313,1,NC12CC3CC(CC(C3)C1)C2,direct
Cotellic,autoimmune disease,15,0,OC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)[C@@H]1CCCCN1,direct
PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release,sepsis,17,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,fuzzy:pantoprazole sodium delayed-release delayed-release
NABUMETONE,the aspirin triad,1295,1,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
ABRAXANE,severe infection,18,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Arsenic Trioxide,myocardial infarction,1,0,O=[As]O[As]=O,direct
Prenate Pixie,sepsis,17,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Chlorothiazide Sodium,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
Pioglitazone,hypersensitivity,313,1,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
Danazol,pregnancy,16,0,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3,direct
CYCLOBENZAPRINE HYDROCHLORIDE,muscle spasm,457,1,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
AmBisome,pregnancy,16,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
MultiHance,chronic kidney disease,3,0,[Gd+3].OC(=O)CN(CCN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)C(COCC1=CC=CC=C1)C(O)=O,direct
Bromocriptine mesylate,uncontrolled hypertension,1337,1,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
Bromocriptine Mesylate,uncontrolled hypertension,1337,1,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
Propranolol hydrochloride,autoimmune disease,15,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Cyltezo,active ankylosing spondylitis,520,1,CC(C)O,direct
NORLIQVA,hypertension,11,0,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=CC=CC=C1Cl)C(=O)OC,direct
PROCORT,chronic obstructive pulmonary disease (COPD),6,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
DAPZURA RT,comparator agents,736,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
Pegasys,chc who,681,1,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O,fuzzy:pearsys
Onfi,hypersensitivity,313,1,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,direct
Vyalev,sepsis,17,0,C[C@@](CC1=CC=C(OP(O)(O)=O)C(O)=C1)(NN)C(O)=O,direct
ACETYLCYSTEINE,cancer (metastatic),9,0,CC(=O)N[C@@H](CS)C(O)=O,direct
Meclofenamate Sodium,peptic ulcer,1110,1,CC1=C(Cl)C(NC2=CC=CC=C2C(O)=O)=C(Cl)C=C1,direct
Topotecan Hydrochloride,severe infection,18,0,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
Ketorolac Tromethamine,hypersensitivity,313,1,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
propranolol hydrochloride,hypertrophic subaortic stenosis,899,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate",diabetes mellitus,5,0,CC(N)CC1=CC=CC=C1,direct
DIGOX,hypersensitivity,313,1,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,direct
Oxycodone Hydchloride,anemia,13,0,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C,direct
imatinib mesylate,thrombocytopenia,79,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Tikosyn,hypertension,11,0,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Body Scrub,pregnancy,16,0,O.O.[Al+3].[Al+3].[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-],direct
Eucrisa,diabetes mellitus,5,0,OB1OCC2=C1C=CC(OC1=CC=C(C=C1)C#N)=C2,direct
dexamethasone,cancer (metastatic),9,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Lodosyn,stroke,7,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Bacitracin,cancer (metastatic),9,0,CC[C@H](C)[C@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC,direct
Sofosbuvir and Velpatasvir,pregnancy,16,0,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
UrNeva,myocardial infarction,1,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Hydroxyzine HCL,hypersensitivity,313,1,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Saxagliptin,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12C[C@]1([H])N([C@@H](C2)C#N)C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,direct
COSELA,hypersensitivity,313,1,CN1CCN(CC1)C1=CN=C(NC2=NC3=C(C=C4N3C3(CCCCC3)CNC4=O)C=N2)C=C1,direct
Potassium Chloride Extended-release,chronic kidney disease,3,0,[Cl-].[K+],direct
Trifluoperazine Hydrochloride,chronic kidney disease,3,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
donepezil hydrochloride,hypersensitivity,313,1,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
ALVAIZ,liver disease (non-cirrhotic),20,0,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,direct
"Betamethasone Dipropionate USP, 0.05%",liver disease (non-cirrhotic),20,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
SUNITINIB MALATE,liver disease (non-cirrhotic),20,0,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,direct
HALOPERIDOL LACTATE,diabetes mellitus,5,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Oxycodone and Acetaminophen,stroke,7,0,CC(=O)NC1=CC=C(O)C=C1,direct
Oralone,AIDS,10,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
plerixafor,congestive heart failure,2,0,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
SULINDAC,the aspirin triad,1295,1,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O,direct
Cyclobenzaprine Hydrochloride,chronic kidney disease,3,0,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
PredniSONE,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
DILTIAZEM HYDROCHLORIDE in SODIUM CHLORIDE,ventricular tachycardia,1357,1,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,fuzzy:esmolol hydrochloride in sodium chloride
Lamivudine and Zidovudine,hypersensitivity,313,1,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
Neomycin Sulfate,sepsis,17,0,[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O.[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O,fuzzy:capreomycin sulfate
Atracurium Besylate,diabetes mellitus,5,0,[O-]S(=O)(=O)C1=CC=CC=C1.[O-]S(=O)(=O)C1=CC=CC=C1.COC1=CC2=C(C=C1OC)C(CC1=CC(OC)=C(OC)C=C1)[N+](C)(CCC(=O)OCCCCCOC(=O)CC[N+]1(C)CCC3=C(C=C(OC)C(OC)=C3)C1CC1=CC(OC)=C(OC)C=C1)CC2,direct
AKEEGA,mental illness,14,0,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Spironolactone,pregnancy,16,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
Carbamazepine,increased intraocular pressure,927,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Promethazine,pregnancy,16,0,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Molindone Hydrochloride,severe infection,18,0,CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2,direct
Escitalopram oxalate,mental illness,14,0,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
Romidepsin,lymphoma,269,1,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,direct
Desoximetasone,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Prednisolone Sodium Phosphate,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Multaq,myocardial infarction,1,0,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,direct
RECARBRIO,hypersensitivity,313,1,CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O,direct
Flumazenil,renal failure,19,0,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,direct
TREANDA,myocardial infarction,1,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
ACITRETIN,edema,417,1,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1,direct
Nyamyc,myocardial infarction,1,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
MultiHance,hypersensitivity,313,1,[Gd+3].OC(=O)CN(CCN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)C(COCC1=CC=CC=C1)C(O)=O,direct
adenosine,mental illness,14,0,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
FLUPHENAZINE DECANOATE,cancer (localized),8,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
tofacitinib,lung disease,375,1,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,direct
Methylprednisolone acetate,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
ACETAMINOPHEN AND CODEINE,pregnancy,16,0,CC(=O)NC1=CC=C(O)C=C1,direct
Dihydroergotamine Mesylate,hypertension,39,1,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
AZITHROMYCIN,pregnancy,16,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Normosol-R and Dextrose,moderate blood loss,1015,1,[Cl-].[K+],direct
PLERIXAFOR,chronic kidney disease,3,0,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
Idarubicin Hydrochloride,bone marrow suppression,101,1,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O,direct
tacrolimus,chronic kidney disease,3,0,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,direct
ELIGARD,congestive heart failure,2,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Olmesartan Medoxomil and Hydrochlorothiazide,hypersensitivity,313,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Deferiprone,hypertension,11,0,CN1C=CC(=O)C(O)=C1C,direct
Ionite H,hypertension,11,0,[F-].[Na+],direct
EPIFOAM,hypersensitivity,313,1,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
ISOTRETINOIN,tics,23,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Retisert,asthma,12,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Alkindi Sprinkle,anemia,13,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Amyvid,cognitive impairment who,733,1,[H]N(C1=C([H])C([H])=C(\C([H])=C(/[H])C2=C([H])N=C(OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])[18F])C([H])=C2[H])C([H])=C1[H])C([H])([H])[H],direct
NATEGLINIDE,hypersensitivity,313,1,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,direct
Lacosamide,diabetes mellitus,5,0,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
"amlodipine,valsartan and hydrochlorothiazide",hypercalcemia and hypophosphatemia,875,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,"fuzzy:amlodipine, valsartan and hydrochlorothiazide"
FLAVOXATE HYDROCHLORIDE,suspected glaucoma,1282,1,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,direct
Omeprazole,pregnancy,16,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Morphine Sulfate,acute ulcerative colitis,556,1,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,direct
Pravastatin sodium,primary dysbetalipoproteinemia who,1172,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Amlodipine and valsartan,sepsis,17,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Inflammacin,the aspirin triad,1295,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Cladribine,hairy cell leukemia,845,1,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
Cyclosporine Modified,chronic plaque psoriasis,702,1,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Dimethyl fumarate,chronic obstructive pulmonary disease (COPD),6,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
Stivarga,neutropenia,85,1,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,direct
Propofol Injectable Emulsion,hypersensitivity,313,1,CC(C)C1=CC=CC(C(C)C)=C1O,direct
Loxapine,liver cirrhosis,4,0,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,direct
DIURIL,stroke,7,0,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
lenalidomide,mm when pembrolizumab,1014,1,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
BRIDION,asthma,12,0,O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3O[C@H](CSCCC(O)=O)[C@@H](O[C@H]4O[C@H](CSCCC(O)=O)[C@@H](O[C@H]5O[C@H](CSCCC(O)=O)[C@@H](O[C@H]6O[C@H](CSCCC(O)=O)[C@@H](O[C@H]7O[C@H](CSCCC(O)=O)[C@@H](O[C@H]8O[C@H](CSCCC(O)=O)[C@@H](O[C@H]9O[C@H](CSCCC(O)=O)[C@@H](O[C@H]1O[C@@H]2CSCCC(O)=O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,direct
IOPIDINE 1%,hypersensitivity,313,1,NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1,direct
Venclexta,myocardial infarction,1,0,CC1(C)CCC(CN2CCN(CC2)C2=CC=C(C(=O)NS(=O)(=O)C3=CC=C(NCC4CCOCC4)C(=C3)[N+]([O-])=O)C(OC3=CN=C4NC=CC4=C3)=C2)=C(C1)C1=CC=C(Cl)C=C1,direct
URSODIOL,severe infection,18,0,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
DermacinRx Lidotral,asthma,12,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Azathioprine Sodium,myocardial infarction,1,0,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
VOQUEZNA DUAL PAK,cancer (localized),8,0,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
PROCYSBI,asthma,12,0,NCCS,direct
ISOSORBIDE DINITRATE,congestive heart failure,41,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
tramadol hydrochloride,renal failure,19,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
pentazocine and naloxone,acute abdominal conditions,537,1,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,direct
Mozobil,diabetes mellitus,5,0,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
Sulfasalazine,liver disease (non-cirrhotic),20,0,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,direct
Lenvima,liver disease (non-cirrhotic),20,0,COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O,direct
SILODOSIN,hypersensitivity,313,1,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,direct
Cladribine,edema,417,1,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
HULIO,anti-adalimumab antibody,602,1,CC(C)O,direct
Diltiazem hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
HYDROCORTISONE ACETATE PRAMOXINE HYDROCHLORIDE,cancer (localized),8,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
colchicine,renal failure,19,0,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Sumatriptan Succinate,risk factors,1216,1,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,direct
TAVNEOS,mental illness,14,0,CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C2=CC=C(NC3CCCC3)C=C2)C(=O)C2=C(F)C=CC=C2C)C=C1C(F)(F)F,direct
PROCAINAMIDE HYDROCHLORIDE,stroke,7,0,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
Methylphenidate,hypertension,11,0,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
raloxifene hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,direct
Hyoscyamine sulfate,myocardial infarction,1,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Diphenoxylate Hydrochloride and Atropine Sulfate,obstructive jaundice,1073,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
Ethamolin,hypertension,11,0,NCCO.CCCCCCCC\C=C/CCCCCCCC(O)=O,direct
Chlordiazepoxide Hydrochloride and Clidinium Bromide,cancer (localized),8,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
PHENERGAN,pregnancy,16,0,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Trileptal,urinary tract infection,249,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Pemfexy,cancer (localized),8,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
Everolimus,functional carcinoid tumors,820,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,direct
rifabutin,tuberculosis,213,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21,direct
Proctocort,anemia,13,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Delestrogen,liver cirrhosis,4,0,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
diflunisal,the aspirin triad,1295,1,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,direct
NAROPIN,chronic obstructive pulmonary disease (COPD),6,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
Potassium Chloride in Sodium Chloride,edema,417,1,[Cl-].[K+],direct
Amnesteem,congestive heart failure,2,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral,bone marrow depression,637,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
SPIRONOLACTONE,chronic kidney disease,3,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
dimethyl fumarate,liver disease (non-cirrhotic),20,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
Hectorol,depression,27,1,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
Vilazodone Hydrochloride,mdd including,990,1,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,direct
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE,mental illness,14,0,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3,direct
BUDESONIDE,congestive heart failure,2,0,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Acetaminophen and Codeine Phosphate,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
Diphenoxylate hydrochloride and atropine sulfate,acute ulcerative colitis,556,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
Levetiracetam in Sodium Chloride,cancer (localized),8,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Rozerem,insomnia,441,1,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,direct
DESMOPRESSIN ACETATE,hyponatremia,137,1,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
"Clotrimazole Topical Solution USP, 1%",diabetes mellitus,5,0,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Vitrexate FE,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
CEFAZOLIN,diabetes mellitus,5,0,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,direct
POLOCAINE(R) -MPF (MEPIVACAINE HCI),renal failure,19,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
CHLORPROMAZINE HYDROCHLORIDE,diabetes mellitus,5,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
ACETAMINOPHEN,hypersensitivity,313,1,CC(=O)NC1=CC=C(O)C=C1,direct
Mometasone Furoate,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
daptomycin,prosthetic valve endocarditis,1186,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
Ciprofloxacin and Dexamethasone,intact tympanic membranes,939,1,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,direct
SODIUM PHENYLACETATE and SODIUM BENZOATE,myocardial infarction,1,0,OC(=O)C1=CC=CC=C1,direct
Physicians EZ Use M-pred,anemia,13,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Vizamyl,alzheimer's disease,35,1,CNC1=C([18F])C=C(C=C1)C1=NC2=CC=C(O)C=C2S1,direct
Foltamin,cancer (metastatic),9,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Midazolam in Sodium Chloride,hemodynamic instability,852,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
SELEGILINE HYDROCHLORIDE,autoimmune disease,15,0,C[C@H](CC1=CC=CC=C1)N(C)CC#C,direct
Norpace CR,life-threatening arrhythmias who,964,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
Prochlorperazine,dementia,7,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Ethacrynic Acid,arrhythmia,43,1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Paclitaxel,normal baseline and,1057,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Diacomit,liver disease (non-cirrhotic),20,0,CC(C)(C)C(O)\C=C\C1=CC2=C(OCO2)C=C1,direct
Flurazepam Hydrochloride,asthma,12,0,CCN(CC)CCN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1F,direct
prochlorperazine edisylate,previous brain damage,1166,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Nitrofurantoin Monohydrate/Macrocrystal,pregnancy,16,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
MEPIVACAINE HYDROCHLORIDE,sepsis,17,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Deferoxamine,chronic kidney disease,3,0,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
"Carisoprodol Tablets, USP, 350 mg",cancer (localized),8,0,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
DOBUTAMINE,hypersensitivity,313,1,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
Bortezomib,neutropenia,85,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Exjade,advanced malignancies,563,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Quinapril,asthma,12,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
NUPLAZID,liver disease (non-cirrhotic),20,0,CC(C)COC1=CC=C(CNC(=O)N(CC2=CC=C(F)C=C2)C2CCN(C)CC2)C=C1,direct
Betamethasone Valerate,myocardial infarction,1,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
PERPHENAZINE,convulsive disorders,751,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Kit for the Preparation of Technetium Tc 99m Sulfur Colloid,melanoma,273,1,[99Tc].S1SSSSSSS1,direct
NITROSTAT,chronic kidney disease,3,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Vitrexyl,diabetes mellitus,5,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Hydrochlorothiazide,diabetes mellitus,5,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Atenolol,angina pectoris,596,1,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,direct
INLYTA,advanced rcc,568,1,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,direct
PACLITAXEL PACLITAXEL,mental illness,14,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Lamivudine and Zidovudine,asthma,12,0,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
Voltaren,hypersensitivity,313,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
CHLOROQUINE PHOSPHATE,autoimmune disease,15,0,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,direct
DOPTELET,thrombocytopenia,79,1,OC(=O)C1CCN(CC1)C1=C(Cl)C=C(C=N1)C(=O)NC1=NC(C2=CC(Cl)=CS2)=C(S1)N1CCN(CC1)C1CCCCC1,direct
Rayaldee,hyperparathyroidism,123,1,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,direct
Zolpidem tartrate sublingual,diabetes mellitus,5,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Dexrazoxane,hypertension,11,0,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,direct
metronidazole,cancer (localized),8,0,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Sotalol Hydrochloride AF,cancer (localized),8,0,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
CARBAMAZEPINE ER,depression,27,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
TARGADOX,liver disease (non-cirrhotic),20,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Cefpodoxime Proxetil,autoimmune disease,15,0,[H][C@]12SCC(COC)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
Vitrexate FE,hypertension,11,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
IOPIDINE 1%,cancer (metastatic),9,0,NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1,direct
VALSARTAN AND HYDROCHLOROTHIAZIDE,diabetes mellitus,5,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Bupivacaine hydrochloride,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Dalfampridine,stroke,7,0,NC1=CC=NC=C1,direct
Unithroid,stroke,7,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
Memantine Hydrochloride,AIDS,10,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE,hypotension,75,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Irinotecan hydrochloride,cancer (metastatic),9,0,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
"Lansoprazole, Amoxicillin, Clarithromycin",mental illness,14,0,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Sulfamethox-TMP DS,congestive heart failure,2,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Caffeine Citrate Oral Solution,chronic obstructive pulmonary disease (COPD),6,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Clofarabine,all or aml,583,1,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,direct
propofol,hypersensitivity,313,1,CC(C)C1=CC=CC(C(C)C)=C1O,direct
daptomycin,liver cirrhosis,4,0,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
"Fluocinolone Acetonide Topical Solution USP, 0.01%",congestive heart failure,2,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
TECFIDERA,myocardial infarction,1,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
penicillamine,asthma,12,0,[H][C@](N)(C(O)=O)C(C)(C)S,direct
Virazole,tachycardia,47,1,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Pentam 300,severe infection,18,0,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
Iluvien,liver cirrhosis,4,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Carboplatin,poor performance status,1139,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
APTENSIO XR,autoimmune disease,15,0,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
isosorbide mononitrate,cancer (localized),8,0,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,direct
desoximetasone,diabetes mellitus,5,0,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Dexlansoprazole delayed release,chronic kidney disease,3,0,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1,direct
LEXISCAN,lung disease,375,1,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
Procainamide Hydrochloride,heart block,59,1,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
CASPOFUNGIN ACETATE,pregnancy,16,0,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
LASTACAFT,anemia,13,0,CN1CCC(CC1)=C1C2=NC=C(C=O)N2CCC2=CC=CC=C12,direct
isosorbide mononitrate,congestive heart failure,41,1,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,direct
QUELICIN,asthma,12,0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,direct
Potassium Chloride Extended-release,autoimmune disease,15,0,[Cl-].[K+],direct
Midazolam Hydrochloride,cardiovascular instability,670,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Pantoprazole Sodium DR,hypertension,11,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
ROSUVASTATIN,hypersensitivity,313,1,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Zarontin,hypersensitivity,313,1,CCC1(C)CC(=O)NC1=O,direct
KENALOG-10,anemia,13,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Livita Adults,hypersensitivity,313,1,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Bromocriptine mesylate,myocardial infarction,49,1,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
Tilia Fe,severe androgen excess,1234,1,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],direct
Midodrine Hydrochloride,hypertension,39,1,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,direct
Haldol Decanoate,chronic kidney disease,3,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Mexiletine Hydrochloride,myocardial infarction,49,1,CC(N)COC1=C(C)C=CC=C1C,direct
Ketoprofen,the aspirin triad,1295,1,CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1,direct
Liothyronine Sodium,liver cirrhosis,4,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
POSACONAZOLE,hypokalemia,133,1,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
INDERAL LA,asthma,12,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Promethazine Hydrochloride and Phenylephrine Hydrochloride,AIDS,10,0,CNC[C@H](O)C1=CC(O)=CC=C1,direct
XARELTO,chronic kidney disease,3,0,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,direct
Colcrys,cancer (metastatic),9,0,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Niacin,hyperlipidemia,143,1,OC(=O)C1=CN=CC=C1,direct
BACLOFEN,hypersensitivity to baclofen,884,1,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
POTASSIUM CHLORIDE,significant cardiac arrhythmias,1259,1,[Cl-].[K+],direct
Oxcarbazepine,hyponatremia,137,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
MethylPREDNISolone,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Xanax XR,depression,27,1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
ZEVTERA,AIDS,10,0,[H][C@@]1(NC(=O)C(=N/O)\C2=NSC(N)=N2)C(=O)N2C(C(O)=O)=C(CS[C@]12[H])\C=C1/CCN(C1=O)[C@]1([H])CCN(C1)C(=O)OCC1=C(C)OC(=O)O1,direct
Methscopolamine Bromide,renal failure,19,0,[Br-].[H][C@@]12O[C@]1([H])[C@H]1C[C@H](C[C@@H]2[N+]1(C)C)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
VITRAKVI,solid tumors that,1265,1,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1,direct
Norpace CR,sepsis,17,0,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
BIMATOPROST,hypertension,39,1,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
PAMELOR,depressive symptoms,769,1,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
MLK F4 Kit,mental illness,14,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Diltiazem hydrochloride,hypotension,75,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Albuterol Sulfate,hypersensitivity,313,1,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Procto-Med HC,pregnancy,16,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Icosapent Ethyl,stroke,7,0,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Imipramine Pamoate,cancer (metastatic),9,0,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
LACOSAMIDE,partial-onset seizures,1106,1,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
Macrodantin,congestive heart failure,2,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
promethazine hydrochloride,bone-marrow depression,639,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
1% LIDOCAINE HCI,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Procainamide Hydrochloride,severe infection,18,0,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
FLUPHENAZINE HYDROCHLORIDE,psychosis,31,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
ANASPAZ,stroke,7,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
PRAZIQUANTEL,AIDS,10,0,O=C(C1CCCCC1)N1CC2N(CCC3=CC=CC=C23)C(=O)C1,direct
Omeprazole,renal failure,19,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
LEVOPHED(R) NOREPINEPHRINE BITARTRATE,pregnancy,16,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Paroxetine,severe infection,18,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Quflora Pediatric,autoimmune disease,15,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
HYCAMTIN,lung cancer,215,1,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
PROSCAR,diabetes mellitus,5,0,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,direct
COSOPT PF,congestive heart failure,2,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Neomycin Sulfate,congestive heart failure,2,0,[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O.[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O,fuzzy:capreomycin sulfate
DMT SUIK,asthma,12,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ProHance,chronic obstructive pulmonary disease (COPD),6,0,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,direct
Tranexamic Acid,cancer (metastatic),9,0,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Midazolam in Sodium Chloride,pediatric patients,13,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Fluticasone Propionate and Salmeterol,liver disease (non-cirrhotic),20,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
"Sodium Sulfate, Potassium Sulfate, and Magnesium Sulfate Bowel Prep kit",normal baseline who,1060,1,[Mg++].[O-]S([O-])(=O)=O,"fuzzy:sodium sulfate, potassium sulfate and magnesium sulfate oral"
SCENESSE,hypersensitivity,313,1,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,direct
MALARONE,malaria,305,1,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,direct
DOFETILIDE,cancer (localized),8,0,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
Ferrlecit,sepsis,17,0,[O--].[O--].[O--].[Na+].[Fe+3].[Fe+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,direct
Sotalol Hydrochloride,bronchospastic diseases,653,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Nicotrol,chronic kidney disease,3,0,CN1CCC[C@H]1C1=CN=CC=C1,direct
IBUPROFEN,hypersensitivity,313,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Dexamethasone 1.5 mg,tuberculosis,213,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
MOMETASONE FUROATE MONOHYDRATE,cancer (localized),8,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
BETAXOLOL HYDROCHLORIDE,untreated pheochromocytoma,1345,1,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
ELCYS,asthma,12,0,N[C@@H](CS)C(O)=O,direct
Carnitor,hypersensitivity,313,1,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
SINGULAIR,hypersensitivity,313,1,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
CHANTIX,diabetes mellitus,5,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Nicotrol,renal failure,19,0,CN1CCC[C@H]1C1=CN=CC=C1,direct
Dorzolamide and Timolol,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Danazol,edema,417,1,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC3=C(C[C@]12C)C=NO3,direct
FLUMAZENIL,hypersensitivity,313,1,CCOC(=O)C1=C2CN(C)C(=O)C3=C(C=CC(F)=C3)N2C=N1,direct
butalbital and acetaminophen,acetaminophen allergy,513,1,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,direct
AVODART,prostate cancer,265,1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])NC(=O)C=C[C@]4(C)[C@@]3([H])CC[C@]12C)C(=O)NC1=CC(=CC=C1C(F)(F)F)C(F)(F)F,direct
Halcinonide,pregnancy,16,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Envarsus XR,hypersensitivity,313,1,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,direct
Carnitor SF,edema,417,1,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
BORTEZOMIB,multiple myeloma,1024,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
APTENSIO XR,anemia,13,0,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
Cromolyn Sodium,bronchial asthma,650,1,OC(COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O)COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O,direct
Brimonidine Tartrate and Timolol Maleate,asthma,193,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Analpram HC,congestive heart failure,2,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
AirDuo Digihaler,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
SSD,diabetes mellitus,5,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
Stivarga,thrombocytopenia,79,1,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,direct
Albendazole,hypersensitivity,313,1,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,direct
DOXY 100(TM) DOXYCYCLINE,chronic kidney disease,3,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
carisoprodol,cancer (metastatic),9,0,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
Hyoscyamine ER,diabetes mellitus,5,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
VIBATIV,chronic obstructive pulmonary disease (COPD),6,0,CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC2=C3OC4=CC=C(C=C4Cl)[C@@H](O)[C@@H](NC(=O)[C@@H](CC(C)C)NC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]4C(C=C2OC2=C(Cl)C=C(C=C2)[C@@H](O)[C@@H]2NC(=O)[C@H](NC4=O)C4=CC(=C(O)C=C4)C4=C(O)C(CNCP(O)(O)=O)=C(O)C=C4[C@H](NC2=O)C(O)=O)=C3)O[C@@H](C)[C@H]1O,direct
penicillamine,aplastic anemia,103,1,[H][C@](N)(C(O)=O)C(C)(C)S,direct
TOBI,sepsis,17,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
ketorolac tromethamine,anemia,13,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Depen,anemia,81,1,[H][C@](N)(C(O)=O)C(C)(C)S,direct
Anastrozole,mental illness,14,0,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,direct
VERELAN,myocardial infarction,1,0,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,direct
Triamcinolone Acetonide,unexplained diarrhea,1341,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Ganciclovir,stroke,7,0,NC1=NC2=C(N=CN2COC(CO)CO)C(=O)N1,direct
CEFADROXIL,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
Hepzato Kit,melanoma,273,1,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Lurasidone Hydrochloride,severe infection,18,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Gadavist,hypersensitivity,313,1,OC[C@H](O)[C@H](CO)[N+]12CC[N+]3(CC([O-])=O)CC[N+]4(CC([O-])=O)CC[N+](CC([O-])=O)(CC1)[Gd-]234,direct
Dorzolamide and Timolol,hypertension,11,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Ramelteon,chronic obstructive pulmonary disease (COPD),6,0,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,direct
DALFAMPRIDINE,pregnancy,16,0,NC1=CC=NC=C1,direct
Venclexta,autoimmune disease,15,0,CC1(C)CCC(CN2CCN(CC2)C2=CC=C(C(=O)NS(=O)(=O)C3=CC=C(NCC4CCOCC4)C(=C3)[N+]([O-])=O)C(OC3=CN=C4NC=CC4=C3)=C2)=C(C1)C1=CC=C(Cl)C=C1,direct
Lisdexamfetamine dimesylate,myocardial infarction,1,0,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
Nestabs ONE,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
hydrocortisone acetate pramoxine hcl,sepsis,17,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Tramadol Hydrochloride,chronic non-malignant pain,697,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Cyclogyl,glaucoma,481,1,CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1,direct
Melphalan Hydrochloride,hypertension,11,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Vitrexate,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
LEVETIRACETAM,cancer (metastatic),9,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
RUBY-FILL,cancer (metastatic),9,0,[82Rb+],direct
LAMIVUDINE,chronic kidney disease,3,0,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,direct
PROCORT,hypersensitivity,313,1,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Candesartan Cilexetil and Hydrochlorothiazide,symptomatic hypotension,1287,1,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1,direct
Benzphetamine Hydrochloride,cancer (localized),8,0,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,direct
Tolmetin Sodium,myocardial infarction,1,0,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,direct
edaravone,hypertension,11,0,CC1=NN(C(=O)C1)C1=CC=CC=C1,direct
Depo-Medrol,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
"Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate",normal baseline who,1060,1,[Mg++].[O-]S([O-])(=O)=O,direct
TOBI,hypertension,11,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Fentanyl Buccal,hypertension,11,0,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
Montelukast,stroke,7,0,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
Methylene Blue,renal failure,19,0,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,direct
Depen,stroke,7,0,[H][C@](N)(C(O)=O)C(C)(C)S,direct
Cyclophosphamide,chronic kidney disease,3,0,ClCCN(CCCl)P1(=O)NCCCO1,direct
Dabigatran Etexilate,stroke,7,0,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
SYMPAZAN,hypersensitivity,313,1,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,direct
Ammonia N 13,hypertension,11,0,[13NH3],direct
Matulane,liver disease (non-cirrhotic),20,0,CNNCC1=CC=C(C=C1)C(=O)NC(C)C,direct
Tetracaine,tics,23,1,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
ZIANA,chronic kidney disease,3,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
BIVALIRUDIN,AIDS,10,0,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,direct
Anastrozole,ldl elevations,959,1,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,direct
Ojjaara,mf who,1007,1,O=C(NCC#N)C1=CC=C(C=C1)C1=CC=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1,direct
BETAPACE,paroxysmal afib that,1101,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Ropivacaine Hydrochloride,cancer (localized),8,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
Sofosbuvir and Velpatasvir,insomnia,441,1,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
CIDOFOVIR DIHYDRATE,cancer (metastatic),9,0,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,direct
Davimet with Fluoride,chronic kidney disease,3,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Propafenone Hydrochloride,renal failure,19,0,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,direct
Pentobarbital Sodium,asthma,12,0,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,direct
DICLOFENAC SODIUM,AIDS,10,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Cortisone Acetate,osteoporosis,163,1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Texacort,stroke,7,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
"Butalbita,Acetaminophen and Caffeine",hypersensitivity,313,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
NALBUPHINE HCI,asthma,193,1,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
BUPIVACAINE HCI,renal failure,19,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
propofol,pregnancy,16,0,CC(C)C1=CC=CC(C(C)C)=C1O,direct
Prilosec,cancer (metastatic),9,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
PNV-Omega,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Diazepam,glaucoma,481,1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,direct
LENALIDOMIDE,liver cirrhosis,4,0,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
Coreg,severe hepatic impairment,1245,1,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
Menatrol,cancer (metastatic),9,0,CC1=C(O)C(CO)=C(CO)C=N1,direct
TAVNEOS,anca-associated vasculitis,594,1,CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C2=CC=C(NC3CCCC3)C=C2)C(=O)C2=C(F)C=CC=C2C)C=C1C(F)(F)F,direct
CIMETIDINE,liver disease (non-cirrhotic),20,0,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N,direct
NOCDURNA,chronic obstructive pulmonary disease (COPD),6,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
ANAFRANIL,pregnancy,16,0,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
PROPECIA,congestive heart failure,2,0,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,direct
TRAMADOL HYDROCHLORIDE,osteoarthritis,161,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Telmisartan and Hydrochlorothiazide,AIDS,10,0,CCCC1=NC2=C(C=C(C=C2C)C2=NC3=CC=CC=C3N2C)N1CC1=CC=C(C=C1)C1=CC=CC=C1C(O)=O,direct
fluphenazine hydrochloride,dementia-related psychosis,766,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
METROGEL,chronic kidney disease,3,0,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
"PredniSONE Tablets, USP, 10 mg",cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Amlodipine and Olmesartan Medoxomil,kidney failure,373,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Hydroxyzine HCL,mental illness,14,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Mycobutin,renal failure,19,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21,direct
Promethazine Hydrochloride,bone-marrow depression,639,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Trileptal,sepsis,17,0,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Epclusa,anemia,81,1,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
FLUCONAZOLE,vaginal candidiasis,1349,1,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
LEVOXYL,stroke,7,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
MEROPENEM,autoimmune disease,15,0,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
Carmustine,hypersensitivity,313,1,ClCCNC(=O)N(CCCl)N=O,direct
Adalimumab-aacf,active psa,532,1,CC(C)O,direct
Pantoprazole sodium delayed-release,severe infection,18,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
oseltamivir phosphate,anemia,13,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
bortezomib,neutropenia,85,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Trezix,mental illness,14,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Cladribine,liver cirrhosis,4,0,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
Paclitaxel protein-bound particles for injectable suspension (albumin-bound),sepsis,291,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Accucaine,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
DILTIAZEM HYDROCHLORIDE,congestive heart failure,2,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Cabergoline,hypertension,39,1,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,direct
Mycostatin,cancer (metastatic),9,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Pindolol,bronchospastic diseases,653,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CN2,direct
metolazone,stroke,7,0,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,direct
isosorbide dinitrate and hydralazine hydrochloride,hypotension,75,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
ETOPOPHOS,refractory testicular tumors,1203,1,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@@H]1O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O,direct
SOTALOL HYDROCHLORIDE,arrhythmia,43,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Icosapent Ethyl,severe hypertriglyceridemia,1247,1,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Methotrexate,non-neoplastic diseases,1051,1,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
lurasidone hydrochloride,bipolar depression,632,1,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Lanreotide Acetate,hypersensitivity,313,1,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],direct
rifabutin,autoimmune disease,15,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21,direct
Nifedipine,tight aortic stenosis,1320,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Vancomycin Hydrochloride for Oral Solution,anemia,13,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
ROSUVASTATIN CALCIUM,asthma,12,0,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Caffeine Citrate Oral Solution,necrotizing enterocolitis,1032,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
SSD,mental illness,14,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
ProAir Digihaler,hypersensitivity to albuterol,882,1,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Budesonide,hypersensitivity,313,1,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Nilutamide,pregnancy,16,0,CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,direct
Tizanidine Hydrochloride,hypersensitivity,313,1,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Butal/APAP/Caff,anemia,13,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
memantine hydrochloride,congestive heart failure,2,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Tizanidine HCl,liver disease (non-cirrhotic),20,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Quazepam,mental illness,14,0,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2,direct
Brevital Sodium,cancer (localized),8,0,CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O,direct
SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE),autoimmune disease,15,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Hydroxychloroquine sulfate,severe infection,18,0,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
Bactrim DS,pneumonia,201,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Cuprimine,severe infection,18,0,[H][C@](N)(C(O)=O)C(C)(C)S,direct
XYLOCAINE,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
KENALOG-40,AIDS,10,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
"PredniSONE Tablets, USP, 10 mg",tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ASMANEX HFA,persistent asthma,1118,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
dihydroergotamine mesylate,risk factors,1216,1,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
VORICONAZOLE,hypersensitivity,313,1,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Methenamine Mandelate,diabetes mellitus,5,0,C1N2CN3CN1CN(C2)C3,direct
VORICONAZOLE,anemia,13,0,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
citalopram hydrobromide,asthma,12,0,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
Davimet-M,hypersensitivity,313,1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
HYZAAR,hypersensitivity,313,1,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
Butal/APAP/Caff,sepsis,17,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Erlotinib Hydrochloride,pancreatic cancer,1097,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
CIDOFOVIR DIHYDRATE,chronic kidney disease,3,0,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,direct
FAMCICLOVIR,laboratory abnormalities that,956,1,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O,direct
Alogliptin,chronic obstructive pulmonary disease (COPD),6,0,CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O,direct
Latuda,myocardial infarction,1,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
BUPIVACAINE HCl,AIDS,10,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Tetracaine Hydrochloride,diabetes mellitus,5,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
Fluorescein Sodium and Benoxinate Hydrochloride,hypersensitivity,313,1,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
Macrobid,hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
BIVALIRUDIN,myocardial infarction,1,0,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,direct
Quinapril HCL and Hydrochlorothiazide,diabetes mellitus,5,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
valsartan,autoimmune disease,15,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Cimetidine,preexisting arthritis,1156,1,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N,direct
Dyanavel XR,cancer (localized),8,0,CC(N)CC1=CC=CC=C1,direct
FIRMAGON,cancer (localized),8,0,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(N)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(=O)[C@@H]2CC(=O)NC(=O)N2)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,direct
CITALOPRAM HYDROBROMIDE,hypersensitivity,313,1,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
Bromocriptine Mesylate,hypertension,39,1,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
Zolpidem tartrate,insomnia,441,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Kalydeco,severe infection,18,0,CC(C)(C)C1=CC(=C(O)C=C1NC(=O)C1=CNC2=CC=CC=C2C1=O)C(C)(C)C,direct
cefdinir,tics,23,1,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,direct
Alendronate Sodium,severe infection,18,0,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
desoximetasone,asthma,12,0,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
CLORAZEPATE DIPOTASSIUM,glaucoma,481,1,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,direct
BRIDION,diabetes mellitus,5,0,O[C@@H]1[C@@H](O)[C@@H]2O[C@H]3O[C@H](CSCCC(O)=O)[C@@H](O[C@H]4O[C@H](CSCCC(O)=O)[C@@H](O[C@H]5O[C@H](CSCCC(O)=O)[C@@H](O[C@H]6O[C@H](CSCCC(O)=O)[C@@H](O[C@H]7O[C@H](CSCCC(O)=O)[C@@H](O[C@H]8O[C@H](CSCCC(O)=O)[C@@H](O[C@H]9O[C@H](CSCCC(O)=O)[C@@H](O[C@H]1O[C@@H]2CSCCC(O)=O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O,direct
Diltiazem HCl CD,myocardial infarction,49,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Cladribine,anemia,81,1,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
Irbesartan and Hydrochlorothiazide,myocardial infarction,1,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
COMBIVIR,hypersensitivity,313,1,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
Galantamine,hypersensitivity,313,1,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
Compro,previous brain damage,1166,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
NABUMETONE,impaired renal function,919,1,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
Xalkori,alk-positive imt,581,1,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,direct
ACETYLCYSTEINE,renal failure,19,0,CC(=O)N[C@@H](CS)C(O)=O,direct
fulvestrant,diabetes mellitus,5,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],direct
Omeprazole,hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
ABILIFY,congestive heart failure,2,0,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
fluphenazine hydrochloride,liver cirrhosis,4,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Brimonidine Tartrate/Timolol Maleate,cancer (metastatic),9,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Amoxapine,cardiovascular disorders,669,1,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1,direct
Cortisone Acetate,diabetes mellitus,111,1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Triloan II SUIK,liver disease (non-cirrhotic),20,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Amnesteem,cancer (metastatic),9,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Nardil,cancer (metastatic),9,0,NNCCC1=CC=CC=C1,direct
Definity,pediatric patients,13,1,FC(F)(F)C(F)(F)C(F)(F)F,direct
Normosol-R and Dextrose,asthma,12,0,[Cl-].[K+],direct
CARTIA XT,hypertension,11,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
BETAXOLOL HYDROCHLORIDE,congestive heart failure,2,0,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
LIDOCAINE HCI AND EPINEPHRINE,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Pioglitazone Hydrochloride,hypersensitivity,313,1,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
Vitrexyl,mental illness,14,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
deferasirox,sepsis,17,0,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
CARBOPLATIN,sepsis,17,0,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Nabumetone,anemia,13,0,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
TREANDA,hypersensitivity,313,1,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
amiloride hydrochloride,persistent hyperkalemia,1119,1,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
Alacort,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Triloan II SUIK,mental illness,14,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
LIDOCAINE AND PRILOCAINE,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
FEBUXOSTAT,pregnancy,16,0,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
IRBESARTAN AND HYDROCHLOROTHIAZIDE,hypersensitivity,313,1,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
NITROGLYCERIN LINGUAL,shock,419,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Ranitidine,stroke,7,0,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O,direct
Olanzapine,congestive heart failure,2,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Azithromycin Monohydrate,cancer (localized),8,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
AK-FLUOR,anemia,13,0,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
Accucaine,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Monoferric,asthma,12,0,[Fe+3].OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O,direct
Melphalan,cancer (localized),8,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
"Brimonidine Tartrate ophthalmic solution, 0.15%",hypertension,39,1,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
VIVJOA,hypersensitivity,313,1,O[C@@](CN1C=NN=N1)(C1=CC=C(F)C=C1F)C(F)(F)C1=CC=C(C=N1)C1=CC=C(OCC(F)(F)F)C=C1,direct
Vitafol Fe Plus,an overactive thyroid,592,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
CAPTOPRIL AND HYDROCHLOROTHIAZIDE,skin rash,1262,1,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Edaravone,congestive heart failure,2,0,CC1=NN(C(=O)C1)C1=CC=CC=C1,direct
Fareston,severe infection,18,0,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,direct
Vilazodone Hydrochloride,stroke,7,0,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,direct
Haldol Decanoate,dementia,7,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
MLK Kit F2,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Midazolam hydrochloride,sepsis,17,0,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
TRAMADOL HYDROCHLORIDE,liver cirrhosis,4,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
VAFSEO,sepsis,17,0,OC(=O)CNC(=O)C1=C(O)C=C(C=N1)C1=CC(Cl)=CC=C1,direct
calcium chloride,myocardial infarction,1,0,[Cl-].[Cl-].[Ca++],direct
desoximetasone,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
TERIFLUNOMIDE,cancer (metastatic),9,0,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
Memantine,pregnancy,16,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Salsalate,asthma,12,0,OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O,direct
ERTAPENEM SODIUM,the laboratory test,1306,1,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
"sodium sulfate, potassium sulfate, and magnesium sulfate",renal failure,19,0,[Mg++].[O-]S([O-])(=O)=O,"fuzzy:sodium sulfate, potassium sulfate and magnesium sulfate"
TESTOSTERONE CYPIONATE,liver disease (non-cirrhotic),20,0,[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Xenical,renal failure,19,0,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,direct
Dialyvite with Zinc,liver cirrhosis,4,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Alprazolam XR,depression,27,1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
Docetaxel anhydrous,myocardial infarction,1,0,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
donepezil hydrochloride,autoimmune disease,15,0,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
DESOXIMETASONE,mental illness,14,0,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Thalitone,hypersensitivity,313,1,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
PHENDIMETRAZINE TARTRATE,AIDS,10,0,C[C@H]1[C@@H](OCCN1C)C1=CC=CC=C1,direct
ZITUVIO,AIDS,10,0,N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F,direct
nystatin,mental illness,14,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Arsenic trioxide,liver cirrhosis,4,0,O=[As]O[As]=O,direct
Theo-24,chronic obstructive pulmonary disease (COPD),6,0,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
oseltamavir phosphate,autoimmune disease,15,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
ADENOSINE,chronic kidney disease,3,0,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
SAPHRIS,chronic obstructive pulmonary disease (COPD),6,0,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
RIFAMPIN,mental illness,14,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
Cytomel,hypertension,11,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
Nisoldipine,myocardial infarction,1,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C,direct
SOTALOL HYDROCHLORIDE,paroxysmal afib that,1101,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Vinorelbine,nsclc who,1068,1,[H][C@@]12N(C)C3=CC(OC)=C(C=C3[C@@]11CCN3CC=C[C@](CC)([C@@]13[H])[C@@]([H])(OC(C)=O)[C@]2(O)C(=O)OC)[C@]1(C[C@@]2([H])CN(CC(CC)=C2)CC2=C1NC1=CC=CC=C21)C(=O)OC,direct
Sotalol Hydrochloride,renal failure,19,0,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Heparin Sodium and Dextrose,the following conditions,1301,1,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C=O,fuzzy:heparin sodium in dextrose
lurasidone hydrochloride,severe infection,18,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
CIDOFOVIR DIHYDRATE,preexisting diabetes mellitus,1160,1,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,direct
Varenicline,cancer (localized),8,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Epidiolex,AIDS,10,0,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1,direct
FLUOCINOLONE ACETONIDE,autoimmune disease,15,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
DEXAMETHASONE SODIUM PHOSPHATE,a stressed myocardium,508,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Emtriva,hypertension,11,0,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,direct
Methenamine Mandelate,autoimmune disease,15,0,C1N2CN3CN1CN(C2)C3,direct
Indium in 111 Oxyquinoline,cancer (metastatic),9,0,[111In+3].[O-]C1=CC=CC2=C1N=CC=C2.[O-]C1=CC=CC2=C1N=CC=C2.[O-]C1=CC=CC2=C1N=CC=C2,direct
calcipotriene,known hypercalcemia,950,1,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE,autoimmune disease,15,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
Acarbose,cancer (metastatic),9,0,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,direct
dimethyl fumarate,hypersensitivity,313,1,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
Jentadueto,asthma,12,0,CN(C)C(=N)NC(N)=N,direct
SILVADENE,sepsis,291,1,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
MOMETASONE FUROATE,sepsis,17,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
VYXEOS,liver cirrhosis,4,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,direct
Fluocinonide Cream,diabetes mellitus,5,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,direct
XARELTO,stroke,51,1,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,direct
E-Z-Disk,asthma,12,0,[Ba++].[O-]S([O-])(=O)=O,direct
Evoxac,stroke,7,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
AMOXICILLIN AND CLAVULANATE POTASSIUM,pediatric patients,13,1,[H][C@@]12CC(=O)N1[C@@H](C(O)=O)\C(O2)=C\CO,direct
Benazepril Hydrochloride and Hydrochlorothiazide,cancer (metastatic),9,0,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,direct
pravastatin sodium,atherosclerosis,357,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Methylphenidate,psychosis,31,1,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
DYMISTA,autoimmune disease,15,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Tolsura,diabetes mellitus,5,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
LISINOPRIL and HYDROCHLOROTHIAZIDE,impaired renal function,919,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Rifadin IV NOVAPLUS,sepsis,17,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
HYDROXYCHLOROQUINE SULFATE,cancer (metastatic),9,0,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
PrednisoLONE,diabetes mellitus,5,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Mycobutin,tuberculosis,213,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21,direct
Methyldopa,liver cirrhosis,4,0,C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O,direct
Sevelamer Carbonate,bowel obstruction,641,1,NCC=C.ClCC1CO1,direct
Nestabs ONE,diabetes mellitus,5,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Diclofenac Sodium,chronic kidney disease,3,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
OXCARBAZEPINE,insomnia,441,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
METHADOSE,pregnancy,16,0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Omeprazole/Sodiium Bicarbonate,hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,fuzzy:omeprazole/sodium bicarbonate
FABHALTA,liver cirrhosis,4,0,CCO[C@H]1CCN(CC2=C(OC)C=C(C)C3=C2C=CN3)[C@@H](C1)C1=CC=C(C=C1)C(O)=O,direct
LIDOCAINE HCl,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
EPINEPHRINE,shock,419,1,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
VERAPAMIL HYDROCHLORIDE,severe infection,18,0,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,direct
Sorafenib Tosylate,hypersensitivity,313,1,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
Sumansetron,severe hepatic impairment,1245,1,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,direct
Doxycycline Hyclate,adult periodontitis,558,1,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
ACCUTANE,tics,23,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Enalapril Maleate and Hydrochlorothiazide,AIDS,10,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
VAFSEO,chronic kidney disease,245,1,OC(=O)CNC(=O)C1=C(O)C=C(C=N1)C1=CC(Cl)=CC=C1,direct
Alprazolam Extended Release,chronic obstructive pulmonary disease (COPD),6,0,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
furosemide,cancer (localized),8,0,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O,direct
triamcinolone acetonide,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Carbatrol,sepsis,17,0,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Gloperba,chronic kidney disease,3,0,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
POLOCAINE(R) -MPF (MEPIVACAINE HCI),congestive heart failure,2,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Urso 250,primary biliary cholangitis,1170,1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
ENALAPRIL MALEATE,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
IQ Dental Mepivacaine,hypersensitivity,313,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
ETHOSUXIMIDE,asthma,12,0,CCC1(C)CC(=O)NC1=O,direct
amiloride hydrochloride,cancer (metastatic),9,0,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
Polocaine-MPF,pregnancy,16,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Esomeprazole DR,stroke,7,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Temozolomide,AIDS,10,0,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
Nabumetone 500 mg,severe infection,18,0,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
Lamotrigine,epilepsy a,796,1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
"Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide",pregnancy,16,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Fluphenazine Hydrochoride,dementia,7,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,fuzzy:fluphenazine hydrochloride
Gengraf,AIDS,10,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
DORZOLAMIDE HYDROCHLORIDE,cancer (metastatic),9,0,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
HYZAAR,congestive heart failure,2,0,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
azithromycin monohydrate,pneumonia who,1132,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
UDSxMP Medicated System,hypersensitivity,313,1,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O,direct
Ibandronate Sodium,myocardial infarction,1,0,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,direct
metronidazole,blood dyscrasias metronidazole,636,1,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Plerixafor,lymphoma,269,1,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
Cyklokapron,subarachnoid hemorrhage,1275,1,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Mulpleta,thrombocytopenia,79,1,CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C1=CSC(NC(=O)C2=CC(Cl)=C(\C=C(/C)C(O)=O)C(Cl)=C2)=N1,direct
Metoclopramide,documented lesions,784,1,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,direct
Carteolol Hydrochloride,glaucoma,481,1,CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2,direct
rifabutin,active tuberculosis,535,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21,direct
Metopirone,cancer (metastatic),9,0,CC(C)(C(=O)C1=CN=CC=C1)C1=CC=CN=C1,direct
Fluocinolone acetonide,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Clobazam,hypersensitivity,313,1,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,direct
prochlorperazine maleate,sepsis,17,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Loxapine,psychosis,31,1,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,direct
Cuprimine,liver disease (non-cirrhotic),20,0,[H][C@](N)(C(O)=O)C(C)(C)S,direct
Labetalol hydrochloride,this tumor,1318,1,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Methadone Hydrochloride,cancer (localized),8,0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Teflaro,cancer (metastatic),9,0,[H][C@]12SCC(SC3=NC(=CS3)C3=CC=[N+](C)C=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC)\C1=NSC(NP(O)(O)=O)=N1)C([O-])=O,direct
NITROGLYCERIN LINGUAL,pregnancy,16,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
ZIOPTAN,mental illness,14,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
GEMCITABINE,various malignancies,1350,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
Sertraline,hypersensitivity,313,1,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,direct
TENORMIN,angina pectoris,596,1,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,direct
SINEMET,hypersensitivity,313,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Levalbuterol,diabetes mellitus,5,0,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
Lidocaine hydrochloride,severe infection,18,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Levocarnitine,asthma,12,0,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
ONDANSETRON,anemia,13,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Lyrica CR,chronic obstructive pulmonary disease (COPD),6,0,CC(C)C[C@H](CN)CC(O)=O,direct
Tizanidine hydrochloride,multiple sclerosis,153,1,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
EOVIST,diabetes mellitus,5,0,[Gd+3].[H][C@@](CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O)(CC1=CC=C(OCC)C=C1)N(CC(O)=O)CC(O)=O,direct
timolol maleate,liver cirrhosis,4,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
lurasidone hydrochloride,asthma,12,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Alacort,pregnancy,16,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
HALOPERIDOL DECANOATE,stroke,7,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
brexpiprazole,mdd and schizophrenia,989,1,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,direct
Cevimeline,other conditions,1087,1,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
Theo-24,hypersensitivity,313,1,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Haldol Decanoate,psychosis,31,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Diltiazem Hydrochloride EXTENDED RELEASE,pregnancy,16,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
azithromycin,asthma,12,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Mirtazapine,liver disease (non-cirrhotic),20,0,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1,direct
Deferasirox,advanced malignancies,563,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Pfizerpen,asthma,12,0,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,direct
Dimethyl Fumarate,hypersensitivity,313,1,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
Travoprost Ophthalmic Solution,myocardial infarction,1,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Memantine HCL,hypersensitivity,313,1,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Brimonidine,hypertension,39,1,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE,severe androgen excess,1234,1,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],direct
PREGABALIN,hypersensitivity,313,1,CC(C)C[C@H](CN)CC(O)=O,direct
Methylprednisolone,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Capecitabine 500mg,hypersensitivity,313,1,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
Tobramycin,myocardial infarction,1,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
CHLORPROMAZINE HCI,severe infection,18,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
PLERIXAFOR,lymphoma,269,1,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
FENTORA,stroke,7,0,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
ZALDYON,liver disease (non-cirrhotic),20,0,NC1=CC(C(O)=O)=C(O)C=C1,direct
Deferasirox,decreased egfr,761,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
PharmapureRx Lidocaine HCl 4.12%,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
"PredniSONE Tablets, USP, 20 mg",stroke,7,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Carbidopa,narrow-angle glaucoma,1030,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Promethazine with Codeine,hypersensitivity,313,1,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,direct
Nitrofurantoin,mental illness,14,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
NOREPINEPHRINE BITARTRATE,mental illness,14,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Atovaquone and Proguanil Hydrochloride,pregnancy,16,0,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,direct
Succinylcholine Chloride,liver disease (non-cirrhotic),20,0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,direct
Matzim LA,chronic stable angina,705,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
DALFAMPRIDINE,liver disease (non-cirrhotic),20,0,NC1=CC=NC=C1,direct
TARCEVA,chronic kidney disease,3,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
Vascepa,myocardial infarction,1,0,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
CAFCIT,necrotizing enterocolitis,1032,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Nifedipine ER,tight aortic stenosis,1320,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Zoledronic Acid,the following conditions,1301,1,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
tacrolimus,autoimmune disease,15,0,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,direct
Sevelamer Carbonate For Oral Suspension,cancer (metastatic),9,0,NCC=C.ClCC1CO1,direct
Amitriptyline HCL,asthma,12,0,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
ETOPOPHOS,lymphoma,269,1,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@@H]1O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O,direct
Colazal,cancer (metastatic),9,0,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,direct
ACETAZOLAMIDE EXTENDED-RELEASE,cancer (localized),8,0,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
calcium chloride,renal failure,19,0,[Cl-].[Cl-].[Ca++],direct
Lidotran,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
FIRMAGON,anemia,13,0,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(N)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(=O)[C@@H]2CC(=O)NC(=O)N2)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CC=CN=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,direct
ACCRUFER,AIDS,10,0,[Fe+3].CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1.CC1=C([O-])C(=O)C=CO1,direct
CAPLYTA,myocardial infarction,1,0,[H][C@]12CCN(CCCC(=O)C3=CC=C(F)C=C3)C[C@@]1([H])C1=CC=CC3=C1N2CCN3C,direct
CLONAZEPAM,chronic kidney disease,3,0,[O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1,direct
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE,pregnancy,16,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Cyclosporine Modified,chronic kidney disease,3,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Hectorol,insomnia,441,1,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
Butalbital/Acetaminophen/Caffeine,hypertension,11,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Amoxapine,cancer (localized),8,0,ClC1=CC2=C(OC3=CC=CC=C3N=C2N2CCNCC2)C=C1,direct
Fenofibrate,cirrhosis,231,1,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
Niacin,chronic kidney disease,3,0,OC(=O)C1=CN=CC=C1,direct
CELESTONE SOLUSPAN,asthma,12,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Hydrocodone Bitartrate and Acetaminophen,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
Physician EZ Use Joint Tunnel and Trigger Kit,diabetes mellitus,5,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Adapalene and benzoyl peroxide,cancer (metastatic),9,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Vasotec,cancer (localized),8,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
Iluvien,stroke,7,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE,severe infection,18,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
CAPTOPRIL AND HYDROCHLOROTHIAZIDE,mental illness,14,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
"Carbidopa Tablets, 25 mg",anemia,13,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Tolectin,the aspirin triad,1295,1,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,fuzzy:tolmetin
METHYLPREDNISOLONE,diabetes mellitus,5,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Paclitaxel protein-bound particles for injectable suspension (albumin-bound),and without neutropenia,595,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
TIADYLT ER,hypotension,75,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
EPOPROSTENOL,congestive heart failure,41,1,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,direct
Leflunomide,cancer (localized),8,0,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
DILTIAZEM HYDROCHLORIDE,autoimmune disease,15,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Regadenoson,mental illness,14,0,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
Teriflunomide,autoimmune disease,15,0,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
midazolam,acute narrow-angle glaucoma,546,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Iluvien,myocardial infarction,1,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
CARBIDOPA AND LEVODOPA,narrow-angle glaucoma,1030,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Ceftazidime,stroke,7,0,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
Diphenoxylate Hydrochloride and Atropine Sulfate,sepsis,17,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
BOTOX,urinary tract infection,249,1,ONC(=O)\C=C\C1=CC=C(Cl)C=C1Cl,direct
Haloperidol decanoate,dementia,7,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Chlorpromazine hydrochloride,liver disease (non-cirrhotic),20,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
carmustine,hypersensitivity,313,1,ClCCNC(=O)N(CCCl)N=O,direct
adapalene and benzoyl peroxide,myocardial infarction,1,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND,and without neutropenia,595,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Mozobil,liver cirrhosis,4,0,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
THEOPHYLLINE,hypersensitivity,313,1,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
cisatracurium besylate,stroke,7,0,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,direct
Fluocinonide Cream,cancer (localized),8,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,direct
ACCUTANE,stroke,7,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Abiraterone acetate,metastatic crpc,997,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
lacosamide,partial-onset seizures who,1108,1,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
Fareston,liver cirrhosis,4,0,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,direct
Spritam,congestive heart failure,2,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
SIMBRINZA,myocardial infarction,1,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Oxycodone and Acetaminophen,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
Dorzolamide hydrochloride and timolol maleate,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Aripiprazole,stroke,7,0,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
NALBUPHINE HCI,liver disease (non-cirrhotic),20,0,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
Vasotec,AIDS,10,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
Actonel,the following conditions,1301,1,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
PNV-DHA,nutritional deficiencies or,1071,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Adalimumab-aacf,active ankylosing spondylitis,520,1,CC(C)O,direct
Perphenazine,convulsive disorders,751,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
MEXILETINE HYDROCHLORIDE,ventricular arrhythmias,1354,1,CC(N)COC1=C(C)C=CC=C1C,direct
Strattera,glaucoma,481,1,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
Magnesium Sulfate,stroke,7,0,[Mg++].[O-]S([O-])(=O)=O,direct
CARVEDILOL,myocardial infarction,1,0,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
DILTIAZEM HYDROCHLORIDE,chronic stable angina,705,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Regadenoson,lung disease,375,1,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
CYCLOSET,secondary parkinsonism,1224,1,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
ABRAXANE,sepsis,291,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Rivastigmine,congestive heart failure,2,0,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,direct
SILVER SULFADIAZINE,sepsis,291,1,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
Isordil Titradose,stroke,7,0,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
Lamivudine and Zidovudine,congestive heart failure,2,0,CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O,direct
Vancomycin Hydrochloride for Oral Solution,myocardial infarction,1,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
Granisetron Hydrochloride,mental illness,14,0,CN1N=C(C(=O)N[C@@H]2C[C@@H]3CCC[C@H](C2)N3C)C2=C1C=CC=C2,direct
METHADOSE,seizure disorders methadone,1226,1,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,direct
omeprazole and sodium bicarbonate,pregnancy,16,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
ENBREL,psa or as,1187,1,OCC1=CC=CC=C1,direct
posaconazole,edema,417,1,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
Adasuve,the following,1299,1,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,direct
prochlorperazine edisylate,congestive heart failure,2,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
MIDODRINE HYDROCHLORIDE,hypertension,39,1,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,direct
LIDOCAINE HYDROCHLORIDE AND DEXTROSE,pregnancy,16,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ZOMIG,stroke,7,0,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
Cartia XT,chronic kidney disease,3,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
diclofenac potassium,diabetes mellitus,5,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Oralone,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Moexipril Hydrochloride,cancer (metastatic),9,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O,direct
Hydrocodone Bitartrate And Acetaminophen,chronic overdose,698,1,CC(=O)NC1=CC=C(O)C=C1,direct
atomoxetine,glaucoma,481,1,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
ACARBOSE,hypersensitivity,313,1,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,direct
NESTABS DHA Prenatal Multi-vitamin/Mineral Supplement with DHA/EPA,hypertension,11,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
CEVIMELINE,stroke,7,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
AMPHETAMINE SULFATE,comorbid depressive symptoms,735,1,CC(N)CC1=CC=CC=C1,direct
Amitriptyline Hydrochloride,sepsis,17,0,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
AMMONIA N-13,congestive heart failure,2,0,[13NH3],direct
emtricitabine,hypersensitivity,313,1,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,direct
CARBOPLATIN,impaired kidney function,917,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
THAM,cancer (metastatic),9,0,NC(CO)(CO)CO,direct
Glipizide and Metformin HCl,diabetes mellitus,5,0,CN(C)C(=N)NC(N)=N,direct
VALCHLOR,sepsis,17,0,CN(CCCl)CCCl,direct
Lurasidone Hydrochloride,cancer (metastatic),9,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Ammonia N-13,AIDS,10,0,[13NH3],direct
Chlordiazepoxide Hydrochloride,hypertension,11,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Cisatracurium,hypertension,11,0,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,direct
Face Cream,renal failure,257,1,OC(=O)C1=CC=CC=C1O,fuzzy:acne cream
Folitin-Z,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
INVEGA TRINZA,stroke,7,0,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCC(O)C2=N1,direct
Buprenorphine Hydrochloride,asthma,193,1,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,direct
bendamustine hydrochloride,hypersensitivity,313,1,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
CARBOPLATIN,stroke,7,0,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Propofol,hypersensitivity,313,1,CC(C)C1=CC=CC(C(C)C)=C1O,direct
Jevtana,prostate cancer,265,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C4=CC=CC=C4)C(C)=C([C@@H](OC)C(=O)[C@]1(C)[C@H](C[C@H]1OC[C@@]21OC(C)=O)OC)C3(C)C,direct
Haloperidol,psychosis,31,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Propranolol hydrochloride,hypertrophic subaortic stenosis,899,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Diltiazem Hydrochloride EXTENDED RELEASE,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
LAMOTRIGINE Kit,pediatric patients,13,1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution,depression,27,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
IBUPAK,liver disease (non-cirrhotic),20,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Ibutilide Fumarate,tachycardia,47,1,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Toronova II SUIK,congestive heart failure,2,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Brimonidine,sepsis,17,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
REGIOCIT,increased bleeding risks,924,1,[Na+].[Cl-],direct
Gentamicin Sulfate Opth Solution,hypersensitivity,313,1,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,direct
ZOMIG,hypersensitivity,313,1,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
Normosol-R,diabetes mellitus,5,0,[Cl-].[K+],direct
Phenylephrine Hydrochloride,renal failure,19,0,CNC[C@H](O)C1=CC(O)=CC=C1,direct
Nisoldipine,hypersensitivity,313,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C,direct
LEVOLEUCOVORIN CALCIUM,AIDS,10,0,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
TRIESENCE,liver cirrhosis,4,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ranolazine,AIDS,10,0,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,direct
Adalimumab-adbm,active as,521,1,CC(C)O,direct
haloperidol,dementia,7,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Proctosol-HC,autoimmune disease,15,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Methylene Blue,congestive heart failure,2,0,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,direct
pantoprazole sodium,hypersensitivity,313,1,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
FLUCONAZOLE,renal failure,19,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Tranexamic Acid in Sodium Chloride,subarachnoid hemorrhage,1275,1,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Perphenazine,psychosis,31,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Valsartan and hydrochlorothiazide,severe hypertension,1246,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
DEFENCATH,myocardial infarction,1,0,O=S1(=O)CCN(CN2CCS(=O)(=O)NC2)CN1,direct
SOMATULINE DEPOT,documented hepatic impairment,783,1,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],direct
COSOPT PF,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Benazepril Hydrochloride and Hydrochlorothiazide,asthma,193,1,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,direct
Dexamethasone sodium phosphate,diabetes mellitus,5,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Dexatran,renal failure,19,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
OZEMPIC,pregnancy,16,0,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CN=CN1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O,direct
Afinitor,functional carcinoid tumors,820,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,direct
Glipizide,renal failure,19,0,CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,direct
IXEMPRA,breast cancer,263,1,[H][C@]12C[C@H](NC(=O)C[C@H](O)C(C)(C)C(=O)[C@H](C)[C@@H](O)[C@@H](C)CCC[C@@]1(C)O2)C(\C)=C\C1=CSC(C)=N1,direct
Zolpidem Tartrate,insomnia,441,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
ALBENZA,hypersensitivity,313,1,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,direct
Sensorcaine,AIDS,10,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
SSD,liver disease (non-cirrhotic),20,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
Diphenoxylate Hydrochloride and Atropine Sulfate,acute ulcerative colitis,556,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
CAPTOPRIL AND HYDROCHLOROTHIAZIDE,hypertension,39,1,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
GLYRX-PF,hypersensitivity,313,1,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
Capecitabine 500mg,cancer (metastatic),9,0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
ChlorproMAZINE Hydrochloride,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
fluphenazine hydrochloride,pregnancy,16,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Prednisolone Sodium Phosphate Oral Solution,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Propafenone HCl,chronic atrial fibrillation,685,1,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,direct
DROPERIDOL,long qt syndrome,61,1,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,direct
Tramadol Hydrochloride Extended-Release,chronic non-malignant pain,697,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Balsalazide Disodium,hypersensitivity,313,1,OC(=O)CCNC(=O)C1=CC=C(C=C1)\N=N\C1=CC=C(O)C(=C1)C(O)=O,direct
FABHALTA,pnh receiving fabhalta,1134,1,CCO[C@H]1CCN(CC2=C(OC)C=C(C)C3=C2C=CN3)[C@@H](C1)C1=CC=C(C=C1)C(O)=O,direct
Tafinlar,congestive heart failure,2,0,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,direct
Haloperidol,dementia,7,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
TIAZAC EXTENDED RELEASE,myocardial infarction,49,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Moexipril Hydrochloride,essential hypertension who,807,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O,direct
Ropivacaine Hydrochloride,cancer (metastatic),9,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
Doxercalciferol,ckd on dialysis,713,1,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
Montelukast,hypersensitivity,313,1,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
Promethazine,AIDS,10,0,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
VANFLYTA,renal failure,19,0,CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1,direct
Aminophylline,asthma,12,0,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Colesevelam Hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,NCC=C.ClCC1CO1,fuzzy:sevelamer hydrochloride
Amphetamine Sulfate,mental illness,14,0,CC(N)CC1=CC=CC=C1,direct
Deferasorox,advanced malignancies,563,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Promethazine Hydrochloride and Phenylephrine Hydrochloride,bone-marrow depression,639,1,CNC[C@H](O)C1=CC(O)=CC=C1,direct
Tegretol,symptomatic hyponatremia,1286,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Soma,autoimmune disease,15,0,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,direct
ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE,hypersensitivity,313,1,CC(=O)OC1=CC=CC=C1C(O)=O,direct
Cortisone Acetate,hypertension,39,1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Azelastine hydrochloride and Fluticasone propionate,seasonal allergic rhinitis,1223,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Tizanidine,anemia,13,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide",hypertension,39,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Cladribine,tachycardia,47,1,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
Alvesco,liver cirrhosis,4,0,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,direct
citalopram hydrobromide,liver cirrhosis,4,0,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
HYDROCORTISONE,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Diflucan,liver cirrhosis,4,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
CINACALCET,congestive heart failure,2,0,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
THAM,diabetes mellitus,5,0,NC(CO)(CO)CO,direct
Morphine Sulfate,chronic ulcerative colitis,707,1,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])C=C[C@@H]2O,direct
Dabigatran Etexilate,myocardial infarction,1,0,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
Levothyroxine Sodium,sepsis,17,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
Amlodipine and valsartan,hypersensitivity,313,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
RIBAVIRIN,heart disease,377,1,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
SUCRALFATE,hypersensitivity,313,1,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,direct
Hydrocortisone,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Allopurinol,hypertension,11,0,OC1=NC=NC2=C1C=NN2,direct
Alcaine,autoimmune disease,15,0,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,direct
DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Fluvastatin,chronic obstructive pulmonary disease (COPD),6,0,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,direct
Cephalexin,hypertension,11,0,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
QUINAPRIL,myocardial infarction,1,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Adefovir dipivoxil,chronic kidney disease,3,0,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C,direct
Aromasin,hypersensitivity,313,1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C,direct
SUPREP Bowel Prep,normal baseline who,1060,1,[Mg++].[O-]S([O-])(=O)=O,direct
ORPHENGESIC FORTE,cancer (localized),8,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Brimonidine Tartrate/Timolol Maleate,autoimmune disease,15,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Carbidopa and Levodopa,liver cirrhosis,4,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
CHLOROTHIAZIDE SODIUM,anemia,13,0,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
Olopatadine Hydrochloride,perennial allergic rhinitis,1111,1,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2,direct
Omnaris,myocardial infarction,1,0,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,direct
Lidocaine hydrochloride,sepsis,17,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Methylprednisolone acetate,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
XARELTO,pregnancy,16,0,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,direct
IPRATROPIUM BROMIDE,hypertension,11,0,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,direct
Bacitracin,sepsis,17,0,CC[C@H](C)[C@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC,direct
Pretrate,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Folditam,chronic kidney disease,3,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Mepivacaine,chronic kidney disease,3,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Rivaroxaban,stroke,51,1,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,direct
Celecoxib,diabetes mellitus,5,0,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
Fensolvi,pediatric patients,13,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
AVYCAZ,nephritis,255,1,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
APREMILAST,severe infection,18,0,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,direct
ILOPERIDONE,schizophrenia the following,1222,1,COC1=C(OCCCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C=CC(=C1)C(C)=O,direct
PIOGLITAZONEHYDROCHLORIDE,stroke,7,0,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
PureVit DualFe Plus,liver disease (non-cirrhotic),20,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
nalmefene hydrochloride,hypersensitivity,313,1,OC1=CC=C2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](OC1=C24)C(=C)CC[C@@]35O,direct
Amitriptyline HCL,depressive symptoms,769,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
HYDROCORTISONE VALERATE,myocardial infarction,1,0,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Otezla,diabetes mellitus,5,0,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,direct
Clocortolone Pivalate,mental illness,14,0,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
CARMUSTINE,asthma,12,0,ClCCNC(=O)N(CCCl)N=O,direct
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
CHANTIX,stroke,7,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Chlorthalidone,mental illness,14,0,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
KHAPZORY,autoimmune disease,15,0,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
Neomycin Sulfate,hypersensitivity,313,1,[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](C)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O.[H][C@@]1(CCN=C(N)N1)[C@]1([H])NC(=O)\C(NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CNC1=O)=C/NC(N)=O,fuzzy:capreomycin sulfate
Tamoxifen Citrate,hypersensitivity,313,1,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,direct
ZIPSOR,asthma,12,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
MOMETASONE FUROATE,pregnancy,16,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
PROCTOFOAM HC,cancer (metastatic),9,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
NITROGLYCERIN,hypertension,11,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
CARBOPLATIN,poor performance status,1139,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
NOCDURNA,hyponatremia,137,1,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
Procainamide Hydrochloride,cardiac decompensation,666,1,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
diltiazem hydrochloride,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Dorzolamide Hydrochloride,glaucoma,481,1,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Trifluoperazine Hydrochloride,dementia,7,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Propranolol,chronic obstructive pulmonary disease (COPD),6,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Brexpiprazole,renal failure,19,0,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,direct
Forfivo XL,bulimia,401,1,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Visipaque,coronary artery disease,37,1,CC(=O)N(CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I,direct
lisdexamfetamine dimesylate,chronic obstructive pulmonary disease (COPD),6,0,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
nifedipine,aortic stenosis,55,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
ESOMEPRAZOLE STRONTIUM,asthma,12,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Amphotericin B,other notable reactions,1091,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
ERYTHROMYCIN,myocardial infarction,1,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Deferasirox,sepsis,17,0,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Vaseretic,cancer (metastatic),9,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
Isosorbide Dinitrate,congestive heart failure,41,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
PARAPLATIN,impaired kidney function,917,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Methscopolamine Bromide,congestive heart failure,2,0,[Br-].[H][C@@]12O[C@]1([H])[C@H]1C[C@H](C[C@@H]2[N+]1(C)C)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Sitagliptin and metformin hydrochloride,anemia,13,0,CN(C)C(=N)NC(N)=N,fuzzy:saxagliptin and metformin hydrochloride
Fruzaqla,mcrc who,988,1,CNC(=O)C1=C(C)OC2=CC(OC3=NC=NC4=CC(OC)=C(OC)C=C34)=CC=C12,direct
Xofluza,myocardial infarction,1,0,[H][C@@]12COCCN1C(=O)C1=C(OCOC(=O)OC)C(=O)C=CN1N2[C@H]1C2=CC=C(F)C(F)=C2CSC2=CC=CC=C12,direct
Ceftriaxone Sodium,congestive heart failure,2,0,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
Gemcitabine hydrochloride,various malignancies,1350,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
Timolol maleate,hypertension,11,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
LATANOPROST,liver disease (non-cirrhotic),20,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Nitrofurantoin Monohydrate/ Macrocrystalline,congestive heart failure,2,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Norpace CR,myocardial infarction,49,1,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
Succinylcholine,hypersensitivity,313,1,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,direct
DROXIA,chronic kidney disease,3,0,NC(=O)NO,direct
Norpace CR,cancer (localized),8,0,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
Solu-Cortef,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
meloxicam,liver cirrhosis,4,0,CN1C(C(=O)NC2=NC=C(C)S2)=C(O)C2=C(C=CC=C2)S1(=O)=O,direct
Auryxia,anemia,81,1,O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,direct
"Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide",chronic kidney disease,3,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
KLOR-Con/EF,severe infection,18,0,[K+].OC([O-])=O,direct
Glyburide and Metformin Hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,CN(C)C(=N)NC(N)=N,direct
Methylprednisolone sodium succinate,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
TECFIDERA,renal failure,19,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
Perphenazine and Amitriptyline Hydrochloride,depressive symptoms,769,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Celontin,stroke,7,0,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1,direct
Topiramate,hypersensitivity,313,1,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,direct
Talzenna,hrr gene-mutated mcrpc,874,1,CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1,direct
Depen,diabetes mellitus,5,0,[H][C@](N)(C(O)=O)C(C)(C)S,direct
Gastrografin,mental illness,14,0,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Prochlorperazine Edisylate,mental retardation,993,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Lidogel,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ERTAPENEM SODIUM,hypersensitivity,313,1,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
RISEDRONATE SODIUM,cancer (localized),8,0,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
Fentanyl system,insomnia,441,1,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
XELSTRYM,pediatric patients,13,1,C[C@H](N)CC1=CC=CC=C1,direct
FLAVOXATE HYDROCHLORIDE,glaucoma,481,1,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,direct
ZOLADEX,hypertension,11,0,CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O,direct
Matzim LA,chronic obstructive pulmonary disease (COPD),6,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Xarelto,stroke,51,1,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,direct
Actoplus Met,liver cirrhosis,4,0,CN(C)C(=N)NC(N)=N,direct
Prolia,hypersensitivity to prolia,893,1,OC(=O)[C@@H]1CCCN1,fuzzy:prolina
Carafate,hypersensitivity,313,1,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,direct
Rosuvastatin calcium,stroke,7,0,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Mexiletine hydrochloride,mental illness,14,0,CC(N)COC1=C(C)C=CC=C1C,direct
ESZOPICLONE,congestive heart failure,2,0,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,direct
GALZIN,hypertension,11,0,[Zn++].CC([O-])=O.CC([O-])=O,direct
Ranitidine Hydrochloride,active duodenal ulcer,522,1,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O,direct
VENLAFAXINE,myocardial infarction,1,0,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
phenelzine sulfate,chronic obstructive pulmonary disease (COPD),6,0,NNCCC1=CC=CC=C1,direct
Cardene IV,hypertension,11,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
Hydrochlorothiazide,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Methylprednisolone Acetate,cancer (localized),8,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Fluorescein Sodium and Benoxinate Hydrochloride,diabetes mellitus,5,0,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
Dexrazoxane,diabetes mellitus,5,0,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,direct
LUMIGAN,asthma,12,0,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
PROMETHAZINE HYDROCHLORIDE,bone-marrow depression,639,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Hectorol,urinary tract infection,249,1,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
POSACONAZOLE,hypertension,39,1,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
Bisoprolol Fumarate,event the following,808,1,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,direct
ESOMEPRAZOLE MAGNESIUM,congestive heart failure,2,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
ISOSORBIDE DINITRATE,pregnancy,16,0,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
Oxcarbazepine,tremor,459,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Pentamidine Isethionate,chronic obstructive pulmonary disease (COPD),6,0,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
Cuprimine,anemia,81,1,[H][C@](N)(C(O)=O)C(C)(C)S,direct
Gloperba,AIDS,10,0,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Methenamine Mandelate,nephritis,255,1,C1N2CN3CN1CN(C2)C3,direct
Arsenic trioxide,hypersensitivity to arsenic,883,1,O=[As]O[As]=O,direct
Chlordiazepoxide and Amitriptyline Hydrochloride,hypersensitivity,313,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
AKEEGA,asthma,12,0,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Calcipotriene,hypersensitivity,313,1,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
Ranexa,sepsis,17,0,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,direct
Montelukast Sodium,hypersensitivity,313,1,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
Niferex,AIDS,10,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
isosorbide mononitrate,anemia,13,0,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,direct
CELEBREX,asthma,12,0,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
Xofluza,congestive heart failure,2,0,[H][C@@]12COCCN1C(=O)C1=C(OCOC(=O)OC)C(=O)C=CN1N2[C@H]1C2=CC=C(F)C(F)=C2CSC2=CC=CC=C12,direct
lisdexamfetamine dimesylate,diabetes mellitus,5,0,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CCCCN,direct
timolol maleate ophthalmic gel forming solution,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Salicylic Acid,AIDS,10,0,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,direct
ASMANEX,severe infection,18,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Tetracaine HCL,cancer (localized),8,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
oseltamavir phosphate,hypersensitivity,313,1,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
regadenoson,pregnancy,16,0,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
PIOGLITAZONEHYDROCHLORIDE,hypersensitivity,313,1,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
Nitrofurantoin Monohydrate/Macrocrystals,myocardial infarction,1,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Exforge HCT,pregnancy,16,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Famotidine,asthma,12,0,NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1,direct
Phenergan,depression,27,1,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Modafinil,cancer (metastatic),9,0,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,direct
Mirabegron,myocardial infarction,1,0,NC1=NC(CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2)=CS1,direct
methylphenidate hydrochloride CD,psychosis,31,1,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
Cyclosporine,hypersensitivity,313,1,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Carteolol Hydrochloride,AIDS,10,0,CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2,direct
Daunorubicin Hydrochloride,renal failure,19,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,direct
Mefenamic Acid,liver disease (non-cirrhotic),20,0,CC1=C(C)C(NC2=CC=CC=C2C(O)=O)=CC=C1,direct
Abiraterone,metastatic crpc,997,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Travoprost Ophthalmic,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Clomipramine HCl,chronic kidney disease,3,0,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
dasatinib,AIDS,10,0,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
BIMATOPROST,glaucoma,481,1,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
pentazocine and naloxone,hypertension,11,0,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,direct
triamcinolone acetonide,chronic kidney disease,3,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Timoptic-XE,renal failure,257,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Sodium Acetate,hypertension,11,0,[Na+].CC([O-])=O,direct
Asenapine,renal failure,19,0,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
Procardia XL,aortic stenosis,55,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Carboplatin,hypertension,11,0,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE,cancer (localized),8,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Bromocriptine mesylate,unexplained pleuropulmonary disorders,1342,1,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
"Carisoprodol Tablets, USP, 350 mg",congestive heart failure,2,0,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
Methylene Blue,liver cirrhosis,4,0,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,direct
ISOTRETINOIN,stroke,7,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
ABILIFY MAINTENA,hypersensitivity,313,1,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
Memantine hydrochloride,severe infection,18,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
ACETAMINOPHEN AND CODEINE,cancer (localized),8,0,CC(=O)NC1=CC=C(O)C=C1,direct
Octreotide,pregnancy,16,0,C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=CC=CC=C23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,fuzzy:edotreotide
BETIMOL,sepsis,17,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Salicylic Acid,hepatic impairment,1,1,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,direct
Calcitrene,liver cirrhosis,4,0,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
Daptomycin in Sodium Chloride,comparator agents,736,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
Ropivacaine Hydrochloride,hypersensitivity,313,1,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
AcetaZOLAMIDE,sepsis,17,0,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
CASPOFUNGIN ACETATE,sepsis,17,0,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
benazepril hydrochloride and hydrochlorothiazide,diabetes mellitus,5,0,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,direct
Levocarnitine,hypersensitivity,313,1,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
DEFERASIROX,decreased egfr,761,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Doxepin HCL,mental illness,14,0,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
dihydroergotamine mesylate,uncontrolled hypertension,1337,1,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
Timoptic-XE,stroke,7,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Nystatin,liver cirrhosis,4,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Cyltezo,polyarticular jia who,1137,1,CC(C)O,direct
Amiloride Hydrochloride and Hydrochlorothiazide,anemia,13,0,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
Olumiant,severe alopecia areata,1233,1,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,direct
PERPHENAZINE,pregnancy,16,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Xospata,hypersensitivity,313,1,CCC1=C(NC2CCOCC2)N=C(NC2=CC=C(N3CCC(CC3)N3CCN(C)CC3)C(OC)=C2)C(=N1)C(N)=O,direct
PROVAYBLUE,chronic kidney disease,3,0,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,direct
Lidotral 3.88% Roll on,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
"PredniSONE Tablets, USP, 5 mg",tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Hyronan,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
fenofibrate,pregnancy,16,0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
BiDil,hypotension,75,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
Sevelamer carbonate,stroke,7,0,NCC=C.ClCC1CO1,direct
risedronate sodium,cancer (metastatic),9,0,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
bexarotene,diabetes mellitus,5,0,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,direct
Hydrocaine,liver disease (non-cirrhotic),20,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,fuzzy:hydroxycine
Reclast,chronic kidney disease,3,0,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE,pregnancy,16,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Zolmitriptan,myocardial infarction,1,0,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
Humira,AIDS,10,0,CC(C)O,direct
PRYIDOSTIGMINE BROMIDE,severe infection,18,0,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
POLOCAINE (MEPIVACAINE HCl),hypersensitivity,313,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Acitretin,edema,417,1,COC1=C(C)C(C)=C(\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O)C(C)=C1,direct
Zetia,mental illness,14,0,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
Foltamin,myocardial infarction,1,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Mifepristone,hypersensitivity,313,1,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],direct
Dorzolamide and Timolol,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Angiomax,thrombocytopenia,79,1,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,direct
SUNOSI,a valid assessment,509,1,N[C@@H](COC(N)=O)CC1=CC=CC=C1,direct
Rivastigmine Transdermal System,cancer (localized),8,0,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,direct
Bupropion hydrochloride,severe hepatic cirrhosis,1243,1,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Daptomycin,comparator agents,736,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
Fosinopril Sodium and Hydrochlorothiazide,asthma,193,1,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,direct
Guanfacine,hypersensitivity,313,1,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,direct
hydrochlorothiazide,diabetes mellitus,5,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Pirnuo,mental illness,14,0,C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O,direct
fomepizole,hypersensitivity,313,1,CC1=CNN=C1,direct
Tizanidine,severe infection,18,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
ROPIVACAINE HYDROCHLORIDE,chronic obstructive pulmonary disease (COPD),6,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
NESTABS DHA Prenatal Multi-vitamin/Mineral Supplement with DHA/EPA,asthma,12,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Temozolomide,hypersensitivity,313,1,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
Prenate Elite,diabetes mellitus,5,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
DIANEAL Low Calcium with Dextrose,severe lactic acidosis,1248,1,[Cl-].[Cl-].[Ca++],direct
Prasugrel,chronic obstructive pulmonary disease (COPD),6,0,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,direct
Nembutal Sodium,AIDS,10,0,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,direct
Sulfasalazine,diabetes mellitus,5,0,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,direct
CALQUENCE,liver disease (non-cirrhotic),20,0,CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1,direct
LUMIGAN,myocardial infarction,1,0,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
posaconazole,hypertension,39,1,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
KHAPZORY,anemia,13,0,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
CIPRODEX,renal failure,19,0,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,direct
MIDAZOLAM,hemodynamic instability,852,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
captopril,skin rash,1262,1,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,direct
Multiple Electrolytes pH 7.4,hypersensitivity,313,1,[Cl-].[K+],direct
Rozlytrek,cancer (metastatic),9,0,CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1,direct
METOPROLOL TARTRATE,myocardial infarction,49,1,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
plerixafor,nhl or mm,1038,1,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE,renal failure,19,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
CORDRAN,sepsis,17,0,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,direct
bisoprolol fumarate and hydrochlorothiazide,chronic kidney disease,3,0,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,direct
dicyclomine hydrochloride,mental illness,14,0,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,direct
RIFAMPIN,compromised adrenal function,737,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
Kimyrsa,stroke,7,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
FOSFOMYCIN TROMETHAMINE,myocardial infarction,1,0,C[C@@H]1O[C@@H]1P(O)(O)=O,direct
Estradiol valerate,liver disease (non-cirrhotic),20,0,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
ASENAPINE,pregnancy,16,0,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
Pitavastatin,hypertension,11,0,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
MB CAPS,stroke,7,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,fuzzy:pm caps
DOBUTAMINE,aortic stenosis,55,1,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE,chronic stable angina,705,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
AIRSUPRA,congestive heart failure,2,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
metyrosine,arrhythmia,43,1,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,direct
Bactrim,severe infection,18,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
AK-FLUOR,congestive heart failure,2,0,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
"Brimonidine Tartrate ophthalmic solution, 0.15%",chronic obstructive pulmonary disease (COPD),6,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Lydexa 4.12%,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Tafluprost Ophthalmic,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
Macrobid,chronic obstructive pulmonary disease (COPD),6,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
ChlorproMAZINE Hydrochloride,sepsis,17,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
Citanest Forte DENTAL,sepsis,17,0,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
calcipotriene,sepsis,17,0,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
Topotecan Hydrochloride,anemia,13,0,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
Dronabinol,myocardial infarction,1,0,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,direct
PROPRANOLOL,shock,419,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Potassium Citrate,chronic obstructive pulmonary disease (COPD),6,0,[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,direct
REZZAYO,renal failure,19,0,[H][C@](C)(O)[C@]1([H])\N=C(O)/[C@]([H])(C[C@@]([H])(O)[C@@]([H])(OCC[N+](C)(C)C)\N=C(O)/[C@@]2([H])N(C[C@]([H])(C)[C@]2([H])O)C(=O)[C@@]([H])(\N=C(O)/[C@@]([H])(\N=C(O)/[C@]2([H])C[C@@]([H])(O)CN2C1=O)[C@]([H])(O)[C@@]([H])(O)C1=CC=C(O)C=C1)[C@@]([H])(C)O)\N=C(/O)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CC=C(OCCCCC)C=C1,direct
Lactated Ringers,liver disease (non-cirrhotic),20,0,[Cl-].[K+],direct
Methenamine Mandelate,chronic kidney disease,3,0,C1N2CN3CN1CN(C2)C3,direct
Prednisolone,sepsis,17,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Potassium Chloride ER,significant cardiac arrhythmias,1259,1,[Cl-].[K+],direct
levalbuterol inhalation,hypersensitivity,313,1,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
AMMONIA N-13,anemia,13,0,[13NH3],direct
Cisplatin,pre-existing renal impairment,1152,1,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
ropivacaine hydrochloride,severe infection,18,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
POSACONAZOLE,stroke,7,0,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
Gablofen,severe infection,18,0,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
Glycate,hypersensitivity,313,1,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
bupropion hydrochloride,anemia,13,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
CARTIA XT,hypersensitivity,313,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Cimetidine Hydrochloride,liver cirrhosis,4,0,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N,direct
Stivarga,hypocalcemia,141,1,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,direct
"Sodium sulfate, potassium sulfate and magnesium sulfate",severe infection,18,0,[Mg++].[O-]S([O-])(=O)=O,direct
CLOMID,AIDS,10,0,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
VALSARTAN,cancer (metastatic),9,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
doxepin hydrochloride,diabetes mellitus,5,0,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
XURIDEN,renal failure,19,0,CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N1C=CC(=O)NC1=O,direct
BENZPHETAMINE HYDROCHLORIDE,autoimmune disease,15,0,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,direct
Erythromycin Ethylsuccinate,autoimmune disease,15,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Zolmitriptan OD,cancer (localized),8,0,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
metyrosine,sepsis,17,0,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,direct
Zestoretic,cancer (localized),8,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Calcium Chloride,acute symptomatic hypocalcemia,554,1,[Cl-].[Cl-].[Ca++],direct
posaconazole,hypokalemia,133,1,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
"Butalbital, aspirin, and caffeine",liver cirrhosis,4,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Timolol maleate,liver disease (non-cirrhotic),20,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
CLOBAZAM,cancer (localized),8,0,CN1C2=C(C=C(Cl)C=C2)N(C2=CC=CC=C2)C(=O)CC1=O,direct
TREANDA,cancer (localized),8,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Prevacid,hypersensitivity,313,1,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Erythromycin ethylsuccinate,liver cirrhosis,4,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Triamcinolone acetonide,liver disease (non-cirrhotic),20,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Prochlorperazine,liver cirrhosis,4,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Diazepam Intensol,glaucoma,481,1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,direct
Baclofen,hypersensitivity to baclofen,884,1,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
Differin,cancer (metastatic),9,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Montelukast Sodium,congestive heart failure,2,0,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
Diovan,liver cirrhosis,4,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
carbamazepine,depression,27,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Ribotin-E,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Lidocaine and Prilocaine,congestive heart failure,2,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Acetaminophen And Codeine,diabetes mellitus,5,0,CC(=O)NC1=CC=C(O)C=C1,direct
raloxifene hydrochloride,mental illness,14,0,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,direct
Radiaura Skin Recovery,sepsis,17,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
FOSCARNET SODIUM,hypersensitivity,313,1,OC(=O)P(O)(O)=O,direct
Ventrixyl Fe,liver cirrhosis,4,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Propafenone Hydrochloride,AIDS,10,0,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,direct
Celontin,autoimmune disease,15,0,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1,direct
Cortisone Acetate,tics,23,1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
SUPRANE,autoimmune disease,15,0,FC(F)OC(F)C(F)(F)F,direct
Prenatrix,stroke,7,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
ZOLEDRONIC ACID,asthma,12,0,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
Citalopram,chronic obstructive pulmonary disease (COPD),6,0,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
Loperamide hydrochloride,mental illness,14,0,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
DABIGATRAN,non-valvular atrial fibrillation,1053,1,CN1C(CNC2=CC=C(C=C2)C(N)=N)=NC2=C1C=CC(=C2)C(=O)N(CCC(O)=O)C1=NC=CC=C1,direct
E-Z-Paste,diabetes mellitus,5,0,[Ba++].[O-]S([O-])(=O)=O,direct
Nizatidine,hypersensitivity,313,1,CNC(NCCSCC1=CSC(CN(C)C)=N1)=C[N+]([O-])=O,direct
atomoxetine,stroke,7,0,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
Desoximetasone,renal failure,19,0,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Potassium Chloride Extended-Release,autoimmune disease,15,0,[Cl-].[K+],direct
CAPTOPRIL AND HYDROCHLOROTHIAZIDE,congestive heart failure,2,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Pregabalin Extended Release,partial onset seizures,1103,1,CC(C)C[C@H](CN)CC(O)=O,direct
Lupron Depot-PED,cancer (localized),8,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
LEVALBUTEROL,severe infection,18,0,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
Iluvien,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
EPIVIR,liver cirrhosis,4,0,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,direct
SODIUM CHLORIDE,anemia,13,0,[Na+].[Cl-],direct
Namenda,severe infection,18,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Brinzolamide,sepsis,17,0,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
vilazodone,mdd including,990,1,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,direct
Desflurane,the event,1298,1,FC(F)OC(F)C(F)(F)F,direct
Esomeprazole magnesium,hypersensitivity,313,1,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Cevimeline Hydrochloride,other conditions,1087,1,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
Digoxin,pediatric patients,13,1,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,direct
VABOMERE,anemia,13,0,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
Silver Sulfadiazine,liver disease (non-cirrhotic),20,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
Levetiracetam Extended-Release,cancer (localized),8,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Dexilant,hypersensitivity,313,1,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1,direct
Cefdinir,hypertension,11,0,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,direct
Prepidil,placenta previa,351,1,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,direct
Meropenem,hypersensitivity,313,1,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
Fluocinolone Acetonide Oil,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
temozolomide,hypersensitivity,313,1,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
DOBUTAMINE HYDROCHLORIDE,aortic stenosis,55,1,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
Sunitinib malate,autoimmune disease,15,0,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,direct
Xofluza,liver cirrhosis,4,0,[H][C@@]12COCCN1C(=O)C1=C(OCOC(=O)OC)C(=O)C=CN1N2[C@H]1C2=CC=C(F)C(F)=C2CSC2=CC=CC=C12,direct
Hyoscyamine sulfate,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Otezla,renal failure,19,0,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,direct
Procainamide Hydrochloride,ventricular arrhythmias,1354,1,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
ISOPROTERENOL HYDROCHLORIDE,hypertension,11,0,CC(C)NCC(O)C1=CC(O)=C(O)C=C1,direct
Vaseretic,chronic kidney disease,3,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
"Butalbital, Aspirin, and Caffeine",cancer (metastatic),9,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
CARMUSTINE,anemia,13,0,ClCCNC(=O)N(CCCl)N=O,direct
Acebutolol Hydrochloride,liver disease (non-cirrhotic),20,0,CCCC(=O)NC1=CC=C(OCC(O)CNC(C)C)C(=C1)C(C)=O,direct
Priftin,hypersensitivity,313,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(O)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(\C=N\N1CCN(CC1)C1CCCC1)=C2O,direct
Pyridostigmine,bronchial asthma,650,1,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
KLOR-CON M,chronic obstructive pulmonary disease (COPD),6,0,[Cl-].[K+],direct
Qsymia,depression,27,1,CC(C)(N)CC1=CC=CC=C1,direct
Desmopressin Acetate,myocardial infarction,1,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
tranexamic acid,active intravascular clotting,526,1,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Sorafenib,hypersensitivity,313,1,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
Methylprednisolone Acetate,anemia,13,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
BUPIVACAINE HCl,autoimmune disease,15,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Venlafaxine hydrochloride,pregnancy,16,0,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
Travatan Z,asthma,12,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Labetalol hydrochloride,congestive heart failure,41,1,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Forfivo XL,sepsis,17,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
lamotrigine,partial-onset seizures who,1108,1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
Lactated Ringers,brain edema,643,1,[Cl-].[K+],direct
Noritate,pregnancy,16,0,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Lodosyn,hypersensitivity,313,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
DEXMETHYLPHENIDATE HYDROCHLORIDE,severe infection,18,0,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,direct
NOREPINEPHRINE BITARTRATE,pregnancy,16,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
tizanidine,multiple sclerosis,153,1,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Docetaxel anhydrous,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
Pantoprazole Sodium DR,hypersensitivity,313,1,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
Dexamethasone 1.5 mg,cerebral malaria,674,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
NOXAFIL,autoimmune disease,15,0,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
Librax,chronic obstructive pulmonary disease (COPD),6,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Azithromycin Monohydrate,liver disease (non-cirrhotic),20,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
SUPRANE,severe infection,18,0,FC(F)OC(F)C(F)(F)F,direct
Dexlido Kit,pancreatitis,233,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Sodium Phenylacetate and Sodium Benzoate,pregnancy,16,0,OC(=O)C1=CC=CC=C1,direct
ONDANSETRON,liver cirrhosis,4,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Sulfamethoxazole and Trimethoprim,anemia,81,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Dextroamphetamine Sulfate Extended-Release,renal failure,19,0,C[C@H](N)CC1=CC=CC=C1,direct
Clomid,any visual symptoms,609,1,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
Paclitaxel,asthma,12,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Hydrocortisone Acetate,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Dorzolamide hydrochloride,myocardial infarction,1,0,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Pramosone Cream,hypersensitivity,313,1,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
budesonide,asthma,12,0,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Paclitaxel protein-bound particles for injectable suspension (albumin-bound),cancer (localized),8,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
leuprolide acetate,liver disease (non-cirrhotic),20,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Trelstar,congestive heart failure,2,0,CC(C)C[C@H](NC(=O)[C@@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,direct
Isosorbide,liver cirrhosis,4,0,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
fulvestrant,hypersensitivity,313,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],direct
acetaZOLAMIDE,cirrhosis,231,1,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
Escitalopram oxalate,cancer (metastatic),9,0,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
Trihexyphenidyl Hydrochloride,cancer (metastatic),9,0,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1,direct
Sotalol,chronic kidney disease,3,0,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
PENTAMIDINE ISETHIONATE,congestive heart failure,2,0,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
DELSTRIGO,stroke,7,0,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,direct
Sitagliptin,autoimmune disease,15,0,N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F,direct
Propranolol,cancer (localized),8,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Linezolid,liver disease (non-cirrhotic),20,0,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,direct
Pradaxa,chronic kidney disease,3,0,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
Dexmethylphenidate Hydrochloride,pediatric patients,13,1,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,direct
Adalimumab,active psa,532,1,CC(C)O,direct
Vaseline Moisturizing Cream,chronic obstructive pulmonary disease (COPD),6,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,fuzzy:viractin moisturizing cream
DoubleDex Kit,pancreatitis,233,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Vitafol-OB Plus DHA Prenatal Supplement Plus DHA,myocardial infarction,1,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Lopid,cancer (metastatic),9,0,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,direct
nifedipine,congestive heart failure,2,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
Rapamune,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
azithromycin dihydrate,liver disease (non-cirrhotic),20,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Lidotran,diabetes mellitus,5,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Carboplatin,normal baseline values,1059,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
HICON,pregnancy,16,0,[131I-],direct
carisoprodol,severe infection,18,0,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
Integra Plus,congestive heart failure,2,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
LEVALBUTEROL,liver disease (non-cirrhotic),20,0,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
atenolol,angina pectoris,596,1,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,direct
PNV-Omega,nutritional deficiencies or,1071,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Isosorbide Dinitrate,diabetes mellitus,5,0,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
Lidocaine Hydrochloride and Dextrose,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Depo-Estradiol,congestive heart failure,2,0,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1,direct
Gentak,congestive heart failure,2,0,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,direct
Esomeprazole Magnesium,anemia,13,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Folcyteine,hypersensitivity,313,1,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Caffeine Citrate Oral Solution,cancer (localized),8,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Dicyclomine Hydrochloride,renal failure,19,0,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,direct
Daptomycin in Sodium Chloride,prosthetic valve endocarditis,1186,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
Ribavirin,tics,23,1,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Erythrocin Lactobionate,hypersensitivity,313,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
ABRILADA,active psa,532,1,CC(C)O,direct
ASMANEX HFA,asthma,193,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Xipere,mental illness,14,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
LYVISPAH,pregnancy,16,0,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
ibandronate sodium,apr-like events,613,1,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Docetaxel anhydrous,renal failure,19,0,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release,renal failure,19,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,fuzzy:pantoprazole sodium delayed-release delayed-release
ALTAFLUOR,AIDS,10,0,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
Iclusig,sepsis,17,0,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1,direct
Lidotran,cancer (localized),8,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
HYDROCHLOROTHIAZIDE,chronic kidney disease,3,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Epinephrine,shock,419,1,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
leucovorin calcium,renal failure,19,0,[H]C(=O)N1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2,direct
PNV-DHA,autoimmune disease,15,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
temozolomide,cancer (localized),8,0,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
Ursodiol,hypersensitivity,313,1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
CHLORDIAZEPOXIDE HYDROCHLORIDE,cancer (localized),8,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Tigan,chronic kidney disease,3,0,COC1=CC(=CC(OC)=C1OC)C(=O)NCC1=CC=C(OCCN(C)C)C=C1,direct
Sitagliptin,hypersensitivity,313,1,N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F,direct
Qbrexza,congestive heart failure,2,0,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
TRIHEXYPHENIDYL HYDROCHLORIDE,agitation,21,1,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1,direct
PROCTOZONE-HC,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
MOMETASONE FUROATE MONOHYDRATE,congestive heart failure,2,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
amantadine,hypersensitivity,313,1,NC12CC3CC(CC(C3)C1)C2,direct
"sodium sulfate, potassium sulfate, and magnesium sulfate",AIDS,10,0,[Mg++].[O-]S([O-])(=O)=O,"fuzzy:sodium sulfate, potassium sulfate and magnesium sulfate"
"SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE",normal baseline who,1060,1,[Mg++].[O-]S([O-])(=O)=O,direct
Xenical,pediatric patients,13,1,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,direct
CISplatin,pre-existing renal impairment,1152,1,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
AZITHROMYCIN,cancer (localized),8,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
Valium,liver disease (non-cirrhotic),20,0,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,direct
Prenatryl,anemia,13,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
BUTAL/APAP/CAFFEINE,acetaminophen allergy,513,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,fuzzy:butal/apap/caff
ONGLYZA,hypersensitivity,313,1,[H][C@@]12C[C@]1([H])N([C@@H](C2)C#N)C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,direct
ISOVUE 300,liver cirrhosis,4,0,C[C@H](O)C(=O)NC1=C(I)C(C(=O)NC(CO)CO)=C(I)C(C(=O)NC(CO)CO)=C1I,direct
Quinapril and Hydrochlorothiazide,congestive heart failure,2,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Capecitabine,sepsis,17,0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
REZZAYO,hypersensitivity,313,1,[H][C@](C)(O)[C@]1([H])\N=C(O)/[C@]([H])(C[C@@]([H])(O)[C@@]([H])(OCC[N+](C)(C)C)\N=C(O)/[C@@]2([H])N(C[C@]([H])(C)[C@]2([H])O)C(=O)[C@@]([H])(\N=C(O)/[C@@]([H])(\N=C(O)/[C@]2([H])C[C@@]([H])(O)CN2C1=O)[C@]([H])(O)[C@@]([H])(O)C1=CC=C(O)C=C1)[C@@]([H])(C)O)\N=C(/O)C1=CC=C(C=C1)C1=CC=C(C=C1)C1=CC=C(OCCCCC)C=C1,direct
Oxycodone Hydrochloride and Acetaminophen,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
Tobramycin Ophthalmic Solution,pregnancy,16,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Gleevec,neutropenia,85,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Dialyvite with Zinc,diabetes mellitus,5,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
METHYLPREDNISOLONE,congestive heart failure,2,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",myocardial infarction,1,0,CC(N)CC1=CC=CC=C1,direct
MELPHALAN HYDROCHLORIDE,stroke,7,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Liothyronine sodium,chronic kidney disease,3,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
Dimethyl Fumarate,mental illness,14,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
Methylene blue,acquired methemoglobinemia,517,1,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,direct
Sulindac,AIDS,10,0,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O,direct
Alogliptin,hypersensitivity,313,1,CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O,direct
CARNITOR,bronchospasm,197,1,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
SCENESSE,chronic kidney disease,3,0,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,direct
Oxycodone/APAP,chronic obstructive pulmonary disease (COPD),6,0,CC(=O)NC1=CC=C(O)C=C1,direct
Betaxolol Hydrochloride,liver disease (non-cirrhotic),20,0,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
Betamethasone dipropionate,diabetes mellitus,5,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Ibandronate Sodium,the following conditions,1301,1,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,direct
DIAZEPAM,chronic obstructive pulmonary disease (COPD),6,0,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,direct
VALSARTAN AND HYDROCHLOROTHIAZIDE,stroke,7,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
PENCICLOVIR,renal failure,19,0,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,direct
Nefazodone Hydrochloride,myocardial infarction,1,0,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,direct
UDSx Medicated System,hypersensitivity,313,1,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O,direct
zolpidem tartrate,renal failure,19,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Lurasidone Hydrochloride,another indication,601,1,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Fluvastatin,hypersensitivity,313,1,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,direct
Bexarotene,AIDS,10,0,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,direct
Pitavastatin Calcium,hyperlipidemia,143,1,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
Lisinopril and Hydrochlorothiazide,renal artery stenosis,1209,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Hydrocaine,hypersensitivity,313,1,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,fuzzy:hydroxycine
diclofenac potassium,AIDS,10,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Azopt,glaucoma,481,1,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
PANTOPRAZOLE SODIUM I.V.,myocardial infarction,1,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
MEMANTINE,chronic obstructive pulmonary disease (COPD),6,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Matzim LA,pregnancy,16,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
AcetaZOLAMIDE,cirrhosis,231,1,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
Ranexa,chronic angina,684,1,COC1=CC=CC=C1OCC(O)CN1CCN(CC(=O)NC2=C(C)C=CC=C2C)CC1,direct
SPIRONOLACTONE,diabetes mellitus,5,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
benzphetamine hydrochloride,heart disease,377,1,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,direct
furosemide,chronic kidney disease,3,0,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(=C1)C(O)=O,direct
NADOLOL,angina pectoris,596,1,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,direct
spironolactone,stroke,7,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
Vancocin,hypersensitivity,313,1,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
UrNeva,hypersensitivity,313,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
CEFPROZIL,tics,23,1,[H][C@]12SCC(C=CC)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
Calcium Chloride,liver cirrhosis,4,0,[Cl-].[Cl-].[Ca++],direct
Rifabutin,tuberculosis,213,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(C(O)=C3C)C(=O)C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)=C1NC3(CCN(CC3)CC(C)C)N=C21,direct
ATENOLOL AND CHLORTHALIDONE,cancer (localized),8,0,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
PRASUGREL,acs undergoing pci,519,1,CC(=O)OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,direct
Cotellic,anemia,13,0,OC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)[C@@H]1CCCCN1,direct
Voriconazole,renal failure,19,0,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Bromocriptine Mesylate,congestive heart failure,2,0,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
Cinacalcet Hydrochloride,liver cirrhosis,4,0,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Cefprozil,tics,23,1,[H][C@]12SCC(C=CC)=C(N1C(=O)[C@@]2([H])NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
Sofosbuvir and Velpatasvir,cirrhosis,231,1,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
Nitroglycerin,these conditions,1310,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Davimet-M,asthma,12,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Cefuroxime Axetil,pregnancy,16,0,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,direct
Qbrexza,medical conditions that,992,1,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
PREDNISONE,diabetes mellitus,5,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Dobutamine Hydrochloride in Dextrose,hypertension,11,0,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
Atomoxetine,anemia,13,0,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
Levetiracetam Levetiracetam,partial seizures,1104,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
Timoptic,stroke,7,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
RELAFEN DS,impaired renal function,919,1,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
LEVETIRACETAM Extended-release,hypersensitivity,313,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
FARXIGA,hypersensitivity,313,1,CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1,direct
BOSULIF,hypersensitivity,313,1,COC1=CC(NC2=C(C=NC3=CC(OCCCN4CCN(C)CC4)=C(OC)C=C23)C#N)=C(Cl)C=C1Cl,direct
Idamycin PFS,bone marrow suppression,101,1,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O,direct
DOXAPRAM HYDROCHLORIDE,chronic obstructive pulmonary disease (COPD),6,0,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,direct
ERLOTINIB,cancer (metastatic),9,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
Ibuprofen,aspirin-sensitive asthma,615,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
Donnatal,hypersensitivity,313,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Eohilia,pregnancy,16,0,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Rexulti,myocardial infarction,1,0,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,direct
Glycopyrrolate,AIDS,10,0,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
Dexamethasone Intensol,cerebral malaria,674,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Rosuvastatin,AIDS,10,0,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Pain Relieving Patch,renal failure,257,1,CC(C)C1CCC(C)CC1O,direct
Triloan SUIK,liver cirrhosis,4,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
VERELAN,hypersensitivity,313,1,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,direct
Methsuximide,liver disease (non-cirrhotic),20,0,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1,direct
Lurasidone hydrochloride,depression,27,1,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Vyzulta,glaucoma,481,1,O[C@H](CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OCCCCO[N+]([O-])=O)CCC1=CC=CC=C1,direct
Ventrixyl,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
NOREPINEPHRINE BITARTRATE IN SODIUM CHLORIDE,acute hypotensive states,540,1,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
MIDAZOLAM,hypersensitivity,313,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
glycopyrrolate,congestive heart failure,2,0,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
Tricor,congestive heart failure,2,0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
DOXEPIN HYDROCHLORIDE,chronic kidney disease,3,0,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
Imbruvica,liver disease (non-cirrhotic),20,0,NC1=NC=NC2=C1C(=NN2[C@@H]1CCCN(C1)C(=O)C=C)C1=CC=C(OC2=CC=CC=C2)C=C1,direct
PHENYTOIN SODIUM,autoimmune disease,15,0,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
aripiprazole,congestive heart failure,2,0,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
TRAMADOL HYDROCHLORIDE,chronic non-malignant pain,697,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
ibuprofen,mental illness,14,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
bortezomib,chronic kidney disease,3,0,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Bendamustine,hypersensitivity,313,1,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Escitalopram oxalate,liver cirrhosis,4,0,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
BUPIVACAINE HCI,anemia,13,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Nalocet,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
UROGESIC BLUE,chronic obstructive pulmonary disease (COPD),6,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
PRENATE Restore,diabetes mellitus,5,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Vitramyn,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Lenalidomide,liver disease (non-cirrhotic),20,0,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
Succinylcholine Chloride,pregnancy,16,0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,direct
Spironolactone and Hydrochlorothiazide,anemia,13,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
Levetiracetam,pgtc seizures,1120,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
Calcitriol,hypercalcemia,139,1,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,direct
PRUDOXIN,glaucoma,481,1,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
TriStart DHA,AIDS,10,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
CEVIMELINE HYDROCHLORIDE,hypertension,11,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
Desonide,hypertension,11,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Zolpidem Tartrate,asthma,12,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Dutasteride and tamsulosin hydrochloride,prostate cancer,265,1,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O,direct
Tafinlar,solid tumors,1264,1,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,direct
MEROPENEM,liver cirrhosis,4,0,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
Trezix,hypertension,11,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
LIDOCAINE HCI AND EPINEPHRINE,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Ojjaara,anemia,13,0,O=C(NCC#N)C1=CC=C(C=C1)C1=CC=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1,direct
ZAVZPRET,congestive heart failure,2,0,CN1CCC(CC1)N1CCN(CC1)C(=O)[C@@H](CC1=CC2=C(NN=C2)C(C)=C1)NC(=O)N1CCC(CC1)C1=CC2=C(NC1=O)C=CC=C2,direct
ANCOBON,pregnancy,16,0,NC1=C(F)C=NC(=O)N1,direct
Neo-Synalar,diabetes mellitus,5,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Sodium Ferric Gluconate Complex in Sucrose,hypersensitivity,313,1,[O--].[O--].[O--].[Na+].[Fe+3].[Fe+3].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O.OC[C@H]1O[C@@](CO)(O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@@H]1O,direct
CIDOFOVIR,hypersensitivity,313,1,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,direct
PENCICLOVIR,cancer (localized),8,0,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,direct
Neo-Synalar,myocardial infarction,1,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Esterified Estrogens and Methyltestosterone,hypersensitivity,313,1,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(OS(O)(=O)=O)C=C3,direct
Sorbitol,AIDS,10,0,OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,direct
Tetracycline Hydrochloride,pregnancy,16,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
Zestoretic,impaired renal function,919,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
doxycycline hyclate,impaired renal function,919,1,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Propafenone Hydrochloride,chronic atrial fibrillation,685,1,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,direct
Tizanidine Hydrochloride,impaired hepatic function,915,1,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Metronidazole500 mg 500 mg,stroke,7,0,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
ceftriaxone,hypersensitivity,313,1,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate",comorbid depressive symptoms,735,1,CC(N)CC1=CC=CC=C1,direct
Bupivacaine HCl,liver disease (non-cirrhotic),20,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
PREDNISOLONE,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
venlafaxine,chronic kidney disease,3,0,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
"Travoprost Ophthalmic Solution, 0.004%",chronic kidney disease,3,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Sumatriptan Succinate,uncontrolled hypertension,1337,1,CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1,direct
NALMEFENE HYDROCHLORIDE,congestive heart failure,2,0,OC1=CC=C2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](OC1=C24)C(=C)CC[C@@]35O,direct
Caspofungin Acetate,asthma,12,0,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
ABRILADA,active ankylosing spondylitis,520,1,CC(C)O,direct
LIDOCAINE HCI AND EPINEPHRINE WITH EPINEPHRINE,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
FLUPHENAZINE HYDROCHLORIDE,dementia-related psychosis,766,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Otrexup,hypersensitivity,313,1,CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O,direct
QUVIVIQ,hypersensitivity,313,1,COC1=CC(C(=O)N2CCC[C@@]2(C)C2=NC3=C(N2)C=CC(Cl)=C3C)=C(C=C1)N1N=CC=N1,direct
Ethacrynic Acid,sepsis,17,0,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
UltraCare Anesthetic Gel,cancer (metastatic),9,0,CCOC(=O)C1=CC=C(N)C=C1,direct
POTASSIUM CITRATE EXTENDED RELEASE,diabetes mellitus,5,0,[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,direct
LAMIVUDINE,cancer (localized),8,0,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,direct
NABUMETONE,chronic obstructive pulmonary disease (COPD),6,0,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
risedronate sodium,congestive heart failure,2,0,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
CEVIMELINE HYDROCHLORIDE,asthma,12,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
Naproxen Sodium,hypersensitivity,313,1,COC1=CC2=C(C=C1)C=C(C=C2)[C@H](C)C(O)=O,direct
Docetaxel,solid tumors,1264,1,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
Gavreto,nsclc in arrow,1067,1,CO[C@@]1(CC[C@@H](CC1)C1=NC(NC2=NNC(C)=C2)=CC(C)=N1)C(=O)N[C@@H](C)C1=CC=C(N=C1)N1C=C(F)C=N1,direct
Captopril,hypertension who,898,1,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,direct
INDERAL LA,renal failure,19,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
TAVNEOS,chronic obstructive pulmonary disease (COPD),6,0,CC1=CC=C(NC(=O)[C@H]2CCCN([C@H]2C2=CC=C(NC3CCCC3)C=C2)C(=O)C2=C(F)C=CC=C2C)C=C1C(F)(F)F,direct
Multi-Specialty Kit,severe infection,18,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Hydromorphone Hydrochloride,chronic ulcerative colitis,707,1,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O,direct
ARIPIPRAZOLE,severe infection,18,0,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
Tinidazole,cancer (metastatic),9,0,CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O,direct
NITROFURANTOIN (monohydrate/macrocrystals),cancer (localized),8,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
JARDIANCE,diabetes mellitus,5,0,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C1,direct
clofarabine,mental illness,14,0,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,direct
AmBisome,stroke,7,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Carbatrol,symptomatic hyponatremia,1286,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
ARIMIDEX,anemia,13,0,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,direct
Nuedexta,cancer (metastatic),9,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
AMPYRA,AIDS,10,0,NC1=CC=NC=C1,direct
Depo-Medrol,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Adalimumab-aacf,cancer (localized),8,0,CC(C)O,direct
Denavir,hypersensitivity,313,1,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,direct
Zolpidem tartrate,primary insomnia who,1177,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
APREPITANT,the aprepitant regimen,1294,1,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,direct
Epinephrine,mental illness,14,0,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Clorazepate Dipotassium,hypersensitivity,313,1,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,direct
Methyldopa,hemolytic anemia,107,1,C[C@](N)(CC1=CC=C(O)C(O)=C1)C(O)=O,direct
Pramipexole dihydrochloride,or without levodopa,1082,1,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
VELCADE,insomnia,441,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Pentamidine Isethionate,hypersensitivity,313,1,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
Lialda,asthma,12,0,NC1=CC(C(O)=O)=C(O)C=C1,direct
Orgovyx,hypersensitivity,313,1,CONC(=O)NC1=CC=C(C=C1)C1=C(CN(C)C)C2=C(S1)N(CC1=C(F)C=CC=C1F)C(=O)N(C2=O)C1=CC=C(OC)N=N1,direct
Oxycodone and Acetaminophen,congestive heart failure,2,0,CC(=O)NC1=CC=C(O)C=C1,direct
Multaq,AIDS,10,0,CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2,direct
Timoptic,cancer (metastatic),9,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
RIBAVIRIN,tachycardia,47,1,NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
ETHACRYNATE SODIUM,anemia,13,0,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Pramipexole Dihydrochloride,congestive heart failure,2,0,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
Imbruvica,thrombocytopenia,79,1,NC1=NC=NC2=C1C(=NN2[C@@H]1CCCN(C1)C(=O)C=C)C1=CC=C(OC2=CC=CC=C2)C=C1,direct
Plasma-Lyte 148,hypersensitivity,313,1,[Cl-].[K+],direct
Kit for the Preparation of Technetium Tc 99m Sulfur Colloid,congestive heart failure,2,0,[99Tc].S1SSSSSSS1,direct
Carbidopa and Levodopa,anemia,13,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
MEPIVACAINE HYDROCHLORIDE,hypertension,11,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
LENALIDOMIDE,renal failure,19,0,NC1=CC=CC2=C1CN(C1CCC(=O)NC1=O)C2=O,direct
FENOFIBRATE,AIDS,10,0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
Salsalate,hypersensitivity,313,1,OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O,direct
Albuterol Sulfate HFA,hypersensitivity,313,1,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
theophylline,hypersensitivity,313,1,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
OXCARBAZEPINE,vertigo,469,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
CARDENE IV,aortic stenosis,55,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
Fluocinonide,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,direct
dasatinib,pregnancy,16,0,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
CYSTEINE HYDROCHLORIDE,cancer (localized),8,0,N[C@@H](CS)C(O)=O,direct
OZEMPIC,pancreatitis,233,1,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CN=CN1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O,direct
POTASSIUM CHLORIDE,whom there,1362,1,[Cl-].[K+],direct
LIDOCAINE HCI AND EPINEPHRINE,renal failure,19,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
latanoprost,myocardial infarction,1,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Multiple Electrolytes pH 7.4,AIDS,10,0,[Cl-].[K+],direct
SOLU-MEDROL,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Epitol,anemia,13,0,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Antiperspirant,AIDS,10,0,O.[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Cl-],direct
PROCAINAMIDE HYDROCHLORIDE,chronic obstructive pulmonary disease (COPD),6,0,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
CLOMID,hypersensitivity,313,1,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
LODOCO,stroke,51,1,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
PureVit DualFe Plus,anemia,13,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Prilosec,severe infection,18,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
"SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE",pregnancy,16,0,[Mg++].[O-]S([O-])(=O)=O,direct
Folixate,hypersensitivity,313,1,CN1[C@@H](CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)N=C(N)N2,direct
Fenofibric acid,sepsis,17,0,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
Calcipotriene,renal failure,19,0,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
PROCAINAMIDE HCI,renal failure,19,0,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
Methadone Hydrochloride,renal failure,19,0,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Plasma-Lyte 148,severe renal impairment,1253,1,[Cl-].[K+],direct
Butalbital And Acetaminophen,acetaminophen allergy,513,1,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,direct
Cyclosporine Modified,cancer (localized),8,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Donepezil,stroke,7,0,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
ELMIRON,severe infection,18,0,O[C@@H]1CO[C@@H](O[C@@H]2CO[C@@H](O)[C@H](OS(O)(=O)=O)[C@H]2OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O,direct
albuterol sulfate,hypersensitivity,313,1,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Metopirone,hypersensitivity,313,1,CC(C)(C(=O)C1=CN=CC=C1)C1=CC=CN=C1,direct
Docetaxel anhydrous,AIDS,10,0,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
URSODIOL,hypersensitivity,313,1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
Fenofibrate,renal failure,19,0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
Lidocaine Hydrochloride and Hydrocortisone Acetate,AIDS,10,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
LUMIGAN,chronic obstructive pulmonary disease (COPD),6,0,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
JARDIANCE,diabetes mellitus,111,1,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C1,direct
zolmitriptan,chronic obstructive pulmonary disease (COPD),6,0,CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12,direct
Vancomycin,myocardial infarction,1,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
OZOBAX DS,hypersensitivity to baclofen,884,1,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
pyridostigmine bromide,autoimmune disease,15,0,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
carisoprodol,hypertension,11,0,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
Vueway,chronic obstructive pulmonary disease (COPD),6,0,[Gd+3].OCC(O)CNC(=O)CCC(N1CCN(CC2=CC=CC(CN(CC1)C(CCC(=O)NCC(O)CO)C([O-])=O)=N2)C(CCC(=O)NCC(O)CO)C([O-])=O)C([O-])=O,direct
Caspofungin Acetate,concomitant opc,742,1,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
Orgovyx,liver cirrhosis,4,0,CONC(=O)NC1=CC=C(C=C1)C1=C(CN(C)C)C2=C(S1)N(CC1=C(F)C=CC=C1F)C(=O)N(C2=O)C1=CC=C(OC)N=N1,direct
ALVAIZ,AIDS,10,0,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,direct
BUPIVACAINE HCl,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Fluphenazine hydrochloride,asthma,12,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Exjade,cancer (metastatic),9,0,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
DMT SUIK,inflammatory bowel disease,223,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
PROPECIA,pregnancy,16,0,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,direct
Desonide,AIDS,10,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
aspirin-dipyridamole,hypersensitivity,313,1,CC(=O)OC1=CC=CC=C1C(O)=O,direct
Oraqix,liver cirrhosis,4,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Clofarabine,mental illness,14,0,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,direct
GUANFACINE,stroke,7,0,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,direct
FLUCONAZOLE,diabetes mellitus,5,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
CITALOPRAM HYDROBROMIDE,renal failure,19,0,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
Flecainide Acetate,sustained vt,1285,1,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1,direct
LIDOCAINE HCI AND DEXTROSE,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
TOBI,stroke,7,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Omnaris,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,direct
Albuterol Sulfate Inhalation Solution,chronic kidney disease,3,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE,hypersensitivity,313,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
SEVELAMER CARBONATE,bowel obstruction,641,1,NCC=C.ClCC1CO1,direct
KHAPZORY,congestive heart failure,2,0,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
Midazolam in Sodium Chloride,renal failure,19,0,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Caffeine Citrate,necrotizing enterocolitis,1032,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
SEREVENT DISKUS,asthma,193,1,OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1,direct
Levothyroxine sodium,diabetes mellitus,5,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
Scarzen,cancer (localized),8,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
CEFADROXIL,tics,23,1,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=C(O)C=C1)C(O)=O,direct
Cladribine,leukemia,267,1,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
ANASTROZOLE,ldl elevations,959,1,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,direct
VAFSEO,chronic kidney disease,3,0,OC(=O)CNC(=O)C1=C(O)C=C(C=N1)C1=CC(Cl)=CC=C1,direct
Tobramycin Ophthalmic Solution,hypersensitivity,313,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
NOREPINEPHRINE BITARTRATE,acute hypotensive states,540,1,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Donepezil hydrochloride,cancer (localized),8,0,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
Pimozide,depression,27,1,FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1,direct
KENALOG-10,asthma,12,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
METOLAZONE,AIDS,10,0,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,direct
FloLipid,liver disease (non-cirrhotic),20,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
doxycycline hyclate,asthma,12,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
caffeine citrate,necrotizing enterocolitis,1032,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Diltiazem Hydrochloride Extended-Release,liver cirrhosis,4,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Topotecan hydrochloride,myocardial infarction,1,0,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
Dihydroergotamine mesylate,liver disease (non-cirrhotic),20,0,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
Accupril,liver disease (non-cirrhotic),20,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Nystatin Topical Powder,AIDS,10,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
posaconazole,refractory opc,1202,1,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
CEFPODOXIME PROXETIL,cancer (metastatic),9,0,[H][C@]12SCC(COC)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
Erlotinib Hydrochloride,nsclc whose tumors,1069,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
NOXAFIL,asthma,12,0,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
levetiracetam,hypersensitivity,313,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
Nitrofurantoin,chronic kidney disease,3,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
"Testosterone Gel, 1%",hypertension,39,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
ONDANSETRON,AIDS,10,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
POSACONAZOLE,edema,417,1,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
ORPHENGESIC FORTE,cancer (metastatic),9,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Flavoxate Hydrochloride,chronic kidney disease,3,0,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,direct
Fluconazole,serious underlying diseases,1232,1,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Venclexta,cancer (localized),8,0,CC1(C)CCC(CN2CCN(CC2)C2=CC=C(C(=O)NS(=O)(=O)C3=CC=C(NCC4CCOCC4)C(=C3)[N+]([O-])=O)C(OC3=CN=C4NC=CC4=C3)=C2)=C(C1)C1=CC=C(Cl)C=C1,direct
Irinotecan Hydrochloride,hypersensitivity,313,1,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
Doxepin HCL,chronic obstructive pulmonary disease (COPD),6,0,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
Mestinon,autoimmune disease,15,0,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
"PredniSONE Tablets, USP, 10 mg",chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Fycompa,renal failure,19,0,O=C1N(C=C(C=C1C1=CC=CC=C1C#N)C1=NC=CC=C1)C1=CC=CC=C1,direct
Clomiphene Citrate,any visual symptoms,609,1,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,direct
atomoxetine,cancer (metastatic),9,0,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
Meropenem and Sodium Chloride,cancer (localized),8,0,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
Teriflunomide,hypertension,11,0,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
amantadine,stroke,7,0,NC12CC3CC(CC(C3)C1)C2,direct
Lidotral 3.88% Roll on,congestive heart failure,2,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
calcipotriene,anemia,13,0,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
FAMCICLOVIR,severe infection,18,0,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O,direct
Midazolam,hemodynamic instability,852,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Niacor,pregnancy,16,0,OC(=O)C1=CN=CC=C1,direct
Famciclovir,chronic kidney disease,3,0,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O,direct
doxepin hydrochloride,glaucoma,481,1,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
VITRAKVI,stroke,7,0,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1,direct
Se-Natal 19,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
tetracycline hydrochloride,severe infection,18,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
FENOFIBRIC ACID DELAYED-RELEASE,severe hypertriglyceridemia,1247,1,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
bortezomib,liver cirrhosis,4,0,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Epirubicin Hydrochloride,pregnancy,16,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
ALVAIZ,aplastic anemia,103,1,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,direct
Vitrexyl,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Febuxostat,gout who,842,1,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
CINACALCET,primary hpt who,1173,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Rayaldee,chronic kidney disease,245,1,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,direct
BUSULFAN,hypersensitivity,313,1,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
Lisinopril and Hydrochlorothiazide,impaired renal function,919,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
ConZip,chronic non-malignant pain,697,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Foltrexyl,hypersensitivity,313,1,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
betamethasone dipropionate,hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
tafluprost,congestive heart failure,2,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
Venclexta,newly diagnosed aml,1033,1,CC1(C)CCC(CN2CCN(CC2)C2=CC=C(C(=O)NS(=O)(=O)C3=CC=C(NCC4CCOCC4)C(=C3)[N+]([O-])=O)C(OC3=CN=C4NC=CC4=C3)=C2)=C(C1)C1=CC=C(Cl)C=C1,direct
IBUPAK,hypersensitivity,313,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
FENTORA,breakthrough pain,649,1,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
Gablofen,liver cirrhosis,4,0,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
Medroloan SUIK,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
CombiPatch (estradiol/norethindrone acetate transdermal system),breast cancer,263,1,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],direct
Adalimumab-aacf,active psoriatic arthritis,533,1,CC(C)O,direct
KOURZEQ,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Dorzolamide Hydrochloride,hypertension,39,1,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
aspirin-dipyridamole,cancer (localized),8,0,CC(=O)OC1=CC=CC=C1C(O)=O,direct
TUKYSA,metastatic breast cancer,995,1,CC1=CC(NC2=NC=NC3=CC=C(NC4=NC(C)(C)CO4)C=C23)=CC=C1OC1=CC2=NC=NN2C=C1,direct
metronidazole,hypersensitivity,313,1,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
IC-Green,hypersensitivity,313,1,CC1(C)C(=CC=CC=CC=CC2=[N+](CCCCS([O-])(=O)=O)C3=CC=C4C=CC=CC4=C3C2(C)C)N(CCCCS(O)(=O)=O)C2=CC=C3C=CC=CC3=C12,direct
Noritate,hypersensitivity,313,1,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
SOLTAMOX,metastatic breast cancer,995,1,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,direct
TRIDERM,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
"Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride",renal failure,19,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
IRINOTECAN HYDROCHLORIDE,autoimmune disease,15,0,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
Dichlorphenamide,diabetes mellitus,5,0,NS(=O)(=O)C1=CC(=C(Cl)C(Cl)=C1)S(N)(=O)=O,direct
Carafate,cancer (localized),8,0,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,direct
Terconazole Vaginal Cream 0.8%,vulvovaginal candidiasis,1361,1,CC(C)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
dimethyl fumarate,hypertension,11,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
Folixapure,chronic obstructive pulmonary disease (COPD),6,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
VIIBRYD,asthma,12,0,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,direct
Methylprednisolone Sodium Succinate,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Nalbuphine Hydrochloride,asthma,193,1,O[C@H]1CC[C@@]2(O)[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC2CCC2)[C@H]1O5,direct
MethylPREDNISolone,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Talicia,asthma,12,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Clomipramine HCl,liver disease (non-cirrhotic),20,0,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
Cimetidine,renal failure,19,0,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N,direct
NeuLumEX,hypersensitivity,313,1,[Ba++].[O-]S([O-])(=O)=O,direct
Dasatinib,pregnancy,16,0,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
FLUCYTOSINE,hypersensitivity,313,1,NC1=C(F)C=NC(=O)N1,direct
Spritam,chronic kidney disease,3,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Sodium Iodide I-131,chronic obstructive pulmonary disease (COPD),6,0,[131I-],direct
Absorica LD,tics,23,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
oxycodone and acetaminophen,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
ERTAPENEM SODIUM,pregnancy,16,0,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
AMINOPHYLLINE,hypersensitivity,313,1,NCCN.CN1C2=C(NC=N2)C(=O)N(C)C1=O.CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
VITRAKVI,renal failure,19,0,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=C(F)C=CC(F)=C1,direct
Dihydroergotamine mesylate,uncontrolled hypertension,1337,1,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
CIDOFOVIR,preexisting diabetes mellitus,1160,1,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,direct
levalbuterol inhalation,renal failure,19,0,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
Pyrimethamine,cancer (metastatic),9,0,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1,direct
Midazolam Hydrochloride,AIDS,10,0,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Reclast,the following conditions,1301,1,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
Pentobarbital Sodium,chronic kidney disease,3,0,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,direct
Adapalene and benzoyl peroxide,AIDS,10,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Isosorbide dinitrate,myocardial infarction,49,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
Rayaldee,sepsis,17,0,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,direct
Carboplatin,autoimmune disease,15,0,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
diltiazem hydrochloride,chronic kidney disease,3,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Pryidostigmine Bromide,bronchial asthma,650,1,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Dofetilide 0.125mg,mental illness,14,0,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
ANCOBON,autoimmune disease,15,0,NC1=C(F)C=NC(=O)N1,direct
Diltiazem HCL ER,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Lignospan Forte,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Signifor LAR,liver disease (non-cirrhotic),20,0,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,direct
Soma,hypersensitivity,313,1,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,direct
Dexmethylphenidate Hydrochloride,myocardial infarction,1,0,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,direct
Forfivo XL,diabetes mellitus,5,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
NADOLOL,tics,23,1,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,direct
FLUDROCORTISONE ACETATE,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Omeprazole and Sodium Bicarbonate,mental illness,14,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Diclofenac Sodium Delayed Release,considerable dehydration,749,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
SEREVENT DISKUS,less severe asthma,963,1,OCC1=C(O)C=CC(=C1)C(O)CNCCCCCCOCCCCC1=CC=CC=C1,direct
MOTPOLY XR,partial-onset seizures who,1108,1,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
DMT SUIK,renal failure,19,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Atropine Sulfate,glaucoma,481,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
Azathioprine Sodium,asthma,12,0,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Ryaltris,hypersensitivity,313,1,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2,direct
Kimyrsa,chronic obstructive pulmonary disease (COPD),6,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
Pramipexole Dihydrochloride Extended-Release,concomitant levodopa,741,1,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
Torsemide,hypersensitivity,313,1,CC(C)NC(=O)NS(=O)(=O)C1=C(NC2=CC=CC(C)=C2)C=CN=C1,direct
MANNITOL,hypersensitivity,313,1,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,direct
Lidocaine and prilocaine,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Pomalyst,ks who,954,1,NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,direct
ACETAMINOPHEN,mental illness,14,0,CC(=O)NC1=CC=C(O)C=C1,direct
Uro-MP,diabetes mellitus,5,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Caffeine Citrate,anemia,13,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Pioglitazone,severe infection,18,0,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
Hydrocodone Bitartrate and Acetaminophen,acetaminophen allergy,513,1,CC(=O)NC1=CC=C(O)C=C1,direct
timolol maleate,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Pfizerpen,impaired renal function,919,1,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,direct
Benazepril Hydrochloride,edema,417,1,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,direct
Leep RediKit,mental illness,14,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Camptosar,hypersensitivity,313,1,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
Nebivolol Hydrochloride,chronic obstructive pulmonary disease (COPD),6,0,OC(CNCC(O)C1CCC2=C(O1)C=CC(F)=C2)C1CCC2=C(O1)C=CC(F)=C2,direct
Bendeka,pregnancy,16,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
CAPRELSA,sepsis,17,0,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,direct
Ethacrynic acid,anemia,13,0,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
glycopyrrolate,ileostomy or colostomy,910,1,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
Dialyvite 3000,chronic kidney disease,3,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Mulpleta,diabetes mellitus,5,0,CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C1=CSC(NC(=O)C2=CC(Cl)=C(\C=C(/C)C(O)=O)C(Cl)=C2)=N1,direct
Asenapine,pediatric patients,13,1,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
Solu-Cortef,chronic kidney disease,3,0,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Differin,hypersensitivity,313,1,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Pemfexy,pregnancy,16,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
Suprane,the event,1298,1,FC(F)OC(F)C(F)(F)F,direct
PredniSONE,mental illness,14,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ACETAMINOPHEN AND CODEINE PHOSPHATE,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
Irinotecan Hydrochloride 40 mg/2 mL,chronic obstructive pulmonary disease (COPD),6,0,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
YUPELRI,severe infection,18,0,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1,direct
Quinidine gluconate,ventricular arrhythmias,1354,1,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
ANAFRANIL,depressive symptoms,769,1,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,direct
Matulane,hypersensitivity,313,1,CNNCC1=CC=C(C=C1)C(=O)NC(C)C,direct
Uro-MP,hypersensitivity,313,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Benazepril Hydrochloride,renal failure,19,0,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,direct
Colchicine,hepatic impairment,1,1,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
ezetimibe,cancer (localized),8,0,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
METOLAZONE,pregnancy,16,0,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,direct
CELESTONE SOLUSPAN,cerebral malaria,674,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Diclona,mental illness,14,0,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,fuzzy:diclonina
COSOPT PF,renal failure,19,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Midazolam Hydrochloride,acute narrow-angle glaucoma,546,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
UltraCare Anesthetic Gel,pregnancy,16,0,CCOC(=O)C1=CC=C(N)C=C1,direct
Salicylic Acid,mental illness,14,0,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,direct
Idamycin PFS,acute leukemia,543,1,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O,direct
Cefazolin,myocardial infarction,1,0,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,direct
Trileptal,anxiety,19,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Succinylcholine Chloride,hypersensitivity,313,1,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,direct
XYLOCAINE MPF,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Carbidopa,stroke,7,0,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
diclofenac sodium,the aspirin triad,1295,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
leflunomide,congestive heart failure,2,0,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
ABRAXANE,and without neutropenia,595,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Fluvoxamine Maleate,pediatric patients,13,1,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,direct
Claravis,edema,417,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,direct
Fluconazole in Sodium Chloride,mental illness,14,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Gemfibrozil,anemia,13,0,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,direct
LEUCOVORIN CALCIUM,pneumonia,201,1,[H]C(=O)N1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2,direct
Esomeprazole magnesium,stroke,7,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Vancomycin Hydrochloride,severe infection,18,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
ATROPINE SULFATE,brain lesions,644,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
CARBOPLATIN,myocardial infarction,1,0,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
DOBUTAMINE,stroke,7,0,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
Lumryz,chronic kidney disease,3,0,[Na+].OCCCC([O-])=O,direct
Arava,hypersensitivity,313,1,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
KOURZEQ,renal failure,19,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Flecainide Acetate,recent myocardial infarction,1199,1,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1,direct
Acne Patch,renal failure,257,1,CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)C(O[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)C(O)=O)[C@H]2NC(C)=O)[C@H](O)[C@H]1O)C(O)=O,fuzzy:acnepatch
Sofosbuvir and Velpatasvir,decompensated cirrhosis,759,1,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
Cartia XT,myocardial infarction,49,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
LOPERAMIDE HYDROCHLORIDE,acute ulcerative colitis,556,1,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
PIOGLITAZONE,hypersensitivity,313,1,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
atenolol,myocardial infarction,1,0,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,direct
BOTOX,cervical dystonia,677,1,ONC(=O)\C=C\C1=CC=C(Cl)C=C1Cl,direct
hyoscyamine sulfate,chronic obstructive pulmonary disease (COPD),6,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
amlodipine and valsartan,renal failure,19,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Deferasirox oral,deferasirox oral granules,763,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
potassium chloride,significant cardiac arrhythmias,1259,1,[Cl-].[K+],direct
SOTYLIZE,arrhythmia,43,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Phenohytro,liver cirrhosis,4,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Ery-Ped,severe infection,18,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
AMPHETAMINE SULFATE,asthma,12,0,CC(N)CC1=CC=CC=C1,direct
TESTOSTERONE ENANTHATE,hypersensitivity,313,1,[H][C@@]12CC[C@H](OC(=O)CCCCCC)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Dialyvite with Zinc,renal failure,19,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Nuedexta,hypersensitivity,313,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
XELJANZ XR,rheumatoid arthritis,159,1,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,direct
PROPRANOLOL,asthma,193,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
TAUVID,diabetes mellitus,5,0,[18F]C1=CC=C(C=N1)C1=CC=C2C(NC3=C2C=NC=C3)=C1,direct
Prednisone,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
PROCHLORPERAZINE MALEATE,liver cirrhosis,4,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
isosorbide dinitrate and hydralazine hydrochloride,severe infection,18,0,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
SEVELAMER HYDROCHLORIDE,renal failure,19,0,NCC=C.ClCC1CO1,direct
Plaquenil,porphyria the condition,1141,1,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
MESALAMINE,congestive heart failure,2,0,NC1=CC(C(O)=O)=C(O)C=C1,direct
DAPZURA RT,cancer (metastatic),9,0,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
HYDROCORTISONE,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Lidocaine HCl - Hydrocortisone Acetate with Aloe,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
CitraNatal Assure,hypersensitivity,313,1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Memantine,hypersensitivity,313,1,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Levoleucovorin Calcium,asthma,12,0,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
LIDOCAINE HCI AND DEXTROSE,diabetes mellitus,5,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
pentobarbital sodium,liver cirrhosis,4,0,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,direct
Body Scrub,severe infection,18,0,O.O.[Al+3].[Al+3].[O-][Si]([O-])([O-])O[Si]([O-])([O-])[O-],direct
nalmefene hydrochloride,cancer (metastatic),9,0,OC1=CC=C2C[C@H]3N(CC4CC4)CC[C@@]45[C@@H](OC1=C24)C(=C)CC[C@@]35O,direct
cisatracurium besylate,myocardial infarction,1,0,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,direct
DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE,myocardial infarction,1,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Butalbital And Acetaminophen,autoimmune disease,15,0,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,direct
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
OZURDEX,liver disease (non-cirrhotic),20,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Diovan,hypersensitivity,313,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Betoptic S,hypersensitivity,313,1,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
Topotecan,depression,27,1,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
CARBOPLATIN,these outcomes,1313,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Epidiolex,congestive heart failure,2,0,CCCCCC1=CC(O)=C([C@@H]2C=C(C)CC[C@H]2C(C)=C)C(O)=C1,direct
Deferasirox oral,advanced malignancies,563,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Synalar,cancer (localized),8,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
PharmapureRx Lidocaine HCl 4.12%,cancer (metastatic),9,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
silodosin,cancer (localized),8,0,C[C@H](CC1=CC2=C(N(CCCO)CC2)C(=C1)C(N)=O)NCCOC1=CC=CC=C1OCC(F)(F)F,direct
Deferoxamine Mesylate,chronic anemia,683,1,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
Stivarga,hypokalemia,133,1,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,direct
NIFEdipine,myocardial infarction,1,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OC,direct
SOTYLIZE,paroxysmal afib that,1101,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
PENTAMIDINE ISETHIONATE,diabetes mellitus,5,0,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
TIBSOVO,edema,417,1,[H][C@@](N(C(=O)[C@]1([H])CCC(=O)N1C1=NC=CC(=C1)C#N)C1=CC(F)=CN=C1)(C(=O)NC1CC(F)(F)C1)C1=C(Cl)C=CC=C1,direct
Adefovir dipivoxil,anemia,13,0,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C12)OCOC(=O)C(C)(C)C,direct
TAZORAC,plaque psoriasis,1128,1,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,direct
CLOFARABINE,all or aml,583,1,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,direct
Caldolor,hypokalemia,133,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
prednisone,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
citalopram hydrobromide,hypersensitivity,313,1,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
OXALIPLATIN,autoimmune disease,15,0,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,direct
Methamphetamine Hydrochloride,liver cirrhosis,4,0,CN[C@@H](C)CC1=CC=CC=C1,direct
Cisatracurium Besylate,AIDS,10,0,COC1=CC2=C(C=C1OC)[C@@H](CC1=CC(OC)=C(OC)C=C1)[N@@+](C)(CCC(=O)OCCCCCOC(=O)CC[N@@+]1(C)CCC3=C(C=C(OC)C(OC)=C3)[C@H]1CC1=CC(OC)=C(OC)C=C1)CC2,direct
tizanidine hydrochloride,renal failure,19,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Guanfacine Hydrochloride,hypersensitivity,313,1,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,direct
SUPRANE,anemia,13,0,FC(F)OC(F)C(F)(F)F,direct
Amantadine HCL,hypersensitivity,313,1,NC12CC3CC(CC(C3)C1)C2,direct
E.E.S 400,diabetes mellitus,5,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,direct
ATACAND HCT,symptomatic hypotension,1287,1,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1,direct
DOCETAXEL,myocardial infarction,1,0,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
Brimonidine,anemia,13,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Oxaliplatin,chronic kidney disease,3,0,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,direct
Topiramate,AIDS,10,0,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,direct
Levothyroxine Sodium,thyrotoxicosis,113,1,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
LAMOTRIGINE Kit,partial-onset seizures who,1108,1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
CALCIUM CHLORIDE,severe infection,18,0,[Cl-].[Cl-].[Ca++],direct
ERLOTINIB HYDROCHLORIDE,diabetes mellitus,5,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
Topotecan Hydrochloride,cancer (metastatic),9,0,CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O,direct
HULIO,active ankylosing spondylitis,520,1,CC(C)O,direct
ABRILADA,anti-adalimumab antibody,602,1,CC(C)O,direct
Plasma-Lyte A,AIDS,10,0,[Cl-].[K+],direct
Carbidopa and Levodopa,glaucoma,481,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Levetiracetam Extended-release,AIDS,10,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
ESOMEPRAZOLE MAGNESIUM,sepsis,17,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Lynparza,diabetes mellitus,5,0,FC1=CC=C(CC2=NNC(=O)C3=CC=CC=C23)C=C1C(=O)N1CCN(CC1)C(=O)C1CC1,direct
ZIOPTAN,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
Cytomel,congestive heart failure,2,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
BUPIVACAINE HYDROCHLORIDE,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
CALQUENCE,hematologic malignancies,849,1,CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1,direct
PRYIDOSTIGMINE BROMIDE,asthma,193,1,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Arsenic trioxide,apl who,611,1,O=[As]O[As]=O,direct
febuxostat,gout,147,1,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
YUPELRI,chronic obstructive pulmonary disease (COPD),6,0,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1,direct
SUTENT,metastatic rcc,1005,1,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,direct
Cefotan,anemia,81,1,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)OC)C(O)=O,direct
PROCRIT,cancer on chemotherapy,658,1,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,fuzzy:procort
Penicillin G Potassium,autoimmune disease,15,0,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,direct
Lanreotide Acetate,documented hepatic impairment,783,1,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],direct
Prenate Pixie,severe infection,18,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
LEVETIRACETAM Extended-release,anemia,13,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Haloperidol Decanoate,psychosis,31,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Prochlorperazine Edisylate,previous brain damage,1166,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
ROBAXIN,renal impairment,1211,1,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
EXEMESTANE,AIDS,10,0,[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC(=C)C2=CC(=O)C=C[C@]12C,direct
LABETALOL HCl,this tumor,1318,1,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Cytarabine,bone marrow suppression,101,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,direct
Anti Aging Serum,congestive heart failure,2,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,fuzzy:anti-aging serum
Melphalan Hydrochloride,myocardial infarction,1,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Strong Iodine Solution,tuberculosis,213,1,II,direct
SOTALOL HYDROCHLORIDE,liver disease (non-cirrhotic),20,0,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Brimonidine Tartrate and Timolol Maleate,sinus bradycardia,1261,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Propranolol,asthma,193,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
UROCIT-K,peptic ulcer disease,219,1,[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,direct
"Sodium sulfate, potassium sulfate and magnesium sulfate",normal baseline who,1060,1,[Mg++].[O-]S([O-])(=O)=O,direct
Tizanidne hydrochloride,severe infection,18,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Quinapril HCL and Hydrochlorothiazide,pre-existing renal impairment,1152,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Meropenem and Sodium Chloride,hypersensitivity,313,1,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
Cefoxitin and Dextrose,hypertension,11,0,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@]2(NC(=O)CC1=CC=CS1)OC)C(O)=O,direct
Lignospan Standard,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
"Fluocinolone Acetonide Topical Solution USP, 0.01%",stroke,7,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Midazolam Hydrochloride,hypersensitivity,313,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Beleodaq,asthma,12,0,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1,direct
Physician EZ Use Joint Tunnel and Trigger Kit,active tuberculosis,535,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Auryxia,anemia,13,0,O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,direct
TAVALISSE,severe infection,18,0,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC,direct
fluconazole,serious underlying diseases,1232,1,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Flavoxate Hydrochloride,glaucoma,481,1,CC1=C(OC2=C(C=CC=C2C(=O)OCCN2CCCCC2)C1=O)C1=CC=CC=C1,direct
LEVALBUTEROL,hypertension,11,0,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
Desipramine Hydrochloride,depressive symptoms,769,1,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Pemetrexed disodium,mpm who,1020,1,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
Brinzolamide,cancer (localized),8,0,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Strattera,narrow angle glaucoma,1029,1,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
Timoptic-XE,hypertension,11,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Dextrose and Electrolyte No. 48,edema,417,1,[Cl-].[K+],direct
Rifadin IV,compromised adrenal function,737,1,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
tetracycline hydrochloride,chronic kidney disease,3,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
LEVETIRACETAM solution,partial seizures,1104,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
PRENATE Enhance,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Norgesic Forte,myasthenia gravis,151,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Ozempic,pancreatitis,233,1,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CN=CN1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O,direct
Doxycycline Monohydrate,impaired renal function,919,1,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Dotremin,hypersensitivity,313,1,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
"sodium sulfate, potassium sulfate, and magnesium sulfate",normal baseline who,1060,1,[Mg++].[O-]S([O-])(=O)=O,"fuzzy:sodium sulfate, potassium sulfate and magnesium sulfate"
HALOPERIDOL,psychosis,31,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Buprenorphine Hydrochloride,renal failure,19,0,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,direct
Vitafol Fe Plus,sepsis,17,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Mirtazapine,hypersensitivity,313,1,CN1CCN2C(C1)C1=CC=CC=C1CC1=C2N=CC=C1,direct
Soma,severe infection,18,0,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,direct
LIDOCAINE HYDROCHLORIDE,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
SPIRONOLACTONE,the following conditions,1301,1,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
INVOKANA,liver cirrhosis,4,0,[H][C@]1(O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C1=CC=C(C)C(CC2=CC=C(S2)C2=CC=C(F)C=C2)=C1,direct
Trisenox,hypersensitivity,313,1,O=[As]O[As]=O,direct
Ethacrynate Sodium,stroke,7,0,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
Clonidine hydrochloride,congestive heart failure,2,0,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
FARXIGA,stroke,7,0,CCOC1=CC=C(CC2=C(Cl)C=CC(=C2)[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C=C1,direct
SUBVENITE,partial-onset seizures who,1108,1,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
Acetaminophen,anemia,13,0,CC(=O)NC1=CC=C(O)C=C1,direct
Ammonia N-13,autoimmune disease,15,0,[13NH3],direct
Brimonidine Tartrate,anemia,13,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
LATANOPROST,asthma,12,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
CABERGOLINE,severe infection,18,0,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,direct
Diphenoxylate Hydrochloride and Atropine Sulfate,diabetes mellitus,5,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
SOTALOL HYDROCHLORIDE,life-threatening ventricular arrhythmias,966,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
fenofibrate,severe hypertriglyceridemia,1247,1,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
HYDROCODONE/APAP,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
PRENATE Enhance,liver disease (non-cirrhotic),20,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Sodium Phenylacetate and Sodium Benzoate,otc and cps,1083,1,OC(=O)C1=CC=CC=C1,direct
Quinapril HCL and Hydrochlorothiazide,impaired liver function,918,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
ProAir RespiClick,hypersensitivity to albuterol,882,1,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Kit for the Preparation of Technetium Tc 99m Sulfur Colloid,cancer (localized),8,0,[99Tc].S1SSSSSSS1,direct
Fluocinonide,anemia,13,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,direct
TREANDA,cancer (metastatic),9,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Alendronate,the following conditions,1301,1,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
DIAZEPAM,open-angle glaucoma who,1081,1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,direct
Istalol,liver cirrhosis,4,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Trisenox,myocardial infarction,1,0,O=[As]O[As]=O,direct
LIPIODOL,cancer (localized),8,0,COC1=CC=C(C=C1)C(=O)CC(=O)C1=CC=C(C=C1)C(C)(C)C,fuzzy:lipidol
Ambien,sepsis,17,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Lyrica CR,partial onset seizures,1103,1,CC(C)C[C@H](CN)CC(O)=O,direct
MEMANTINE,liver disease (non-cirrhotic),20,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Ambien,cancer (metastatic),9,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Tobramycin Inhalation Solution Pak,congestive heart failure,2,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Lomotil,obstructive jaundice,1073,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
YONSA,sepsis,17,0,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Deferoxamine mesylate,severe infection,18,0,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
NITROGLYCERIN,shock,419,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Diltiazem Hydrochloride,chronic stable angina,705,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Simvastatin,severe infection,18,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
PHENYTOIN SODIUM,chronic obstructive pulmonary disease (COPD),6,0,O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
METHYLPREDNISOLONE,asthma,12,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Cyltezo,active psa,532,1,CC(C)O,direct
ABILIFY MAINTENA,pregnancy,16,0,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
Keppra XR,severe infection,18,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Amphetamine Sulfate,comorbid depressive symptoms,735,1,CC(N)CC1=CC=CC=C1,direct
carmustine,renal failure,19,0,ClCCNC(=O)N(CCCl)N=O,direct
Trezix,acetaminophen allergy,513,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
PROPRANOLOL HYDROCHLORIDE,pregnancy,16,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Beleodaq,cancer (localized),8,0,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1,direct
Pioglitazone Hydrochloride and Metformin Hydrochloride,severe renal impairment,1253,1,CN(C)C(=N)NC(N)=N,direct
Cytalux,chronic obstructive pulmonary disease (COPD),6,0,CC1(C)\C(=C/C=C2\CCCC(\C=C\C3=[N+](CCCCS(O)(=O)=O)C4=C(C=C(C=C4)S([O-])(=O)=O)C3(C)C)=C2OC2=CC=C(C[C@H](NC(=O)C3=CC=C(NCC4=CN=C5N=C(N)NC(=O)C5=N4)C=C3)C(O)=O)C=C2)N(CCCCS(O)(=O)=O)C2=C1C=C(C=C2)S(O)(=O)=O,direct
RAMELTEON,insomnia,441,1,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,direct
Ciprofloxacin and dexamethasone,anemia,13,0,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,direct
Folditam,hypersensitivity,313,1,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Nuvigil,hypersensitivity,313,1,NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1,direct
OSCIMIN,liver disease (non-cirrhotic),20,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
sucralfate,chronic obstructive pulmonary disease (COPD),6,0,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,direct
TRIHEXYPHENIDYL HYDROCHLORIDE,stroke,7,0,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1,direct
Vitrexyl plus Iron,cancer (metastatic),9,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Mesalamine,hypersensitivity,313,1,NC1=CC(C(O)=O)=C(O)C=C1,direct
Iclusig,newly diagnosed cp-cml,1034,1,CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1,direct
Cosyntropin,stroke,7,0,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O,direct
Eligard,prostate cancer,265,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
CARBAMAZEPINE,symptomatic hyponatremia,1286,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
Metolazone,chronic obstructive pulmonary disease (COPD),6,0,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,direct
hydrocortisone,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE,liver disease (non-cirrhotic),20,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
Amphetamine Sulfate,chronic obstructive pulmonary disease (COPD),6,0,CC(N)CC1=CC=CC=C1,direct
Sensorcaine,liver disease (non-cirrhotic),20,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Dotremin,sepsis,17,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
LIDOCAINE HCI AND EPINEPHRINE,pregnancy,16,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
LOTRONEX,severe infection,18,0,CN1C2=C(C3=CC=CC=C13)C(=O)N(CC1=C(C)NC=N1)CC2,direct
CARISOPRODOL,stroke,7,0,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,direct
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution,asthma,193,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
"DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE",autoimmune disease,15,0,CC(N)CC1=CC=CC=C1,direct
Idamycin PFS,mental illness,14,0,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O,direct
DOCETAXEL,solid tumors,1264,1,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
Diltiazem HCL ER,myocardial infarction,49,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
"Timolol Maleate Ophthalmic Gel Forming Solution, 0.25%",hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Vyzulta,hypertension,39,1,O[C@H](CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\C=C/CCCC(=O)OCCCCO[N+]([O-])=O)CCC1=CC=CC=C1,direct
Oxymorphone hydrochloride,hypertension,11,0,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1(O)CCC2=O,direct
Foscavir,cancer (localized),8,0,OC(=O)P(O)(O)=O,direct
Methylene blue,pediatric patients,13,1,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,direct
Diflucan,hypersensitivity,313,1,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
BUPROPION HYDROCHLORIDE,cancer (metastatic),9,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
MEROPENEM,bacterial meningitis,626,1,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
Iluvien,non-infectious uveitis,1044,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Paclitaxel protein-bound particles for injectable suspension (albumin-bound),severe infection,18,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral,congestive heart failure,2,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,stroke,7,0,CC(=O)NC1=CC=C(O)C=C1,direct
Loperamide hydrochloride,acute ulcerative colitis,556,1,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
TAZORAC,acne vulgaris,516,1,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC2=C(SCCC2(C)C)C=C1,direct
Trimipramine Maleate,anemia,13,0,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Azathioprine Sodium,leukemia,267,1,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
Diclofenac Sodium,the aspirin triad,1295,1,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
GADOTERIDOL,diabetes mellitus,5,0,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,direct
Sorafenib Tosylate,rcc or hcc,1198,1,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
Neupro,rls receiving neupro,1217,1,CCCN(CCC1=CC=CS1)[C@H]1CCC2=C(O)C=CC=C2C1,direct
DIGOX,chronic atrial fibrillation,685,1,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,direct
Amlodipine besylate and Olmesartran medoxomil,stroke,51,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Unithroid,pediatric patients,13,1,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
Diltiazem Hydrochloride Extended-Release,myocardial infarction,49,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Foliflex,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
VABOMERE,renal failure,19,0,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
Norco,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
Escitalopram,asthma,12,0,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
Trileptal,vertigo,469,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Corvert,tachycardia,47,1,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
"Clotrimazole Topical Solution USP, 1%",cancer (metastatic),9,0,ClC1=CC=CC=C1C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Vancocin,liver cirrhosis,4,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
Flucytosine,cancer (localized),8,0,NC1=C(F)C=NC(=O)N1,direct
Salicylic Acid,impaired blood circulation,912,1,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,direct
Donepezil Hydrochloride,hypersensitivity,313,1,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
Keppra XR,congestive heart failure,2,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Brevital Sodium,hypersensitivity,313,1,CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O,direct
MELPHALAN HYDROCHLORIDE,renal damage,1210,1,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
SALICYLIC ACID,AIDS,10,0,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,direct
Vraylar,hypersensitivity,313,1,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=C(Cl)C(Cl)=CC=C2)CC1,direct
Tolsura,asthma,12,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
UBRELVY,chronic kidney disease,3,0,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=NC=CC=C42)C(=O)N1CC(F)(F)F)C1=CC=CC=C1,direct
olmesartan medoxomil-hydrochlorothiazide,hypersensitivity,313,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Evoxac,pregnancy,16,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
ondansetron hydrochloride,asthma,12,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
NITRO-DUR,cancer (localized),8,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
perphenazine,psychic depression,1192,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
"Butalbital, Acetaminophen, and Caffeine",hypertension,11,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide",congestive heart failure,2,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
nitrofurantoin macrocrystals,hypertension,11,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Fenofibric Acid,severe hypertriglyceridemia,1247,1,CC(C)(OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1)C(O)=O,direct
montelukast sodium,liver disease (non-cirrhotic),20,0,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
Lamivudine,myocardial infarction,1,0,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,direct
Caspofungin Acetate,autoimmune disease,15,0,[H][C@@]12C[C@@H](O)CN1C(=O)[C@@H](NC(=O)[C@]([H])(C[C@@H](O)[C@@H](NCCN)NC(=O)[C@@H]1[C@@H](O)CCN1C(=O)[C@@H](NC(=O)[C@@H](NC2=O)[C@H](O)[C@@H](O)C1=CC=C(O)C=C1)[C@H](O)CCN)NC(=O)CCCCCCCC[C@@H](C)C[C@@H](C)CC)[C@@H](C)O,direct
Isordil Titradose,liver disease (non-cirrhotic),20,0,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
GEMCITABINE,laboratory or non-laboratory,957,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
Benzphetamine Hydrochloride,heart disease,377,1,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,direct
Capecitabine 500mg,metastatic colorectal cancer,996,1,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
CARNITOR,hypertension,11,0,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
Chemet,diabetes mellitus,5,0,OC(=O)[C@@H](S)[C@@H](S)C(O)=O,direct
voriconazole,acute ia,541,1,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Azelastine hydrochloride and Fluticasone propionate,stroke,7,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
DEFINITY RT,anemia,13,0,FC(F)(F)C(F)(F)C(F)(F)F,direct
ONGLYZA,chronic kidney disease,3,0,[H][C@@]12C[C@]1([H])N([C@@H](C2)C#N)C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2,direct
CIMDUO,congestive heart failure,2,0,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,direct
Fentanyl Buccal,cancer (metastatic),9,0,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
Amiloride Hydrochloride,liver disease (non-cirrhotic),20,0,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
Lurasidone hydrochloride,severe infection,18,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
PROMETHAZINE DM,chronic kidney disease,3,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Concept OB,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Kiprofen,the aspirin triad,1295,1,CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1,direct
Lunesta,hypersensitivity,313,1,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,direct
haloperidol decanoate,psychosis,31,1,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate",comorbid depressive symptoms,735,1,CC(N)CC1=CC=CC=C1,direct
benzphetamine hydrochloride,autoimmune disease,15,0,C[C@@H](CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,direct
Prepidil,asthma,12,0,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,direct
Cosyntropin,hypertension,11,0,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O,direct
Liothyronine sodium,anemia,13,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
RADICAVA,AIDS,10,0,CC1=NN(C(=O)C1)C1=CC=CC=C1,direct
Chlordiazepoxide Hydrochloride and Clidinium Bromide,pregnancy,16,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
gentamicin sulfate,hypersensitivity,313,1,[H][C@@]1(CN)CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)N.[H][C@]1(CC[C@@H](N)[C@@H](O[C@]2([H])[C@@H](N)C[C@@H](N)[C@H](O[C@@]3([H])OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1)C(C)NC,direct
FloLipid,homozygous familial hypercholesterolemia,872,1,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
MEMANTINE,hypersensitivity,313,1,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Mefenamic Acid,the aspirin triad,1295,1,CC1=C(C)C(NC2=CC=CC=C2C(O)=O)=CC=C1,direct
Hyosyne,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
bisoprolol fumarate and hydrochlorothiazide,chronic obstructive pulmonary disease (COPD),6,0,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,direct
CETIRIZINE HYDROCHLORIDE,liver disease (non-cirrhotic),20,0,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral,depression,27,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
oxaliplatin,hypersensitivity,313,1,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,direct
COSOPT PF,asthma,12,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
valsartan,anemia,13,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Levalbuterol,hypersensitivity,313,1,CC(C)(C)NC[C@H](O)C1=CC(CO)=C(O)C=C1,direct
Bortezomib,relapsed multiple myeloma,1205,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
tacrolimus,liver disease (non-cirrhotic),20,0,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,direct
Daraprim,hypertension,11,0,CCC1=C(C(N)=NC(N)=N1)C1=CC=C(Cl)C=C1,direct
PROPRANOLOL,anemia,13,0,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
polymyxin b sulfate and trimethoprim sulfate,stroke,7,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
BRIMONIDINE TARTRATE and TIMOLOL MALEATE,asthma,193,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Nabumetone 500 mg,the aspirin triad,1295,1,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
DILTIAZEM HYDROCHLORIDE in SODIUM CHLORIDE,liver cirrhosis,4,0,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,fuzzy:esmolol hydrochloride in sodium chloride
SIROLIMUS,myocardial infarction,1,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
Ropivacaine hydrochloride,AIDS,10,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
Folitin-Z,severe infection,18,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Perphenazine and Amitriptyline Hydrochloride,sepsis,17,0,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Galantamine,renal failure,19,0,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,direct
Armodafinil,sepsis,17,0,NC(=O)C[S@@](=O)C(C1=CC=CC=C1)C1=CC=CC=C1,direct
Rozerem,pregnancy,16,0,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,direct
VIDAZA,mental illness,14,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Lisinopril and hydrochlorothiazide,stroke,7,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
FLEQSUVY,hypersensitivity,313,1,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
budesonide,AIDS,10,0,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
LEUKERAN,lymphoma,269,1,OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl,direct
Guanfacine Hydrochloride,congestive heart failure,2,0,NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl,direct
Celecoxib 200 mg,post-surgical pain,1145,1,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
Coreg,severe infection,18,0,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
NITROSTAT,autoimmune disease,15,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Alvesco,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,direct
LEVOPHED(R) NOREPINEPHRINE BITARTRATE,stroke,7,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
ETHOSUXIMIDE,stroke,7,0,CCC1(C)CC(=O)NC1=O,direct
XELPROS,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
bortezomib,insomnia,441,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Fluconazole,diabetes mellitus,5,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
COSOPT,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Clofarabine,pediatric patients,13,1,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,direct
Adalimumab,active as,521,1,CC(C)O,direct
Esomeprazole Sodium,hypersensitivity,313,1,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
nitroglycerin,stroke,7,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
mupirocin,hypersensitivity,313,1,C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O,direct
Fluphenazine hydrochloride,anemia,13,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
ENDOCET,hypertension,11,0,CC(=O)NC1=CC=C(O)C=C1,direct
Dopram,cancer (metastatic),9,0,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,direct
ZEGERID,cancer (localized),8,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Levbid,asthma,12,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Tasmar,severe infection,18,0,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,direct
Ala-Scalp,mental illness,14,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
melphalan hydrochloride,renal damage,1210,1,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Tizanidne hydrochloride,cancer (metastatic),9,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
"Carbidopa Tablets, 25 mg",hypersensitivity,313,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
ertapenem sodium,the laboratory test,1306,1,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Nitrofurantoin Mono,mental illness,14,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
nystatin and triamcinolone acetonide,hypersensitivity,313,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Capecitabine,cancer (localized),8,0,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O,direct
Toronova SUIK,cancer (metastatic),9,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Sodium Chloride,edema,417,1,[Na+].[Cl-],direct
MOMETASONE FUROATE MONOHYDRATE,renal failure,19,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)C3=CC=CO3)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
PREGABALIN,autoimmune disease,15,0,CC(C)C[C@H](CN)CC(O)=O,direct
Bactrim DS,diabetes mellitus,5,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Carbamazepine,symptomatic hyponatremia,1286,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
XYLOCAINE,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Hydroxyzine Hydrochloride,diabetes mellitus,5,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
EZETIMIBE,chronic kidney disease,3,0,[H][C@]1(CC[C@H](O)C2=CC=C(F)C=C2)C(=O)N(C2=CC=C(F)C=C2)[C@]1([H])C1=CC=C(O)C=C1,direct
ZITUVIO,severe infection,18,0,N[C@@H](CC(=O)N1CCN2C(C1)=NN=C2C(F)(F)F)CC1=CC(F)=C(F)C=C1F,direct
Venexa FE,myocardial infarction,1,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Cyclosporine Modified,hypersensitivity,313,1,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
IBU,hypersensitivity,313,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
TARGADOX,impaired renal function,919,1,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Tramadol Hydrochloride and Acetaminophen,acetaminophen allergy,513,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Hydrocortisone Acetate,hypertension,11,0,[H][C@@]12CC[C@](O)(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
GaviLyte - C TM,severe ulcerative colitis,1255,1,[Cl-].[K+],direct
TRAMADOL HYDROCHLORIDE,cancer (metastatic),9,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Erlotinib Hydrochloride,AIDS,10,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND,sepsis,291,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
cyanocobalamin,pregnancy,16,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
ALVAIZ,hepatitis,229,1,CC1=NN(C(=O)\C1=N/NC1=CC=CC(C2=CC=CC(=C2)C(O)=O)=C1O)C1=CC=C(C)C(C)=C1,direct
QUININE SULFATE,the following,1299,1,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12,direct
NITROGLYCERIN,myocardial infarction,1,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
"Brompheniramine maleate, pseudoephedrine hydrochloride,",hypertension,39,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
leuprolide acetate,mental illness,14,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
XYLOCAIN (LIDOCAINE HCl ),diabetes mellitus,5,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Vizamyl,cognitive impairment who,733,1,CNC1=C([18F])C=C(C=C1)C1=NC2=CC=C(O)C=C2S1,direct
Pravastatin sodium,diabetes mellitus,5,0,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Pro-C-Dure 6 Kit,myocardial infarction,1,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Alprazolam Extended Release,anorexia,399,1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
Zydelig,lymphoma,269,1,[H][C@@](CC)(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,direct
CitraNatal 90 DHA,hypersensitivity,313,1,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Trileptal,ataxia,465,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Ribotin-E,AIDS,10,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
fluphenazine hydrochloride,renal failure,19,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
PANRETIN,hypersensitivity,313,1,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,direct
Azasan,chronic kidney disease,3,0,CN1C=NC(=C1SC1=NC=NC2=C1NC=N2)[N+]([O-])=O,direct
KENGREAL,severe renal impairment,1253,1,CSCCNC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC(SCCC(F)(F)F)=N1,direct
BRIMONIDINE TARTRATE and TIMOLOL MALEATE,stroke,7,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Trimipramine Maleate,depression,27,1,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
DMT SUIK,pancreatitis,233,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Diltiazem HCl CD,pregnancy,16,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Lansoprazole DR,mental illness,14,0,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Rifadin IV,renal failure,19,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
LEVETIRACETAM solution,hypersensitivity,313,1,CC[C@H](N1CCCC1=O)C(N)=O,direct
Potassium Chloride,diabetes mellitus,5,0,[Cl-].[K+],direct
LISINOPRIL and HYDROCHLOROTHIAZIDE,pregnancy,16,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Imipramine Pamoate,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12,direct
CitraNatal 90 DHA,asthma,12,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Epclusa,insomnia,441,1,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
RISEDRONATE SODIUM,liver disease (non-cirrhotic),20,0,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
Zoledronic Acid,asthma,12,0,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
Thalomid,mm when pembrolizumab,1014,1,O=C1N(C2CCC(=O)NC2=O)C(=O)C2=CC=CC=C12,direct
Dexamethasone Sodium Phosphate,anemia,13,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Plasma-Lyte A,chronic obstructive pulmonary disease (COPD),6,0,[Cl-].[K+],direct
Metoprolol,diabetes mellitus,5,0,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
Dutasteride and tamsulosin hydrochloride,hypertension,11,0,CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC(=C(OC)C=C1)S(N)(=O)=O,direct
Acetaminophen and Codeine,acetaminophen allergy,513,1,CC(=O)NC1=CC=C(O)C=C1,direct
APREMILAST,chronic obstructive pulmonary disease (COPD),6,0,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,direct
Ramelteon,insomnia,441,1,CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2,direct
LEXISCAN(R) (REGADENOSON),diabetes mellitus,5,0,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
Meclizine Hydrochloride,severe infection,18,0,CC1=CC(CN2CCN(CC2)C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)=CC=C1,direct
Lutathera,pediatric patients,13,1,[177Lu+3].C[C@@H](O)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=C2C=CC=C3)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(O)=O,direct
YONSA,liver metastases,967,1,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Spravato,anxiety,19,1,CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl,direct
Sertraline Hydrochloride,depressive symptoms,769,1,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,direct
Menatrol,anemia,13,0,CC1=C(O)C(CO)=C(CO)C=N1,direct
tranexamic acid,subarachnoid hemorrhage,1275,1,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Uceris,congestive heart failure,2,0,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
DALFAMPRIDINE,cancer (metastatic),9,0,NC1=CC=NC=C1,direct
Metolazone,severe infection,18,0,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,direct
Dalfampridine,ms as follows,1022,1,NC1=CC=NC=C1,direct
Hydrocodone/APAP,myocardial infarction,1,0,CC(=O)NC1=CC=C(O)C=C1,direct
METROGEL,AIDS,10,0,CC1=NC=C(N1CCO)[N+]([O-])=O,direct
Trileptal,hyponatremia,137,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
LEUKERAN,congestive heart failure,2,0,OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl,direct
Levetiracetam Extended-Release,anemia,13,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
CERIANNA,autoimmune disease,15,0,[H][C@@]12C[C@@H]([18F])[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
IYUZEH,hypertension,11,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Depo-Estradiol,asthma,12,0,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=CC(O)=CC=C4[C@@]3([H])CC[C@]12C)OC(=O)CCC1CCCC1,direct
EVEROLIMUS,chronic kidney disease,3,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](OCCO)[C@@H](C1)OC,direct
Dialyvite with Zinc,hypersensitivity,313,1,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Nystop,cancer (metastatic),9,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
DEFINITY RT,autoimmune disease,15,0,FC(F)(F)C(F)(F)C(F)(F)F,direct
Silver Sulfadiazine,sepsis,291,1,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
deferasirox,decreased egfr,761,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Apixaban,the following conditions,1301,1,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,direct
Ibuprofen,anemia,13,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
"sodium sulfate, potassium sulfate, and magnesium sulfate",chronic obstructive pulmonary disease (COPD),6,0,[Mg++].[O-]S([O-])(=O)=O,"fuzzy:sodium sulfate, potassium sulfate and magnesium sulfate"
Methylprednisolone,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
DURYSTA,oag or oht,1072,1,CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1,direct
posaconazole,thrombocytopenia,79,1,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
ORPHENGESIC FORTE,pregnancy,16,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Dialyvite,renal failure,19,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
DESOXIMETASONE,autoimmune disease,15,0,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
"CycloSPORINE, Modfied",asthma,12,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Diazepam,renal failure,19,0,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,direct
tacrolimus,hypersensitivity,313,1,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,direct
Rivastigmine,these events,1312,1,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,direct
VOQUEZNA,liver disease (non-cirrhotic),20,0,CNCC1=CN(C(=C1)C1=CC=CC=C1F)S(=O)(=O)C1=CC=CN=C1,direct
Kiprofen,chronic obstructive pulmonary disease (COPD),6,0,CC(C(O)=O)C1=CC(=CC=C1)C(=O)C1=CC=CC=C1,direct
Rozlytrek,cancer (localized),8,0,CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1,direct
YUPELRI,cancer (localized),8,0,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1,direct
Selegiline Hydrochloride,hypertension,11,0,C[C@H](CC1=CC=CC=C1)N(C)CC#C,direct
Cladribine,poisoning,425,1,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
Ranitidine,active duodenal ulcer,522,1,CNC(NCCSCC1=CC=C(CN(C)C)O1)=C[N+]([O-])=O,direct
Gengraf,hypersensitivity,313,1,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Mirabegron,hypertension,11,0,NC1=NC(CC(=O)NC2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2)=CS1,direct
Citalopram,stroke,7,0,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
phenelzine sulfate,depressive symptoms,769,1,NNCCC1=CC=CC=C1,direct
Dopram,chronic obstructive pulmonary disease (COPD),6,0,CCN1CC(CCN2CCOCC2)C(C1=O)(C1=CC=CC=C1)C1=CC=CC=C1,direct
Dronabinol,hypersensitivity,313,1,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,direct
Gemcitabine,various malignancies,1350,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
Doxycycline Monohydrate,hypertension,11,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Bromocriptine mesylate,hypertension,39,1,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
TECFIDERA,hypersensitivity,313,1,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
Kyzatrex,hypertension,39,1,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,direct
AirDuo Digihaler,hypertension,11,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Ceftriaxone Sodium,hypersensitivity,313,1,[H][C@]12SCC(CSC3=NC(=O)C(=O)NN3C)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CSC(N)=N1)C(O)=O,direct
ALENDRONATE SODIUM,hypertension,11,0,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
ICOSAPENT ETHYL,pancreatitis,233,1,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Penciclovir,congestive heart failure,2,0,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,direct
Dorzolamide Hydrochloride and Timolol Maleate Preservative Free,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
AMITRIPTYLINE HCL,autoimmune disease,15,0,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
POLYMYXIN B SULFATE and TRIMETHOPRIM SULFATE,anemia,13,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Idarubicin Hydrochloride,pregnancy,16,0,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O,direct
Kit for the Preparation of Technetium Tc 99m Sulfur Colloid,chronic kidney disease,3,0,[99Tc].S1SSSSSSS1,direct
Diovan HCT,hypersensitivity,313,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Humira,active psa,532,1,CC(C)O,direct
Estradiol Valerate,hypersensitivity,313,1,[H][C@@]12CC[C@H](OC(=O)CCCC)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Clindamycin Phosphate 1.2% and Tretinoin 0.025%,pregnancy,16,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
Cimetidine Hydrochloride,preexisting arthritis,1156,1,CN\C(NCCSCC1=C(C)NC=N1)=N\C#N,direct
"Travoprost Ophthalmic Solution, 0.004%",hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Losartan Potassium and Hydrochlorothiazide,hepatic impairment cannot,858,1,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
ESOMEPRAZOLE MAGNESIUM,anemia,13,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
cefdinir,cancer (metastatic),9,0,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,direct
polymyxin b sulfate and trimethoprim sulfate,AIDS,10,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
ARISTADA INITIO,hypersensitivity,313,1,CCCCCCCCCCCC(=O)OCN1C(=O)CCC2=CC=C(OCCCCN3CCN(CC3)C3=C(Cl)C(Cl)=CC=C3)C=C12,direct
Spritam,severe infection,18,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Labetalol Hydrochloride,congestive heart failure,41,1,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Rectiv,severe anemia,1235,1,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Mycostatin,hypersensitivity,313,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Effer-K Orange,liver cirrhosis,4,0,[K+].OC([O-])=O,direct
Gemfibrozil,significantly elevated triglycerides,1260,1,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,direct
Valium,open-angle glaucoma who,1081,1,CN1C2=C(C=C(Cl)C=C2)C(=NCC1=O)C1=CC=CC=C1,direct
Febuxostat,liver cirrhosis,4,0,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
Ethacrynic acid,hypokalemia,133,1,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
DAPTOMYCIN,comparator agents,736,1,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](CC(=O)C2=CC=CC=C2N)NC(=O)[C@@H](NC(=O)[C@@H](CO)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN)NC(=O)CNC1=O)[C@H](C)CC(O)=O,direct
LEUCOVORIN CALCIUM,advanced colorectal cancer,560,1,[H]C(=O)N1C(CNC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)CNC2=C1C(=O)NC(N)=N2,direct
pravastatin sodium,stroke,51,1,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Pemfexy,mpm who,1020,1,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
LIDOCAINE HYDROCHLORIDE AND DEXTROSE,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Brimonidine Tartrate/Timolol Maleate,congestive heart failure,2,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
BUPIVACAINE HCl,cancer (metastatic),9,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Isordil Titradose,myocardial infarction,49,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
Tafluprost Ophthalmic,stroke,7,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
Metoclopramide,epilepsy metoclopramide,797,1,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,direct
Calcipotriene,cancer (metastatic),9,0,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
Bisoprolol fumarate,event the following,808,1,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,direct
Binosto,anemia,13,0,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Zilretta,autoimmune disease,15,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Amitriptyline Hydrochloride,depressive symptoms,769,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Cisplatin,cancer (localized),8,0,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
MITIGARE,hepatic impairment,1,1,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Doxorubicin Hydrochloride,multiple myeloma,1024,1,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
SINEMET,glaucoma,481,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Vilazodone Hydrochloride,mental illness,14,0,NC(=O)C1=CC2=CC(=CC=C2O1)N1CCN(CCCCC2=CNC3=C2C=C(C=C3)C#N)CC1,direct
RIFAMPIN,liver disease (non-cirrhotic),20,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
PRENATE Restore,renal failure,19,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Foltrate,anemia,13,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Toronova SUIK,liver disease (non-cirrhotic),20,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Plerixafor,insomnia,441,1,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
Penicillin G Potassium,impaired renal function,919,1,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,direct
dihydroergotamine mesylate,autoimmune disease,15,0,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
Tafluprost Ophthalmic,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
"Brompheniramine maleate, pseudoephedrine hydrochloride,",coronary artery disease,37,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Oxaliplatin,hypersensitivity,313,1,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,direct
GEMCITABINE,non-laboratory data,1047,1,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
ASENAPINE,sepsis,17,0,CN1CC2C(C1)C1=C(OC3=CC=C(Cl)C=C23)C=CC=C1,direct
Folixapure,cancer (localized),8,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
URIMAR-T CAPS,renal failure,19,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Dexlansoprazole,AIDS,10,0,CC1=C(OCC(F)(F)F)C=CN=C1C[S@@](=O)C1=NC2=CC=CC=C2N1,direct
brexpiprazole,hypersensitivity,313,1,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,direct
MACI,the following conditions,1301,1,COC1=C(O)C=CC(CNC(=O)CCCC\C=C\C(C)C)=C1,fuzzy:mac
Dorzolamide Hydrochloride and Timolol Maleate,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
KLOR-CON M,significant cardiac arrhythmias,1259,1,[Cl-].[K+],direct
Enalapril Maleate and Hydrochlorothiazide,anemia,13,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
CELESTONE SOLUSPAN,liver cirrhosis,4,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Radiaura Skin Recovery,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
venlafaxine,stroke,7,0,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
"PredniSONE Tablets, USP, 20 mg",chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
TRANEXAMIC ACID,liver disease (non-cirrhotic),20,0,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
propafenone hydrochloride,diabetes mellitus,5,0,CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1,direct
DOXY 100(TM) DOXYCYCLINE,sepsis,17,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Focalin,pediatric patients,13,1,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,direct
Bromocriptine Mesylate,stroke,51,1,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
Trileptal,tremor,459,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
methylphenidate hydrochloride,asthma,12,0,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
SPIRONOLACTONE,mental illness,14,0,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
CARBOplatin,impaired kidney function,917,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
HUMIRA,active as,521,1,CC(C)O,direct
Sulfasalazine,rheumatoid arthritis who,1215,1,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,direct
Methamphetamine Hydrochloride,psychosis,31,1,CN[C@@H](C)CC1=CC=CC=C1,direct
Acamprosate Calcium,chronic obstructive pulmonary disease (COPD),6,0,CC(=O)NCCCS(O)(=O)=O,direct
"Clobetasol Propionate Cream USP, 0.05% Clobetasol Propionate Cream USP, 0.05%",hypersensitivity,313,1,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Labetalol Hydrochloride,this tumor,1318,1,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Phenylephrine Hydrochloride,pregnancy,16,0,CNC[C@H](O)C1=CC(O)=CC=C1,direct
Ertapenem,stroke,7,0,[H][C@]12[C@@H](C)C(S[C@]3([H])CN[C@@]([H])(C3)C(=O)NC3=CC=CC(=C3)C(O)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O,direct
Oseltamivir phosphate,stroke,7,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
QUININE SULFATE,mental illness,14,0,[H][C@]1(C[C@@H]2CC[N@]1C[C@@H]2C=C)[C@H](O)C1=CC=NC2=CC=C(OC)C=C12,direct
Bendamustine,chronic lymphocytic leukemia,693,1,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Sensorcaine,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
Fluticasone Propionate,mental illness,14,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
ondansetron hydrochloride,severe infection,18,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Rykindo extended-release microspheres,hypertension,11,0,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,direct
Loperamide hydrochloride,renal failure,19,0,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
cephalexin,sepsis,17,0,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
Exjade,ntdt abbreviation,1070,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
TREANDA,congestive heart failure,2,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Glucagon,mental illness,14,0,O,direct
Thalitone,stroke,7,0,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
ROSUVASTATIN,homozygous familial hypercholesterolemia,872,1,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Rocklatan,edema,417,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
ZIOPTAN,anemia,13,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
Budesonide,liver cirrhosis,4,0,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
CAPRELSA,stroke,7,0,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,direct
DOFETILIDE,paroxysmal atrial fibrillation,1102,1,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,direct
QUINIDINE SULFATE,ventricular arrhythmias,1354,1,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
Ativan,psychosis,31,1,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,direct
Varenicline,hypertension,11,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
SIROLIMUS,chronic kidney disease,3,0,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
BORTEZOMIB,thrombocytopenia,79,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
THAM,liver disease (non-cirrhotic),20,0,NC(CO)(CO)CO,direct
Mefenamic Acid,AIDS,10,0,CC1=C(C)C(NC2=CC=CC=C2C(O)=O)=CC=C1,direct
DEXRAZOXANE,breast cancer,263,1,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,direct
ZOLINZA,congestive heart failure,2,0,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,direct
Lidocaine Hydrochloride and Epinephrine Bitartrate,autoimmune disease,15,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Leuprolide Acetate,metastatic prostate cancer,1004,1,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
ACETAZOLAMIDE,cancer (metastatic),9,0,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
Ibutilide Fumarate,chronic atrial fibrillation,685,1,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Ambien CR,primary insomnia who,1177,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
LAMIVUDINE,hypersensitivity,313,1,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,direct
Adalimumab,anti-adalimumab antibody,602,1,CC(C)O,direct
Korlym,congestive heart failure,2,0,[H][C@@]12CC[C@@](O)(C#CC)[C@@]1(C)C[C@H](C1=CC=C(C=C1)N(C)C)C1=C3CCC(=O)C=C3CC[C@@]21[H],direct
Propranolol Hydrochloride,hypertrophic subaortic stenosis,899,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
SYMPROIC,hypersensitivity,313,1,[H][C@@]12OC3=C4C(C[C@@]5([H])N(CC6CC6)CC[C@@]14[C@@]5(O)CC(C(=O)NC(C)(C)C1=NC(=NO1)C1=CC=CC=C1)=C2O)=CC=C3O,direct
Finasteride,cancer (metastatic),9,0,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,direct
ACCOLATE,cirrhosis,231,1,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,direct
Mozobil,nhl or mm,1038,1,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
Ifosfamide,altered renal function,587,1,ClCCNP1(=O)OCCCN1CCCl,direct
Doxorubicin Hydrochloride Liposome,myocardial infarction,1,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
Clindamycin Phosphate and Tretinoin,liver disease (non-cirrhotic),20,0,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,direct
Argatroban,congestive heart failure,2,0,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2,direct
Lignospan Forte,mental illness,14,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Amantadine HCl,hypersensitivity,313,1,NC12CC3CC(CC(C3)C1)C2,direct
Betaxolol,mental illness,14,0,CC(C)NCC(O)COC1=CC=C(CCOCC2CC2)C=C1,direct
Mexiletine hydrochloride,life-threatening ventricular arrhythmia,965,1,CC(N)COC1=C(C)C=CC=C1C,direct
Cytomel,pediatric patients,13,1,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
Nicardipine Hydrochloride,hypersensitivity,313,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
Oxcarbazepine,anemia,13,0,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
SILVADENE,cancer (localized),8,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
Lioresal (baclofen),hypotension,75,1,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
sorafenib,hcc or dtc,847,1,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1,direct
Nystatin Cream,myocardial infarction,1,0,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Fluticasone Propionate,hypersensitivity,313,1,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Hydrocortisone Cream,cancer (localized),8,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
ACCOLATE,asthma on accolate,617,1,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,direct
CYTARABINE,diabetes mellitus,5,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,direct
EVOMELA,anemia,81,1,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
metyrosine,malignant pheochromocytoma,979,1,C[C@](N)(CC1=CC=C(O)C=C1)C(O)=O,direct
Finasteride,prostate cancer,265,1,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,direct
"brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide",hypertension,39,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
ERLOTINIB,anorexia,399,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
Isosorbide dinitrate,congestive heart failure,41,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide",liver disease (non-cirrhotic),20,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
simvastatin,anemia,13,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
Nesina,hypersensitivity,313,1,CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O,direct
Zoledronic Acid,underlying risk factors,1340,1,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
Rapivab,severe infection,18,0,[H][C@@]1([C@@H](NC(C)=O)C(CC)CC)[C@H](O)[C@H](C[C@H]1NC(N)=N)C(O)=O,direct
Quinidine gluconate,hypertension,11,0,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
PIOGLITAZONE,sepsis,17,0,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
Perphenazine,dementia,7,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Diltiazem HCL ER,hypotension,75,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Fludrocortisone Acetate,congestive heart failure,2,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Diflorasone Diacetate,myocardial infarction,1,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
ZEGERID,hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Lovastatin,severe infection,18,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)[C@@H](C)CC,direct
Reyvow,heart disease,377,1,CN1CCC(CC1)C(=O)C1=CC=CC(NC(=O)C2=C(F)C=C(F)C=C2F)=N1,direct
ESZOPICLONE,pregnancy,16,0,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,direct
BETHKIS,hypersensitivity,313,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
toremifene citrate,mental illness,14,0,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,direct
MLK F1 Kit,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
pramosone,hypersensitivity,313,1,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Chloroquine Phosphate,cancer (localized),8,0,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,direct
Dicyclomine HCl,cancer (localized),8,0,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,direct
Metoprolol,hypertension,11,0,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
ORSERDU,autoimmune disease,15,0,CCNCCC1=CC=C(CN(CC)C2=C(C=CC(OC)=C2)[C@@H]2CCC3=CC(O)=CC=C3C2)C=C1,direct
CHLORTHALIDONE,sepsis,17,0,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Dobutamine Hydrochloride in Dextrose,aortic stenosis,55,1,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
ADAPALENE AND BENZOYL PEROXIDE,anemia,13,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Melphalan hydrochloride,stroke,7,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
VELCADE,relapsed multiple myeloma,1205,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
KETOROLAC TROMETHAMINE,AIDS,10,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Ethosuximide,liver cirrhosis,4,0,CCC1(C)CC(=O)NC1=O,direct
MYLERAN,stroke,7,0,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
POTASSIUM CITRATE,peptic ulcer disease,219,1,[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,direct
Accupril,cancer (localized),8,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
SENSIPAR,cancer (localized),8,0,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
ITRACONAZOLE,anemia,13,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Otezla,liver disease (non-cirrhotic),20,0,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,direct
CIDOFOVIR,hypersensitivity to cidofovir,886,1,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,direct
ibuprofen,pregnancy,16,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
ICOSAPENT ETHYL,liver cirrhosis,4,0,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Levothyroxine sodium,asthma,12,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
ERLEADA,anemia,13,0,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F,direct
Quinidine Gluconate,ventricular arrhythmias,1354,1,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
Lacosamide,partial-onset seizures who,1108,1,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
Norepinephrine,AIDS,10,0,NC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Pentazocine and naloxone,congestive heart failure,2,0,CC1C2CC3=C(C=C(O)C=C3)C1(C)CCN2CC=C(C)C,direct
Qulipta,severe infection,18,0,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=C4C=CC=N2)C(=O)N1CC(F)(F)F)C1=C(F)C(F)=CC=C1F,direct
labetalol hydrochloride,liver cirrhosis,4,0,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Lomotil,hypersensitivity,313,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
Foscavir,hypertension,11,0,OC(=O)P(O)(O)=O,direct
Abilify MyCite,hypersensitivity,313,1,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
Thiothixene,mental retardation,993,1,CN(C)S(=O)(=O)C1=CC2=C(SC3=CC=CC=C3\C2=C\CCN2CCN(C)CC2)C=C1,direct
esomeprazole magnesium,pregnancy,16,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
"PredniSONE Tablets, USP, 5 mg",asthma,12,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Mekinist,hypertension,11,0,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1,direct
FLUOCINONIDE,mental illness,14,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,direct
Hydroxym,renal failure,19,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Pentam 300,cancer (localized),8,0,NC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,direct
Aricept,chronic kidney disease,3,0,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
Lidocaine Hydrochloride and Epinephrine,liver cirrhosis,4,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Chemet,hypersensitivity,313,1,OC(=O)[C@@H](S)[C@@H](S)C(O)=O,direct
Oxycodone Hydchloride,autoimmune disease,15,0,COC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5C,direct
dasatinib,chronic phase cml,701,1,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
NYSTATIN AND TRIAMCINOLONE ACETONIDE,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Sulindac,marginal cardiac function,984,1,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O,direct
QUINIDINE SULFATE,heart disease,377,1,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
Tacrolimus,anemia,13,0,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]1C)OC,direct
TENORMIN,hypertension,11,0,CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1,direct
NOCDURNA,autoimmune disease,15,0,NC(=O)CC[C@@H]1NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCNC(N)=N)C(=O)NCC(N)=O,direct
Monoferric,chronic kidney disease,3,0,[Fe+3].OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O,direct
omeprazole sodium bicarbonate,stroke,7,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
NESTABS DHA Prenatal Multi-vitamin/Mineral Supplement with DHA/EPA,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Cystografin Dilute,hypersensitivity,313,1,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Tromethamine,liver cirrhosis,4,0,NC(CO)(CO)CO,direct
Idarubicin Hydrochloride,acute leukemia,543,1,C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=CC=CC=C3C(=O)C1=C2O)C(C)=O,direct
Bexarotene,congestive heart failure,2,0,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,direct
ANASTROZOLE,autoimmune disease,15,0,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,direct
Flecainide Acetate,chronic atrial fibrillation,685,1,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1,direct
TREANDA,chronic obstructive pulmonary disease (COPD),6,0,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,direct
Glyburide,chronic obstructive pulmonary disease (COPD),6,0,COC1=C(C=C(Cl)C=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,direct
Perphenazine and Amitriptyline Hydrochloride,dementia,7,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Docetaxel,other tumor types,1093,1,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
Epirubicin Hydrochloride,cancer (localized),8,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
CARBOplatin,mental illness,14,0,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
ETHACRYNATE SODIUM,mental illness,14,0,CCC(=C)C(=O)C1=C(Cl)C(Cl)=C(OCC(O)=O)C=C1,direct
liothyronine sodium,pediatric patients,13,1,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,direct
VUITY,autoimmune disease,15,0,CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O,direct
Ibutilide Fumarate,atrial fibrillation,65,1,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
POTASSIUM CHLORIDE,brain edema,643,1,[Cl-].[K+],direct
"Desonide Ointment, 0.05%",chronic kidney disease,3,0,[H][C@@]12C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
CALCITRIOL,hypercalcemia,139,1,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,direct
Foltrate,mental illness,14,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Phenylephrine Hydrochloride,thyrotoxicosis,113,1,CNC[C@H](O)C1=CC(O)=CC=C1,direct
OXALIPLATIN,hypersensitivity,313,1,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,direct
Pramipexole dihydrochloride,autoimmune disease,15,0,CCCN[C@H]1CCC2=C(C1)SC(N)=N2,direct
phenelzine sulfate,endogenous features,793,1,NNCCC1=CC=CC=C1,direct
Cinacalcet,hypertension,39,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Rapamune,lymphangioleiomyomatosis safety,974,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
Neoral,cancer (metastatic),9,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Butal/APAP/Caff,hypersensitivity,313,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
"Travoprost Ophthalmic Solution USP, 0.004% Travoprost",cancer (metastatic),9,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Ryaltris,allergic rhinitis,585,1,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2,direct
Diphenoxylate hydrochloride and atropine sulfate,chronic obstructive pulmonary disease (COPD),6,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
Cefazolin Sodium,pediatric patients,13,1,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,direct
SODIUM CHLORIDE,brain edema,643,1,[Na+].[Cl-],direct
IPRATROPIUM BROMIDE,perennial rhinitis,1112,1,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,direct
Loxapine,asthma,12,0,CN1CCN(CC1)C1=NC2=CC=CC=C2OC2=C1C=C(Cl)C=C2,direct
Ondansetron,tics,23,1,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Zintrexyl-C,pregnancy,16,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Hydroxychloroquine Sulfate,porphyria the condition,1141,1,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
Imbruvica,chronic kidney disease,3,0,NC1=NC=NC2=C1C(=NN2[C@@H]1CCCN(C1)C(=O)C=C)C1=CC=C(OC2=CC=CC=C2)C=C1,direct
DEXMETHYLPHENIDATE HYDROCHLORIDE,renal failure,19,0,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,direct
Imipenem and Cilastatin,sepsis,17,0,CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O,direct
Fioricet,hypersensitivity,313,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
"Brompheniramine, Pseudoephedrine, Dextromethorphan",renal failure,19,0,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
olopatadine hydrochloride,cancer (localized),8,0,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2,direct
clofarabine,all or aml,583,1,[H][C@]1(F)[C@H](O)[C@@H](CO)O[C@H]1N1C=NC2=C(N)N=C(Cl)N=C12,direct
Nicotrol,hypersensitivity,313,1,CN1CCC[C@H]1C1=CN=CC=C1,direct
Paroxetine,hypersensitivity,313,1,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
ROSUVASTATIN CALCIUM,sepsis,17,0,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
voriconazole,hypertension,11,0,C[C@@H](C1=NC=NC=C1F)[C@](O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
ELIGARD,liver disease (non-cirrhotic),20,0,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,direct
Nitrofurantoin Macrocrystals,hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
UBRELVY,chronic obstructive pulmonary disease (COPD),6,0,C[C@@H]1[C@@H](C[C@H](NC(=O)C2=CN=C3C[C@]4(CC3=C2)C(=O)NC2=NC=CC=C42)C(=O)N1CC(F)(F)F)C1=CC=CC=C1,direct
Myoview,coronary artery disease,37,1,CCOCCP(CCOCC)CCP(CCOCC)CCOCC,direct
SORILUX,anemia,13,0,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
Paroxetine,marked abnormalities,985,1,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
azithromycin monohydrate,pneumonia,201,1,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate",the following conditions,1301,1,CC(N)CC1=CC=CC=C1,direct
AMLODIPINE AND VALSARTAN,hypersensitivity,313,1,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
IOPIDINE 1%,chronic kidney disease,3,0,NC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1,direct
Bupivacaine Hydrochloride,hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE,diabetes mellitus,5,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
CETIRIZINE HYDROCHLORIDE,chronic kidney disease,3,0,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Flecainide Acetate,cancer (localized),8,0,FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1,direct
Fluvastatin,chd who,682,1,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,direct
ARIPIPRAZOLE,hypersensitivity,313,1,ClC1=CC=CC(N2CCN(CCCCOC3=CC4=C(CCC(=O)N4)C=C3)CC2)=C1Cl,direct
Oxcarbazepine,vertigo,469,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
Sulindac,congestive heart failure,2,0,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O,direct
Pomalyst,myocardial infarction,1,0,NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O,direct
Pitavastatin Calcium,hypertension,11,0,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
PROCHLORPERAZINE,mental retardation,993,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Fycompa,partial-onset seizures,1106,1,O=C1N(C=C(C=C1C1=CC=CC=C1C#N)C1=NC=CC=C1)C1=CC=CC=C1,direct
ESOMEPRAZOLE STRONTIUM,hypersensitivity,313,1,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Granisetron Hydrochloride,renal failure,19,0,CN1N=C(C(=O)N[C@@H]2C[C@@H]3CCC[C@H](C2)N3C)C2=C1C=CC=C2,direct
ProAir Digihaler,cancer (localized),8,0,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
SPIRONOLACTONE,primary hyperaldosteronism,1174,1,[H][C@@]12CC[C@@]3(CCC(=O)O3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@]([H])(CC2=CC(=O)CC[C@]12C)SC(C)=O,direct
Xanax XR,anorexia,399,1,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,direct
Erlotinib,nsclc whose tumors,1069,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
hydrocodone bitartrate and acetaminophen,chronic overdose,698,1,CC(=O)NC1=CC=C(O)C=C1,direct
Deferasirox,deferasirox granules,762,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
METHYLPHENIDATE HYDROCHLORIDE,psychosis,31,1,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
Delzicol,anemia,13,0,NC1=CC(C(O)=O)=C(O)C=C1,direct
Diltiazem hydrochloride,impaired ventricular function,921,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Deferoxamine,chronic anemia,683,1,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
CHLORDIAZEPOXIDE HCL AND CLIDINIUM BROMIDE,renal failure,19,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
IYUZEH,renal failure,19,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
DOBUTAMINE HYDROCHLORIDE,hypersensitivity,313,1,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
"butalbital, aspirin, and caffeine",asthma,12,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Ifosfamide,hypertension,11,0,ClCCNP1(=O)OCCCN1CCCl,direct
OLANZAPINE,diabetes mellitus,5,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
ERLOTINIB HYDROCHLORIDE,hypertension,11,0,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
Levsin,autoimmune disease,15,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE),hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
tramadol hydrochloride,asthma,193,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Amlodipine besylate and Olmesartan medoxomil,kidney failure,373,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
ketorolac tromethamine,liver cirrhosis,4,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
Omlonti,glaucoma,481,1,CC(C)OC(=O)CNC1=CC=CC(CN(CC2=CC=C(C=C2)N2C=CC=N2)S(=O)(=O)C2=CC=CN=C2)=N1,direct
PredniSONE,severe infection,18,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
LIDO BDK,chronic obstructive pulmonary disease (COPD),6,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Irinotecan Hydrochloride 40 mg/2 mL,hypersensitivity,313,1,CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12,direct
Pioglitazone,cancer (metastatic),9,0,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,direct
ONDANSETRON,congestive heart failure,2,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
lansoprazole,stroke,7,0,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Edaravone,hypersensitivity,313,1,CC1=NN(C(=O)C1)C1=CC=CC=C1,direct
Travoprost Ophthalmic Solution,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Dicyclomine HCl,hypertension,11,0,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,direct
ATAZANAVIR,cancer (localized),8,0,COC(=O)N[C@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@@H](O)CN(CC1=CC=C(C=C1)C1=CC=CC=N1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C,direct
Rifadin IV,severe infection,18,0,CO[C@H]1\C=C\O[C@@]2(C)OC3=C(C2=O)C2=C(O)C(\C=N\N4CCN(C)CC4)=C(NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C(O)=C2C(O)=C3C,direct
K-Phos No. 2,elevated urinary ph,790,1,[K+].OP(O)([O-])=O,direct
itraconazole,pregnancy,16,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Escitalopram,hypersensitivity,313,1,CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
Mepivacaine Hydrochloride,renal failure,19,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
"Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral",chronic kidney disease,3,0,[Mg++].[O-]S([O-])(=O)=O,direct
Theo-24,anemia,13,0,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Estring,breast cancer,263,1,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Lopid,significantly elevated triglycerides,1260,1,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,direct
DALFAMPRIDINE,chronic kidney disease,3,0,NC1=CC=NC=C1,direct
ALTAFLUOR,congestive heart failure,2,0,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
Epitol,diabetes mellitus,5,0,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
ADAPALENE AND BENZOYL PEROXIDE,stroke,7,0,COC1=C(C=C(C=C1)C1=CC2=C(C=C1)C=C(C=C2)C(O)=O)C12CC3CC(CC(C3)C1)C2,direct
Glipizide,non-insulin-dependent diabetes,1045,1,CC1=NC=C(N=C1)C(=O)NCCC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC1CCCCC1,direct
Amcinonide,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12C[C@H]3OC4(CCCC4)O[C@@]3(C(=O)COC(C)=O)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
EPIFOAM,liver cirrhosis,4,0,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Gloperba,cancer (metastatic),9,0,COC1=CC2=C(C(OC)=C1OC)C1=CC=C(OC)C(=O)C=C1[C@H](CC2)NC(C)=O,direct
Dorzolamide Hydrochloride and Timolol Maleate ophthalmic Solution,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Arsenic Trioxide,hypersensitivity to arsenic,883,1,O=[As]O[As]=O,direct
Multiple Electrolytes pH 7.4,anemia,13,0,[Cl-].[K+],direct
Phenergan,liver disease (non-cirrhotic),20,0,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Methocarbamol and Aspirin,cancer (localized),8,0,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
Tizanidine HCl,sepsis,17,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
Quinapril and Hydrochlorothiazide,impaired liver function,918,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Tizanidne hydrochloride,pregnancy,16,0,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,direct
PANTOPRAZOLE SODIUM I.V.,autoimmune disease,15,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
ICOSAPENT ETHYL,congestive heart failure,2,0,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Paroxetine,AIDS,10,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Finasteride,hypertension,11,0,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,direct
fluphenazine hydrochloride,severe infection,18,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Doxycycline,hypertension,11,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
SOMATULINE DEPOT,anemia,13,0,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],direct
Dorzolamide HCl,chronic obstructive pulmonary disease (COPD),6,0,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
Retisert,uveitis,491,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
ConZip,anemia,13,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
KENGREAL,diabetes mellitus,5,0,CSCCNC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC(SCCC(F)(F)F)=N1,direct
pregabalin,severe infection,18,0,CC(C)C[C@H](CN)CC(O)=O,direct
Diclona,myocardial infarction,1,0,CCCCOC1=CC=C(C=C1)C(=O)CCN1CCCCC1,fuzzy:diclonina
Tramadol Hydrochloride,congestive heart failure,2,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
XELSTRYM,asthma,12,0,C[C@H](N)CC1=CC=CC=C1,direct
AZASITE,mental illness,14,0,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O,direct
haloperidol decanoate,cancer (localized),8,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
ALBUTEROL SULFATE,hypersensitivity,313,1,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Citalopram,depressive symptoms,769,1,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
Multiple Electrolytes pH 5.5,liver disease (non-cirrhotic),20,0,[Cl-].[K+],direct
omeprazole sodium bicarbonate,hypertension,11,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Nitroglycerin In Dextrose,AIDS,10,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Ibuprofen,renal failure,19,0,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
HYZAAR,chronic obstructive pulmonary disease (COPD),6,0,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
Sitagliptin and metformin hydrochloride,sepsis,17,0,CN(C)C(=N)NC(N)=N,fuzzy:saxagliptin and metformin hydrochloride
PERCOCET,acute abdominal conditions,537,1,CC(=O)NC1=CC=C(O)C=C1,direct
Alkindi Sprinkle,cancer (localized),8,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
THAM,myocardial infarction,1,0,NC(CO)(CO)CO,direct
"Butalbita,Acetaminophen and Caffeine",stroke,7,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Provigil,renal failure,19,0,NC(=O)CS(=O)C(C1=CC=CC=C1)C1=CC=CC=C1,direct
DOXIL,liver cirrhosis,4,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
JARDIANCE,cancer (metastatic),9,0,OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C1,direct
ELCYS,hypersensitivity,313,1,N[C@@H](CS)C(O)=O,direct
Paclitaxel,solid tumors who,1266,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Levetiracetam,congestive heart failure,2,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
Tolmetin Sodium,congestive heart failure,2,0,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,direct
CISplatin,renal failure,19,0,[H][N]([H])([H])[Pt](Cl)(Cl)[N]([H])([H])[H],direct
"LIDOCAINE HYDROCHLORIDE, HYDROCORTISONE ACETATE",liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
RADICAVA,asthma,12,0,CC1=NN(C(=O)C1)C1=CC=CC=C1,direct
Nitrofurantoin Monohydrate/Macrocrystal,liver disease (non-cirrhotic),20,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
DOXORUBICIN HYDROCHLORIDE,liver disease (non-cirrhotic),20,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O,direct
Lioresal (baclofen),chronic obstructive pulmonary disease (COPD),6,0,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
ONDANSETRON,tics,23,1,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Namenda,congestive heart failure,2,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Tricor,renal failure,19,0,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,direct
Cabergoline,hypersensitivity,313,1,[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@H](CN2CC=C)C(=O)N(CCCN(C)C)C(=O)NCC,direct
Indomethacin,autoimmune disease,15,0,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,direct
nicardipine hydrochloride,aortic stenosis,55,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
LURASIDONE HYDROCHLORIDE,asthma,12,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Quflora Pediatric,stroke,7,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
"Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride",severe renal impairment,1253,1,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
Paclitaxel protein-bound particles,liver cirrhosis,4,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Brimonidine tartrate and Timolol maleate,chronic obstructive pulmonary disease (COPD),6,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Cefuroxime axetil,stroke,7,0,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,direct
METOLAZONE,hypertension,39,1,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,direct
Clobetasol Propionate ANDA,anemia,13,0,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Dorzolamide Hydrochloride and Timolol Maleate ophthalmic,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
MARINOL,hypersensitivity,313,1,[H][C@@]12C=C(C)CC[C@@]1([H])C(C)(C)OC1=C2C(O)=CC(CCCCC)=C1,direct
SODIUM PHENYLACETATE and SODIUM BENZOATE,otc and cps,1083,1,OC(=O)C1=CC=CC=C1,direct
Abiraterone acetate,autoimmune disease,15,0,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
Hydrocodone Bitartrate And Acetaminophen,cancer (metastatic),9,0,CC(=O)NC1=CC=C(O)C=C1,direct
Levbid,cancer (localized),8,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Nadolol,tics,23,1,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,direct
SUPRANE,hypertension,11,0,FC(F)OC(F)C(F)(F)F,direct
XELJANZ,lung disease,375,1,C[C@@H]1CCN(C[C@@H]1N(C)C1=NC=NC2=C1C=CN2)C(=O)CC#N,direct
CARNITOR,cancer (metastatic),9,0,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
Trifluoperazine Hydrochloride,cancer (metastatic),9,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
EMSAM,autoimmune disease,15,0,C[C@H](CC1=CC=CC=C1)N(C)CC#C,direct
Doxycycline hyclate,liver disease (non-cirrhotic),20,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Carafate,asthma,12,0,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,direct
Mulpleta,hypertension,11,0,CCCCCCO[C@@H](C)C1=C(OC)C(=CC=C1)C1=CSC(NC(=O)C2=CC(Cl)=C(\C=C(/C)C(O)=O)C(Cl)=C2)=N1,direct
ISTODAX,AIDS,10,0,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,direct
Neo-Synalar,hypersensitivity,313,1,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
Travatan Z,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
hydrocortisone acetate pramoxine HCl,hypersensitivity,313,1,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,direct
Procainamide Hydrochloride,liver cirrhosis,4,0,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,direct
Indium In 111 Oxyquinoline,mental illness,14,0,[111In+3].[O-]C1=CC=CC2=C1N=CC=C2.[O-]C1=CC=CC2=C1N=CC=C2.[O-]C1=CC=CC2=C1N=CC=C2,direct
Ursodiol 200 mg,such stones,1278,1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CCC(O)=O,direct
Dabigatran etexilate,asthma,12,0,CCCCCCOC(=O)\N=C(\N)C1=CC=C(NCC2=NC3=C(C=CC(=C3)C(=O)N(CCC(=O)OCC)C3=NC=CC=C3)N2C)C=C1,direct
Lescol XL,heart disease,377,1,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,direct
Caldolor,anemia,81,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
TARGADOX,diabetes mellitus,5,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Midazolam hydrochloride,acute narrow-angle glaucoma,546,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Dobutamine Hydrochloride in Dextrose,sepsis,17,0,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
TEMODAR,hypersensitivity,313,1,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
Halaven,AIDS,10,0,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@H]7O[C@@]8(C[C@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,direct
Ultramicrosize Griseofulvin,pregnancy,16,0,COC1=CC(OC)=C(Cl)C2=C1C(=O)[C@]1(O2)[C@H](C)CC(=O)C=C1OC,direct
gemcitabine,congestive heart failure,2,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
NYSTATIN,hypersensitivity,313,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
PrednisoLONE,cerebral malaria,674,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Solu-Cortef,congestive heart failure,2,0,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
candesartan cilexetil and hydrochlorothiazide,such a history,1277,1,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1,direct
Diazoxide,compromised cardiac reserve,738,1,CC1=NS(=O)(=O)C2=C(N1)C=CC(Cl)=C2,direct
Aridol Bronchial Challenge Test Kit,bronchospasm,197,1,OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,direct
KLOR-Con/EF,hyperkalemia,131,1,[K+].OC([O-])=O,direct
Vitafol Fe Plus,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Nitrofurantoin Monohydrate/Macrocrystal,liver cirrhosis,4,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
HYDROXYCHLOROQUINE SULFATE,diabetes mellitus,5,0,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
Nystop,hypersensitivity,313,1,[H][C@]12C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\C=C\C=C\C=C\C=C\CC\C=C\C=C\[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]1C(O)=O)O2,direct
Rocaltrol,AIDS,10,0,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,direct
DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE,myocardial infarction,49,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
"Adenosine Injection, 6mg/2mL (3mg/mL) Vial",asthma,193,1,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
Fosinopril Sodium and Hydrochlorothiazide,hypersensitivity,313,1,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,direct
Hydrocodone Bitartrate and Acetaminophen,liver cirrhosis,4,0,CC(=O)NC1=CC=C(O)C=C1,direct
Mycozyl HC,hypersensitivity,313,1,CN(C(=S)OC1=CC2=CC=CC=C2C=C1)C1=CC=CC(C)=C1,direct
OZURDEX,severe infection,18,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
CERIANNA,breast cancer,263,1,[H][C@@]12C[C@@H]([18F])[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
bisoprolol fumarate and hydrochlorothiazide,renal failure,19,0,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,direct
pyridostigmine bromide,asthma,193,1,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
DIGOXIN,chronic atrial fibrillation,685,1,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,direct
Isosorbide dinitrate and hydralazine hydrochloride,hypotension,75,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
Plasma-Lyte A,chronic kidney disease,3,0,[Cl-].[K+],direct
foscarnet sodium,diabetes mellitus,5,0,OC(=O)P(O)(O)=O,direct
PANTOPRAZOLE SODIUM I.V.,AIDS,10,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,direct
plerixafor,insomnia,441,1,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed release,cancer (metastatic),9,0,COC1=C(OC)C(CS(=O)C2=NC3=C(N2)C=C(OC(F)F)C=C3)=NC=C1,fuzzy:pantoprazole sodium delayed-release delayed-release
Omeprazole/Sodium Bicarbonate,diabetes mellitus,5,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
INLYTA,renal failure,19,0,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,direct
OXCARBAZEPINE,urinary tract infection,249,1,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,direct
VALSARTAN,diabetes mellitus,5,0,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,direct
Prochlorperazine,sepsis,17,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Paclitaxel,liver disease (non-cirrhotic),20,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
CYCLOSPORINE,chronic obstructive pulmonary disease (COPD),6,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Doxepin hydrochloride,sepsis,17,0,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
PRIALT,hypersensitivity,313,1,[H][C@]12CSSC[C@]3([H])NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@]([H])(NC(=O)[C@]([H])(CSSC[C@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC1=O)C(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC3=O)C(=O)N[C@@]([H])([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N2,direct
Imbruvica,neutropenia,85,1,NC1=NC=NC2=C1C(=NN2[C@@H]1CCCN(C1)C(=O)C=C)C1=CC=C(OC2=CC=CC=C2)C=C1,direct
ZIOPTAN,liver cirrhosis,4,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
Butalbital/Acetaminophen/Caffeine,hypersensitivity,313,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Cetirizine Hydrochloride Oral Solution,anemia,13,0,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Potassium Chloride in Dextrose and Sodium Chloride,asthma,12,0,[Cl-].[K+],direct
CLORAZEPATE DIPOTASSIUM,hypersensitivity,313,1,OC(=O)C1N=C(C2=CC=CC=C2)C2=C(NC1=O)C=CC(Cl)=C2,direct
Hyoscyamine Sulfate,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
KOURZEQ,mental illness,14,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
ketorolac tromethamine,the aspirin triad,1295,1,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
itraconazole,renal failure,19,0,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@H]2CO[C@@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Dimethyl Fumarate,cancer (metastatic),9,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
"Brimonidine Tartrate ophthalmic solution, 0.15%",cancer (localized),8,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
Fluticasone Propionate and Salmeterol,AIDS,10,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Meropenem,stroke,7,0,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
Candesartan Cilexetil and Hydrochlorothiazide,such a history,1277,1,CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=CC=C2)C(=O)OC(C)OC(=O)OC1CCCCC1,direct
Enalapril maleate and hydrochlorothiazide,cancer (metastatic),9,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
CEFAZOLIN,pregnancy,16,0,[H][C@]12SCC(CSC3=NN=C(C)S3)=C(N1C(=O)[C@H]2NC(=O)CN1C=NN=N1)C(O)=O,direct
"PredniSONE Tablets, USP, 5 mg",cancer (metastatic),9,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)CC(=O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Dasatinib,liver cirrhosis,4,0,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
SUTENT,myocardial infarction,1,0,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,direct
nitroglycerin,autoimmune disease,15,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Dicyclomine HCl,prostatic hypertrophy cardiovascular,1184,1,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,direct
IMIQUIMOD,myocardial infarction,1,0,CC(C)CN1C=NC2=C1C1=C(C=CC=C1)N=C2N,direct
ETHOSUXIMIDE,cancer (localized),8,0,CCC1(C)CC(=O)NC1=O,direct
Methylprednisolone,severe infection,18,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Sotalol,arrhythmia,43,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Qsymia,another condition,600,1,CC(C)(N)CC1=CC=CC=C1,direct
Sitagliptin and Metformin Hydrochloride,pancreatitis,233,1,CN(C)C(=N)NC(N)=N,fuzzy:saxagliptin and metformin hydrochloride
NATEGLINIDE,cancer (metastatic),9,0,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,direct
Integra F,hypertension,11,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Moexipril Hydrochloride,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O,direct
Vivacaine,cancer (localized),8,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Triloan II SUIK,active tuberculosis,535,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
POTASSIUM CITRATE EXTENDED RELEASE,peptic ulcer disease,219,1,[K+].[K+].[K+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O,direct
Talzenna,mental illness,14,0,CN1N=CN=C1[C@@H]1[C@H](NC2=C3C1=NNC(=O)C3=CC(F)=C2)C1=CC=C(F)C=C1,direct
Tramadol Hydrochloride Extended-Release,hypertension,11,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Ondansetron Hydrochloride,pregnancy,16,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE HALF STRENGTH,pregnancy,16,0,[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,fuzzy:esterified estrogens and methyltestosterone half-strength
QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE,chronic obstructive pulmonary disease (COPD),6,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Vimpat,chronic obstructive pulmonary disease (COPD),6,0,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
Triamterene and Hydrochlorothiazide,impaired renal function,919,1,NC1=NC(N)=C2N=C(C(N)=NC2=N1)C1=CC=CC=C1,direct
Eszopiclone,chronic obstructive pulmonary disease (COPD),6,0,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=NC=C(Cl)C=C1,direct
MUPIROCIN,myocardial infarction,1,0,C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O,direct
Alclometasone dipropionate,anemia,13,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])[C@H](Cl)CC2=CC(=O)C=C[C@]12C,direct
Baclofen,hypertension,11,0,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,direct
ELIXOPHYLLIN,hypertension,11,0,CN1C2=C(NC=N2)C(=O)N(C)C1=O,direct
Montelukast sodium,hypersensitivity,313,1,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
Fluticasone Propionate,liver cirrhosis,4,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
leflunomide,stroke,7,0,CC1=C(C=NO1)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
DILTIAZEM HYDROCHLORIDE,ventricular tachycardia,1357,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
DermacinRx Purefoltin,hypersensitivity,313,1,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Quinapril HCL and Hydrochlorothiazide,cancer (metastatic),9,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
VELCADE,mantle cell lymphoma,983,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
DILTIAZEM HYDROCHLORIDE in SODIUM CHLORIDE,stroke,7,0,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,fuzzy:esmolol hydrochloride in sodium chloride
Hydrocortisone Cream,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Monoferric,anemia,81,1,[Fe+3].OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O,direct
PROPRANOLOL,bradycardia,45,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
PRAVASTATIN SODIUM,renal failure,19,0,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
Qbrelis,chronic kidney disease,3,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
CORDRAN,pregnancy,16,0,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,direct
Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution,bone marrow depression,637,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
Hydrocortisone,severe infection,18,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Allopurinol,hypersensitivity,313,1,OC1=NC=NC2=C1C=NN2,direct
Omeprazole/Bicarbonate,hypertension,11,0,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
AcetaZOLAMIDE,autoimmune disease,15,0,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
Oseltamivir Phosphate for Oral Suspension,congestive heart failure,2,0,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,direct
Citanest Forte DENTAL,tics,23,1,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Aminocaproic Acid,renal failure,257,1,NCCCCCC(O)=O,direct
Montelukast sodium,cancer (metastatic),9,0,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,direct
XARELTO,myocardial infarction,1,0,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,direct
NeuLumEX,autoimmune disease,15,0,[Ba++].[O-]S([O-])(=O)=O,direct
Fluorescein Sodium and Benoxinate Hydrochloride,hypertension,11,0,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
epinephrine,AIDS,10,0,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Diltiazem HCl CD,renal failure,19,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
BUSULFAN,hypertension,11,0,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
VAFSEO,liver disease (non-cirrhotic),20,0,OC(=O)CNC(=O)C1=C(O)C=C(C=N1)C1=CC(Cl)=CC=C1,direct
LATANOPROST,hypertension,39,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCC1=CC=CC=C1,direct
Stivarga,post-baseline samples which,1144,1,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,direct
diltiazem hydrochloride,hypersensitivity,313,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Aspirin and Extended-Release Dipyridamole,autoimmune disease,15,0,CC(=O)OC1=CC=CC=C1C(O)=O,direct
Methylphenidate Hydrochloride,pregnancy,16,0,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
Isosorbide Mononitrate,congestive heart failure,41,1,[H][C@]12OC[C@@H](O[N+]([O-])=O)[C@@]1([H])OC[C@@H]2O,direct
Gadavist,cancer (localized),8,0,OC[C@H](O)[C@H](CO)[N+]12CC[N+]3(CC([O-])=O)CC[N+]4(CC([O-])=O)CC[N+](CC([O-])=O)(CC1)[Gd-]234,direct
Tramadol Hydrochloride,renal failure,19,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
ZAVZPRET,autoimmune disease,15,0,CN1CCC(CC1)N1CCN(CC1)C(=O)[C@@H](CC1=CC2=C(NN=C2)C(C)=C1)NC(=O)N1CCC(CC1)C1=CC2=C(NC1=O)C=CC=C2,direct
Esomeprazole DR,hypersensitivity,313,1,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Ketorocaine L Kit,the aspirin triad,1295,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
fulvestrant,cancer (metastatic),9,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=CC=C(O)C=C3C[C@@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)[C@@]21[H],direct
Loperamide hydrochloride,hypertension,11,0,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,direct
LACOSAMIDE,partial-onset seizures who,1108,1,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,direct
Metoprolol tartrate,pregnancy,16,0,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,direct
REGIOCIT,chronic kidney disease,3,0,[Na+].[Cl-],direct
emtricitabine,liver disease (non-cirrhotic),20,0,NC1=NC(=O)N(C=C1F)[C@@H]1CS[C@H](CO)O1,direct
esomeprazole,AIDS,10,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Chlorpromazine Hydrochloride,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
Glucagon,cancer (metastatic),9,0,O,direct
Signifor LAR,diabetes mellitus,111,1,NCCCC[C@@H]1NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@@H](NC(=O)[C@@H]2C[C@H](CN2C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC2=CC=C(OCC3=CC=CC=C3)C=C2)NC1=O)OC(=O)NCCN)C1=CC=CC=C1,direct
Nateglinide,hypersensitivity,313,1,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,direct
Octreotide,liver cirrhosis,4,0,C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=CC=CC=C23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1,fuzzy:edotreotide
Vancomycin hydrochloride,hypersensitivity,313,1,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(N)[C@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
Levoleucovorin Calcium,stroke,7,0,NC1=NC(=O)C2=C(NC[C@H](CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N2C=O)N1,direct
FLOLAN,congestive heart failure,2,0,[H][C@]12C[C@@H](O)[C@H](\C=C\[C@@H](O)CCCCC)[C@@]1([H])C\C(O2)=C\CCCC(O)=O,direct
VERAPAMIL HYDROCHLORIDE,chronic obstructive pulmonary disease (COPD),6,0,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,direct
BRINZOLAMIDE,asthma,12,0,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
carbamazepine,symptomatic hyponatremia,1286,1,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C12,direct
fluphenazine decanoate,mental retardation,993,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
CardioGen-82,chronic kidney disease,3,0,[82Rb+],direct
ORSERDU,stroke,7,0,CCNCCC1=CC=C(CN(CC)C2=C(C=CC(OC)=C2)[C@@H]2CCC3=CC(O)=CC=C3C2)C=C1,direct
ALENDRONATE SODIUM,the following conditions,1301,1,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Nulibry,sepsis,17,0,[H][C@@]12COP(O)(=O)O[C@]1([H])C(O)(O)[C@]1([H])NC3=C(NC(N)=NC3=O)N[C@]1([H])O2,direct
Ropivacaine hydrochloride,hypertension,11,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
Bortezomib,insomnia,441,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Pravastatin sodium,anemia,13,0,[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC,direct
PROCHLORPERAZINE,previous brain damage,1166,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Docetaxel,stroke,7,0,[H][C@@]1(C[C@@]2(O)[C@@H](OC(=O)C3=CC=CC=C3)[C@]3([H])[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C(=O)[C@H](O)C(=C1C)C2(C)C)OC(C)=O)OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C1=CC=CC=C1,direct
ISTODAX,lymphoma,269,1,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,direct
SIMBRINZA,hypertension,11,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
PROCHLORPERAZINE MALEATE,diabetes mellitus,5,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Nilandron,hepatic impairment,1,1,CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,direct
PENICILLIN G POTASSIUM,impaired renal function,919,1,[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1)C(O)=O,direct
Cardizem,hypotension,75,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
VARENICLINE,hypersensitivity,313,1,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
Scandonest 3% Plain,hypersensitivity,313,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Humira,mental illness,14,0,CC(C)O,direct
Chlordiazepoxide Hydrochloride and Clidinium Bromide,chronic obstructive pulmonary disease (COPD),6,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Sotalol hydrochloride,ventricular arrhythmias,1354,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Ibutilide Fumarate,sepsis,17,0,CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
YUPELRI,cancer (metastatic),9,0,CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1,direct
Vasotec,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
Tramadol Hydrochloride and Acetaminophen,myocardial infarction,1,0,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
RISPERIDONE,hypersensitivity,313,1,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,direct
FEBUXOSTAT,gout who,842,1,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
Diflucan,chronic kidney disease,3,0,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
Livita Adults,stroke,7,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Nitrofurantoin Monohydrate/ Macrocrystalline,stroke,7,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
SUNITINIB MALATE,stroke,7,0,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,direct
Diltiazem Hydrochloride Extended-Release,hypotension,75,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Bupropion hydrochloride,cancer (localized),8,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Chlorpromazine,anemia,13,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
benazepril hydrochloride and hydrochlorothiazide,asthma,193,1,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,direct
Memantine Hydrochloride,stroke,7,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Caffeine Citrate,renal failure,19,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
amiloride hydrochloride,hyperkalemia,131,1,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
"Omeprazole, Sodium bicarbonate",hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Butalbital And Acetaminophen,chronic obstructive pulmonary disease (COPD),6,0,CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O,direct
RELAFEN DS,the aspirin triad,1295,1,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
Rinvoq,ulcerative colitis rinvoq,1335,1,CC[C@@H]1CN(C[C@@H]1C1=CN=C2C=NC3=C(C=CN3)N12)C(=O)NCC(F)(F)F,direct
CitraNatal Harmony 3.0,myocardial infarction,1,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Bactrim,pneumonia,201,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
"Adenosine Injection, 6mg/2mL (3mg/mL) Vial",cancer (localized),8,0,NC1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1,direct
Hydroxyzine hydrochloride,anemia,13,0,OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Zolpidem Tartrate,chronic insomnia who,690,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
SILVER SULFADIAZINE,AIDS,10,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
Bortezomib,multiple myeloma,1024,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
TAZICEF,severe infection,18,0,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
Prenate Pixie,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Sunitinib Malate,liver cirrhosis,4,0,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,direct
Dexamethasone Sodium Phosphate,a stressed myocardium,508,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Amiloride Hydrochloride,hyperkalemia,131,1,NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N,direct
DermacinRx Purefoltin,diabetes mellitus,5,0,NC1=NC(=O)C2=NC(CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN=C2N1,direct
Ammonul,liver disease (non-cirrhotic),20,0,OC(=O)C1=CC=CC=C1,direct
Librax,asthma,12,0,CNC1=NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=[N+]([O-])C1,direct
Silver Sulfadiazine,liver cirrhosis,4,0,[Ag+].NC1=CC=C(C=C1)S(=O)(=O)[N-]C1=NC=CC=N1,direct
MAGNESIUM SULFATE,heart block,59,1,[Mg++].[O-]S([O-])(=O)=O,direct
Tetracaine Hydrochloride,mental illness,14,0,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,direct
Buprenorphine Hydrochloride,gastrointestinal conditions buprenorphine,824,1,CO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]1CC4=C5C(O[C@@H]2[C@@]35CCN1CC1CC1)=C(O)C=C4,direct
Toronova II SUIK,hypersensitivity,313,1,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
PROCHLORPERAZINE MALEATE,previous brain damage,1166,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE),hypersensitivity,313,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Pemetrexed,chronic obstructive pulmonary disease (COPD),6,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
Exjade,poor performance status,1139,1,OC(=O)C1=CC=C(C=C1)N1N=C(N=C1C1=CC=CC=C1O)C1=CC=CC=C1O,direct
Alinia,hypersensitivity,313,1,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,direct
icosapent ethyl,mental illness,14,0,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Testosterone Cypionate,uncontrolled hypertension,1337,1,[H][C@@]12CC[C@H](OC(=O)CCC3CCCC3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Myoview,liver cirrhosis,4,0,CCOCCP(CCOCC)CCP(CCOCC)CCOCC,direct
Atomoxetine Hydrochloride,narrow angle glaucoma,1029,1,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,direct
NICARDIPINE HYDROCHLORIDE,severe infection,18,0,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,direct
Triamterene and Hydrochlorothiazide,sepsis,17,0,NC1=NC(N)=C2N=C(C(N)=NC2=N1)C1=CC=CC=C1,direct
epinephrine,liver cirrhosis,4,0,CNC[C@H](O)C1=CC(O)=C(O)C=C1,direct
Lurasidone Hydrochloride,depression,27,1,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
CORTEF,tuberculosis,213,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
LACTATED RINGERS,diabetes mellitus,5,0,[Cl-].[K+],direct
Foscarnet Sodium,hypersensitivity,313,1,OC(=O)P(O)(O)=O,direct
Memantine HCL,AIDS,10,0,CC12CC3CC(C)(C1)CC(N)(C3)C2,direct
Bupropion hydrochloride,depressive symptoms,769,1,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Sofosbuvir and Velpatasvir,diabetes mellitus,5,0,CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](N2C=CC(=O)NC2=O)[C@](C)(F)[C@@H]1O)OC1=CC=CC=C1,direct
RECARBRIO,ventilated habp,1352,1,CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O,direct
MINOXIDIL,hypersensitivity,313,1,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1,direct
SODIUM ACETATE,severe infection,18,0,[Na+].CC([O-])=O,direct
HYOSCYAMINE SULFATE,hypertension,11,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Glipizide and Metformin Hydrochloride,liver cirrhosis,4,0,CN(C)C(=N)NC(N)=N,direct
Methylprednisolone Sodium Succinate,diabetes mellitus,5,0,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
HYDROCORTISONE VALERATE,hypersensitivity,313,1,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Donepezil Hydrochloride,diabetes mellitus,5,0,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
Sulfamethoxazole and Trimethoprim DS,pneumonia,201,1,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Propranolol Hydrochloride ER,angina pectoris,596,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
TriStart DHA,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Brimonidine tartrate and Timolol maleate,sepsis,17,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Conray,congenital cardiac conditions,747,1,CNC(=O)C1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND,neutropenia,85,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
teriflunomide,chronic kidney disease,3,0,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
HYALURONIDASE,anemia,13,0,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,direct
Prochlorperazine,stroke,7,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Cefdinir,chronic kidney disease,3,0,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,direct
Sular,angina this,598,1,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC=C1[N+]([O-])=O)C(=O)OCC(C)C,direct
Quazepam,hypertension,11,0,FC1=CC=CC=C1C1=NCC(=S)N(CC(F)(F)F)C2=C1C=C(Cl)C=C2,direct
ENDOCET,gastrointestinal conditions endocet,825,1,CC(=O)NC1=CC=C(O)C=C1,direct
PROCHLORPERAZINE EDISYLATE,hypersensitivity,313,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
TIMOLOL MALEATE,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Foscarnet,hypersensitivity,313,1,OC(=O)P(O)(O)=O,direct
DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Isosorbide Dinitrate,myocardial infarction,49,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
Cefotan,chronic obstructive pulmonary disease (COPD),6,0,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)OC)C(O)=O,direct
SENSORCAINE(R) (BUPIVACAINE HCI AND EPINEPHRINE),stroke,7,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Azacitidine,pregnancy,16,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Hydroxychloroquine sulfate,diabetes mellitus,5,0,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
APREPITANT,diabetes mellitus,5,0,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,direct
Trifluoperazine Hydrochloride,mental illness,14,0,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
AMITRIPTYLINE HCL,cardiovascular disorders,669,1,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
RELAFEN DS,autoimmune disease,15,0,COC1=CC2=C(C=C1)C=C(CCC(C)=O)C=C2,direct
Doxepin HCL,depressive symptoms,769,1,[H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12,direct
Cetirizine Hydrochloride Oral Solution,chronic kidney disease,3,0,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Methadone Hydrochloride,seizure disorders methadone,1226,1,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,direct
SENSIPAR,these symptoms,1314,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Amlodipine besylate and Olmesartan medoxomil,stroke,51,1,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Mefenamic Acid,asthma,12,0,CC1=C(C)C(NC2=CC=CC=C2C(O)=O)=CC=C1,direct
Prochlorperazine,previous brain damage,1166,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
FABHALTA,cancer (metastatic),9,0,CCO[C@H]1CCN(CC2=C(OC)C=C(C)C3=C2C=CN3)[C@@H](C1)C1=CC=C(C=C1)C(O)=O,direct
KLOR-Con/EF,liver cirrhosis,4,0,[K+].OC([O-])=O,direct
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride and DextromethorphanHydrobromide",hypertension,39,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
APTENSIO XR,renal failure,19,0,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,direct
KETOROLAC TROMETHAMINE,pregnancy,16,0,OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1,direct
BRIMONIDINE TARTRATE,autoimmune disease,15,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
citalopram hydrobromide,severe infection,18,0,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,direct
Azulfidine,anemia,13,0,OC(=O)C1=CC(=CC=C1O)\N=N\C1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=C1,direct
Jentadueto,severe infection,18,0,CN(C)C(=N)NC(N)=N,direct
Rozlytrek,pediatric patients,13,1,CN1CCN(CC1)C1=CC=C(C(=O)NC2=NNC3=CC=C(CC4=CC(F)=CC(F)=C4)C=C23)C(NC2CCOCC2)=C1,direct
Daunorubicin Hydrochloride,AIDS,10,0,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(C)=O)C(O)=C1C2=O,direct
Fluphenazine Decanoate,anemia,13,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
Levsin,ileostomy or colostomy,910,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
PENCICLOVIR,mental illness,14,0,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,direct
ANCOBON,hypersensitivity,313,1,NC1=C(F)C=NC(=O)N1,direct
Hydroxychloroquine Sulfate,liver cirrhosis,4,0,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,direct
oxaliplatin,advanced colorectal cancer,560,1,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,direct
Fetroja,hypersensitivity,313,1,[H][C@]12SCC(C[N+]3(CCNC(=O)C4=C(Cl)C(O)=C(O)C=C4)CCCC3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC(N)=N1)C([O-])=O,direct
Lidocaine,diabetes mellitus,5,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
"Sodium Sulfate, Potassium Sulfate, and Magnesium Sulfate Bowel Prep kit",chronic kidney disease,3,0,[Mg++].[O-]S([O-])(=O)=O,"fuzzy:sodium sulfate, potassium sulfate and magnesium sulfate oral"
TAZICEF,liver cirrhosis,4,0,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
benazepril hydrochloride and hydrochlorothiazide,hypersensitivity,313,1,[H][C@@]1(CCC2=CC=CC=C2N(CC(O)=O)C1=O)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,direct
Tramadol Hydrochloride,depression,27,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Biltricide,ocular cysticercosis,1075,1,O=C(C1CCCCC1)N1CC2N(CCC3=CC=CC=C23)C(=O)C1,direct
Lidocort,hypersensitivity,313,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
TRIESENCE,systemic fungal infections,1292,1,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Vitrexate,mental illness,14,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
ACCOLATE,hepatic impairment,1,1,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,direct
CIDOFOVIR DIHYDRATE,severe infection,18,0,NC1=NC(=O)N(C[C@@H](CO)OCP(O)(O)=O)C=C1,direct
Heparin Sodium and Dextrose,hypertension,11,0,[H][C@@](O)(CO)[C@@]([H])(O)[C@]([H])(O)[C@@]([H])(O)C=O,fuzzy:heparin sodium in dextrose
MIDAZOLAM HYDROCHLORIDE,hemodynamic instability,852,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Clocortolone Pivalate,autoimmune disease,15,0,[H][C@@]12C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
Atenolol and Chlorthalidone,untreated pheochromocytoma,1345,1,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Fluphenazine Decanoate,renal failure,19,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
VARENICLINE TARTRATE,cancer (localized),8,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
TAVALISSE,chronic kidney disease,3,0,COC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC,direct
PROCHLORPERAZINE EDISYLATE,mental retardation,993,1,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
doxycycline,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Metopirone,chronic kidney disease,3,0,CC(C)(C(=O)C1=CN=CC=C1)C1=CC=CN=C1,direct
Melphalan Hydrochloride,cancer (localized),8,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
DEPO-MEDROL,cancer (metastatic),9,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Cefotetan,hemolytic anemia,107,1,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)OC)C(O)=O,direct
Amyvid,alzheimer's disease,35,1,[H]N(C1=C([H])C([H])=C(\C([H])=C(/[H])C2=C([H])N=C(OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])[18F])C([H])=C2[H])C([H])=C1[H])C([H])([H])[H],direct
VARENICLINE,mental illness,14,0,C1C2CNCC1C1=C2C=C2N=CC=NC2=C1,direct
BUSULFAN,pregnancy,16,0,CS(=O)(=O)OCCCCOS(C)(=O)=O,direct
Travoprost Ophthalmic,mental illness,14,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Paclitaxel protein-bound particles,cancer (localized),8,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
ibuprofen,the aspirin triad,1295,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
RISPERIDONE,stroke,7,0,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,direct
Glycate,ileostomy or colostomy,910,1,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
Carbidopa,hypersensitivity,313,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
TOBREX,hypertension,11,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
lurasidone hydrochloride,other indication,1090,1,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
DILTIAZEM HYDROCHLORIDE in SODIUM CHLORIDE,anemia,13,0,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,fuzzy:esmolol hydrochloride in sodium chloride
Beleodaq,pregnancy,16,0,ONC(=O)\C=C\C1=CC=CC(=C1)S(=O)(=O)NC1=CC=CC=C1,direct
Halaven,breast cancer,263,1,[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@H]7O[C@@]8(C[C@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2,direct
Zydelig,pregnancy,16,0,[H][C@@](CC)(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,direct
Keppra XR,sepsis,17,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
ROBAXIN,autoimmune disease,15,0,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
Celecoxib,post-surgical pain,1145,1,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
XYLOCAINE- MPF (LIDOCAINE HCl ),chronic obstructive pulmonary disease (COPD),6,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Granisetron hydrochloride,diabetes mellitus,5,0,CN1N=C(C(=O)N[C@@H]2C[C@@H]3CCC[C@H](C2)N3C)C2=C1C=CC=C2,direct
Ceftazidime,hypersensitivity,313,1,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
Pemfexy,chronic obstructive pulmonary disease (COPD),6,0,NC1=NC(=O)C2=C(NC=C2CCC2=CC=C(C=C2)C(=O)N[C@@H](CCC(O)=O)C(O)=O)N1,direct
ENTERO Vu 24%,the following conditions,1301,1,[Ba++].[O-]S([O-])(=O)=O,direct
Prenate Mini,cancer (metastatic),9,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Norgesic,myasthenia gravis,151,1,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Risperidone,cancer (localized),8,0,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,direct
Teflaro,congestive heart failure,2,0,[H][C@]12SCC(SC3=NC(=CS3)C3=CC=[N+](C)C=C3)=C(N1C(=O)[C@H]2NC(=O)C(=N/OCC)\C1=NSC(NP(O)(O)=O)=N1)C([O-])=O,direct
AMITRIPTYLINE HYDROCHLORIDE,autoimmune disease,15,0,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,direct
Ravicti,asthma,12,0,O=C(CCCC1=CC=CC=C1)OCC(COC(=O)CCCC1=CC=CC=C1)OC(=O)CCCC1=CC=CC=C1,direct
FLUVASTATIN SODIUM ER,liver disease (non-cirrhotic),20,0,CC(C)N1C(\C=C\C(O)CC(O)CC(O)=O)=C(C2=CC=CC=C12)C1=CC=C(F)C=C1,direct
Adalimumab,active psoriatic arthritis,533,1,CC(C)O,direct
lurasidone hydrochloride,anemia,13,0,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
methocarbamol,renal impairment,1211,1,COC1=C(OCC(O)COC(N)=O)C=CC=C1,direct
Gengraf,chronic plaque psoriasis,702,1,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Celontin,cancer (localized),8,0,CN1C(=O)CC(C)(C1=O)C1=CC=CC=C1,direct
Gleevec,ph- all who,1121,1,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)CC1,direct
Cefuroxime,pregnancy,16,0,[H][C@]12SCC(COC(N)=O)=C(N1C(=O)[C@H]2NC(=O)C(=N/OC)\C1=CC=CO1)C(O)=O,direct
Flucytosine,stroke,7,0,NC1=C(F)C=NC(=O)N1,direct
CARBOplatin,these outcomes,1313,1,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Zyprexa,cancer (localized),8,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Zoledronic Acid,liver disease (non-cirrhotic),20,0,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,direct
Nadolol,pregnancy,16,0,CC(C)(C)NCC(O)COC1=CC=CC2=C1C[C@H](O)[C@H](O)C2,direct
MELPHALAN HYDROCHLORIDE,anemia,13,0,N[C@@H](CC1=CC=C(C=C1)N(CCCl)CCCl)C(O)=O,direct
Famotidine,hypersensitivity,313,1,NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1,direct
Avalide,hypertension,11,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Deferoxamine,congestive heart failure,2,0,CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN,direct
ZIOPTAN,autoimmune disease,15,0,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\C(F)(F)COC1=CC=CC=C1,direct
SUNOSI,mental illness,14,0,N[C@@H](COC(N)=O)CC1=CC=CC=C1,direct
Reglan,hypersensitivity to metoclopramide,892,1,CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC,direct
Marlido Kit,liver cirrhosis,4,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
FLUORESCEIN,hypersensitivity,313,1,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
Talicia,hypersensitivity,313,1,COC1=CC2=C(C=C1)N=C(N2)S(=O)CC1=NC=C(C)C(OC)=C1C,direct
Regonol,cardiac dysrhythmias,667,1,CN(C)C(=O)OC1=C[N+](C)=CC=C1,direct
Solu-Medrol,asthma,12,0,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Dexamethasone,unexplained diarrhea,1341,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
LANSOPRAZOLE,chronic obstructive pulmonary disease (COPD),6,0,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,direct
Vitafol-OB Plus DHA Prenatal Supplement Plus DHA,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Brexpiprazole,severe infection,18,0,O=C1NC2=CC(OCCCCN3CCN(CC3)C3=C4C=CSC4=CC=C3)=CC=C2C=C1,direct
Gralise,myocardial infarction,1,0,NCC1(CC(O)=O)CCCCC1,direct
Oxycodone/APAP,anemia,13,0,CC(=O)NC1=CC=C(O)C=C1,direct
EUTHYROX,stroke,7,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
esomeprazole magnesium,autoimmune disease,15,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
"Brompheniramine Maleate, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide",coronary artery disease,37,1,[H][C@]12CCCC[C@]11CCN(C)[C@H]2CC2=C1C=C(OC)C=C2,direct
gemcitabine hydrochloride,sepsis,17,0,NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F,direct
Latuda,bipolar depression,632,1,[H][C@@]12[C@H]3CC[C@H](C3)[C@]1([H])C(=O)N(C[C@@H]1CCCC[C@H]1CN1CCN(CC1)C1=NSC3=CC=CC=C13)C2=O,direct
Tramadol HCL ER,osteoarthritis,161,1,COC1=CC=CC(=C1)C1(O)CCCCC1CN(C)C,direct
Cetirizine hydrochloride,myocardial infarction,1,0,OC(=O)COCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,direct
Carbocaine,tics,23,1,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
Nesina,stroke,7,0,CN1C(=O)C=C(N2CCC[C@@H](N)C2)N(CC2=C(C=CC=C2)C#N)C1=O,direct
Prednisolone Sodium Phosphate,asthma,12,0,[H][C@@]12CC[C@](O)(C(=O)COP(O)(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
"SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE",normal baseline who,1060,1,[Mg++].[O-]S([O-])(=O)=O,direct
Rosuvastatin Calcium,hypersensitivity,313,1,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Nitrofurantoin (monohydrate/macrocrystals),cancer (localized),8,0,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
Atovaquone and Proguanil HCl,liver disease (non-cirrhotic),20,0,OC1=C([C@H]2CC[C@@H](CC2)C2=CC=C(Cl)C=C2)C(=O)C2=CC=CC=C2C1=O,direct
VIDAZA,pregnancy,16,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
AcetaZOLAMIDE,chronic kidney disease,3,0,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,direct
Pretrate,hypertension,11,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
XURIDEN,hereditary orotic aciduria,859,1,CC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N1C=CC(=O)NC1=O,direct
MD GASTROVIEW,liver disease (non-cirrhotic),20,0,CC(=O)NC1=C(I)C(C(O)=O)=C(I)C(NC(C)=O)=C1I,direct
Alendronate,myocardial infarction,1,0,NCCCC(O)(P(O)(O)=O)P(O)(O)=O,direct
ERLOTINIB HYDROCHLORIDE,nsclc whose tumors,1069,1,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC(=CC=C1)C#C)=NC=N2,direct
INSADOL,asthma,193,1,[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C)[C@H](C)CC[C@@H](CC)C(C)C,direct
Diltiazem Hydrochloride EXTENDED RELEASE,chronic stable angina,705,1,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
AMPHETAMINE SULFATE,anemia,13,0,CC(N)CC1=CC=CC=C1,direct
Cyklokapron,active intravascular clotting,526,1,NC[C@H]1CC[C@@H](CC1)C(O)=O,direct
Travoprost Ophthalmic,glaucoma,481,1,CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)COC1=CC=CC(=C1)C(F)(F)F,direct
Icosapent,severe hypertriglyceridemia,1247,1,CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O,direct
DOXERCALCIFEROL,ckd on dialysis,713,1,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
Edluar,chronic insomnia who,690,1,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
Keppra,chronic kidney disease,3,0,CC[C@H](N1CCCC1=O)C(N)=O,direct
FloLipid,liver cirrhosis,4,0,[H][C@]12[C@H](C[C@@H](C)C=C1C=C[C@H](C)[C@@H]2CC[C@@H]1C[C@@H](O)CC(=O)O1)OC(=O)C(C)(C)CC,direct
CYCLOPHOSPHAMIDE,rapidly growing tumors,1197,1,ClCCN(CCCl)P1(=O)NCCCO1,direct
Fluphenazine Hydrochloride,sepsis,17,0,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,direct
"Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate",liver cirrhosis,4,0,[Mg++].[O-]S([O-])(=O)=O,direct
Irbesartan,uncomplicated hypertension,1336,1,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
Bupropion hydrochloride,asthma,12,0,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,direct
Carboplatin,AIDS,10,0,[H][N]([H])([H])[Pt]1(OC(=O)C2(CCC2)C(=O)O1)[N]([H])([H])[H],direct
Cardizem,autoimmune disease,15,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Paclitaxel,diabetes mellitus,5,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Sirolimus,lymphangioleiomyomatosis sirolimus,975,1,[H][C@@]1(C[C@@H](C)[C@]2([H])CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@]3([H])CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@@]3([H])C(=O)O2)OC)CC[C@@H](O)[C@@H](C1)OC,direct
DMT SUIK,diabetes mellitus,5,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Hyronan,congestive heart failure,2,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
PREDNISOLONE,severe infection,18,0,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Sotalol,ventricular arrhythmias,1354,1,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Sodium Acetate,hypernatremia,135,1,[Na+].CC([O-])=O,direct
febuxostat,sepsis,17,0,CC(C)COC1=C(C=C(C=C1)C1=NC(C)=C(S1)C(O)=O)C#N,direct
Lydexa 4.12%,stroke,7,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
ZAVZPRET,hypersensitivity,313,1,CN1CCC(CC1)N1CCN(CC1)C(=O)[C@@H](CC1=CC2=C(NN=C2)C(C)=C1)NC(=O)N1CCC(CC1)C1=CC2=C(NC1=O)C=CC=C2,direct
HYDROCODONE BITARTRATE AND ACETAMINOPHEN,chronic obstructive pulmonary disease (COPD),6,0,CC(=O)NC1=CC=C(O)C=C1,direct
Xalkori,chronic obstructive pulmonary disease (COPD),6,0,C[C@@H](OC1=CC(=CN=C1N)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,direct
DONEPEZIL HYDROCHLORIDE,hypersensitivity,313,1,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,direct
PROMETHAZINE HCI,stroke,7,0,CC(CN1C2=CC=CC=C2SC2=CC=CC=C12)N(C)C,direct
Pain Relieving Patch,myocardial infarction,1,0,CC(C)C1CCC(C)CC1O,direct
timolol maleate,glaucoma,481,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
DILTIAZEM HYDROCHLORIDE in SODIUM CHLORIDE,cancer (localized),8,0,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,fuzzy:esmolol hydrochloride in sodium chloride
Lydexa 4.12%,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Definity,chronic kidney disease,3,0,FC(F)(F)C(F)(F)C(F)(F)F,direct
Sulindac,myocardial infarction,1,0,CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(C=C1)S(C)=O,direct
Dobutamine in Dextrose,hypersensitivity,313,1,CC(CCC1=CC=C(O)C=C1)NCCC1=CC(O)=C(O)C=C1,direct
Glipizide and Metformin Hydrochloride,anemia,13,0,CN(C)C(=N)NC(N)=N,direct
Fludrocortisone Acetate,active tuberculosis,535,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Olopatadine Hydrochloride,hypertension,11,0,CN(C)CC\C=C1\C2=CC=CC=C2COC2=C1C=C(CC(O)=O)C=C2,direct
PROPRANOLOL,hypersensitivity,313,1,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,direct
Topiramate,severe infection,18,0,[H][C@@]12CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@@]3([H])[C@]1([H])OC(C)(C)O2,direct
Abiraterone,sepsis,17,0,[H][C@@]12CC=C(C3=CC=CN=C3)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC=C2C[C@@H](O)CC[C@]12C,direct
glycopyrrolate,AIDS,10,0,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,direct
NATEGLINIDE,liver disease (non-cirrhotic),20,0,CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O,direct
Fluocinonide,renal failure,19,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(C)=O,direct
Edluar,chronic obstructive pulmonary disease (COPD),6,0,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,direct
VIDAZA,sepsis,17,0,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
Zetonna,autoimmune disease,15,0,[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(O[C@@H](O2)C1CCCCC1)C(=O)COC(=O)C(C)C,direct
Unithroid,cancer (metastatic),9,0,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(O)=O,direct
Methylene Blue,pediatric patients,13,1,[Cl-].CN(C)C1=CC2=[S+]C3=C(C=CC(=C3)N(C)C)N=C2C=C1,direct
toremifene citrate,cancer (metastatic),9,0,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,direct
Cromolyn Sodium Inhalation Solution,asthma,193,1,OC(COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O)COC1=CC=CC2=C1C(=O)C=C(O2)C(O)=O,direct
Ciprofloxacin and dexamethasone,intact tympanic membranes,939,1,OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O,direct
Ultramicrosize Griseofulvin,hypersensitivity,313,1,COC1=CC(OC)=C(Cl)C2=C1C(=O)[C@]1(O2)[C@H](C)CC(=O)C=C1OC,direct
lamivudine,chronic obstructive pulmonary disease (COPD),6,0,NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1,direct
Sodium phenylacetate and Sodium benzoate,cancer (metastatic),9,0,OC(=O)C1=CC=CC=C1,direct
Methamphetamine Hydrochloride,comorbid depressive symptoms,735,1,CN[C@@H](C)CC1=CC=CC=C1,direct
calcipotriene,hypersensitivity,313,1,O[C@H](\C=C\[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)C1CC1,direct
dihydroergotamine mesylate,hypertension,39,1,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
Neoral,chronic obstructive pulmonary disease (COPD),6,0,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,direct
Nitroglycerin Transdermal Infusion System,myocardial infarction,1,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
LANREOTIDE ACETATE,autoimmune disease,15,0,[H]N([H])CCCCC1N([H])C(=O)C(CC2=CN([H])C3=CC=CC=C23)N([H])C(=O)C(CC2=CC=C(O)C=C2)N([H])C(=O)C(CSSCC(N([H])C(=O)C(N([H])C1=O)C(C)C)C(=O)N([H])C(C(C)O)C(=O)N([H])[H])N([H])C(=O)C(CC1=CC2=CC=CC=C2C=C1)N([H])[H],direct
QUINIDINE SULFATE,chronic obstructive pulmonary disease (COPD),6,0,[H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1,direct
Livalo,hyperlipidemia,143,1,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
Eohilia,hypersensitivity,313,1,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
MEXILETINE HYDROCHLORIDE,myocardial infarction,49,1,CC(N)COC1=C(C)C=CC=C1C,direct
Cosyntropin,hypersensitivity,313,1,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O,direct
XPOVIO,multiple myeloma who,1025,1,FC(F)(F)C1=CC(=CC(=C1)C1=NN(\C=C/C(=O)NNC2=NC=CN=C2)C=N1)C(F)(F)F,direct
CARBIDOPA,narrow-angle glaucoma,1030,1,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,direct
Naropin,autoimmune disease,15,0,CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C,direct
AIRSUPRA,asthma,193,1,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,direct
Caldolor,edema,417,1,CC(C)CC1=CC=C(C=C1)C(C)C(O)=O,direct
DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE,sepsis,17,0,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Irbesartan and Hydrochlorothiazide,AIDS,10,0,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
ETOPOPHOS,sepsis,17,0,[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(O)C(OC)=C1)C1=CC3=C(OCO3)C=C1[C@H]2O[C@@H]1O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](O)[C@H]1O,direct
Ondansetron Hydrochloride,long qt syndrome,61,1,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Synjardy XR,asthma,12,0,CN(C)C(=N)NC(N)=N,direct
nitrofurantoin,hypersensitivity,313,1,[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,direct
SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT,renal failure,19,0,[H][C@@]12CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])C[C@H](C)C2=CC(=O)C=C[C@]12C,direct
Diclofenac potassium,pregnancy,16,0,OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,direct
Cladribine,myocardial infarction,1,0,NC1=C2N=CN([C@H]3C[C@H](O)[C@@H](CO)O3)C2=NC(Cl)=N1,direct
Phenelzine Sulfate,chronic kidney disease,3,0,NNCCC1=CC=CC=C1,direct
Pregabalin Extended Release,hypersensitivity,313,1,CC(C)C[C@H](CN)CC(O)=O,direct
CEFEPIME HYDROCHLORIDE AND DEXTROSE,sepsis,17,0,CO\N=C(/C(=O)N[C@@H]1C(=O)N2[C@]1([H])SCC(C[N+]1(C)CCCC1)=C2C([O-])=O)C1=CSC(N)=N1,direct
Adalimumab-aacf,polyarticular jia who,1137,1,CC(C)O,direct
bivalirudin,mental illness,14,0,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,direct
Colesevelam Hydrochloride,pancreatitis,233,1,NCC=C.ClCC1CO1,fuzzy:sevelamer hydrochloride
Sevelamer carbonate,AIDS,10,0,NCC=C.ClCC1CO1,direct
lisinopril,hypertension,39,1,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Prenate Essential,hypersensitivity,313,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Timolol maleate,hypertension,39,1,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,direct
Fluorescein,hypersensitivity,313,1,OC1=CC=C2C(OC3=CC(O)=CC=C3C22OC(=O)C3=C2C=CC=C3)=C1,direct
Sodium phenylacetate and Sodium benzoate,mental illness,14,0,OC(=O)C1=CC=CC=C1,direct
VUITY,chronic obstructive pulmonary disease (COPD),6,0,CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O,direct
MEROPENEM,hypersensitivity,313,1,[H][C@]1([C@@H](C)O)C(=O)N2C(C(O)=O)=C(S[C@@H]3CN[C@@H](C3)C(=O)N(C)C)[C@H](C)[C@]12[H],direct
Symbyax,sepsis,17,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Cefotan,hemolytic anemia,107,1,[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)C1SC(S1)=C(C(N)=O)C(O)=O)OC)C(O)=O,direct
Estring,asthma,12,0,[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@]1([H])C3=C(CC[C@@]21[H])C=C(O)C=C3,direct
Chlorothiazide sodium,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=C2NC=NS(=O)(=O)C2=C1,direct
Fluticasone Propionate and Salmeterol,asthma,12,0,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
ISOPROTERENOL HYDROCHLORIDE,arrhythmia,43,1,CC(C)NCC(O)C1=CC(O)=C(O)C=C1,direct
LAMOTRIGINE,hypertension,11,0,NC1=NC(N)=C(N=N1)C1=C(Cl)C(Cl)=CC=C1,direct
caffeine citrate,chronic kidney disease,3,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
bexarotene,hypersensitivity,313,1,CC1=CC2=C(C=C1C(=C)C1=CC=C(C=C1)C(O)=O)C(C)(C)CCC2(C)C,direct
Haloperidol Decanoate,sepsis,17,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
teriflunomide,multiple sclerosis,153,1,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,direct
Auryxia,stroke,7,0,O.O.O.O.O.O.O.O.O.O.[Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O.[O-]C(=O)CC([O-])(CC([O-])=O)C([O-])=O,direct
CABOMETYX,advanced rcc,568,1,COC1=CC2=C(C=C1OC)C(OC1=CC=C(NC(=O)C3(CC3)C(=O)NC3=CC=C(F)C=C3)C=C1)=CC=N2,direct
Ibandronate sodium,the following conditions,1301,1,CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)(O)=O,direct
Hydromorphone Hydrochloride,severe infection,18,0,[H][C@@]12OC3=C(O)C=CC4=C3[C@@]11CCN(C)[C@]([H])(C4)[C@]1([H])CCC2=O,direct
CARNITOR,severe infection,18,0,C[N+](C)(C)C[C@H](O)CC([O-])=O,direct
OZURDEX,edema,417,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Isosorbide dinitrate and hydralazine hydrochloride,tachycardia,47,1,[H][C@]12OC[C@H](O[N+]([O-])=O)[C@@]1([H])OC[C@H]2O[N+]([O-])=O,direct
doxycycline hyclate,sepsis,17,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Cephalexin,cancer (metastatic),9,0,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
ESOMEPRAZOLE MAGNESIUM,hypersensitivity,313,1,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
Bactrim,autoimmune disease,15,0,COC1=CC(CC2=CN=C(N)N=C2N)=CC(OC)=C1OC,direct
Midazolam hydrochloride,cardiovascular instability,670,1,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N12,direct
Dorzolamide Hydrochloride Ophthalmic Solution,chronic kidney disease,3,0,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE,chronic kidney disease,3,0,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(O)=O)C(C)(C)O,direct
Dorzolamide Hydrochloride Ophthalmic Solution,hypertension,39,1,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,direct
olanzapine,autoimmune disease,15,0,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,direct
Etodolac ER,the aspirin triad,1295,1,CCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1,direct
Sertraline Hydrochloride,hypersensitivity,313,1,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,direct
Eohilia,hypersensitivity to budesonide,885,1,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Tri-Legest Fe 28 Day,severe androgen excess,1234,1,[H][C@@]12CC[C@@](O)(C#C)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H],direct
Tolectin,cancer (metastatic),9,0,CN1C(CC(O)=O)=CC=C1C(=O)C1=CC=C(C)C=C1,fuzzy:tolmetin
Actonel,myocardial infarction,1,0,OC(CC1=CN=CC=C1)(P(O)(O)=O)P(O)(O)=O,direct
DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE,sepsis,17,0,COC1=CC=C(C=C1)[C@@H]1SC2=C(C=CC=C2)N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,direct
Cyltezo,active psoriatic arthritis,533,1,CC(C)O,direct
Dexamethasone Sodium Phosphate,asthma,12,0,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
TECFIDERA,chronic obstructive pulmonary disease (COPD),6,0,[H]\C(=C(\[H])C(=O)OC)C(=O)OC,direct
Cotellic,myocardial infarction,1,0,OC1(CN(C1)C(=O)C1=C(NC2=C(F)C=C(I)C=C2)C(F)=C(F)C=C1)[C@@H]1CCCCN1,direct
Dextrose in Lactated Ringers,congestive heart failure,2,0,[Cl-].[K+],direct
cephalexin,liver disease (non-cirrhotic),20,0,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
PLERIXAFOR,insomnia,441,1,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,direct
Temozolomide,anaplastic astrocytoma are,593,1,CN1N=NC2=C(N=CN2C1=O)C(N)=O,direct
URIMAR-T CAPS,hypersensitivity,313,1,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,direct
Flotrex,autoimmune disease,15,0,NCCCC(N)(C(F)F)C(O)=O,fuzzy:florexa
Carvedilol Phosphate,hypertension,11,0,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,direct
PrednisoLONE,unexplained diarrhea,1341,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
DOXYCYCLINE HYCLATE,diabetes mellitus,5,0,[H][C@@]12[C@@H](C)C3=CC=CC(O)=C3C(=O)C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@]1([H])[C@H]2O,direct
Betamethasone Sodium Phosphate and Betamethasone Acetate,cerebral malaria,674,1,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Prenate Essential,autoimmune disease,15,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Otezla,active psoriatic arthritis,533,1,CCOC1=CC(=CC=C1OC)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,direct
BUPIVICAINE HYDROCHLORIDE,tics,23,1,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
AZACITIDINE,hypersensitivity,313,1,NC1=NC(=O)N(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O,direct
RISPERIDONE,chronic kidney disease,3,0,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,direct
Bortezomib,thrombocytopenia,79,1,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,direct
Kyzatrex,cancer (localized),8,0,CCCCCCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,direct
Dextrose and Electrolyte No. 48,hypochloremic hypokalemic alkalosis,902,1,[Cl-].[K+],direct
SENSIPAR,ckd who,716,1,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=CC=CC=C12,direct
Dexmethylphenidate Hydrochloride Extended-Release,hypertension,11,0,[H][C@@](C(=O)OC)(C1=CC=CC=C1)[C@@]1([H])CCCCN1,direct
Kitabis Pak,hypersensitivity,313,1,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
hydrocortisone valerate cream,hypersensitivity,313,1,[H][C@@]12CC[C@](OC(=O)CCCC)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Nitrostat,stroke,7,0,[O-][N+](=O)OCC(CO[N+]([O-])=O)O[N+]([O-])=O,direct
Fentanyl system,anorexia,399,1,CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1,direct
Vitrexate,congestive heart failure,2,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
BUDESONIDE,autoimmune disease,15,0,[H][C@@]12C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
Nascobal,pernicious anemia who,1117,1,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Rosuvastatin Calcium,homozygous familial hypercholesterolemia,872,1,CC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O,direct
Cevimeline Hydrochloride,AIDS,10,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
Livita Adults,severe infection,18,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Tobramycin Ophthalmic Solution,chronic obstructive pulmonary disease (COPD),6,0,NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O,direct
Atenolol and Chlorthalidone,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=CC(=C1)C1(O)NC(=O)C2=CC=CC=C12,direct
Clonidine,hypersensitivity,313,1,ClC1=CC=CC(Cl)=C1NC1=NCCN1,direct
HALOPERIDOL DECANOATE,renal failure,19,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
PENCICLOVIR,hypersensitivity,313,1,NC1=NC(=O)C2=C(N1)N(CCC(CO)CO)C=N2,direct
CAPTOPRIL AND HYDROCHLOROTHIAZIDE,impaired renal function,919,1,NS(=O)(=O)C1=C(Cl)C=C2NCNS(=O)(=O)C2=C1,direct
Fluconazole in Sodium Chloride,serious underlying diseases,1232,1,OC(CN1C=NC=N1)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,direct
hydrocort,hypersensitivity,313,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Brimonidine tartrate,autoimmune disease,15,0,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,direct
VANFLYTA,liver cirrhosis,4,0,CC(C)(C)C1=CC(NC(=O)NC2=CC=C(C=C2)C2=CN3C(SC4=C3C=CC(OCCN3CCOCC3)=C4)=N2)=NO1,direct
QUINAPRIL,edema,417,1,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,direct
Chlorpromazine,hypersensitivity,313,1,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
Selegiline Hydrochloride,hypersensitivity,313,1,C[C@H](CC1=CC=CC=C1)N(C)CC#C,direct
Dihydroergotamine mesylate,hypertension,39,1,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,direct
OZURDEX,diabetic macular edema,777,1,[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
PAXIL,gad and ptsd,822,1,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
DROXIA,hemolytic anemia,107,1,NC(=O)NO,direct
SPRYCEL,cancer (localized),8,0,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,direct
toremifene citrate,stroke,7,0,CN(C)CCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,direct
Perphenazine,dementia-related psychosis,766,1,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,direct
Halobetasol Propionate,stroke,7,0,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CCl)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,direct
AVYCAZ,autoimmune disease,15,0,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,direct
Sorbitol,fructose intolerance,819,1,OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO,direct
Finasteride,cancer (localized),8,0,[H][C@@]12CC[C@H](C(=O)NC(C)(C)C)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])NC(=O)C=C[C@]12C,direct
GEMTESA,severe infection,18,0,[H][C@@]1(CC[C@@H](CC2=CC=C(NC(=O)[C@@H]3CCC4=NC=CC(=O)N34)C=C2)N1)[C@H](O)C1=CC=CC=C1,direct
LIDOCAINE HCI AND DEXTROSE,liver cirrhosis,4,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Ondansetron,AIDS,10,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
Kalydeco,any ivacaftor-responsive mutation,608,1,CC(C)(C)C1=CC(=C(O)C=C1NC(=O)C1=CNC2=CC=CC=C2C1=O)C(C)(C)C,direct
Lisinopril and Hydrochlorothiazide,liver cirrhosis,4,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
Potassium Chloride,brain edema,643,1,[Cl-].[K+],direct
Dialyvite 3000,cancer (localized),8,0,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,direct
Tadalafil,hypersensitivity,313,1,[H][C@]12CC3=C(NC4=CC=CC=C34)[C@H](N1C(=O)CN(C)C2=O)C1=CC2=C(OCO2)C=C1,direct
CELEBREX,active gastrointestinal bleeding,523,1,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,direct
ondansetron hydrochloride,AIDS,10,0,CN1C2=C(C3=CC=CC=C13)C(=O)C(CN1C=CN=C1C)CC2,direct
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE,stroke,51,1,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1,direct
Fioricet,mental illness,14,0,CN1C=NC2=C1C(=O)N(C)C(=O)N2C,direct
Hectorol,ckd on dialysis,713,1,[H][C@@]1(CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C)[C@H](C)\C=C\[C@H](C)C(C)C,direct
PACLITAXEL PACLITAXEL,pregnancy,16,0,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
"Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride",severe infection,18,0,[H][C@@]12C[C@@]3([H])C(=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C)C(=O)C1=C(O)C=CC=C1[C@@]3(C)O,direct
Xylocaine MPF,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Bupivacaine HCl,AIDS,10,0,CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
paroxetine hydrochloride,chronic kidney disease,3,0,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,direct
Lomotil,chronic kidney disease,3,0,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,direct
"Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate",liver cirrhosis,4,0,CC(N)CC1=CC=CC=C1,direct
HULIO,active as,521,1,CC(C)O,direct
XPOVIO,AIDS,10,0,FC(F)(F)C1=CC(=CC(=C1)C1=NN(\C=C/C(=O)NNC2=NC=CN=C2)C=N1)C(F)(F)F,direct
Vitrexate,cancer (metastatic),9,0,C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2N=C1\C(C)=C1/N=C(/C=C3\N=C(\C(\C)=C4\[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@@]2(C)N4[Co+]C#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]1CCC(N)=O)OP([O-])(=O)O[C@@H]1[C@@H](CO)O[C@@H]([C@@H]1O)N1C=NC2=C1C=C(C)C(C)=C2,direct
Potassium Chloride ER,sepsis,17,0,[Cl-].[K+],direct
YUTIQ,cancer (metastatic),9,0,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,direct
POSACONAZOLE,cancer (localized),8,0,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
POSACONAZOLE,sepsis,17,0,CC[C@@H]([C@H](C)O)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C2=C(F)C=C(F)C=C2)C=C1,direct
Physician EZ Use Joint Tunnel and Trigger Kit II,liver disease (non-cirrhotic),20,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Cephalexin,congestive heart failure,2,0,[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)[C@H](N)C1=CC=CC=C1)C(O)=O,direct
Chlorpromazine,hypertension,11,0,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,direct
MUPIROCIN,asthma,12,0,C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]1CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]1O,direct
Polocaine-MPF,severe infection,18,0,CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,direct
ESOMEPRAZOLE MAGNESIUM,chronic kidney disease,3,0,COC1=CC2=C(NC(=N2)[S@@](=O)CC2=NC=C(C)C(OC)=C2C)C=C1,direct
CEVIMELINE HYDROCHLORIDE,congestive heart failure,2,0,CC1O[C@@]2(CS1)CN1CCC2CC1,direct
PREGABALIN,chronic obstructive pulmonary disease (COPD),6,0,CC(C)C[C@H](CN)CC(O)=O,direct
Venlafaxine Hydrochloride,recurrent depression who,1200,1,COC1=CC=C(C=C1)C(CN(C)C)C1(O)CCCCC1,direct
Orbactiv,AIDS,10,0,CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O[C@H]4C[C@](C)(NCC5=CC=C(C=C5)C5=CC=C(Cl)C=C5)[C@@H](O)[C@H](C)O4)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O[C@H]1C[C@](C)(N)[C@@H](O)[C@H](C)O1)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2,direct
Terconazole,vulvovaginal candidiasis,1361,1,CC(C)N1CCN(CC1)C1=CC=C(OC[C@@H]2CO[C@](CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,direct
Lidocaine Hydrochloride and Epinephrine Bitartrate,tics,23,1,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Lidocaine,renal failure,19,0,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,direct
Fludrocortisone acetate,active tuberculosis,535,1,[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C,direct
Lisinopril with Hydrochlorothiazide,chronic obstructive pulmonary disease (COPD),6,0,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,direct
haloperidol,renal failure,19,0,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,direct
Sotalol Hydrochloride,liver cirrhosis,4,0,CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1,direct
Enalapril maleate and hydrochlorothiazide,AIDS,10,0,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O,direct
LABETALOL HCl,congestive heart failure,41,1,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,direct
Potassium Chloride Extended-release,significant cardiac arrhythmias,1259,1,[Cl-].[K+],direct
DISOPYRAMIDE PHOSPHATE,pregnancy,16,0,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,direct
DELSTRIGO,severe infection,18,0,[H][C@@](C)(CN1C=NC2=C(N)N=CN=C12)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C,direct
Paclitaxel protein-bound particles,sepsis,291,1,[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C,direct
Bromocriptine mesylate,stroke,51,1,[H][C@@]12CCCN1C(=O)[C@H](CC(C)C)N1C(=O)[C@](NC(=O)[C@H]3CN(C)[C@]4([H])CC5=C(Br)NC6=CC=CC(=C56)C4=C3)(O[C@@]21O)C(C)C,direct
Sunitinib malate,metastatic rcc,1005,1,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,direct
icosapent ethyl,severe hypertriglyceridemia,1247,1,CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC,direct
Pitavastatin Calcium,primary hyperlipidemia,1175,1,O[C@H](C[C@H](O)\C=C\C1=C(N=C2C=CC=CC2=C1C1=CC=C(F)C=C1)C1CC1)CC(O)=O,direct
regadenoson,lung disease,375,1,CNC(=O)C1=CN(N=C1)C1=NC2=C(N=CN2[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C(N)=N1,direct
Nystatin and triamcinolone acetonide,cancer (localized),8,0,[H][C@@]12C[C@@H](O)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,direct
QUELICIN,diabetes mellitus,5,0,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,direct
